<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2210234367
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2001
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        CIPRODAR 500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CIPROFLOXACIN
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        46.95
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="DAR ALDAWA" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DAR ALDAWA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01MA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Ciprodar&reg; contains the active substance ciprofloxacin. Ciprofloxacin is an antibiotic belonging to the fluoroquinolone family. Ciprofloxacin works by killing bacteria that cause infections. It only works with specific strains of bacteria.<br />Adults<br />Ciprodar&reg; is used in adults to treat the following bacterial infections:<br /> respiratory tract infections<br /> long lasting or recurring ear or sinus infections<br /> urinary tract infections<br /> genital tract infections in men and women<br /> gastro-intestinal tract infections and intra-abdominal infections<br /> skin and soft tissue infections<br /> bone and joint infections<br /> to prevent infections due to the bacterium Neisseria meningitidis<br /> anthrax inhalation exposure<br />Ciprofloxacin may be used in the management of patients with low white blood cell counts (neutropenia) who have a fever that is suspected to be due to a bacterial infection.<br />If you have a severe infection or one that is caused by more than one type of bacterium, you may be given additional antibiotic treatment in addition to Ciprodar&reg;.<br />Children and adolescents<br />Ciprodar&reg; is used in children and adolescents, under specialist medical supervision, to treat the following bacterial infections:<br /> lung and bronchial infections in children and adolescents suffering from cystic fibrosis<br /> complicated urinary tract infections, including infections that have reached the kidneys (pyelonephritis)<br /> anthrax inhalation exposure<br />Ciprodar&reg; may also be used to treat other specific severe infections in children and adolescents when your doctor considered this necessary.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Ciprodar&reg;:<br /> If you are allergic to the active substance, to other quinolone drugs or to any of the other ingredients of this medicine<br /> If you are taking tizanidine<br />Take special care with Ciprodar&reg;<br />Talk to your doctor before taking Ciprodar&reg;<br /> if you have ever had kidney problems because your treatment may need to be adjusted<br /> if you suffer from epilepsy or other neurological conditions<br /> if you have a history of tendon problems during previous treatment with antibiotics such as Ciprodar&reg;<br /> if you are diabetic because you may experience a risk of hypoglycaemia with ciprofloxacin.<br /> if you have myasthenia gravis (a type of muscle weakness) because symptoms can be exacerbated.<br /> if you have been diagnosed with an enlargement or &ldquo;bulge&rdquo; of a large blood vessel (aortic aneurysm or large vessel peripheral aneurysm).<br /> if you have experienced a previous episode of aortic dissection (a tear in the aorta wall).<br /> if you have a family history of aortic aneurysm or aortic dissection or other risk factors or predisposing conditions (e.g. connective tissue disorders such as Marfan syndrome, or vascular Ehlers-Danlos syndrome, or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behcet&acute;s disease, high blood pressure, or known atherosclerosis).<br /> if you have heart problems. Caution should be taken when using ciprofloxacin, if you were born with or have family history of prolonged QT interval (seen on ECG, electrical recording of the heart), have salt imbalance in the blood (especially low level of potassium or magnesium in the blood), have a very slow heart rhythm (called &lsquo;bradycardia&rsquo;), have a weak heart (heart failure), have a history of heart attack (myocardial infarction), you are female or elderly or you are taking other medicines that result in abnormal ECG changes<br /> if you or a member of your family is known to have a deficiency in glucose-6-phosphate dehydrogenase (G6PD), since you may experience a risk of anaemia with ciprofloxacin.<br />For the treatment of some genital tract infections, your doctor can prescribe another antibiotic in addition to ciprofloxacin. If there is no improvement in symptoms after 3 days of treatment, please consult your doctor.<br />While taking Ciprodar&reg;<br />Tell your doctor immediately, if any of the following occurs while taking Ciprodar&reg;. Your doctor will decide whether treatment with Ciprodar&reg; needs to be stopped.<br /> Severe, sudden allergic reaction (an anaphylactic reaction/shock, angio-oedema). Even with the first dose, there is a small chance that you may experience a severe allergic reaction with the following symptoms: tightness in the chest, feeling dizzy, sick or faint, or experiencing dizziness when standing up. If this happens, stop taking Ciprodar&reg; and contact your doctor immediately.<br /> Pain and swelling in the joints and tendinitis may occur occasionally, particularly if you are elderly and are also being treated with corticosteroids. Inflammation and ruptures of tendons may occur even within the first 48 hours of treatment or up to several months after discontinuation of Ciprodar&reg; therapy. At the first sign of any pain or inflammation, stop taking Ciprodar&reg;, contact your doctor rest the painful area. Avoid any unnecessary exercise, as this might increase the risk of a tendon rupture.<br /> If you suffer from epilepsy or other neurological conditions such as cerebral ischemia or stroke, you may experience side effects associated with the central nervous system. If seizures happen, stop taking Ciprodar&reg; and contact your doctor immediately.<br /> You may experience symptoms of neuropathy such as pain, burning, tingling, numbness and/or muscle weakness. If this happens, stop taking Ciprodar&reg; and contact your doctor immediately<br /> You may experience psychiatric reactions the first time you take Ciprodar&reg;. If you suffer from depression or psychosis, your symptoms may become worse under treatment with Ciprodar&reg;. In rare cases, depression or psychosis can progress to thoughts of suicide, suicide attempts, or completed suicide. If this happens, stop taking Ciprodar&reg; and contact your doctor immediately.<br /> Quinolone antibiotics may cause disturbances in blood sugar, including both a decrease in blood sugar below normal levels (hypoglycaemia) and an increase in blood sugar above normal levels (hyperglycaemia). Disturbances in blood sugar occurred usually in elderly diabetic patients, receiving concomitant treatment with oral antidiabetic medicines that lower blood sugar (e.g. glibenclamide) or with insulin. Loss of consciousness due to severe reduction in blood sugar (hypoglycaemic coma) has been reported. If you suffer from diabetes, your blood sugar should be carefully monitored.<br /> Diarrhoea may develop while you are taking antibiotics, including Ciprodar&reg;, or even several weeks after you have stopped taking them. If it becomes severe or persistent or you notice that your stool contains blood or mucus, stop taking Ciprodar&reg;and contact your<br />doctor immediately, as this can be life-threatening. Do not take medicines that stop or slow down bowel movements.<br /> If your eyesight becomes impaired or if your eyes seem to be otherwise affected, consult an eye specialist immediately.<br /> Your skin becomes more sensitive to sunlight or ultraviolet (UV) light when taking Ciprodar&reg;. Avoid exposure to strong sunlight, or artificial UV light such as sunbeds.<br /> Tell the doctor or laboratory staff that you are taking Ciprodar&reg; if you have to provide a blood or urine sample.<br /> If you suffer from kidney problems, tell the doctor because your dose may need to be adjusted.<br /> Ciprodar&reg; may cause liver damage. If you notice any symptoms such as loss of appetite, jaundice (yellowing of the skin), dark urine, itching, or tenderness of the stomach, contact your doctor immediately.<br /> Ciprodar&reg; may cause a reduction in the number of white blood cells and your resistance to infection may be decreased. If you experience an infection with symptoms such as fever and serious deterioration of your general condition, or fever with local infection symptoms such as sore throat/pharynx/mouth or urinary problems you should see your doctor immediately. A blood test will be taken to check possible reduction of white blood cells (agranulocytosis). It is important to inform your doctor about your medicine.<br />Taking other medicines<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.<br />Do not take Ciprodar&reg; together with tizanidine, because this may cause side effects such as low blood pressure and sleepiness.<br />The following medicines are known to interact with Ciprodar&reg; in your body. Taking Ciprodar&reg; together with these medicines can influence the therapeutic effect of those medicines. It can also increase the probability of experiencing side effects.<br />Tell your doctor if you are taking:<br /> Vitamin K antagonists (e.g.: warfarin, acenocoumarol, phenprocoumon or fluindione) or other oral anti-coagulants (to thin the blood)<br /> probenecid (for gout)<br /> methotrexate (for certain types of cancer, psoriasis, rheumatoid arthritis)<br /> theophylline (for breathing problems)<br /> tizanidine (for muscle spasticity in multiple sclerosis)<br /> olanzapine (an antipsychotic)<br /> clozapine (an antipsychotic)<br /> ropinirole (for Parkinson&rsquo;s disease)<br /> phenytoin (for epilepsy)<br /> metoclopramide (for nausea and vomiting)<br /> cyclosporin (for skin conditions, rheumatoid arthritis and in organ transplantation)<br /> other medicines that can alter your heart rhythm: medicines that belong to the group of anti-arrhythmics (e.g. quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, some antimicrobials (that belong to the group of macrolides), some antipsychotics.<br /> zolpidem (for sleep disorders)<br />Ciprodar&reg; may increase the levels of the following medicines in your blood:<br /> pentoxifylline (for circulatory disorders)<br /> caffeine<br /> duloxetine (for depression, diabetic nerve damage or incontinence)<br /> lidocaine (for heart conditions or anesthetic use)<br /> sildenafil (e.g. for erectile dysfunction)<br /> agomelatine (for depression)<br />Some medicines reduce the effect of Ciprodar&reg;. Tell your doctor if you take or wish to take:<br /> antacids<br /> omeprazole<br /> mineral supplements<br /> sucralfate<br /> a polymeric phosphate binder (e.g. sevelamer or lanthanum carbonate)<br /> medicines or supplements containing calcium, magnesium, aluminium or iron<br />If these preparations are essential, take Ciprodar&reg; about two hours before or no sooner than four hours after them.<br />Taking Ciprodar&reg; with food and drink<br />Unless you take Ciprodar&reg; during meals, do not eat or drink any dairy products (such as milk or yoghurt) or drinks with added calcium when you take the tablets, as they may affect the absorption of the active substance.<br />Pregnancy and breast-feeding<br />If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.<br />It is preferable to avoid the use of Ciprodar&reg; during pregnancy.<br />Do not take Ciprodar&reg; during breast feeding because ciprofloxacin is excreted in breast milk and can be harmful for your child.<br />Driving and using machines<br />Ciprodar&reg; may make you feel less alert. Some neurological adverse events can occur. Therefore, make sure you know how you react to Ciprodar&reg; before driving a vehicle or operating machinery. If in doubt, talk to your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Your doctor will explain to you exactly how much Ciprodar&reg; you will have to take as well as how often and for how long. This will depend on the type of infection you have and how bad it is.<br />Tell your doctor if you suffer from kidney problems because your dose may need to be adjusted.<br />The treatment usually lasts from 5 to 21 days, but may take longer for severe infections. Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure how many tablets to take and how to take Ciprodar&reg;.<br />a. Swallow the tablets with plenty of fluid. Do not chew the tablets because they do not taste nice.<br />b. Do try to take the tablets at around the same time every day.<br />c. You can take the tablets at mealtimes or between meals. Any calcium you take as part of a meal will not seriously affect uptake. However, do not take Ciprodar&reg; tablets with dairy products such as milk or yoghurt or with fortified fruit juices (e.g. calcium-fortified orange juice).<br />Remember to drink plenty of fluids while you are taking this medicine.<br />If you take more Ciprodar&reg; than you should<br />If you take more than the prescribed dose, get medical help immediately. If possible, take your tablets or the box with you to show the doctor.<br />If you forget to take Ciprodar&reg;<br />Take the normal dose as soon as possible and then continue as prescribed. However, if it is almost time for your next dose, do not take the missed dose and continue as usual. Do not take a double dose to make up for a forgotten dose. Be sure to complete your course of treatment.<br />If you stop taking Ciprodar&reg;<br />It is important that you finish the course of treatment even if you begin to feel better after a few days. If you stop taking this medicine too soon your infection may not be completely cured and the symptoms of the infection may return or get worse. You might also develop resistance to the antibiotic.<br />If you have any further questions about the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. The following section contains the most serious side effects that you can recognize yourself:<br />Stop taking CiprodarR and contact your doctor immediately in order to consider another antibiotic treatment if you notice any of the following serious side effects: Rare (may affect up to 1 in 1,000 people) &bdquo;h Seizure Very rare (may affect up to 1 in 10,000 people) &bdquo;h Severe, sudden allergic reaction with symptoms such as tightness in the chest, feeling dizzy, sick or faint, or experience dizziness when standing up (anaphylactic reaction/shock) &bdquo;h Muscle weakness, inflammation of the tendons which could lead to rupture of the tendon, particularly affecting the large tendon at the back of the ankle (Achilles tendon) &bdquo;h A serious life-threatening skin rash, usually in the form of blisters or ulcers in the mouth, throat, nose, eyes and other mucous membranes such as genitals which may progress to widespread blistering or peeling of the skin (Stevens-Johnson syndrome, toxic epidermal necrolysis). Not known (frequency cannot be estimated from the available data) &bdquo;h Unusual feelings of pain, burning tingling, numbness or muscle weakness in the extremities (neuropathy) &bdquo;h A drug reaction that causes rash, fever, inflammation of internal organs, hematologic abnormalities and systemic illness (DRESS - Drug Reaction with Eosinophilia and Systemic Symptoms, AGEP - Acute Generalised Exanthematous Pustulosis). Other side effects which have been observed during treatment with ciprofloxacin are listed below by how likely they are: Common (may affect up to 1 in 10 people) &bdquo;h nausea, diarrhoea &bdquo;h joint pain and joint inflammation in children Uncommon (may affect up to 1 in 100 people) &bdquo;h joint pain in adults &bdquo;h fungal superinfections &bdquo;h a high concentration of eosinophils, a type of white blood cell &bdquo;h decreased appetite &bdquo;h hyperactivity or agitation &bdquo;h headache, dizziness, sleeping problems, or taste disorders &bdquo;h vomiting, abdominal pain, digestive problems such as stomach upset (indigestion/heartburn), or wind &bdquo;h increased amounts of certain substances in the blood (transaminases and/or bilirubin) &bdquo;h rash, itching, or hives &bdquo;h poor kidney function &bdquo;h pains in your muscles and bones, feeling unwell (asthenia), or fever &bdquo;h increase in blood alkaline phosphatase (a certain substance in the blood) Rare (may affect up to 1 in 1,000 people) &bdquo;h muscle pain, inflammation of the joints, increased muscle tone and cramping<br />&bdquo;h inflammation of the bowel (colitis) linked to antibiotic use (can be fatal in very rare cases) &bdquo;h changes to the blood count (leukopenia, leukocytosis, neutropenia, anaemia), increased or decreased amounts of a blood clotting factor (thrombocytes) &bdquo;h allergic reaction, swelling (oedema), or rapid swelling of the skin and mucous membranes (angio-oedema) &bdquo;h increased blood sugar (hyperglycaemia) &bdquo;h decreased blood sugar (hypoglycaemia) &bdquo;h confusion, disorientation, anxiety reactions, strange dreams, depression (potentially leading to thoughts of suicide, suicide attempts, or completed suicide), or hallucinations &bdquo;h pins and needles, unusual sensitivity to stimuli of the senses, decreased skin sensitivity, tremors, or giddiness &bdquo;h eyesight problems including double vision &bdquo;h tinnitus, loss of hearing, impaired hearing &bdquo;h rapid heartbeat (tachycardia) &bdquo;h expansion of blood vessels (vasodilation), low blood pressure, or fainting &bdquo;h shortness of breath, including asthmatic symptoms &bdquo;h liver disorders, jaundice (cholestatic icterus), or hepatitis &bdquo;h sensitivity to light &bdquo;h kidney failure, blood or crystals in the urine, urinary tract inflammation &bdquo;h fluid retention or excessive sweating &bdquo;h increased levels of the enzyme amylase Very rare (may affect up to 1 in 10,000 people) &bdquo;h a special type of reduced red blood cell count (haemolytic anaemia); a dangerous drop in a type of white blood cells (agranulocytosis); a drop in the number of red and white blood cells and platelets (pancytopenia), which may be fatal; and bone marrow depression, which may also be fatal &bdquo;h allergic reaction called serum sickness-like reaction &bdquo;h mental disturbances (psychotic reactions potentially leading to thoughts of suicide, suicide attempts, or completed suicide) &bdquo;h migraine, disturbed coordination, unsteady walk (gait disturbance), disorder of sense of smell (olfactory disorders), pressure on the brain (intracranial pressure and pseudotumor cerebri) &bdquo;h visual colour distortions &bdquo;h inflammation of the wall of the blood vessels (vasculitis) &bdquo;h pancreatitis &bdquo;h death of liver cells (liver necrosis) very rarely leading to life-threatening liver failure &bdquo;h small, pin-point bleeding under the skin (petechiae); various skin eruptions or rashes &bdquo;h worsening of the symptoms of myasthenia gravis Not known (frequency cannot be estimated from the available data) &bdquo;h syndrome associated with impaired water excretion and low levels of sodium (SIADH) &bdquo;h feeling highly excited (mania) or feeling great optimism and overactivity (hypomania)<br />&bdquo;h abnormal fast heart rhythm, life-threatening irregular heart rhythm, alteration of the heart rhythm (called &iexcl;&yen;prolongation of QT interval&iexcl;&brvbar;, seen on ECG, electrical activity of the heart) &bdquo;h influence on blood clotting (in patients treated with Vitamin K antagonists)<br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p> Keep out of the reach and sight of children.<br /> Do not use Ciprodar&reg; after the expiry date, which is stated on the carton after &ldquo;EXP&rdquo;: The expiry date refers to the last day of that month.<br /> Protect from light. Store in a dry place. Do not store above 30&deg;C.<br /> Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of any medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Ciprodar&reg; contains<br />The active substance is ciprofloxacin.<br />Ciprodar&reg; 250 mg Film Coated Tablets: Each tablet contains 250 mg ciprofloxacin (as ciprofloxacin hydrochloride monohydrate).<br />Ciprodar&reg; 500 mg Film Coated Tablets: Each tablet contains 500 mg ciprofloxacin (as ciprofloxacin hydrochloride monohydrate).<br />Ciprodar&reg; 750 mg Film Coated Tablets: Each tablet contains 750 mg ciprofloxacin (as ciprofloxacin hydrochloride monohydrate).<br />The other ingredients are:<br />Microcrystalline cellulose, sodium startch glycolate, talc, magnesium stearate, maize starch, colloidal anhydrous silica, hypromellose, macrogol 400, titanium dioxide and indigocarmine (E132).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Ciprodar® looks like and contents of the pack
Ciprodar® 250 mg tablets are blue round normal biconvex film coated tablets coded (CIP 250) on one side.
Ciprodar® 500 mg tablets are blue oblonged film coated tablets with a mid-groove on both sides coded (CIP 500) on one side.
Ciprodar® 750 mg tablets are blue oblong-shaped film coated tablets with a mid-groove on both sides coded (CIP 750) on one side.
Pack sizes of 10, 300 and 500 tablets are available for Ciprodar® 250 mg.
Pack sizes of 8, 10 and 500 tablets are available for Ciprodar® 500 mg.
The pack size of 10 tablets is available for Ciprodar® 750 mg.
Not all pack sizes may be marketed.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dar Al Dawa Development &amp; Investment Co. Ltd (Na&rsquo;ur &ndash; Jordan).<br />Tel. (+962 6) 57 27 132<br />Fax. (+962 6) 57 27 776</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2019
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>المادة الفعالة في سيبرودار هي سيبروفلوكساسين. ينتمي سيبروفلوكساسين وهو مضاد حيوي إلى<br />عائلة فلوروكوينولون. يعمل سيبروفلوكساسين عن طريق القضاء على سلالات محددة من<br />البكتيريا التي تسبب العدوى.<br />البالغين<br />يستعمل سيبرودار في البالغين لعلاج العدوى البكتيرية التالية:<br /> إلتهابات الجهاز التنفسي<br /> إلتهابات الأذن والجيوب المتكررة أو طويلة الأمد<br /> إلتهابات المسالك البولية<br /> إلتهابات الجهاز التناسلي لدى الرجال والنساء<br /> التهابات الجهاز الهضمي و التهابات داخل البطن<br /> إلتهابات الجلد والأنسجة اللينة<br /> إلتهابات العظام والمفاصل<br /> لمنع حدوث عدوى ناتجة عن بكتيريا التهاب السحايا النيسيري<br /> التعرض لإستنشاق الجمرة الخبيثة<br />قد يستخدم سيبروفلوكساسين في معالجة المرضى الذين لديهم إنخفاض في كريات الدم البيضاء )قلة العدلات( ويعانون من حمى يشتبه ان تكون ناتجة عن عدوى بكتيرية.<br />في حال حدوث عدوى شديدة أو ناتجة عن أكثر نوع من البكتيريا، من الممكن أن يوصف لك مضاد حيوي آخر بالإضافة إلى سيبرودار.<br />الأطفال وًالم ا رهقين</p><p>يستخدم سيبرودار لعلاج الأطفال والم ا رهقين تحت إش ا رف طبي مختص لعلاج العدوى البكتيرية التالية:<br /> إلتهابات الرئة وعدوى الشعب الهوائية في الأطفال والم ا رهقين الذين يعانون من التليف الكيسي<br /> إلتهابات المسالك البولية المعقدة والتي تتضمن العدوى التي تصل إلى الكلى )التهاب حويضي كلوي(<br /> التعرض لإستنشاق الجمرة الخبيثة<br />قد يستخدم سيبرودار لعلاج أنواع أخرى من العدوى الشديدة في الأطفال والم ا رهقين في حال اعتبر الطبيب ان هذا ضروري.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يمنع استعمال سيبرودار:<br /> إذا كنت تعاني من حساسية تجاه المادة الفعالة، أدوية كينولون الأخرى أو لأي منالمكونات الأخرى في هذا الدواء<br /> إذا كنت تتناول تي ا زنيدين<br />الاحتياطات عند استعمال سيبرودار تحدث إلى طبيبك قبل تناول سًيبرودار:<br /> إذا سبق حدوث أم ا رض في الكلى لديك، قد يستلزم ذلك تعديل العلاج<br /> إذا كنت تعاني من الصرع أو حالات عصبية أخرى<br /> إذا سبق حدوث مشاكل في الأوتار لديك خلال العلاج بمضادات حيوية مثل سيبرودار<br /> إذا كنت تعاني من مرض السكري حيث أنك قد تختبر حدوث إنخفاض في سكر الدم عند تناول سيبروفلوكساسين<br /> إذا كنت تعاني من الوهن العضلي الوبيل )نوع من ضعف العضلات(، قد يحدث تفاقم في الأع ا رض<br /> إذا تم تشخيصك بتضخم أو &quot;انتفاخ&quot; أوعية دموية كبيرة )تمدد الشريان الأبهري أو تمدد الأوعية الدموية الطرفية الكبيرة(.<br /> إذا كنت قد عانيت مسبقا من حالة تسلخ الابهر )تمزق في جدار الشريان الابهر (<br /> إذا كان لديك تاريخ عائلي لتمدد الوعاء الدموي الابهري أو تمزق الأبهر أو عوامل خطر الأخرى أو اضط ا ربات قد تؤدي الى ذلك )مثل اضط ا ربات الأنسجة الضامة كمتلازمة مارفان أو متلازمة اهلر دانلوس الوعائية، أو اضط ا ربات الأوعية الدمويةمثل التهاب الش ا ريين تكاياسو أو التهاب الش ا ريين ذات الخلايا العملاقة، مرض<br />بيتشيت، ارتفاع ضغط الدم ، أو تصلب الش ا ريين المعروف(.<br /> &bull; إذا كنت تعاني من مشاكل في القلب. يجب توخي الحذر عند استخدام سيبروفلوكساسين ، إذا كان عندك منذ الولادة فترة QT طويلة أو كان لديك تاريخ<br />عائلي لفترة QT طويلة )يمكن رؤيتها على تخطيط القلب الكهربائي، التسجيل الكهربائي للقلب( ، كان لديك اختلال في املاح الدم )وخاصة انخفاض مستوى البوتاسيوم أو المغنيسيوم في الدم(، لديك إيقاع قلب بطيء ج دا )يُطلق عليه &quot;بطء القلب&quot;( ، أو لديك ضعف في عضلةالقلب )قصور القلب( ، أو لديك تاريخ من<br />الإصابة بنوبة قلبية )احتشاء عضلة القلب( ، أو كنت أنثى أو كبير في السن أو تتناول أدوية أخرى تؤدي إلى حدوث تغيي ا رت غير طبيعية في تخطيط القلب<br /> &bull; كان من المعروف ان لديك او لدى احد اف ا رد اسرتك نقص في انزيم هيدروجيناز الجلوكوز - 6 فوسفات ) G6PD ( ، حيث قد يواجهك خطر الإصابة بفقر الدم باستخدام سيبروفلوكساسين.<br />لعلاج بعض التهابات الجهاز التناسلي ، يمكن لطبيبك أن يصف مضاد حيوي آخر بالإضافة إلى سيبروفلوكساسين. إذا لم يكن هناك تحسن في الأع ا رض بعد 3 ثلاث أيام من العلاج ، فيرجى استشارة الطبيب<br />أثناء تًناول سًيبرودار أخبر طبيبك على الفور إذا حدث أي من ما يلي خلال تناول سيبرودار. سيقرر طبيبك إذا كنت بحاجة لوقف علاج سيبرودار.<br /> فرط شديد ومفاجئ في الحساسية )تفاعلات تأقية/صدمة، وذمة وعائية(. حتى بعد تناول الجرعة الأولى، توجد فرصة ضئيلة لحدوث تفاعلات حساسية شديدة مع الأع ا رض التالية: ضيق في الصدر، الإحساس بدوخة، تعب أو إغماء، أو دوخة عند الوقوف، في حال حدوث هذا توقف عن تناول سًيبرودار واتصل بطبيبك على الفور.<br /> قد يحدث في بعض الأحيان ألم وانتفاخ في المفاصل والتهاب في الوتر، بشكل خاص اذا كنت كبير في السن وتتلقى علاج الستيرويدات القشرية. قد يحدث إلتهاب وتمزق في الأوتار خلال 48 ساعة الأولى من العلاج وصولا إلى عدة أشهر بعد التوقف عن تناول سًيبرودار. إذا ظهر لديك أي علامات لحدوث أي ألم أو إلتهاب توقف عن تناول سيبرودار مع ا رحة لمنطقة الألم. تجنب أي تمارين غير ضرورية والتي قد تزيد من إحتمالية حدوث تمزق في الأ وتار.<br /> إذا كنت تعاني من الصرع أو حالات عصبية أخرى مثل نقص التروية الدماغية أو السكتة الدماغية، من الممكن أن تظهر لديك تأثي ا رت جانبية متعلقة بالجهاز العصبي المركزي. إذا حدث لديك أي من ما سبق ذكره توقف عن تناول سيبرودار واتصل بطبيبك على الفور.<br /> قد تظهر لديك أع ا رض الاعتلال العصبي مثل الألم ، والحرقة ، والوخز ، وخدر و / أو ضعف العضلات. إذا حدث هذا ، توقف عن تناول سيبرودار واتصل بطبيبك على الفور<br /> قد تظهر لديك تأثي ا رت نفسية عند بدأ تناول سيبرودار. إذا كنت تعاني من إكتئاب أو ذهان، من الممكن أن تسوء الأع ا رض مع تناول سًيبرودار. في حالات نادرة، من الممكن أن يتفاقم الإكتئاب والذهان ويؤدي إلى أفكار أو محاولات إنتحارية أو إنتحار. إذا حدث ذلك توقف عن تناول سيبرودار واتصل بطبيبك على الفور.<br /> قد تسبب المضادات الحيوية من عائلة الكينولون اضط ا ربات في نسبة السكر في الدم ، بما في ذلك انخفاض في نسبة السكر في الدم إلى ما دون المستويات الطبيعية )نقص السكر في الدم( وزيادة في نسبة السكر في الدم أعلى من المستويات الطبيعية )ارتفاع السكر في الدم(. تحدث الاضط ا ربات في نسبة السكر في الدم عادة عند مرضى السكري المسنين ، الذين يتناولنها بالت ا زمن مع الأدوية المضادة لمرض السكر التي تؤخذ عن طريق الفم اولتي تخفض نسبة السكر في الدم )مثل جليبينكلاميد( أو مع الأنسولين. تم الإبلاغ عن فقدان الوعي بسبب الانخفاض الحاد في نسبة السكر في الدم )غيبوبة سكر(. إذا كنت تعاني من مرض السكري ، فيجب م ا رقبة نسبة السكر في الدم لديك بعناية.<br /> &bull; قد يظهر لديك الإسهال أثناء تناولك للمضادات الحيوية ، بما في ذلك سيبرودار ، أو حتى بعد عدة أسابيع من التوقف عن تناولها. في حال اصبح الاسهال شدي دا أو مستم ا ر أو لاحظت أن الب ا رز يحتوي على دم أو مخاط ، توقف عن تناول سيبرودار واتصل بطبيبك على الفور ، لأن ذلك قد يكون مهد دا للحياة. لا تأخذ الأدوية التي توقف أو تبطئ حركات الأمعاء.<br /> &bull; في حال حدث لديك ضعف في البصر تأثرت عيونك بطريقة أخرى ، استشر أخصائي العيون على الفور.<br /> &bull; تصبح بشرتك أكثر حساسية لأشعة الشمس أو الأشعة فوق البنفسجية عند تناول سيبرودار. تجنب التعرض لأشعة الشمس القوية ، أو الأشعة فوق البنفسجية<br />الاصطناعية مثل ك ا رسي الاستلقاء للتشمس.<br /> &bull; أخبر الطبيب أو طاقم المختبر أنك تتناول سيبرودار إذا كان عليك تقديم عينة دم أو بول.<br /> إذا كنت تعاني من مشاكل في الكلى ، أخبر الطبيب لأن الجرعة قد تحتاج إلى تعديل.<br /> &bull; قد يسبب سيبرودار تلف الكبد. إذا لاحظت أي أع ا رض مثل فقدان الشهية ، واليرقان )اصف ا رر الجلد( ، والبول الداكن ، أو الحكة ، أو ألم المعدة لدى الضغط عليها، اتصل بطبيبك على الفور.<br /> &bull; قد يسبب سيبرودار انخفا ضا في عدد خلايا الدم البيضاء وقد تنخفض مقاومتك للعدوى. إذا كنت تعاني من عدوى بأع ا رض مثل الحمى والتدهور الخطير لحالتك العامة ، أو الحمى مع أع ا رض العدوى الموضعية مثل التهاب الحلق / البلعوم / الفم أو مشاكل في المسالك البولية ، يجب عليك م ا رجعة الطبيب على الفور. سيتم إج ا رء اختبار دم للتحقق من حدوث انخفاض في عدد خلايا الدم البيضاء )ندرة المحببات(. من المهم أن تخبر طبيبك عن دوائك.<br />التداخلات الدوائية من أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملاتً غذائية. أخبر طبيبك في حال كنت تأخذ أو قد قمت مؤخ ا ر بأخذ اي أدوية اخرى, بما فيها تلك التي<br />تم الحصول عليها بدون وصفة طبية .<br />يمنع تناول سيبرودار بالت ا زمن مع تي ا زنيدين، قد يسبب ذلك تأثي ا رت جانبية مثل إنخفاض في ضغط الدم ونعاس.<br />من الممكن أن يحدث تفاعل بين هذه الأدوية وسيبرودار في الجسم. فقد يؤثر ت ا زمن سيبرودار مع هذه الأدوية على التأثير العلاجي لها. وقد يزداد احتمال حدوث تأثي ا رت جانبية.<br />أخبر طًبيبك إًذا كًنت تًتناول اًلأدوية اًلتالية:<br />&bull; حاص ا رت ڤيتامين ك )مثل: وارفارين، أسينوكومارول، فينوبروكومون أو فلوانديون( أو غيرها من مضادات التخثر التي تؤخذ عن طريق الفم )مميع الدم(<br />&bull; بروبينسيد )لعلاج النقرس(<br />&bull; ميثوتريكسات )لأنواع معينة من السرطان، الصدفية، إلتهاب المفاصل الروماتويدي(<br />&bull; ثيوفيلين )لمشاكل التنفس(<br />&bull; تي ا زنيدين )تشنج العضلات في التصلب المتعدد(<br />&bull; أولان ا زبين )مضاد للذهان(<br />&bull; كلو ا زبين )مضاد للذهان(<br />&bull; روبينيرول )لمرض باركنسون(<br />&bull; فينيتوين )للصرع(<br />&bull; ميتوكلوب ا رميد )للغثيان والقيء(<br />&bull; سيكلوسبورين )لعلاج الحالات الجلدية، إلتهاب المفاصل الروماتيزمي وز ا رعة الأعضاء(<br />&bull; الأدوية الأخرى التي تؤثر على نظم القلب، الأدوية التي تنتمي إلى مضادات إضط ا رب النظم )مثل كوينيدين، هيدر وكوينيدين، ديسوبي ا رميد، اميودارون، سوتالول، دوفيتيليد، ابيوتليد(، مضادات الاكتئاب ثلاثية الحلقات، مضادات الج ا رثيم )التي تنتمي إلى مجموعة الماكروليدات(، وبعض مضادات الذهان.<br />&bull; زولبيديم )لعلاج اضط ا ربات النوم( من الممكن أن يزيد مستوى الادوية التالية في الدم مع تناول سيبرودار:<br />&bull; بنتوكسيفيلين )لإضط ا ربات الدورة الدموية(<br />&bull; كافيين<br />&bull; دولوكستين )للإكتئاب، تلف الأعصاب الناتج عن السكري أو سلس البول(<br />&bull; ليدوكائين )لأم ا رض القلب أو التخدير(<br />&bull; سيلدينافيل )لعدم القدرة على الانتصاب(<br />&bull; اجوميلاتين )لعلاج الاكتئاب(</p><p>تقلل بعض الأدوية تأثير سيبرودار. أخبر طبيبك إذا كنت تأخذ أو تنوي أخذ:<br />&bull; مضادات الحموضة<br />&bull; أوميب ا رزول<br />&bull; مكملات غذائية تحتوي على المعادن<br />&bull; السوك ا رلفات<br />&bull; ا ربط الفوسفات البوليمري )مثل السيفلامير أو كربونات اللانثانم(<br />&bull; الأدوية أو المكملات الغذائية التي تحتوي على الكالسيوم، المغنيسيوم، الألومنيوم أو الحديد إذا كانت هذه الأدوية ضرورية تناول سيبرودار قبل أخذها بساعتين أو بعد تناولها بمدة لا تقل عن أربع ساعات.<br />تناول سًيبرودار مًع اًلطعام وًالش ا رب إذا لم تأخذ سيبرودار خلال وجبة الطعام، لا تتناول أق ا رص سيبرودار مع الأشربة والأطعمة التي تحتوي على منتجات الألبان )الحليب أو الألبان( أو الأشربة المدعمة بالكالسيوم، من الممكن أن تؤثر على إمتصاص المادة الفعالة.<br />الحمل والرضاعة</p><p>أخبري طبيبك أو الصيدلي قبل تناول هذا الدواء إذا كنت حاملا أو ترضعين طفلك، تعتقدين أنك حاملا أو تنوين الحمل. من المفضل تجنب إستخدام سيبرودار خلال الحمل.<br />لا تتناولي سيبرودار خلال الإرضاع لأن سيبروفلوكساسين يفرز في حليب الأم ومن الممكنأن يسبب ضرر للجنين.</p><p>تأثير سًيبرودار عًلى اًلقيادة ا وستخدام اًلآلات<br />من الممكن أن تشعر بتيقظ أقل عند تناول سيبرودار. وقد تحدث تأثي ا رت عصبية. لذلك تأكد من كيفية تأثير سيبرودار عليك قبل قيادة المركبات أو تشغيل الآلات. إذا كان لديك شك تحدث مع طبيبك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>سيقوم طبيبك بتوضيح طريقة إستخدام سيبرودار وتك ا رر أخذ الجرعات ومدة العلاج. يعتمد ذلك على نوع العدوى وسوء الحالة.<br />أخبر طبيبك إذا كنت تعاني من مشاكل في الكلى، قد تكون بحاجة لتعديل الجرعة.<br />يستمر العلاج عادة لفترة تت ا روح بين 5 إلى 21 يوم، قد يستغرق العلاج فترة أطول في<br />حالات العدوى الشديدة. تناول الدواء كما وصفه طبيبك تماما. تأكد من طبيبك أو الصيدلي<br />إذا لم تكن متأكدا من الجرعة ومن طريقة إستخدام سيبرودار.<br />أ. إبلع الأق ا رص مع كمية وافرة من السوائل. لا تمضغ الأق ا رص لأن طعمها غير<br />مستحسن.<br />ب. تناول الأق ا رص بنفس الوقت يوميا<br />ج. تستطيع أن تتناول الأق ا رص مع وجبة الطعام أو بين الوجبات. لا يؤثر الكالسيوم<br />الذي تتناوله كجزء من الوجبة على الإمتصاص. بالرغم من ذلك لا تتناول سيبرودار<br />مع مشتقات الألبان مثل الحليب أو الألبان أو مع عصائر الفاكهة المدعمة )مثل<br />عصير البرتقال المدعم بالكالسيوم(.<br />تذكر شرب كمية وافرة من السوائل مع سيبرودار.<br />الجرعة ال ا زئدة من سيبرودار إذا تناولت جرعة ا زئدة عن الجرعة التي وصفها طبيبك، يجب أن تحصل على العناية الطبية<br />الفو رية. إذا أمكن قم بأخذ الأق ا رص أو العبوة لي ا رها الطبيب.<br />نسيان تناول جرعة سيبرودار تناول الجرعة الإعتيادية بأقرب وقت وتابع أخذ الجرعات الموصى بها. ولكن إذا كان ذلك<br />قريب من موعد الجرعة التي تليها تجاوز الجرعة التي نسيتها وتابع أخذ الجرعات كالمعتاد.<br />لا تضاعف الجرعة لتعويض الجرعة الفائتة. قم بإكمال فترة العلاج كاملة.<br />التوقف عًن تًناول سًيبرودار من الضروري أن لا تتوقف عن تناول العلاج كاملا حتى وان بدأت تشعر بتحسن بعد عدة<br />أيام، إذا توقفت عن تناول العلاج مبك ا ر، قد لا يحدث لك شفاء تام وقد تعاودك الأع ا رض أو<br />تصبح أسوأ. من الممكن أن تتطور لديك مقاومة ضد المضادات الحيوية.<br />إذا كان لديك إستفسا ا رت أخرى حول استخدام هذا العلاج إستشر طبيبك أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن الادوية الأخرى قد يسبب سيبرودار اع ا رضا جانبية، الا ان هذه الاع ا رض قد لا<br />تظهر عند كل الناس.<br />القسم اًلتالي يًحتوي عًلى اًلاع ا رض اًلجانبية اًلاكثر شًيوعا وًالتي مًن اًلممكن اًلتعرف عًليهاً<br />بنفسك:<br />توقف عن تناول سيبرودار واتصل مع طبيبك على الفور لكي يحولك الى مضاد حيوي اخر<br />في حال لاحظت اي الاع ا رض الجانبية الخطيرة التالية:<br />نادر )ًمن الممكن أن تؤثر على 1 من كل 1000 شخص كحد أقصى(:<br /> صرع<br />نادر جًدا )ًمن الممكن أن تؤثر على 1 من كل 10000 شخص كحد أقصى(:<br /> تفاعلات تحسسية شديدة ومفاجئة يصاحبها اع ا رض مثل ضيق الصدر، الشعور<br />بالدوار، التقيؤ، او الاغماء او في حال اختبرت حدوث دوخة عند الوقوف )ردود فعل<br />تأقية / صدمة تأقية(<br /> ضعف في العضلات، التهاب الاوتار والتي قد تؤدي الى تمزق في الوتر، يؤثر على<br />الاوتار الكبيرة في منطقة ما خلف الكاحل بشكل خاص )وتر العرقوب(<br /> طح جلدي خطير مهدد للحياة، يظهر عادة على شكل بثور او تقرحات في الفم،<br />الحلق، الانف، العينين والاغشية المخاطية الاخرى مثل الاعضاء التناسلية والتي قد<br />تتطور الى ظهور بثور واسعة الانتشار او حدوث تقشر في الجلد )متلازمة ستيفنز &ndash;<br />جونسون، انحلال البشرة السمي(<br />غير مًعروفة )ً لًا يًمكن تًقدير مًعدل اًلتك ا رر مًن اًلبيانات اًلمتاحة(:  شعور غير اعتيادي بالالم، وخز شبيه بالحرق، خد ا رن او ضعف في العضلات في<br />الاط ا رف )اعتلال عصبي(<br /> رد فعل يسبب طفح، حمى، التهاب الاعضاء الداخلية، اختلالات دموية ومرض<br />جهازي ) رد فعل للدواء مع فرط الحمضات واع ا رض جهازية، بثار طفحي معمم<br />حاد(<br />تم رًصد اًلاع ا رض اًلجانبية اًلاخرى اًلتالية خًلال اًلعلاج بًسيبروفلوكساسين، هًذه اًلاع ا رضً<br />مذكورة اًدناه مًع مًعدل تًك ا ررها: شائع )ًمن الممكن أن تؤثر على 1 في 10 أشخاص كحد اقصى(:<br /> غثيان، إسهال<br /> آلام في المفاصل والتهاب المفاصل عند الأطفال<br />غير شًائع )ًمن الممكن أن تؤثر على 1 في 100 شخص كحد أقصى(:<br /> آلام المفاصل عند البالغين<br /> عدوى فطرية إضافية<br /> إرتفاع تركيز الحمضات، وهو نوع من خلايا الدم البيضاء<br /> فقدان الشهية<br /> فرط النشاط أو تهيج<br /> صداع، دوخة، مشاكل في النوم أو إضط ا ربات في الذوق<br /> قيء، آلام في البطن، مشاكل في الجهاز الهضمي مثل إضط ا رب في المعدة )عسر<br />الهضم/حرقة(، أو إنتفاخ<br /> زيادة تركيز بعض المواد في الدم )ت ا رنسامينيز و/أو بيليروبين(<br /> طفح جلدي، حكة، أو شرى<br /> ضعف وظيفة الكلى<br /> آلام في العضلات والعظام، الشعور بالإعياء )وهن(، أو حمى<br /> زيادة في الفوسفاتاز القلوي في الدم )مادة معينة في الدم(<br />نادر )ًمن الممكن أن تؤثر على 1 في 1000 شخص كحد أقصى(:<br /> آلام في العضلات، إلتهاب في المفاصل، زيادة توتر العضلات، أو تشنج عضلي.<br /> إلتهاب في الامعاء )إلتهاب القولون( مرتبط بإستخدام المضادات الحيوية )يمكن أن<br />تؤدي إلى الوفاة في حالات نادرة جدا(<br /> تغيي ا رت في تعداد الدم )قلة الكريات البيض، كثرة الكريات البيض، قلة العدلات، فقر<br />الدم(، زيادة أو إنخفاض كمية عامل تخثر الدم )الصفيحات الدموية(<br /> تفاعلات حساسية، تورم )وذمة(، أو تورم سريع في الجلد والأغشية المخاطية )وذمة<br />وعائية(<br /> زيادة السكر في الدم )فرط سكر الدم(<br /> إنخفاض السكر في الدم )إنخفاض سكر الدم(<br /> إرتباك، توهان، تفاعلات قلق، أحلام غريبة، إكتئاب )مما قد يؤدي إلى أفكار<br />إنتحارية، محاولات إنتحار، أو إنتحار(، أو هلوسات<br /> الإحساس بوخز مثل الإبر والدبابيس، حساسية غير إعتيادية لتحفيز الحواس،<br />إنخفاض حساسية الجلد، رعاش، دوار أو دوخة<br /> مشاكل البصر بما في ذلك الرؤية المزدوجة<br /> طنين، فقدان السمع، ضعف في السمع<br /> سرعة ضربات القلب<br /> توسع الأوعية الدموية، إنخفاض ضغط الدم، أو إغماء<br /> ضيق في التنفس، بما في ذلك أع ا رض الربو<br /> إضط ا ربات الكبد، يرقان )اليرقان الركودي(، أو التهاب الكبد<br /> حساسية للضوء<br /> فشل كلوي، دم أو بلو ا رت في البول، إلتهاب المسالك البولية<br /> إحتباس سوائل أو تعرق مفرط<br /> زيادة مستويات انزيم الأميليز<br />نادر جًدا )ًمن الممكن أن تؤثر على 1 في 10000 شخص كحد أقصى(:<br /> نوع خاص من إنخفاض عدد خلايا الدم الحم ا رء )فقر الدم الإنحلالي(، إنخفاض<br />خطير في نوع من خلايا الدم البيضاء )ندرة المحببات(، إنخفاض في عدد كريات<br />الدم الحم ا رء والبيضاء والصفائح الدموية )قلة الكريات الشاملة( والتي قد تكون قاتلة؛<br />ضمور نخاع العظم، والذي قد يكون قاتلة أيضا<br /> تفاعلات حساسية شديدة )رد فعل تأقي أو صدمة تأقية، والتي قد تسبب الوفاة داء -<br />المصل(<br /> إضط ا ربات عقلية )ردود فعل ذهانية يحتمل أن تؤدي إلى أفكار إنتحارية، محاولات<br />إنتحار، أو إنتحار(<br /> صداع نصفي، إضط ا رب التنسيق، عدم ثبات المشية )إضط ا رب المشية(، إضط ا رب<br />في حاسة الشم، ضغط على الدماغ )ضغط داخل الجمجمة أو ورم دماغي ثابت(<br /> خلل في رؤية الألوان<br /> إلتهاب في جدار الأوعية الدموية )إلتهاب الأوعية الدموية(<br /> إلتهاب البنكرياس<br /> موت خلايا الكبد )نخر الكبد( مما يؤدي بشكل نادر جدا إلى فشل في الكبد مهدد<br />للحياة<br /> نزف تحت الجلد يظهر كنقط صغيرة )نمشات(؛ نتوءات او طفح جلدي متنوعة<br /> تفاقم أع ا رض الوهن العضلي الوبيل<br />التك ا رر غًير مًعروف )ًلا يمكن تقدير معدل التك ا رر من البيانات المتاحة(<br /> متلازمة مرتبطة بضعف إف ا رز الماء وانخفاض مستويات الصوديوم<br /> الشعور بتهيج كبير )هوس( او شعور بالعظمة وفرط النشاط )هوس خفيف(<br /> تسارع غير طبيعي في ضربات القلب، عدم إنتظام في ضربات القلب مهدد للحياة،<br />تغير في نظم القلب )وتسمى &#39;إطالة فترة &#39;QT ، تظهر في تخطيط القلب، تخطيط<br />القلب الكهربائي(<br /> تأثير على تخثر الدم )في المرضى الذين عولجوا بمضادات ڤيتامين K )<br />في حال حدوث اي اع ا رض جانبية، تحدث الى طبيبك او الصيدلي. هذا يشمل اي اع ا رض<br />جانبية غير مذكورة في هذد النشرة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>يحفظ بعيدا عن متناول أيدي الأطفال ونظرهم.<br />لا تستخدم سيبرودار بعد تاريخ الإنتهاء المذكور على العبوة. يدل تاريخ الإنتهاء على اخر يوم<br />من الشهر المذكور.<br />يحفظ بعيدا عن الضوء، في مكان جاف دون 30 درجة مئوية.<br />يجب عدم التخلص من الأدوية في المياه العادمة أو النفايات المنزلية. اسأل الصيدلي حول<br />الطريقة السليمة للتخلص من الادوية التي لم تعد بحاجة اليها. سيساعد هذا في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ماهي محتويات سًيبرودار المادة الفعالة هي سيبروفلوكساسين<br />سيبرودار ٢٥٠ أق ا رص مغلفة: يحتوي كل قرص على ٢٥٠ ملغم سيبروفلوكساسين )على<br />هيئة سيبروفلوكساسين هيدروكلو ا ريد أحادي الماء(.<br />سيبرودار ٥٠٠ أق ا رص مغلفة: يحتوي كل قرص على ٥٠٠ ملغم سيبروفلوكساسين )على<br />هيئة سيبروفلوكساسين هيدروكلو ا ريد أحادي الماء(.<br />سيبرودار ٧٥٠ أق ا رص مغلفة: يحتوي كل قرص على 750 ملغم سيبروفلوكساسين )على<br />هيئة سيبروفلوكساسين هيدروكلو ا ريد أحادي الماء(.<br />المواد غًير اًلفعالة اًلأخرى: سيليلوز دقيق البلورية، أملاح الصوديوم لجليكولات النشا، تالك، ستيا ا رت المغنيسيوم، نشا<br />الذرة، سيليكا غروية لا مائية، هيبروميلوز، ماكروغول، ثاني أكسيد التيتانيوم، لون أزرق<br />( E132 .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ما هو الشكل الصيدلاني لسيبرودار وًوصفه وحجم عبوته أق ا رص سيبرودار 250 هي أق ا رص مغلفة لونها أزرق دائرية الشكل محدبة الوجهين مع خط<br />على الجهتين مرمزة على أحد الوجهين بالرمز .&quot;CIP 250&quot;<br />أق ا رص سيبرودار 500 هي أق ا رص مغلفة لونها أزرق مستطيلة الشكل مع خط على الجهتين<br />مرمزة على أحد الوجهين بالرمز .&quot;CIP 500&quot;<br />أق ا رص سيبرودار 750 هي أق ا رص مغلفة لونها أزرق مستطيلة الشكل مع خط على الجهتين<br />مرمزة على أحد الوجهين بالرمز .&quot;CIP 750&quot;<br />سيبرودار 250 متوفر في عبوات من 10 ، 30٠ و ٥٠٠ قرص مغلف.<br />سيبرودار 500 متوفر في عبوات من 8 ، 10 و ٥٠٠ قرص مغلف.<br />سيبرودار 750 متوفر في عبوات من 10 أق ا رص مغلفة.<br />قد لا يتم تسويق جميع العبوات.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة دار الدواء للتنمية والاستثمار المساهمة المحدودة، )ناعور الأردن( -<br />هاتف. 132 27 57 ( 6 962 )+<br />فاكس. 776 27 57 ( 6 962 )+</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            05 / 2019
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Ciprodar® 500 mg film-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each Ciprodar® 500 tablet contains 500 mg Ciprofloxacin (as ciprofloxacin hydrochloride monohydrate).
For a full list of excipients see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablets.
Ciprodar® 500 mg tablets are blue oblonged film coated tablets with a mid-groove on both sides coded “CIP 500” on one side.
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ciprodar&reg; 500 mg film-coated tablets are indicated for the treatment of the following infections (see sections 4.4 and 5.1). Special attention should be paid to available information on resistance to ciprofloxacin before commencing therapy.<br />Consideration should be given to official guidance on the appropriate use of antibacterial agents.<br />Adults<br />&bull; Lower respiratory tract infections due to Gram-negative bacteria<br />- exacerbations of chronic obstructive pulmonary disease<br />- broncho-pulmonary infections in cystic fibrosis or in bronchiectasis<br />- pneumonia<br />&bull; Chronic suppurative otitis media<br />&bull; Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria<br />&bull; Urinary tract infections<br />&bull; Genital tract infections<br />- gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae<br />- epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae<br />- pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae<br />&bull; Infections of the gastro-intestinal tract (e.g. travellers&#39; diarrhoea)<br />&bull; Intra-abdominal infections<br />&bull; Infections of the skin and soft tissue caused by Gram-negative bacteria<br />&bull; Malignant external otitis<br />&bull; Infections of the bones and joints<br />&bull; Prophylaxis of invasive infections due to Neisseria meningitidis<br />&bull; Inhalation anthrax (post-exposure prophylaxis and curative treatment)<br />Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.<br />Children and adolescents<br />&bull; Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa<br />&bull; Complicated urinary tract infections and pyelonephritis<br />&bull; Inhalation anthrax (post-exposure prophylaxis and curative treatment)<br />Ciprofloxacin may also be used to treat severe infections in children and adolescents when this is considered to be necessary.<br />Treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents (see sections 4.4 and 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The dosage is determined by the indication, the severity and the site of the infection, the susceptibility to ciprofloxacin of the causative organism(s), the renal function of the patient and, in children and adolescents the body weight.<br />The duration of treatment depends on the severity of the illness and on the clinical and bacteriological course.<br />Treatment of infections due to certain bacteria (e.g. Pseudomonas aeruginosa, Acinetobacter or Staphylococci) may require higher ciprofloxacin doses and co-administration with other appropriate antibacterial agents.<br />Treatment of some infections (e.g. pelvic inflammatory disease, intra-abdominal infections, infections in neutropenic patients and infections of bones and joints) may require co-administration with other appropriate antibacterial agents depending on the pathogens involved.<br />Adults</p><table border="1" cellspacing="0" cellpadding="0" align="left"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Indications</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose in mg</strong></p><p>&nbsp;</p></td><td style="vertical-align:top"><p><strong>Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Infections of the lower respiratory tract</p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p>7 to 14 days</p><p><strong>&nbsp;</strong></p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p>Infections of the upper respiratory tract</p></td><td style="vertical-align:top"><p>Acute exacerbation of chronic sinusitis</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>7 to 14 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Chronic suppurative otitis media</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>7 to 14 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Malignant external otitis</p></td><td style="vertical-align:top"><p>750 mg twice daily</p></td><td style="vertical-align:top"><p>28 days up to 3 months</p><p>&nbsp;</p></td></tr><tr><td rowspan="4" style="vertical-align:top"><p>Urinary tract infections (see section 4.4)</p><p>&nbsp;</p></td><td rowspan="2" style="vertical-align:top"><p>Uncomplicated cystitis</p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p>250 mg twice daily to 500 mg twice daily</p></td><td style="vertical-align:top"><p>3 days</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>In pre-menopausal women, 500 mg single dose may be used</p></td></tr><tr><td style="vertical-align:top"><p>Complicated cystitis, Uncomplicated pyelonephritis</p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>7 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Complicated pyelonephritis</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>at least 10 days, it can be continued for longer than 21 days in some specific circumstances (such as abscesses)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Prostatitis</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>2 to 4 weeks (acute) to 4 to 6 weeks (chronic)</p><p>&nbsp;</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>Genital tract infections</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Gonococcal uretritis and cervicitis</p></td><td style="vertical-align:top"><p>500 mg as a single dose</p></td><td style="vertical-align:top"><p>1 day (single dose)</p></td></tr><tr><td style="vertical-align:top"><p>Epididymo-orchitis and pelvic inflammatory diseases</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>at least 14 days</p><p>&nbsp;</p></td></tr><tr><td rowspan="5" style="vertical-align:top"><p>Infections of the gastro-intestinal tract and intra-abdominal infections</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>Diarrhoea caused by bacterial pathogens including <em>Shigella </em>spp. other than <em>Shigella dysenteriae</em> type 1 and empirical treatment of severe travellers&#39; diarrhoea</p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>1 day</p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea caused by <em>Shigella dysenteriae</em> type 1</p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>5 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Diarrhoea caused by <em>Vibrio cholerae</em></p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>3 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Typhoid fever</p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>7 days</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Intra-abdominal infections due to Gram-negative bacteria</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>5 to 14 days</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Infections of the skin and soft tissue</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>7 to 14 days</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Bone and joint infections</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>Max. of 3 months</p><p>&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Neutropenic patients with fever that is suspected to be due to a bacterial infection.</p><p>Ciprofloxacin should be co-administered with appropriate antibacterial agent(s) in accordance to official guidance.</p></td><td style="vertical-align:top"><p>500 mg twice daily to 750 mg twice daily</p></td><td style="vertical-align:top"><p>Therapy should be continued over the entire period of neutropenia</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Prophylaxis of invasive infections due to <em>Neisseria meningitidis</em></p></td><td style="vertical-align:top"><p>500 mg as a single dose</p></td><td style="vertical-align:top"><p>1 day (single dose)</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate.</p><p>Drug administration should begin as soon as possible after suspected or confirmed exposure</p></td><td style="vertical-align:top"><p>500 mg twice daily</p></td><td style="vertical-align:top"><p>60 days from the confirmation of <em>Bacillus anthracis</em> exposure</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p><em><u>Paediatric population</u></em></p><p><em><u>&nbsp;</u></em></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p><strong>Indications</strong></p></td><td style="vertical-align:top"><p><strong>Daily dose in mg</strong></p></td><td style="vertical-align:top"><p><strong>Total duration of treatment (potentially including initial parenteral treatment with ciprofloxacin)</strong></p></td></tr><tr><td style="vertical-align:top"><p>Cystic fibrosis</p></td><td style="vertical-align:top"><p>20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="vertical-align:top"><p>10 to 14 days</p></td></tr><tr><td style="vertical-align:top"><p>Complicated urinary tract infections and pyelonephritis</p></td><td style="vertical-align:top"><p>10 mg/kg body weight twice daily to 20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="vertical-align:top"><p>10 to 21 days</p></td></tr><tr><td style="vertical-align:top"><p>Inhalation anthrax post-exposure prophylaxis and curative treatment for persons able to receive treatment by oral route when clinically appropriate. Drug administration should begin as soon as possible after suspected or confirmed exposure.</p></td><td style="vertical-align:top"><p>10 mg/kg body weight twice daily to 15 mg/kg body weight twice daily with a maximum of 500 mg per dose.</p></td><td style="vertical-align:top"><p>60 days from the confirmation of <em>Bacillus anthracis</em> exposure</p></td></tr><tr><td style="vertical-align:top"><p>Other severe infections</p></td><td style="vertical-align:top"><p>20 mg/kg body weight twice daily with a maximum of 750 mg per dose.</p></td><td style="vertical-align:top"><p>According to the type of infections</p></td></tr></tbody></table><p><em><u>&nbsp;</u></em></p><p><em><u>Elderly patients</u></em></p><p>Geriatric patients should receive a dose selected according to the severity of the infection and the patient&#39;s creatinine clearance.</p><p><em><u>Patients with renal and hepatic impairment</u></em></p><p>Recommended starting and maintenance doses for patients with impaired renal function:</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p><strong>Creatinine Clearance </strong></p><p><strong>[mL/min/1.73 m&sup2;]</strong></p></td><td style="vertical-align:top"><p><strong>Serum Creatinine </strong></p><p><strong>[&micro;mol/L]</strong></p><p><strong>&nbsp;</strong></p></td><td style="vertical-align:top"><p><strong>Oral Dose </strong></p><p><strong>[mg]</strong></p><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>&gt; 60</p></td><td style="vertical-align:top"><p>&lt; 124</p></td><td style="vertical-align:top"><p>See Usual Dosage.</p></td></tr><tr><td style="vertical-align:top"><p>30-60</p></td><td style="vertical-align:top"><p>124 to 168</p></td><td style="vertical-align:top"><p>250-500 mg every 12 h</p></td></tr><tr><td style="vertical-align:top"><p>&lt; 30</p></td><td style="vertical-align:top"><p>&gt; 169</p></td><td style="vertical-align:top"><p>250-500 mg every 24 h</p></td></tr><tr><td style="vertical-align:top"><p>Patients on haemodialysis</p></td><td style="vertical-align:top"><p>&gt; 169</p></td><td style="vertical-align:top"><p>250-500 mg every 24 h (after dialysis)</p></td></tr><tr><td style="vertical-align:top"><p>Patients on peritoneal dialysis</p></td><td style="vertical-align:top"><p>&gt; 169</p></td><td style="vertical-align:top"><p>250-500 mg every 24 h</p></td></tr></tbody></table><p>In patients with impaired liver function no dose adjustment is required.<br />Dosing in children with impaired renal and/or hepatic function has not been studied.<br />Method of administration<br />Tablets are to be swallowed unchewed with fluid. They can be taken independent of mealtimes. If taken on an empty stomach, the active substance is absorbed more rapidly. Ciprofloxacin tablets should not be taken with dairy products (e.g. milk, yoghurt) or mineral-fortified fruit-juice (e.g. calcium-fortified orange juice) (see section 4.5).<br />In severe cases or if the patient is unable to take tablets (e.g. patients on enteral nutrition), it is recommended to commence therapy with intravenous ciprofloxacin until a switch to oral administration is possible.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Hypersensitivity to the active substance, to other quinolones or to any of the excipients (see section 6.1).
 Concomitant administration of ciprofloxacin and tizanidine (see section 4.5).
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Severe infections and mixed infections with Gram-positive and anaerobic pathogens<br />Ciprofloxacin monotherapy is not suited for treatment of severe infections and infections that might be due to Gram-positive or anaerobic pathogens. In such infections ciprofloxacin must be co-administered with other appropriate antibacterial agents.<br />Streptococcal Infections (including Streptococcus pneumoniae)<br />Ciprofloxacin is not recommended for the treatment of streptococcal infections due to inadequate efficacy.<br />Genital tract infections<br />Gonococcal uretritis, cervicitis, epididymo-orchitis and pelvic inflammatory diseases may be caused by fluoroquinolone-resistant Neisseria gonorrhoeae isolates.<br />Therefore, ciprofloxacin should be administered for the treatment of gonococcal uretritis or cervicitis only if ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded.<br />For epididymo-orchitis and pelvic inflammatory diseases, empirical ciprofloxacin should only be considered in combination with another appropriate antibacterial agent (e.g. a cephalosporin) unless ciprofloxacin-resistant Neisseria gonorrhoeae can be excluded. If clinical improvement is not achieved after 3 days of treatment, the therapy should be reconsidered.<br />Urinary tract infections<br />Resistance to fluoroquinolones of Escherichia coli &ndash; the most common pathogen involved in urinary tract infections &ndash; varies across the European Union. Prescribers are advised to take into account the local prevalence of resistance in Escherichia coli to fluoroquinolones.<br />The single dose of ciprofloxacin that may be used in uncomplicated cystitis in pre-menopausal women is expected to be associated with lower efficacy than the longer treatment duration. This is all the more to be taken into account as regards the increasing resistance level of Escherichia coli to quinolones.<br />Intra-abdominal infections<br />There are limited data on the efficacy of ciprofloxacin in the treatment of post-surgical intra-abdominal infections.<br />Travellers&#39; diarrhoea<br />The choice of ciprofloxacin should take into account information on resistance to ciprofloxacin in relevant pathogens in the countries visited.<br />Infections of the bones and joints<br />Ciprofloxacin should be used in combination with other antimicrobial agents depending on the results of the microbiological documentation.<br />Inhalational anthrax<br />Use in humans is based on in-vitro susceptibility data and on animal experimental data together with limited human data. Treating physicians should refer to national and/or international consensus documents regarding the treatment of anthrax.<br />Paediatric population<br />The use of ciprofloxacin in children and adolescents should follow available official guidance. Ciprofloxacin treatment should be initiated only by physicians who are experienced in the treatment of cystic fibrosis and/or severe infections in children and adolescents.<br />Ciprofloxacin has been shown to cause arthropathy in weight-bearing joints of immature animals. Safety data from a randomised double-blind study on ciprofloxacin use in children (ciprofloxacin: n=335, mean age = 6.3 years; comparators: n=349, mean age = 6.2 years; age range = 1 to 17 years) revealed an incidence of suspected drug-related arthropathy (discerned from joint-related clinical signs and symptoms) by Day +42 of 7.2% and 4.6%. Respectively, an incidence of drug-related arthropathy by 1-year follow-up was 9.0% and 5.7%. The increase of suspected drug-related arthropathy cases over time was not statistically significant between groups. Treatment should be initiated only after a careful<br />benefit/risk evaluation, due to possible adverse events related to joints and/or surrounding tissue (see section 4.8).<br />Broncho-pulmonary infections in cystic fibrosis<br />Clinical trials have included children and adolescents aged 5-17 years. More limited experience is available in treating children between 1 and 5 years of age.<br />Complicated urinary tract infections and pyelonephritis<br />Ciprofloxacin treatment of urinary tract infections should be considered when other treatments cannot be used, and should be based on the results of the microbiological documentation.<br />Clinical trials have included children and adolescents aged 1-17 years.<br />Other specific severe infections<br />Other severe infections in accordance with official guidance, or after careful benefit-risk evaluation when other treatments cannot be used, or after failure to conventional therapy and when the microbiological documentation can justify a ciprofloxacin use.<br />The use of ciprofloxacin for specific severe infections other than those mentioned above has not been evaluated in clinical trials and the clinical experience is limited. Consequently, caution is advised when treating patients with these infections.<br />Hypersensitivity<br />Hypersensitivity and allergic reactions, including anaphylaxis and anaphylactoid reactions, may occur following a single dose (see section 4.8) and may be life-threatening. If such reaction occurs, ciprofloxacin should be discontinued and an adequate medical treatment is required.<br />Musculoskeletal System<br />Ciprofloxacin should generally not be used in patients with a history of tendon disease/disorder related to quinolone treatment. Nevertheless, in very rare instances, after microbiological documentation of the causative organism and evaluation of the risk/benefit balance, ciprofloxacin may be prescribed to these patients for the treatment of certain severe infections, particularly in the event of failure of the standard therapy or bacterial resistance, where the microbiological data may justify the use of ciprofloxacin.<br />Tendinitis and tendon rupture (especially Achilles tendon), sometimes bilateral, may occur with ciprofloxacin, even within the first 48 hours of treatment. Inflammation and ruptures of tendon may occur even up to several months after discontinuation of ciprofloxacin therapy. The risk of tendinopathy may be increased in elderly patients or in patients concomitantly treated with corticosteroids (see section 4.8).<br />At any sign of tendinitis (e.g. painful swelling, inflammation), ciprofloxacin treatment should be discontinued. Care should be taken to keep the affected limb at rest.<br />Ciprofloxacin should be used with caution in patients with myasthenia gravis, because symptoms can be exacerbated (see section 4.8).<br />Aortic aneurysm and dissection<br />Epidemiologic studies report an increased risk of aortic aneurysm and dissection after intake of fluoroquinolones, particularly in the older population.<br />Therefore, fluoroquinolones should only be used after careful benefit-risk assessment and after consideration of other therapeutic options in patients with positive family history of aneurysm disease,<br />or in patients diagnosed with pre-existing aortic aneurysm and/or dissection, or in presence of other risk factors or conditions predisposing for aortic aneurysm and dissection (e.g. Marfan syndrome, vascular Ehlers-Danlos syndrome, Takayasu arteritis, giant cell arteritis, Behcet&#39;s disease, hypertension, known atherosclerosis).<br />In case of sudden abdominal, chest or back pain, patients should be advised to immediately consult a physician in an emergency department.<br />Vision disorders<br />If vision becomes impaired or any effects on the eyes are experienced, an eye specialist should be consulted immediately.<br />Photosensitivity<br />Ciprofloxacin has been shown to cause photosensitivity reactions. Patients taking ciprofloxacin should be advised to avoid direct exposure to either extensive sunlight or UV irradiation during treatment (see section 4.8).<br />Central Nervous System<br />Ciprofloxacin like other quinolones are known to trigger seizures or lower the seizure threshold. Cases of status epilepticus have been reported. Ciprofloxacin should be used with caution in patients with CNS disorders which may be predisposed to seizure. If seizures occur ciprofloxacin should be discontinued (see section 4.8). Psychiatric reactions may occur even after first administration of ciprofloxacin. In rare cases, depression or psychosis can progress to suicidal ideations/thoughts culminating in attempted suicide or completed suicide. In the occurrence of such cases, ciprofloxacin should be discontinued.<br />Cases of polyneuropathy (based on neurological symptoms such as pain, burning, sensory disturbances or muscle weakness, alone or in combination) have been reported in patients receiving ciprofloxacin. Ciprofloxacin should be discontinued in patients experiencing symptoms of neuropathy, including pain, burning, tingling, numbness, and/or weakness in order to prevent the development of an irreversible condition (see section 4.8).<br />Cardiac disorders<br />Caution should be taken when using fluoroquinolones, including ciprofloxacin, in patients with known risk factors for prolongation of the QT interval such as, for example:<br />&bull; congenital long QT syndrome<br />&bull; concomitant use of drugs that are known to prolong the QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics)<br />&bull; uncorrected electrolyte imbalance (e.g. hypokalaemia, hypomagnesaemia)<br />&bull; cardiac disease (e.g. heart failure, myocardial infarction, bradycardia)<br />Elderly patients and women may be more sensitive to QTc-prolonging medications. Therefore, caution should be taken when using fluoroquinolones, including ciprofloxacin, in these populations.<br />(See section 4.2 Elderly patients, section 4.5, section 4.8, section 4.9).<br />Dysglycaemia<br />As with all quinolones, disturbances in blood glucose, including both hypoglycaemia and hyperglycaemia have been reported (see section 4.8), usually in elderly diabetic patients, receiving concomitant treatment with an oral hypoglycaemic agent (e.g. glibenclamide) or with insulin. Cases of hypoglycaemic coma have been reported. In diabetic patients, careful monitoring of blood glucose is recommended.<br />Gastrointestinal System<br />The occurrence of severe and persistent diarrhoea during or after treatment (including several weeks after treatment) may indicate an antibiotic-associated colitis (life-threatening with possible fatal outcome), requiring immediate treatment (see section 4.8). In such cases, ciprofloxacin should immediately be discontinued, and an appropriate therapy initiated. Anti-peristaltic drugs are contraindicated in this situation.<br />Renal and urinary system<br />Crystalluria related to the use of ciprofloxacin has been reported (see section 4.8). Patients receiving ciprofloxacin should be well hydrated and excessive alkalinity of the urine should be avoided.<br />Impaired renal function<br />Since ciprofloxacin is largely excreted unchanged via renal pathway dose adjustment is needed in patients with impaired renal function as described in section 4.2 to avoid an increase in adverse drug reactions due to accumulation of ciprofloxacin.<br />Hepatobiliary system<br />Cases of hepatic necrosis and life-threatening hepatic failure have been reported with ciprofloxacin (see section 4.8). In the event of any signs and symptoms of hepatic disease (such as anorexia, jaundice, dark urine, pruritus, or tender abdomen), treatment should be discontinued.<br />Glucose-6-phosphate dehydrogenase deficiency<br />Haemolytic reactions have been reported with ciprofloxacin in patients with glucose-6-phosphate dehydrogenase deficiency. Ciprofloxacin should be avoided in these patients unless the potential benefit is considered to outweigh the possible risk. In this case, potential occurrence of haemolysis should be monitored.<br />Resistance<br />During or following a course of treatment with ciprofloxacin bacteria that demonstrate resistance to ciprofloxacin may be isolated, with or without a clinically apparent superinfection. There may be a particular risk of selecting for ciprofloxacin-resistant bacteria during extended durations of treatment and when treating nosocomial infections and/or infections caused by Staphylococcus and Pseudomonas species.<br />Cytochrome P450<br />Ciprofloxacin inhibits CYP1A2 and thus may cause increased serum concentration of concomitantly administered substances metabolised by this enzyme (e.g. theophylline, clozapine, olanzapine, ropinirole, tizanidine, duloxetine, agomelatine). Therefore, patients taking these substances concomitantly with ciprofloxacin should be monitored closely for clinical signs of overdose, and<br />determination of serum concentrations (e.g. of theophylline) may be necessary (see section 4.5). Co-administration of ciprofloxacin and tizanidine is contra-indicated.<br />Methotrexate<br />The concomitant use of ciprofloxacin with methotrexate is not recommended (see section 4.5).<br />Interaction with tests<br />The in-vitro activity of ciprofloxacin against Mycobacterium tuberculosis might give false negative bacteriological test results in specimens from patients currently taking ciprofloxacin.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of other products on ciprofloxacin:<br />Drugs known to prolong QT interval<br />Ciprofloxacin, like other fluoroquinolones, should be used with caution in patients receiving drugs known to prolong QT interval (e.g. Class IA and III anti-arrhythmics, tricyclic antidepressants, macrolides, antipsychotics) (see section 4.4).<br />Chelation Complex Formation<br />The simultaneous administration of ciprofloxacin (oral) and multivalent cation-containing drugs and mineral supplements (e.g. calcium, magnesium, aluminium, iron), polymeric phosphate binders (e.g. sevelamer or lanthanum carbonate), sucralfate or antacids, and highly buffered drugs (e.g. didanosine tablets) containing magnesium, aluminium, or calcium reduces the absorption of ciprofloxacin. Consequently, ciprofloxacin should be administered either 1-2 hours before or at least 4 hours after these preparations. The restriction does not apply to antacids belonging to the class of H2 receptor blockers.<br />Food and Dairy Products<br />Dietary calcium as part of a meal does not significantly affect absorption. However, the concurrent administration of dairy products or mineral-fortified drinks alone (e.g. milk, yoghurt, calcium-fortified orange juice) with ciprofloxacin should be avoided because absorption of ciprofloxacin may be reduced.<br />Probenecid<br />Probenecid interferes with renal secretion of ciprofloxacin. Co-administration of probenecid and ciprofloxacin increases ciprofloxacin serum concentrations.<br />Metoclopramide<br />Metoclopramide accelerates the absorption of ciprofloxacin (oral) resulting in a shorter time to reach maximum plasma concentrations. No effect was seen on the bioavailability of ciprofloxacin.<br />Omeprazole<br />Concomitant administration of ciprofloxacin and omeprazole containing medicinal products results in a slight reduction of Cmax and AUC of ciprofloxacin.<br />Effects of ciprofloxacin on other medicinal products:<br />Tizanidine<br />Tizanidine must not be administered together with ciprofloxacin (see section 4.3). In a clinical study with healthy subjects, there was an increase in serum tizanidine concentration (Cmax increase: 7-fold, range: 4 to 21-fold; AUC increase: 10-fold, range: 6 to 24-fold) when given concomitantly with ciprofloxacin. Increased serum tizanidine concentration is associated with a potentiated hypotensive and sedative effect.<br />Methotrexate<br />Renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin, potentially leading to increased plasma levels of methotrexate and increased risk of methotrexate-associated toxic reactions. The concomitant use is not recommended (see section 4.4).<br />Theophylline<br />Concurrent administration of ciprofloxacin and theophylline can cause an undesirable increase in serum theophylline concentration. This can lead to theophylline-induced side effects that may rarely be life threatening or fatal. During the combination, serum theophylline concentrations should be checked and the theophylline dose reduced as necessary (see section 4.4).<br />Other xanthine derivatives<br />On concurrent administration of ciprofloxacin and caffeine or pentoxifylline (oxpentifylline), raised serum concentrations of these xanthine derivatives were reported.<br />Phenytoin<br />Simultaneous administration of ciprofloxacin and phenytoin may result in increased or reduced serum levels of phenytoin such that monitoring of drug levels is recommended.<br />Cyclosporin<br />A transient rise in the concentration of serum creatinine was observed when ciprofloxacin and cyclosporin containing medicinal products were administered simultaneously. Therefore, it is frequently (twice a week) necessary to control the serum creatinine concentrations in these patients.<br />Vitamin K antagonists<br />Simultaneous administration of ciprofloxacin with a vitamin K antagonist may augment its anti-coagulant effects. The risk may vary with the underlying infection, age and general status of the patient<br />so that the contribution of ciprofloxacin to the increase in INR (international normalised ratio) is difficult to assess. The INR should be monitored frequently during and shortly after co-administration of ciprofloxacin with a vitamin K antagonist (e.g., warfarin, acenocoumarol, phenprocoumon, or fluindione).<br />Duloxetine<br />In clinical studies, it was demonstrated that concomitant use of duloxetine with strong inhibitors of the CYP450 1A2 isozyme such as fluvoxamine, may result in an increase of AUC and Cmax of duloxetine. Although no clinical data are available on a possible interaction with ciprofloxacin, similar effects can be expected upon concomitant administration (see section 4.4).<br />Ropinirole<br />It was shown in a clinical study that concomitant use of ropinirole with ciprofloxacin, a moderate inhibitor of the CYP450 1A2 isozyme, results in an increase of Cmax and AUC of ropinirole by 60% and 84%, respectively. Monitoring of ropinirole-related side effects and dose adjustment as appropriate is recommended during and shortly after co-administration with ciprofloxacin (see section 4.4).<br />Lidocaine<br />It was demonstrated in healthy subjects that concomitant use of lidocaine containing medicinal products with ciprofloxacin, a moderate inhibitor of CYP450 1A2 isozyme, reduces clearance of intravenous lidocaine by 22%. Although lidocaine treatment was well tolerated, a possible interaction with ciprofloxacin associated with side effects may occur upon concomitant administration.<br />Clozapine<br />Following concomitant administration of 250 mg ciprofloxacin with clozapine for 7 days, serum concentrations of clozapine and N-desmethylclozapine were increased by 29% and 31%, respectively. Clinical surveillance and appropriate adjustment of clozapine dosage during and shortly after co-administration with ciprofloxacin are advised (see section 4.4).<br />Sildenafil<br />Cmax and AUC of sildenafil were increased approximately twofold in healthy subjects after an oral dose of 50 mg given concomitantly with 500 mg ciprofloxacin. Therefore, caution should be used prescribing ciprofloxacin concomitantly with sildenafil taking into consideration the risks and the benefits.<br />Agomelatine<br />In clinical studies, it was demonstrated that fluvoxamine, as a strong inhibitor of the CYP450 1A2 isoenzyme, markedly inhibits the metabolism of agomelatine resulting in a 60-fold increase of agomelatine exposure. Although no clinical data are available for a possible interaction with<br />ciprofloxacin, a moderate inhibitor of CYP450 1A2, similar effects can be expected upon concomitant administration (see &#39;Cytochrome P450&#39; in section 4.4).<br />Zolpidem<br />Co-administration of ciprofloxacin may increase blood levels of zolpidem, concurrent use is not recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />The data that are available on administration of ciprofloxacin to pregnant women indicates no malformative or feto/neonatal toxicity of ciprofloxacin. Animal studies do not indicate direct or indirect harmful effects with respect to reproductive toxicity. In juvenile and prenatal animals exposed to quinolones, effects on immature cartilage have been observed, thus, it cannot be excluded that the drug could cause damage to articular cartilage in the human immature organism / foetus (see section 5.3).<br />As a precautionary measure, it is preferable to avoid the use of ciprofloxacin during pregnancy.<br />Breastfeeding<br />Ciprofloxacin is excreted in breast milk. Due to the potential risk of articular damage, ciprofloxacin should not be used during breast-feeding.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Due to its neurological effects, ciprofloxacin may affect reaction time. Thus, the ability to drive or to operate machinery may be impaired.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The most commonly reported adverse drug reactions (ADRs) are nausea and diarrhoea.<br />ADRs derived from clinical studies and post-marketing surveillance with ciprofloxacin (oral, intravenous, and sequential therapy) sorted by categories of frequency are listed below. The frequency analysis takes into account data from both oral and intravenous administration of ciprofloxacin.</p><table border="1" cellspacing="0" cellpadding="0" style="width:662px"><tbody><tr><td style="vertical-align:top"><p><strong>System Organ Class</strong></p></td><td style="vertical-align:top"><p><strong>Common</strong></p><p>&ge; 1/100 to &lt; 1/10</p></td><td style="vertical-align:top"><p><strong>Uncommon</strong></p><p>&ge; 1/1,000 to &lt; 1/100</p></td><td style="vertical-align:top"><p><strong>Rare</strong></p><p>&ge; 1/10,000 to &lt; 1/1,000</p></td><td style="vertical-align:top"><p><strong>Very Rare</strong></p><p>&lt; 1/10,000</p></td><td style="vertical-align:top"><p><strong>Frequency not known</strong></p><p>(cannot be estimated from the available data)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Infections and Infestations</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Mycotic super-infections</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Blood and Lymphatic System Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Eosinophilia</p></td><td style="vertical-align:top"><p>Leukopenia</p><p>Anaemia</p><p>Neutropenia</p><p>Leukocytosis</p><p>Thrombocytopenia</p><p>Thrombocytaemia</p></td><td style="vertical-align:top"><p>Haemolytic anaemia</p><p>Agranulocytosis</p><p>Pancytopenia (life-threatening)</p><p>Bone marrow depression (life-threatening)</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Immune System Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Allergic reaction</p><p>Allergic oedema / angiooedema</p></td><td style="vertical-align:top"><p>Anaphylactic reaction</p><p>Anaphylactic shock (life-threatening) (see section 4.4)</p><p>Serum sickness-like reaction</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Endocrine disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Syndrome of inappropriate secretion of antidiuretic hormone (SIADH)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism and Nutrition Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Decreased appetite</p></td><td style="vertical-align:top"><p>Hyperglycaemia</p><p>Hypoglycaemia (see section 4.4)</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Psychiatric Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Psychomotor hyperactivity / agitation</p></td><td style="vertical-align:top"><p>Confusion and disorientation</p><p>Anxiety reaction</p><p>Abnormal dreams</p><p>Depression (potentially culminating in suicidal ideations/thoughts or suicide attempts and completed suicide) (see section 4.4)</p><p>Hallucinations</p></td><td style="vertical-align:top"><p>Psychotic reactions (potentially culminating in suicidal ideations/ thoughts or suicide attempts and completed suicide) (see section 4.4)</p></td><td style="vertical-align:top"><p>Mania, incl. hypomania</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Headache</p><p>Dizziness</p><p>Sleep disorders</p><p>Taste disorders</p></td><td style="vertical-align:top"><p>Par- and Dysaesthesia</p><p>Hypoaesthesia</p><p>Tremor</p><p>Seizures (including status epilepticus see section 4.4)</p><p>Vertigo</p></td><td style="vertical-align:top"><p>Migraine</p><p>Disturbed coordination</p><p>Gait disturbance</p><p>Olfactory nerve disorders</p><p>Intracranial hypertension and pseudotumor cerebri)</p></td><td style="vertical-align:top"><p>Peripheral neuropathy and polyneuropathy (see section 4.4)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Eye Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Visual disturbances (e.g. diplopia)</p></td><td style="vertical-align:top"><p>Visual colour distortions</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Ear and Labyrinth Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Tinnitus</p><p>Hearing loss / Hearing impaired</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Tachycardia</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Ventricular arrhythmia and torsades de pointes (reported predominantly in patients with risk factors for QT prolongation), ECG QT prolonged (see sections 4.4 and 4.9)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Vascular Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Vasodilatation</p><p>Hypotension</p><p>Syncope</p></td><td style="vertical-align:top"><p>Vasculitis</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Respiratory, Thoracic and Mediastinal Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Dyspnoea (including asthmatic condition)</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td><td style="vertical-align:top"><p>Nausea</p><p>Diarrhoea</p></td><td style="vertical-align:top"><p>Vomiting</p><p>Gastrointestinal and abdominal pains</p><p>Dyspepsia</p><p>Flatulence</p></td><td style="vertical-align:top"><p>Antibiotic associated colitis (very rarely with possible fatal outcome) (see section 4.4)</p></td><td style="vertical-align:top"><p>Pancreatitis</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Increase in transaminases</p><p>Increased bilirubin</p></td><td style="vertical-align:top"><p>Hepatic impairment</p><p>Cholestatic icterus</p><p>Hepatitis</p></td><td style="vertical-align:top"><p>Liver necrosis (very rarely progressing to life-threatening hepatic failure) (see section 4.4)</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Rash</p><p>Pruritus</p><p>Urticaria</p></td><td style="vertical-align:top"><p>Photosensitivity reactions (see section 4.4)</p></td><td style="vertical-align:top"><p>Petechiae</p><p>Erythema multiforme</p><p>Erythema nodosum</p><p>Stevens-Johnson syndrome (potentially life-threatening)</p><p>Toxic epidermal necrolysis (potentially life-threatening)</p></td><td style="vertical-align:top"><p>Acute Generalised Exanthematous Pustulosis (AGEP)</p><p>Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)</p></td></tr><tr><td style="vertical-align:top"><p><strong>Musculo-skeletal and Connective Tissue Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Musculo-skeletal pain (e.g. extremity pain, back pain, chest pain)</p><p>Arthralgia</p></td><td style="vertical-align:top"><p>Myalgia</p><p>Arthritis</p><p>Increased muscle tone and cramping</p></td><td style="vertical-align:top"><p>Muscular weakness</p><p>Tendinitis</p><p>Tendon rupture (predominantly Achilles tendon) (see section 4.4)</p><p>Exacerbation of symptoms of myasthenia gravis (see section 4.4)</p></td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Renal and Urinary Disorders</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Renal impairment</p></td><td style="vertical-align:top"><p>Renal failure</p><p>Haematuria</p><p>Crystalluria (see section 4.4)</p><p>Tubulointerstitial nephritis</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>General Disorders and Administration Site Conditions</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Asthenia</p><p>Fever</p></td><td style="vertical-align:top"><p>Oedema</p><p>Sweating (hyperhidrosis)</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top">&nbsp;</td></tr><tr><td style="vertical-align:top"><p><strong>Investigations</strong></p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>Increase in blood alkaline phosphatase</p></td><td style="vertical-align:top"><p>Increased amylase</p></td><td style="vertical-align:top">&nbsp;</td><td style="vertical-align:top"><p>International normalised ratio increased (in patients treated with Vitamin K antagonists)</p></td></tr></tbody></table><p><u>Paediatric population</u></p><p>The incidence of arthropathy (arthralgia, arthritis), mentioned above, is referring to data collected in studies with adults. In children, arthropathy is reported to occur commonly (see section 4.4).</p><p><strong>To report any side effects:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Saudi Arabia</p><table border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&frac34;&nbsp;&nbsp;&nbsp; <strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call NPC at: + 966 112038222, Exts: 2317-2356-2353-2354-2334-2340</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Toll free phone: 8002490000</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&minus;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: www.sfda.gov.sa/npc</p></td></tr></tbody></table><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>An overdose of 12 g has been reported to lead to mild symptoms of toxicity. An acute overdose of 16 g has been reported to cause acute renal failure.<br />Symptoms in overdose consist of dizziness, tremor, headache, tiredness, seizures, hallucinations, confusion, abdominal discomfort, renal and hepatic impairment as well as crystalluria and haematuria. Reversible renal toxicity has been reported.<br />Apart from routine emergency measures, e.g. ventricular emptying followed by medical carbon it is recommended to monitor renal function, including urinary pH and acidify, if required, to prevent crystalluria. Patients should be kept well hydrated. Calcium or magnesium containing antacids may theoretically reduce the absorption of ciprofloxacin in overdoses<br />Only a small quantity of ciprofloxacin (&lt;10%) is eliminated by haemodialysis or peritoneal dialysis.<br />In the event of overdose, symptomatic treatment should be implemented. ECG monitoring should be undertaken, because of the possibility of QT interval prolongation.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Fluoroquinolones, ATC code: J01MA02<br />Mechanism of action:<br />As a fluoroquinolone antibacterial agent, the bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.<br />Pharmacokinetic/pharmacodynamic relationship:<br />Efficacy mainly depends on the relation between the maximum concentration in serum (Cmax) and the minimum inhibitory concentration (MIC) of ciprofloxacin for a bacterial pathogen and the relation between the area under the curve (AUC) and the MIC.<br />Mechanism of resistance:<br />In-vitro resistance to ciprofloxacin can be acquired through a stepwise process by target site mutations in both DNA gyrase and topoisomerase IV. The degree of cross-resistance between ciprofloxacin and other fluoroquinolones that results is variable. Single mutations may not result in clinical resistance, but multiple mutations generally result in clinical resistance to many or all active substances within the class.<br />Impermeability and/or active substance efflux pump mechanisms of resistance may have a variable effect on susceptibility to fluoroquinolones, which depends on the physiochemical properties of the various active substances within the class and the affinity of transport systems for each active substance. All in-vitro mechanisms of resistance are commonly observed in clinical isolates. Resistance mechanisms that inactivate other antibiotics such as permeation barriers (common in Pseudomonas aeruginosa) and efflux mechanisms may affect susceptibility to ciprofloxacin.<br />Plasmid-mediated resistance encoded by qnr-genes has been reported.<br />Spectrum of antibacterial activity:<br />Breakpoints separate susceptible strains from strains with intermediate susceptibility and the latter from resistant strains:<br />EUCAST Recommendations&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:94%"><tbody><tr><td style="vertical-align:top"><p><strong>Microorganisms</strong></p></td><td style="vertical-align:top"><p><strong>Susceptible</strong></p></td><td style="vertical-align:top"><p><strong>Resistant</strong></p></td></tr><tr><td style="vertical-align:top"><p><em>Enterobacteriaceae</em></p></td><td style="vertical-align:top"><p>S &le; 0.25 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 &nbsp;mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Salmonella spp.</em></p></td><td style="vertical-align:top"><p>S &le; 0.06 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.06 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Pseudomonas spp.</em></p></td><td style="vertical-align:top"><p>S &le; 0.5 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Acinetobacter spp.</em></p></td><td style="vertical-align:top"><p>S 1 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 1 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Staphylococcus spp.<sup>1</sup></em></p></td><td style="vertical-align:top"><p>S &le; 1 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 1 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Haemophilus influenzae</em></p></td><td style="vertical-align:top"><p>S &le; 0.06 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.06 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Moraxella catarrhalis</em></p></td><td style="vertical-align:top"><p>S &le; 0.125 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.125 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria gonorrhoeae</em></p></td><td style="vertical-align:top"><p>S &le; 0.03 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.06 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Neisseria meningitidis</em></p></td><td style="vertical-align:top"><p>S &le; 0.03 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.03 mg/L</p></td></tr><tr><td style="vertical-align:top"><p><em>Non-species-related breakpoints</em><strong><em>*</em></strong></p></td><td style="vertical-align:top"><p>S &le; 0.25 mg/L</p></td><td style="vertical-align:top"><p>R &gt; 0.5 mg/L</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>1 <em>Staphylococcus</em> spp. - breakpoints for ciprofloxacin relate to high dose therapy.</p><p>* Non-species-related breakpoints have been determined mainly on the basis of PK/PD data and are independent of MIC distributions of specific species. They are for use only for species that have not been given a species-specific breakpoint and not for those species where susceptibility testing is not recommended.</p></td></tr></tbody></table><p>The prevalence of acquired resistance may vary geographically and with time for selected species and local information on resistance is desirable, particularly when treating severe infections. As necessary, expert advice should be sought when the local prevalence of resistance is such that the utility of the agent in at least some types of infections is questionable.<br />Groupings of relevant species according to ciprofloxacin susceptibility (for Streptococcus species see section 4.4)&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:95%"><tbody><tr><td style="vertical-align:top"><p><strong>COMMONLY SUSCEPTIBLE SPECIES</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Bacillus anthracis </em>(1)</p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Aeromonas </em>spp.</p><p><em>Brucella </em>spp.</p><p><em>Citrobacter koseri</em></p><p><em>Francisella tularensis</em></p><p><em>Haemophilus ducreyi</em></p><p><em>Haemophilus influenzae*</em></p><p><em>Legionella </em>spp.</p><p><em>Moraxella catarrhalis*</em></p><p><em>Neisseria meningitidis</em></p><p><em>Pasteurella </em>spp.</p><p><em>Salmonella </em>spp.<em>*</em></p><p><em>Shigella </em>spp.<em>*</em></p><p><em>Vibrio </em>spp.</p><p><em>Yersinia pestis</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Anaerobic micro-organisms</u></p><p><em>Mobiluncus</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other micro-organisms</u></p><p><em>Chlamydia trachomatis</em> ($)</p><p><em>Chlamydia pneumoniae</em> ($)</p><p><em>Mycoplasma hominis </em>($)</p><p><em>Mycoplasma pneumoniae</em> ($)</p></td></tr><tr><td style="vertical-align:top"><p><strong>SPECIES FOR WHICH ACQUIRED RESISTANCE MAY BE A PROBLEM</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Enterococcus faecalis</em> ($)</p><p><em>Staphylococcus </em>spp. *(2)</p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Acinetobacter baumannii<sup>+</sup></em></p><p><em>Burkholderia cepacia<sup>+</sup> *</em></p><p><em>Campylobacter </em>spp.<em><sup>+</sup> *</em></p><p><em>Citrobacter freundii*</em></p><p><em>Enterobacter aerogenes</em></p><p><em>Enterobacter cloacae*</em></p><p><em>Escherichia coli*</em></p><p><em>Klebsiella oxytoca</em></p><p><em>Klebsiella pneumoniae*</em></p><p><em>Morganella morganii*</em></p><p><em>Neisseria gonorrhoeae*</em></p><p><em>Proteus mirabilis*</em></p><p><em>Proteus vulgaris*</em></p><p><em>Providencia </em>spp.</p><p><em>Pseudomonas aeruginosa*</em></p><p><em>Pseudomonas fluorescens</em></p><p><em>Serratia marcescens*</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Anaerobic micro-organisms</u></p><p><em>Peptostreptococcus </em>spp.</p><p><em>Propionibacterium acnes</em></p></td></tr><tr><td style="vertical-align:top"><p><strong>INHERENTLY RESISTANT ORGANISMS</strong></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-positive micro-organisms</u></p><p><em>Actinomyces</em></p><p><em>Enteroccus faecium</em></p><p><em>Listeria monocytogenes</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Aerobic Gram-negative micro-organisms</u></p><p><em>Stenotrophomonas maltophilia</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Anaerobic micro-organisms</u></p><p><em>Excepted as listed above</em></p></td></tr><tr><td style="vertical-align:top"><p><u>Other micro-organisms</u></p><p><em>Mycoplasma genitalium </em></p><p><em>Ureaplasma urealitycum</em></p></td></tr><tr><td style="vertical-align:top"><p>* Clinical efficacy has been demonstrated for susceptible isolates in approved clinical indications</p><p><sup>+ </sup>Resistance rate 50% in one or more EU countries</p><p>($): Natural intermediate susceptibility in the absence of acquired mechanism of resistance</p><p>(1): Studies have been conducted in experimental animal infections due to inhalations of <em>Bacillus anthracis</em> spores; these studies reveal that antibiotics starting early after exposition avoid the occurrence of the disease if the treatment is made up to the decrease of the number of spores in the organism under the infective dose. The recommended use in human subjects is based primarily on <em>in-vitro</em> susceptibility and on animal experimental data together with limited human data. Two-month treatment duration in adults with oral ciprofloxacin given at the following dose, 500 mg bid, is considered as effective to prevent anthrax infection in humans. The treating physician should refer to national and/or international consensus documents regarding treatment of anthrax.</p><p>(2): Methicillin-resistant <em>S. aureus</em> very commonly express co-resistance to fluoroquinolones. The rate of resistance to methicillin is around 20 to 50% among all staphylococ</p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Following oral administration of single doses of 250 mg, 500 mg, and 750 mg of ciprofloxacin tablets, ciprofloxacin is absorbed rapidly and extensively, mainly from the small intestine, reaching maximum serum concentrations 12 hours later.<br />Single doses of 100750 mg produced dose-dependent maximum serum concentrations (Cmax) between 0.56 and 3.7 mg/L. Serum concentrations increase proportionately with doses up to 1000 mg.<br />The absolute bioavailability is approximately 7080%.<br />A 500 mg oral dose given every 12 hours has been shown to produce an area under the serum concentration-time curve (AUC) equivalent to that produced by an intravenous infusion of 400 mg ciprofloxacin given over 60 minutes every 12 hours.<br />Distribution<br />Protein binding of ciprofloxacin is low (2030%). Ciprofloxacin is present in plasma largely in a non-ionised form and has a large steady state distribution volume of 23 L/kg body weight. Ciprofloxacin reaches high concentrations in a variety of tissues such as lung (epithelial fluid, alveolar macrophages, biopsy tissue), sinuses, inflamed lesions (cantharides blister fluid), and the urogenital tract (urine, prostate, endometrium) where total concentrations exceeding those of plasma concentrations are reached.<br />Biotransformation<br />Low concentrations of four metabolites have been reported, which were identified as: desethyleneciprofloxacin (M 1), sulphociprofloxacin (M 2), oxociprofloxacin (M 3) and formylciprofloxacin (M 4). The metabolites display in-vitro antimicrobial activity but to a lower degree<br />Ciprofloxacin is known to be a moderate inhibitor of the CYP 450 1A2 iso-enzymes.<br />Elimination<br />Ciprofloxacin is largely excreted unchanged both renally and, to a smaller extent, faecally. The serum elimination half-life in subjects with normal renal function is approximately 47 hours.<br />&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:95%"><tbody><tr><td colspan="3" style="vertical-align:top"><p>Excretion of ciprofloxacin (% of dose)</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p>&nbsp;</p><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p><strong>Oral Administration</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Urine</strong></p></td><td style="vertical-align:top"><p><strong>Faeces</strong></p></td></tr><tr><td style="vertical-align:top"><p>Ciprofloxacin</p></td><td style="vertical-align:top"><p>44.7</p></td><td style="vertical-align:top"><p>25.0</p></td></tr><tr><td style="vertical-align:top"><p>Metabolites (M<sub>1</sub> -M<sub>4</sub> )</p></td><td style="vertical-align:top"><p>11.3</p></td><td style="vertical-align:top"><p>7.5</p></td></tr></tbody></table><p><br />Renal clearance is between 180300 mL/kg/h and the total body clearance is between 480600 mL/kg/h. Ciprofloxacin undergoes both glomerular filtration and tubular secretion. Severely impaired renal function leads to increased half-lives of ciprofloxacin of up to 12 h.<br />Non-renal clearance of ciprofloxacin is mainly due to active trans-intestinal secretion and metabolism. 1% of the dose is excreted via the biliary route. Ciprofloxacin is present in the bile in high concentrations.<br />Paediatric patients<br />The pharmacokinetic data in paediatric patients are limited.<br />In a study in children Cmax and AUC were not age-dependent (above one year of age). No notable increase in Cmax and AUC upon multiple dosing (10 mg/kg three times daily) was observed.<br />In 10 children with severe sepsis Cmax was 6.1 mg/L (range 4.68.3 mg/L) after a 1-hour intravenous infusion of 10 mg/kg in children aged less than 1 year compared to 7.2 mg/L (range 4.711.8 mg/L) for children between 1 and 5 years of age. The AUC values were 17.4 mg*h/L (range 11.832.0 mg*h/L) and 16.5 mg*h/L (range 11.023.8 mg*h/L) in the respective age groups.<br />These values are within the range reported for adults at therapeutic doses. Based on population pharmacokinetic analysis of paediatric patients with various infections, the predicted mean half-life in children is approx. 45 hours and the bioavailability of the oral suspension ranges from 50 to 80%.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazards for humans based on conventional studies of single dose toxicity, repeated dose toxicity, carcinogenic potential, or toxicity to reproduction.<br />Like a number of other quinolones, ciprofloxacin is phototoxic in animals at clinically relevant exposure levels. Data on photomutagenicity/photocarcinogenicity show a weak photomutagenic or phototumorigenic effect of ciprofloxacin in-vitro and in animal experiments. This effect was comparable to that of other gyrase inhibitors.<br />Articular tolerability:<br />As reported for other gyrase inhibitors, ciprofloxacin causes damage to the large weight-bearing joints in immature animals. The extent of the cartilage damage varies according to age, species and dose; the damage can be reduced by taking the weight off the joints. Studies with mature animals (rat, dog) revealed no evidence of cartilage lesions. In a study in young beagle dogs, ciprofloxacin caused severe articular changes at therapeutic doses after two weeks of treatment, which were still observed after 5 months.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Inactive ingredients: Microcrystalline cellulose, sodium startch glycolate, maize starch, talc, magnesium stearate, colloidal anhydrous silica, hypromellose, macrogol 400, titanium dioxide indigocarmine (E132).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Protect from light, store in a dry place. Do not store above 30 C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0" style="width:389px"><tbody><tr><td><p><strong>Immediate packaging</strong></p></td><td><p><strong>Outer packaging</strong></p></td></tr><tr><td style="vertical-align:top"><table border="0" cellspacing="0" cellpadding="0" style="width:421px"><tbody><tr><td style="vertical-align:top"><p>PVDC</p><p>Aluminum foil</p></td></tr></tbody></table></td><td style="vertical-align:top"><p>Carton</p><p>Leaflet</p></td></tr></tbody></table><p>Pack sizes of 8, 10, and 500 film coated tablets<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Dar Al Dawa Development & Investment Co. Ltd.
P.O.Box 9364
Na’ur - Jordan
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                23/05/2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="data:image/png; base64,iVBORw0KGgoAAAANSUhEUgAABAAAAAQACAYAAAB/HSuDAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyZpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8&#x2B;IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDcuMC1jMDAwIDc5LmRhYmFjYmIsIDIwMjEvMDQvMTQtMDA6Mzk6NDQgICAgICAgICI&#x2B;IDxyZGY6UkRGIHhtbG5zOnJkZj0iaHR0cDovL3d3dy53My5vcmcvMTk5OS8wMi8yMi1yZGYtc3ludGF4LW5zIyI&#x2B;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&#x2B;IDwvcmRmOlJERj4gPC94OnhtcG1ldGE&#x2B;IDw/eHBhY2tldCBlbmQ9InIiPz6u6p4rAANKO0lEQVR42uzdB3wUdf7/8c&#x2B;W9EYqJIFQQ28hQOidIE2qKNgRzo6enpxy6s9ezsepx9nu/P3PdufP3hUbKCqoqFQRFUEwdEILASlJ9j8zkLCZzMzOllRez7s1YbO72WwGks97Pt/P1&#x2B;HxeAQAAAAAADRsTl4CAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAEAAAAAAAAAACAAAAAAAAQAAAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAAAIAAAAAAABAAAAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAEAAAAAAAAAACAAAAAAAAAABAAAAAAAAIAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAAAAAIAAAAAAABAAAAAAAAAAAEAAAAAAAAgAAAAAAAAAAQAAAAAAACAAAAAAAAAABAAAAAAAAAAAgAAAAAAAEAAAAAAAAAACAAAAAAAACAAAAAAAAAABAAAAAAAAKC&#x2B;cdf2E3A4HHwXAAAAAACnBY/HU2ufmw4AAAAAAABOAwQAAAAAAAAQAAAAAAAAgIbAzUsAAADqiOoeDOThJQYAEAAAAADU7&#x2B;I&#x2B;lM&#x2B;BoAAAQAAAAABQT4r9UD9/QgEAAAEAAACg4K/Fz&#x2B;mpha&#x2B;RMAAAQAAAAAAo&#x2B;mv4sQK5ryeEz5cwAABAAAAAACj6/bi/I8jHsFuIe0LwGEbPhyAAAEAAAAAATtvC3&#x2B;HHYzlq6TlaBQOeAD8/YQAAgAAAAACcdkW/I8DHDdUSA0&#x2B;Aj&#x2B;sJoqgnDAAAEAAAAIAGWfhbFfmOAO8XbBDgsVGMe2x&#x2B;nlCEAQQBAAACAAAAcNoU/Y4AQoJAnp/ZOn&#x2B;HQTjg8TMQCDQMoCsAAEAAAAAAGmzRb/RxRwge124IYPa&#x2B;wyQUMAsE7IQBdAUAAAgAAABAgyr87Rb9jiBv48/1HpPb&#x2B;FoG4DEo5PX389gMA3w9H19fB2EAAIAAAAAA1HrRH2xB7&#x2B;/H/X3Ovtbvi67Q1xfzHhtBglUY4DF5nzAAAEAAAAAA6lXRH2hRH&#x2B;jH7DwfX8W&#x2B;VcFf/jGzHQI84rs7QIQlAgAAAgAAAFCPC39/WvztFvZW1/sKEQINAIwGAXpMggGjQMAqDLDTFSAWz4WuAAAAAQAAAKiVot9X4W9VqPsq&#x2B;h02wgN/5gb44rG4zmMSFJgV8x6LMMD7eQUaBtAVAAAgAAAAANVS9FsV&#x2B;v4W/WaFvD/XSQBBgD8FcTCFv511/x4JfIkAXQEAAAIAAAAQ8sI/VFP8/S3wHRaBQTDdAHbYKf6Nin6PRZFvFAYYhQZ0BQAACAAAAECtFP2&#x2B;Cn9/W/zNCnqrP1vdxs7nrKni3&#x2B;h6szBAPzPAaomA2AgCzL4Of77XhAEAAAIAAABOw8Lfztn&#x2B;YFr8g/2z1XUSRAhgJwDw&#x2B;BEIlBkU&#x2B;Q6Tx3AYhAR2uwLYThAAQAAAAABFv1/3sTNMz5&#x2B;z/VZFe3WGAoG&#x2B;HmaFvVUAYPVnh&#x2B;56q8LfYxIC6L8HRh9nO0EAAAEAAAAU/baLfjuBgK&#x2B;z/f62&#x2B;Af6sUADALPt/Yyu8wQQAJSZfKzMz&#x2B;DAzuBA70BAhMGBAAACAAAAKPx9FPq&#x2B;zvZXV4u/00bR7xT/OwJ8hRxiUfRbhQC&#x2B;CvcyXcFepiu&#x2B;PRahgdEZfX9nBTA4EABAAAAAAEW/YQEvPj4WbIu/VQFvt&#x2B;i3c3&#x2B;7gYWdAMCfoX8ek6LdVxig7xJwSOi6AthOEABAAAAAAEW/rUAg1Gf77Rb3Ru8H2w0QTADgz1l/j9fzK7MIA8wKfqvPYVX46z9PqLYTDCQMIAgAAAKA04PHw888AECIq35FkIV/oC3&#x2B;RsW0v0V/&#x2B;Z99tfh738Yp9joE/JkNUOlrb926dfjs2bNbTJ06dVxaWlr3JUuWPPvAAw8sW7RoUZFJEGAnBHCa/NkoDAjmYlb4V8d2goEsEXB4/V5U734xUp&#x2B;y9185/Z&#x2B;9f99Tr1ffLysrE5fLpV1XWlqqvV9SUirld3M6ndptyt8vLVVvf&#x2B;IwV2/v8ah/diu3KdVuo96//HHUt&#x2B;p91Ev55z1&#x2B;/Lh235KSEgkLc8tx9a16f/W5Oh3iUm6rfn71/upjevTfUVGfs0ecynNwKU&#x2B;yVHm//OuIjo6Sw4d/124Wo7x/5MhR7fpS5eJUbus4&#x2B;TzU56zeKDw8TI4cPSbxcbGy/0CR9jnV26nPKTwsTHucw4cPS2RkpHY/9Xa/H/ldeX5lpw5S5bHLTn7skHJbz8nneOL/Hik/itTP2SghQXtNDhYf1r429XWMi41V/nxIvYH2PMOUz3vie3LidTh27JhEhIcrX69Le83KX4fomCg5pjx39TZO5XUrKS3Vvqfl3yuX06V8vcrXGBauPOcjyvNUHl/9Xp18DdTXIiE&#x2B;Tvbt2699H9TXVHVU&#x2B;Xzq66C8WtpzUJ/vie9bifb46m3dbrfs3l0ojRo1qvh8J44DV8X3Qr00zcyQwj17lPu5tNdRPQ6Ki4slJjZa1G9BRESE8j06UnH8qfctKS3Rvt7Sk49Rfr36/TimHDsVz//kP0zq16V&#x2B;/UVFxdpr4tSOCfX77VSep0syM9Jlc8EW7T7q1&#x2B;LWjjXlsZXjOEz5/qtv1e&#x2B;TS3mO4vBoX6f69amvtfr5U1OTpbBwb8Xxq35MvV597VJTU6ToYLHs3LlLig8dlri4GDmqfE/ClNu4lM&#x2B;tvq&#x2B;&#x2B;Ztrxf/JrKf&#x2B;LlZKUKMXKsXrs2FE5fuy4JCl/PnDgoPZc1M/tPvn9Vj&#x2B;rekzExsRor2WHdtnyy4ZftcdQv&#x2B;fq51K/l&#x2B;rxo/6dUI/5rp07yroff9Zuo35f1ddUfd4x0dHSulULfjEhAAAAoM4V/b4K/0Bb/CUEhb4/AYD&#x2B;OrOAQH8bw8L/nnvuaZ&#x2B;fn5&#x2B;XnZ09KD4&#x2B;vlP59Weccca9/fv3X//DDz&#x2B;8d/XVV7&#x2B;9efPmI7t27SrxEQCYDfwrf7/MIAwwCwD097F6398lArW2naD3cezhLAkAEAAAAICgin6rQr&#x2B;mW/yNinCnwftOk&#x2B;LfznW&#x2B;QoEqz6lt27ZRU6dOzZwzZ85lycnJXd1ud4zRixgXF5edl5c3Z/HixdMKCwvX/PLLL6tuvPHGhcuWLTtoUmgbFehmZ/7LLK4zWrfvEd9LBUSMOwvMHqdWtxMsP74JAgCAAAAAAAr/6in67RT&#x2B;oWjxD9UZfqPC3yocMA0C5s2blz158uSBrVq16pWYmNjJ7usaFRWV3qxZM/WS/9FHH03Ytm3b99u3b980bNiwN3SFu0tOnb136Qp67zP73oW/WTeAUQDgq0PA320J68R2gnQFAAABAAAAFP3&#x2B;Ff2&#x2B;Cv9AWvwlBIW&#x2B;iP0z996FvP5jTgmgO2D27NlNp02blqs4Iy4urrnb7Y4O5vsUHx/fVr20b99eCgsL85cvX/7Bgw8&#x2B;uOT999/fa1Cg60OAMqk8F8DoY1ahgHfRb3SW3mrXAKvtBEWs5weI1NB2gnQFAAABAAAAFP72Cn2zs/11scXf6sy&#x2B;08d1loFAQkKC&#x2B;6mnnhres2fP/hkZGb1cLldkdXzvkpOTO48cObJz//79z/v222/f&#x2B;PXXX7c8&#x2B;uijq7755puDJiGAnYJff1tfoYBRV0Ag2wmatfsHu52gUTDg198LwgAAIAAAAICi37roF/F/oJ9ZEBDKFn&#x2B;HjSLf7Oy/ZUBwzTXXtFAK8k59&#x2B;/Ydm5iYmB3EDAW/REdHNx40aNClAwYMKJkyZcqOjz766D8//vjj9n/&#x2B;85/rN2/e/LtJCKAPA/ShgHfhX/51GIUCRgV6mUnBbzY4sDq3EwzZ4ECCAAAgAAAA4HQp&#x2B;n0V/v4O9Aumxd&#x2B;7ODcr8P1dz2/3baXrevfuHXfHHXcM79ChQ/eMjIwewbb4B8PpdLpjY2ObTpo06cbjx48XX3HFFTsef/zxx5555plffvzxx8MWIYDdt1ahgNlwP6vlAfVqO0G6AgCAAAAAgIZe&#x2B;Ptztr86WvzN2vqDafEPpPCveNu8efPIu&#x2B;&#x2B;&#x2B;u2///v0HZGZm5oaFhcXWte&#x2B;7&#x2B;pwSEhLa3HDDDfddddVVu5cuXfrmI488smTjxo3Fa9euPaQr7ssvTh9vjQp/o8GB&#x2B;u4C7&#x2B;us3mc7QQAAAQAAADVc9OsLePHxsWBb/L2LeBH7Lf52h/L529rv0l/vdrudXbt2jbvnnnuG5uTkDElLS&#x2B;tcH44Fl8sVHhsbm5mfn3/FgAEDzjp8&#x2B;PDuZcuWfXzDDTcs&#x2B;uGHH4p1xb0&#x2B;FLDTDRDIbgK1tZ2gUcEvuuKfwYEAQAAAAMBpVfTbCQRCfbbfTou/SOBb9gXy1jl06NCk2bNnd&#x2B;/Tp0/fZs2a5bnd7qj6eoxER0enqpcxY8Z0HDBgwMR9&#x2B;/b9tmrVqmUTJkx432bxXyr&#x2B;Dw60u52g/n3vojxU2wnqi32zgIuuAAAgAAAAoEEW/oG2&#x2B;BsV9P4W/SJV2/qN1vBbFfsi9qb32yr41fdbtWoVde2113YaN27cmLS0tLYxMTFNGtpxEx8fn6VemjdvPqCgoKDf2rVrV9x1112ffPHFF/vE99KAQAYHOkyKf7udASKBbSeoL&#x2B;DZThAACAAAADitin5fhX&#x2B;gLf4SYKEfSJt/sGf9nfrr8/LyEq6&#x2B;&#x2B;urcsWPHntWoUaM2p8vx1LRp0z7qZcCAAZPWrl37yTbFDTfc8Nkvv/xySPxfGqB/W15oG&#x2B;0cUBPbCYqEbnCgGNzW9t9VwgAAIAAAAKA6i36rQr&#x2B;mW/xFqq7ztzvQz85Zf19n/w1vrxS9SRMnTmw5efLk0Y0bN&#x2B;4YFRWVWlPb99U1aqdD7969p6vvDxkyZPLq1as/2bhxY8HNN9/8zdatW49IYIMDrZYM1NZ2ggwOBAACAAAAGkzhX9da/O2e4Rexv8Y/qLX9jz/&#x2B;eO&#x2B;8vLzubdu2HagUvo050ipr1KhRy0GDBrUcMGDA8VGjRq154403Xn/nnXc2vPfee7vFvBMglNsJitTudoIOk0BBjyUCAEAAAABArRb9vgr/QFr8JQSFvr6YtxMA&#x2B;DO937LVf/jw4cnnn39&#x2B;lwkTJpyjrn93Op1hHG3W1NcoPT29xx/&#x2B;8IfO55577o6vvvpqwQcffLBi0aJFO1euXHnQIggIxXaC3tfV9HaC&#x2B;kBAhK4AACAAAACgDhX&#x2B;ds7218UWfzvr&#x2B;P0a5Of11vXoo4/2GjhwYK&#x2B;WLVvmxsbGNq0r32&#x2B;13jtxKZM9e/bIvn37JSIiQn77bbPExydo1&#x2B;/atVsSEuIlMzNTjh49pr09duyYcl1CjT5XdTtBNTTJz8&#x2B;/dMiQIQeLi4u3f/HFFwv&#x2B;/e9/L/v4448LDx06pO4QoN8lwE53ANsJ6v7&#x2B;EwQAAAEAAICiP5iiX8T/gX5mQUBttPiLUWFvdvusrKyo8847r/mECRP6t2/ffoBS9Kc7nc468bvBgQMHZMuWAvn1119l7drvZceOnepZdikuPiiNG6dLUdEBad68uRQW7laKbrfaii&#x2B;HDh2Wffv2itvt0kKA48ePS1ZWM/n99yNy5pkTtNtHR0dLVFSU1MT4gvDw8LikpKS4M888s&#x2B;3IkSN3K8X/7gceeODR//73v5tPzgqwsySgTKqe1a8P2wn6MziQrgAAIAAAAFD013qLv6/iX/wo9L2Lc30xb7fFP9j1/VoY0LFjx5h///vfU1u1atU9JSWlg/Iyu&#x2B;rC9/vo0aOyZMkSee&#x2B;9d5TCfo&#x2B;UlByXpk2bydChQ5VCPksOH/5dcnNzlSJ/nyQmJiofL1GK/cq/yqjXFRcXa4GAGiBs2bJFCgq2yPjx4yQnJ0cmT54sZ511ltY5UJPUoYnq5c4777z3mmuuWb9ixYovb7311k9&#x2B;&#x2B;umn4pNdAeUFvHd3gL5LINClAvrtBEWstxa0MzjQ13aC/gwONAsD6AoAAAIAAACFv8/CP9CBfqFq8Tdr6w&#x2B;mxT&#x2B;QNf0V1zVp0iTiD3/4Q/bo0aN7d&#x2B;3adXh0dHSdGei3du1aeeedt&#x2B;WTTz6RJk3SZcSI4dKtWzdp1ixL4uLi1Lb6SrdXi3/tlxh31V9j1OvU4l918OBB2bBhgyxe/KlcfvnlMnLkSOncuYv2eKtWrZQFCxZIXl6eDBw4yPCxqkN4eHh8RkZGrjovYPDgwZO3b9/&#x2B;w&#x2B;rVq1fcf//9X33zzTcHDIr&#x2B;6tpO0GhugNF2gh6pp9sJlpWVEQYAAAEAAKCBFv36Al58fCzYFn/vIl7Efou/WaFvVeyL2Dy77319fHx82Pjx4xtfddVVI9u0adMjKSkpu660&#x2B;KvUNfr33nu3Uvy/oxT83eXuu&#x2B;&#x2B;W3NyeAT9eaWmp7NixQwsTli37Wg4dOiTt27eXOXOuVQr/zrJ58yZ55pmnZcmSL2Tnzp3SokVLeeWVV7Tugief/F9JTk6u0eM9NjY2Izs7O0P53gwbPnz45oKCglXKa/H5vHnz1hgU/zW5naBI9Q4OrJHtBJVjnSUCAEAAAABooEW/nUAg1Gf77bT4i9hfzx&#x2B;KLfycY8aMSVWK/n49evQY1Lhx46519ft/zz33yIoVK&#x2B;Tpp5&#x2B;VTp06BRUkvPLKy/Lll19qbf/qY1100cXSs2dPiYqKlu&#x2B;&#x2B;&#x2B;1Zmz75ENm7cKNnZbWXMmLFyxhmjJSUlRZsx8Mc/XiNXXXWF/N//vVhbfw&#x2B;c6naC6qV9&#x2B;/Yj8vPzF/z888&#x2B;//P3vf//u66&#x2B;/PiC1s52gr8GBVtsH1tntBOkKAEAAAABA/Sv8A23xNyro/S36Raq29Rut4bc70C/QFv9Krf6pqanh48aNazJz5swhOTk5I2NiYtLr6vdfPRn70EMPyvz5f5clS5ZKhw4dAn4steifN&#x2B;9GadWqtUycOFGU10A5vpyydetW&#x2B;d///V&#x2B;tE6CwsFAmT54iN930F2nRooU2TLBcy5Yt5eWXX9FCg2effUYuuODCWn1twsLCYnNzc89SLp7hw4f/8PPPPy9fuXLlD4888sgPP/300yGLIt9odoBVN4Dd7QTNthY0Wy5g9WcR68GB3s9BpBoGB3p3BRAGACAAAACg7hb9vgr/QFv8JcBCP5A2/2DP&#x2B;ldZ2z979uysqVOn9uzcuXNvdW15fTgW1q9fL/fff5&#x2B;21t/f4n/79u2yd&#x2B;/eio6B9PQm0rt3nvzyyy&#x2B;yYsVKbXjgp58ukoKCAsnOzlY&#x2B;x0gZPXqMpKWlWRTd4dK/f395&#x2B;umnaj0A8D5mlefcSb3069fv&#x2B;FlnnbXum2&#x2B;&#x2B;&#x2B;fSrr75a/8wzz2zcsmXLUTFeGhDq7QS9hwU6xHz9vz4YCGVXgD9hgO2ivjwMYHkAAAIAAABqr&#x2B;i3KvRrusVfpOo6f6fB9XbW84tFcW9rkJ/61u12uwYOHJh41VVX9e7bt&#x2B;&#x2B;QpKSk1hEREY3q03GhDubbtatQ8vPzbd1enfq/fPl38tprr8qePXulqGi/NGmSIZdffqW0bNlC7r77Htm4cYN8/fVX8u6772rD/oYNGy5ZWc2rDBA0P1ad2i4EdZFSqIapSznGjRvXVXnNii688MJvHn300ZcXLVq0Y82aNcUS&#x2B;MBAq6UCTrFu/7caHOhrRwERthMEAAIAAMBpXfjXtRZ/u2f4Raq3xb8iDLjooosyZ86cOTgvL2&#x2B;Kusd8fT0&#x2B;1Lb72NhY&#x2B;eqrr2XWrD&#x2B;Y3k490//222/JBx98oG6jJ&#x2B;PHj9fO1KtefPFF5c9jRSmM5c4775Qzz5wgbdu2k/PPD&#x2B;wM/scffyS33HJLnX/t1F0EsrOzhz/00EODd&#x2B;zYsXrZsmWLX3rppZVvvvnmDhvbCdoZHGhnO0GzDgE7uwZYFf76gj9U2wn6HQaUlJQQBAAgAAAAoBqLfl&#x2B;FfyAt/hKCQl9f4NsJAPyZ3m86zT8iIkId6Jd2zjnndB08eHB&#x2B;YmJiC6UAbFTfj5XWrVvLvHk3yf33368U3bdK8&#x2B;bNKz62a9cuWb16lSgFrWzdukVatWojt912m1bcq50AS5cukXfeeUu53W6ZOnWK5OTkKpceAT&#x2B;XoqIiue66P0q3bl3l/PMvqE9/39zqVoITJkzoccYZZ&#x2B;zbvXv3&#x2B;nffffdt5bLx7bff3inVu52gR8yXBRh1CPgKBkSqdztBv5cIuN3uisciDABAAAAAQOgKfztn&#x2B;2ujxd&#x2B;swLezxt/fs/6VrmvZsmX0fffdNyA3N7dnVlZWb3UwXEM6ZpSvR266aZ5W0M&#x2B;de4PMm/cX2bNnj3zyySJZt26dxMfHy9ixY2Xo0GGSlJSktfbfeOOftYF&#x2B;cXFxMmrUGdKvX3/p3r17wM9B3TlA3Q7w4Ycf1nYi&#x2B;PbbbyUyMrJevp4RERGJTZs27T179uwe5513XuG2bdu&#x2B;v/nmm5956aWXdpoU//50BxgNEDQr/L2HBTaY7QS9w4DjxwkDABAAAAAo&#x2B;quj6Bfxf6CfWRBQnS3&#x2B;VsW9QywG&#x2B;OlDgGnTpjW&#x2B;/PLLB/fv3/8cpeiIVreHa8jH0Z133iV33XWH3H777ZKQEC99&#x2B;/aVmTNnSsuWraSo6IB888238vLLL8qOHTuUYj9HHnroYWnfvoNa8Ab0&#x2B;UpLS2XXrp2yYMH7snDhR7J//37Jy&#x2B;srjz32uKSlNa73r6fT6XTHxMQ0yc7ObvLUU091ve&#x2B;&#x2B;&#x2B;35aqFDeX7t06dL94v/AwJrYTlC8ggOrwYFm2wWKRUhg9u&#x2B;LUTBgM7xyn9xOkFkBAAgAAAAU/VZFv6/C39&#x2B;BfsG0&#x2B;HsX8CKBtfgHu65fa/Vv2bJl1Mmz/b2aNWvWIzw8POF0OabUQv7mm29Vt2NTjy/tDPyaNavl2muv0Vr91SPu/PMvknvvvU8SE5P8fnx1npt62bJli3z66afaIMGCgs2SkdFUzj77HBk4cJDyuIkN8rWNjo5OU46ttJkzZ&#x2B;ZNnDjxl8LCwoL33nvv40cfffTHjRs3/m5R/Id6O0GzDgGPQfFdj7YTPPXvYWkp2wkCIAAAAFD42yn6zQp5X9f7O9DP6eN9f1v8/R7g531dnz59EpTCrHO/fv16tW3bdojb7Y4JYseEeh8CeIuKipYWLVrIkSNHJTIyXNav/1lefvkVrUMgOjpGUlNTT/wC43ZJmzbZ2o4CSrGrTfHftGmjNvVfPTe7atVKOXTokOzdu095rN8lLS1VBgwYKP36/VkyMjJOm9fX6XSGp6SkdFQv7dq1Gz5t2rTvdu7cuXn&#x2B;/PnvPfvss1t1QYBRd4A&#x2B;KPDYCAccYr4sIFTbCYpYzw8QqaHtBF2uE9sJHj9&#x2B;nCAAAAEAAOC0LPr1Bbz4&#x2B;FiwLf7eRbyI/RZ/s0LfqtgX8WOQn&#x2B;im&#x2B;P/5z38&#x2B;Oz09vW1CQkKrhnr8HDx4UAoLC&#x2B;WZZ55WW6aVwvw3pQBPUYrvAdK7d&#x2B;&#x2B;KIt5ImzZt5Npr/6i9rw4EVIv3r7/&#x2B;WkpLS&#x2B;THH3&#x2B;UpUuXalv/bdq0SWvpd7vd2tvo6CjtPsnJqVJScly6deumdRaonQN5eXlaJ8BpmrF4/712N23aNE&#x2B;9PProo/1nz569aNmyZWtvv/32VUVFRcel/m0naNbuH&#x2B;x2gkbBgE9hYWEVj6Uce4QBAAgAAACnTdFvJxAI9dl&#x2B;Oy3&#x2B;IvbX84ekxV8pROPmzJnTTSl8e3To0CHf5XJFNJRjZv78v2vt9YMGDZYBAwZIo0aNtLPuDzxwv/ztbw8qhXcfmTJlssTGFsp//vMf&#x2B;cc//qEV5dddd72cc8450qFDJ7E66tLS0rS3WVmndglQ769Si/7Dhw9r2wkeP35cO/OvXpxOp9nxzV9yL8rrlql8z85Xv29Tp05dunbt2uUrV678dd68easl8IGBVjMCrHYTKL&#x2B;dUcFvNjiwOrcTDHpwoHIcVtzH42FeAAACAABAwyn8A23xNyro/S36Raq29Rut4bc70C/QFv9Krf6ZmZmRs2fPbj1t2rQzMjIyOiQkJLRoiMeO2r7/1Vdfyr/&#x2B;9aQ0b95MJk6cJPn5&#x2B;XLRRTOVwv8sadmypfz3v/&#x2B;RgoIt2uT/Dh06Sr9&#x2B;faV9&#x2B;/YSFxcvgRx55QW&#x2B;&#x2B;lZ5XbX31cIfgcvKyuqnXkaNGnVMOWaXLFV8/vnnG5988snNEvx2gnYGB1p1CJhdXy&#x2B;2E/T&#x2B;N5auAAAEAACA&#x2B;lr0&#x2B;yr8A23xlwAL/UDa/IM9619pbb/b7XbOnTu37ZgxY3p16dJlaHx8fDOx115cb02ePFnOOWe6NrBPHbD3wQcfaWf/e/XqJRdfPEsKC/fIxx9/LMnJidogv4EDB0rjxk04G19HqfMCWrduPbRVq1ZDpk2btj8/P///LVq06KcXXnhh6759&#x2B;45JYNsJGhX&#x2B;RoMD9TMGvK&#x2B;zer/ebCfo3RVw6NBhwgAABAAAgDpX9FsV&#x2B;jXd4i9SdZ2/0&#x2B;B6O&#x2B;v5Ray37vM5yK/8OqXYj500aVLz6dOnj27Tps1gt9sd2RCOl6KiIomJibE8uz5p0kT55ZcNcv3110u/fv3lkktmy7Jly&#x2B;T111&#x2B;TJ554VPvzq6&#x2B;&#x2B;xl&#x2B;&#x2B;evhvRUREROLkyZOvGTt2bNEtt9zy2xNPPPHMqlWrdr///vu7jx49WqYr/u12B5QX2EbhgK/dBGprO0Gjgl90xb/fXQExMdHafQ4dJggAQAAAAKj9wj/QFn/xUeAHUvT7c4ZfpAZa/NW3d911V6ehQ4f26NSp08CG1uKvnrV/&#x2B;OEHJTk5RYYMGaquEZe4uLgqt3vooYfls88&#x2B;kxdeeEHuuOM26datu9x//1/lsccek7CwcGHpc/3mdDrDoqKiktXL7bff3v3gwYNbCwsLf3322WdfeeONN35buXLlQR/Fv35nAadUPbsfzHaC&#x2B;ve9i/JQbSeoL/bN/h0MqCsgJjq64j5Hjx3jLwwAAgAAQK0U/b4K/0Ba/CUEhb6&#x2B;wLcTAPgzvd90mr/a4j9nzpxW48eP75mTkzMsNjY2w&#x2B;VyNZCz/Qfl&#x2B;ef/I0uWLNHW8Gdnt5Vrr71OHnzwb3LjjTcoRf292pr&#x2B;vLzeWiAQHx&#x2B;v3a9Xr97a5fzzL5Dp08&#x2B;WRYs&#x2B;Vd4/XxYuXKSt/0fD&#x2B;mclLi6uqXq55ZZb8q688soNe/bs&#x2B;W3GjBn/Wr169cGSkpIysbedoNk2gnZ3DigT&#x2B;50BIoFtJ6gv4GtkO8GI8HDtPkeOHCUIAEAAAACokcLfztn&#x2B;2mjxNyvw7azx9/esf5UQ4NZbb&#x2B;0wderUoV26dJnQEI&#x2B;bo0ePakP61Hb/a6&#x2B;9VjIzM2XUqHyZP3&#x2B;&#x2B;7NmzV9au/V4eeeQf8tBDf5P27TvI2WefI2PHjpXOnTtr91e34MvJ6SGNGiXJ4MGDpGnTpvxlbMDUWQEpKSkdlEv7jz76qNWuXbs2Ll68&#x2B;ItrrrnmG&#x2B;VYKhHjToBgtxP0NRQwlNsJioRucKAY3NZSZGRExWMdOUoYAIAAAAAQ2qJfTIp6s4/ZHehnFgRUZ4u/VXHvEJMBfvq3iYmJ4TNnzmw&#x2B;evTonNzc3JFxcXEZDWn7Pr3U1BS55JJZMnPmJdq2fq&#x2B;99qp8&#x2B;ulimTZtmra9X9&#x2B;&#x2B;feWVV16VVatWyerVqyU&#x2B;PrbSIL&#x2B;YmFi5&#x2B;&#x2B;57tBDBbBs&#x2B;NMx/fpKSkrLVS7t27YaPGzduRUFBwfqvv/569bXXXrvcoPg3WxJgpxugurYTFKk8O0CkDg0OjIzwCgPoDABAAAAAFP0hKPrtBAK&#x2B;zvYH0&#x2B;LvXcCLBNbiH8y6/opW/zFjxqTOnTt3WHZ2dk6TJk26KcVsg/05qRRpsmfPbjl4sFiKiw9Kp05dtDP6zZo1k4svvlhcLrfcdNNNsn37NqXwXylJSYnaNn&#x2B;TJk02Oh61LQFxWv&#x2B;b5M7MzOylXvr06TNj3LhxizZs2PDjY489tuTNN9/cZRIGhHo7QZHAthN0WhT&#x2B;/nQFGC0zMBLQEoHyzoDDh38nCABAAAAAFP62Cn9/BvpVR4u/WVt/MC3&#x2B;AQ/yU9/Gx8eHXXLJJS0uv/zyyS1bthzgdrujGvIxtGHDRrnzzttkwYL3pU&#x2B;fPHU7Mq2F/6677pb4&#x2B;Dhp0yZb1q5dK&#x2B;HhYTJv3jwZM2a01vav7mDG9n2wq3Xr1sPUS//&#x2B;/Se/8cYbT2/YsGHHI4888vPu3buPiX8DA/3dTtD7Ol/bCRotFwjF4MBAZgXYDgOUv690BQAgAAAAin7Tol9fwIuPjwXb4u9dxIvYb/E3K/Stin0RPwb5yamBfq7Ro0enXHvttUM7derUS13L3FBb/NX1/aqSkhJtW7&#x2B;oqEgZNGiI/OEPl2pn&#x2B;9esWSPvvPOOfPbZYq3&#x2B;OHSoWK688iptGGDbtm0p&#x2B;hEU5ZhrMmPGjD97PJ6SWbNmrf7www/fW7FixZb58&#x2B;dvPFnwGm0n6KtLwO7gQF/bCZrNB7CznaBYXOd9fbUODizvCjh0iO0EARAAAABFv/1AINRn&#x2B;&#x2B;20&#x2B;IvYX88fkhb/adOmNZk0aVLHAQMGDE1PT&#x2B;&#x2B;hFP3hDfH4KS0tleXLl8vnn38u7777lnTo0EnWr18vCQkJMnz4cMnN7Sk9e/bUWvzfffdtSUlJVd7/i4waNUo72x8ZGclfQoT03zNFWEZGRu5FF12Ue/bZZ&#x2B;/505/&#x2B;tP6FF1549eOPPy5YtGjRHt0uAh6x7hIwmg1gtVSgtrcT9GdwYGDbCcac2k6wmDAAAAEAAJw2hX&#x2B;gLf5GBb2/Rb9I1bZ&#x2B;ozX8dgf6BdriX6nVXz3b//DDD&#x2B;eOGzdubFpaWruoqKiUhnCslJWVyeLFi&#x2B;Xf//5/MmjQIOnff4B07NhR&#x2B;9jSpUtlxIih2kvx5ptqgZ8iLpdTvv9&#x2B;jVx22WUSHR0t119/vdx4400ya9YsadIkTSkg4vgLiBqh/B1MbtasWfKf/vSnXrNnz968YMGCF2&#x2B;99davdu3adbSoqKjEq4D37g4w6xLwd6mAfjtBEeutBY2Kf3&#x2B;3E/RncKBZGGC7qI89GQb8/vsRggAABAAA0ACLfl&#x2B;Ff6At/hJgoR9Im3&#x2B;wZ/2rrO2fMGFC2gUXXNBD0btFixYDG9pxo7b0Hz58WGJjY&#x2B;W&#x2B;&#x2B;&#x2B;7TCvx27TrI9OnTpVu3bjJjxnlaB8Czzz6jnflXw4FNmzZLYmKitGjRXDvjrw7&#x2B;Gz9&#x2B;PH8JUVv/9rkaNWrUSjlmbxo7dmzB/v37C55//vnXHnnkkZ&#x2B;2bt36u0HR7&#x2B;/gwPJC29d2gnY6BMwCgDq7nWBUVOSproDiQ4QBAAgAAKCeFf1WhX5Nt/iLVF3nb3egn52z/r7O/hteN3jw4MQLL7yw8/Dhw0ekpKS0jY6OTmmox1B4eLiMGDFCcnJy5NJLL5Mfflgr7733nvz5z3Ola9cuMmHCZG1rP3WK/6ZNmyQjo6lW&#x2B;F9xxRWiFFjidLqkW7eu/GVEnRAfH99MvcydO7f3pZdeumnbtm3rXn311YUmgwOrcztB78GB&#x2B;k4C/fv&#x2B;LhGote0EY2NjKu5zsLiYMAAgAAAA1OHCP9AWf/FR4AdS9Ptzhl&#x2B;kelv8Kwr/p556qn/v3r17tmzZsm9UVFRSQz&#x2B;O1MF&#x2B;L774glLI/0OKig7Kv/71pMyYca42wf/ss8&#x2B;Wjz/&#x2B;SJ544jGtvf&#x2B;CCy7UugS8XXfddeqaYUlKSuYvJeoUdevNxMTENuqlXbt2I2fPnr3u888///Cyyy77bN&#x2B;&#x2B;fcfEvBOgOrcTtNMtYDYo0Oi&#x2B;tbqdYFxsrOPkvyMEAQABAACgDhb9vgr/QFr8JQSFvr7AtxMA&#x2B;DO933Ka//Dhw5OnTZvWfuzYsWMyMjJ6OU6jcfVHjhyRO&#x2B;&#x2B;8QwoKCkQpkuT999&#x2B;X22&#x2B;/XdatWyt9&#x2B;vSVxx57Qu69N07bui8ioupAP3X6P1Dnf0l1uyPT09NzpkyZ0nHw4MGjN2zYsGrx4sUrH3rooXUW2wmazQ6w6gawu52g2daC9XI7wYiIiIr77Nt/gDAAIAAAANRy4W/nbH9dbPG3s47fr0F&#x2B;5W&#x2B;bNGkSeeedd/YcMGBAn6ysrNzo6OjU0/HYUtf0X331HJk//&#x2B;&#x2B;yY8cOeeutN0UpkORPf7peunbtJmlpqeqZVP4SokFQt&#x2B;hs3LhxV/XSu3fvKdOnT//up59&#x2B;&#x2B;n7hwoVrHnjggfVivjQg1NsJeg8LtLOdoEeqDhgUqYPbCSY2StDuw6wAgAAAAFCzRb&#x2B;YFPVmH7M70M8sCAhli7/DZpEv4uPsvvdbpdCPuvTSS7PHjh3bPzs7e0BUVFSag83ptZb/vLze6v7f0q5de8nIyBBeFjT4X1zd7mh1qKd6GTp06IELL7xwyfr169fdfvvtX6xcufKgBD4w0GqpgFPsDwvUdwL42lFApHq2EzQKBnzynhXAdoIAAQAAoPqLfjuBgK&#x2B;z/cG0&#x2B;HsX52YFvq8W/2DX9WthQJMmTSJuvvnmbpMnT56qtgFzpFWmbu2nXoDTVXh4eEKnTp3GqJdevXoN&#x2B;fLLLz95/fXX17z66qvbjx496h0CWC0JsFoqYGc7QbMOATu7BlgV/vqCv&#x2B;YHB57cTlB1oOggYQBAAAAAFP5BFv7&#x2B;DPSrjhZ/s7b&#x2B;YFr8/R7g532derb/6quv7jB48ODczp07D4&#x2B;MjEzmbD8AKx6PR&#x2B;2AyZ06dWqPCRMm/D537tyPvvnmmxVvvfXW&#x2B;rfffnunVO92gmbD/fy5mBX&#x2B;1bGdYEBLBBLi47T7HP6drgCAAAAAKPr9Kfr1Bbz4&#x2B;FiwLf7eRbyI/RZ/s0LfqtgX8XOQn/o2IiLCdeWVV7Y877zzRmRlZXVOSkpqR9EPwI9/lyveVZcIdO3adULnzp3HTp8&#x2B;fe&#x2B;6desWv/7664vffPPNgrVr1x4S/wYG2hkgaFb4Gw0LrPfbCUZHneoKKDrIdoIAAQAAUPT7KvrtBAKhPttvp8VfxHrLvlC2&#x2B;Gtn/hMTE8Pvu&#x2B;&#x2B;&#x2B;3IkTJ05NTU3trLzMTK0D4De1A8D7n2n1fXU7wejo6LTc3NyzunXrNua6664ruOeee&#x2B;YvWbJk13fffVdUUlJSKv4NDKyJ7QTFKzgI5XaCRgW/6Ip/v7sC4uNObCfIDgIAAQAAUPj7Lvqtinujgt7fol&#x2B;kalu/0Rp&#x2B;q2JfJPDp/Yat/kqhHz516tTM2bNnj8rKyuqSlJSUTeEPIMh/qysFAerbSr/sut0xyr817e&#x2B;55557jxw5cqCgoGD1vffe&#x2B;/IXX3yx97fffvvdovi36g4QMV8qYBYA&#x2B;OoQ0Lfyh2o7QX2xb/YzKaCugPIdBFTMCgAIAADgdCv6fRX&#x2B;gbb4S4CFfiBt/sGe9a&#x2B;0tl/55ds5Z86cVmPHju3ZrVu3/snJye3F3tRqAAgZdWigeunYsWPW008/PWzv3r0bNm3atPYvf/nLG998883&#x2B;oqKiErHeTlAfFNhZKuAwKfpDuZ2g&#x2B;LhOpIa2EyyfFXDgQBFBAEAAAAANqui3KvRrusVfpOo6f7sD/eyc9fd19t/wOnWg3yOPPDKsb9&#x2B;&#x2B;&#x2B;QkJCc3DwsJiONoAVCf92X&#x2B;Tf/O17QTT0tK6qJe33norf&#x2B;vWrSvfeeedD&#x2B;fOnbvi5PKA&#x2B;radYHUODhSD21oHAQnxFY/FEgGAAAAA6nPhH2iLv/go8AMp&#x2B;v05wy9if41/wG&#x2B;VX6pdl156adbUqVP7dOnSZWBycnK2cLYfQB0ODCIjI5Nat2497Morr&#x2B;w3duzYpdu2bf/t//7v&#x2B;S/&#x2B;9a9/bRbjs//BbidotZtA&#x2B;e2MCn6zwYF2txOslcGB3ksEjh8/ThgAEAAAQL0q&#x2B;n0V/oG0&#x2B;EsICn19MW8nAPBner9lq//FF1/cbPz48V0GDhx4RqNGjbLUNbccbQBq&#x2B;N93Wx0A5YW//j4ulyuyTZs2w1q3bi19&#x2B;/Y564orrli4efPmDa&#x2B;88sqq5557bqtU7QgIphvA7uBAq&#x2B;UB1bGdoMMkUKjyEkoASwTCwsK0&#x2B;xTu2UsQABAAAECdLvztnO2viy3&#x2B;dtbx&#x2B;zXIr/xtVlZW9BNPPDGyffv2XZT385RfnqM40gDUFrMhgGZhgf4&#x2B;5dedXCIQ07lz5zOVi4waNer3K6644o1ly5atuuaaa5ZbFP&#x2B;&#x2B;ugOMCn9fgwOrcztBEfPBgdXaFZCSnMQSAYAAAADqZdEv4v9AP7MgIJQt/g6bRb4YXO&#x2B;yCgGuvPLK5sOGDWs/YsSIqfHx8c050gDUxxDAOwjQP0b5x9T3XS53VK9evaarWwoq/&#x2B;4tWrBgwaLly5dvf/PNN3ccOnRInRdQKv5vJ2h3cGB1bicoFtd5X1&#x2B;t2wmWLxGgKwAgAACA2ij6fRX&#x2B;/g70C6bF37s4NyvwfbX4B7u&#x2B;XwsDunXrFnfPPfcM6dixY05mZmZOWFhYLEcbgDr4M8B28e9d7FuFAuV/dDqd7rZt2&#x2B;W3aZM99MiRI/tuuumm75544ok3v/vuu91fffXVARvFf6lJwW9nqYC/gwO9i/JQdAX4Mzgw6K6AooNsJwgQAABA9Rb&#x2B;/pztr44Wf7O2/mBa/ANZ019x3ZAhQxKnT5/eYfjw4cOaNWuWo26fxZEGoC4X/6EKDLyXBOg5nc6w6OjotPbtO4z&#x2B;29/&#x2B;NrS4&#x2B;NCOX35Z/9Xjjz/&#x2B;4cKFC3du2bLlqFgvCdAX/f4uFfAu/s0GB/raNcDf7QT9GRxoFgbYLurj405sJ7hj5y6CAIAAAABCVvTrC3jx8bFgW/y9i3gR&#x2B;y3&#x2B;ZoW&#x2B;VbEvYvPsvuim&#x2B;Hfq1CnmrrvuGjJo0KCJ8fHxWRxpAOoD/Tp&#x2B;q04Ao7X/6vve9zHuDlCvP/VndXBgQkJCi9zc3BaPP/742F27dv3w8MMPP/Pkk0/&#x2B;eujQoeNiPCfAn8GB5YW20c4BZgW/1XaCHqlH2wk2aZxW8Vh79u4jDAAIAABQ9AdV9NsJBEJ9tt9Oi7&#x2B;I/S37QrGFn7Nfv36NLrnkks4DBw4c0KJFizxa/AHU9zDAx88S06Cg8oBApYIuO1X8m9eyDgkLC4/LzMzMu&#x2B;uuuzpef/31mzZv3rzm6aefXvjcc89tOXr0aKkEv52gfsmA3e0ERUI3OLDWthNMTkqsuM/vR44QBgAEAAAo/C0L/0Bb/I0Ken&#x2B;LfpGqbf1Ga/itin2RwKf3G7b6d&#x2B;/ePW7GjBltJk6ceEZ6enqHmJiY9ABfZwCoCz8n/B4CaNX&#x2B;f&#x2B;rxvD9m9KOjcs0bERER17hx4y7qpXPnLqP&#x2B;8pe//LJu3brvnn766S9feumlHWK9i0B1bSfoa3Cg1aDAOredYFRkpHafPXvoCgAIAABQ9NsLAfRFv4j9Fn8JsNAPpM0/2LP&#x2B;Vdb2qwP97rjjjkEjRoyYHh0d3ZgjDUBDDQMCvb1&#x2B;J4BTt9OHAFWH4nsvK4iOjkqOjs5MzszM7N23b99JN99888p/P/XUWw8/9NAGCW47QX03gN3tBM22FjRbLmD1Z5HgthO0eiHtdQUkn&#x2B;oKYBcBgAAAwOlT9FsV&#x2B;jXd4i9SdZ2/3YF&#x2B;ds76&#x2B;zr7b3hdXl5ewtSpU1tNmDBhZEZGRhd1gJXyUjs54gA0FIGc/S&#x2B;/vVnBX36bsjKPj&#x2B;Lf4yt8cERHx6S3b98&#x2B;/X9uvS33kpmXrFq//ue1L7700soXX3hhqxjvEmCnO8Df7QS9hwU6xHz9vz4YqI7tBO2EAbaL&#x2B;vJdBHbtLiQIAAgAADTQwr&#x2B;utfjbPcMvYn&#x2B;Nf1Br&#x2B;&#x2B;fPn9&#x2B;jX79&#x2B;udnZ2X3i4&#x2B;ObcaQBOA1&#x2B;ntgKAfRLBvRDAcsDAO9lAJVDAOPl7WZBRPljREdHpbVt23akehk0eNCWa66e88WGXzduuu1//mfphg0bDkvgAwOtlgo4xbr932pwoK8dBUTq0HaCaakpFfcpLj5EGAAQAABoQEW/r8I/kBZ/CUGhry/m7QQA/kzvt2z1HzNmTOptt912plL091aK/qZOpzOcow0AdNXlyQLdqGCvGgQYtf8b1auVAwhfYURcbHzT3J49z1Eukp&#x2B;fv2n1qlULFyxY8N2DDz64XlfMe3cH&#x2B;DM40M52gmYdAnZ2DbAq/PUFf6i2E7QdBsTGxpzoCthFVwBAAACgPhf&#x2B;ds7218UWfzvr&#x2B;P0a5Of11vXXv/61q/ILZL&#x2B;2bdsOjIqKSuFIA3Ca/WwxLejNbu8dAhgFBPpBgMYDAY1PbpsNJdQHCR7lfw7lf&#x2B;p2ggMHDbqkT98&#x2B;Z48bN/7VlStX/Pzcc8/9uGLFigNSdWlAKLcT9Ij5sgCjDgFfwYBI9W4n6PcSgbS0U10BO3ftJgwAAQAANJCiX8T/gX5mQUAoW/wdNot8MSrszW6fmpoafsEFFzSfMmVKv06dOg2KjY1N52w/AH7eOPwOAfRhgK8fWcYP66kSRvh6DuXFv7ewsPDYfv37Xdi7d6/DF1544YHFn3328pIvvvjpjTfeKDi5REBf3PvTHWA0QNCs8PceFthgthNsnJZacZ8dO3cRBoAAAADqUNHvq/D3d6BfMC3&#x2B;3sW5WYHvq8U/2PX9WhgwYcKEtBtuuCE/Ozs7JyUlpYNS9IdxtAE43Rmt5w8kMLB6jPKlACfuVx4E6OtX0Z3xLx80aPQDz/zHpDssLNrtdkePGT16ztAhQ/fecMPcvUuXLnnvjjvuWPz9998fLCkpKTUo7mt7O0HxCg6sBgeabRcoJiGBUcGvT1/8HhzYpHGadp/dhXsIAkAAAAC1WPgHOtAvVC3&#x2B;Zm39wbT4B7Kmv&#x2B;K6mJgY9zXXXNM2Pz9fHeo3NSwsLJYjDQCMC/lQP9apNf364l8M61b9/azuY9QFoL9hZGRkknoZPXrMnCFDhp67YsXydx588MEPv/322/07d&#x2B;48alH8W3UHBLKdoFmHgMeg&#x2B;A7ldoL6Yt/s94OAugJSU5Ir7rOdrgAQAABAjRT9&#x2B;gJefHws2BZ/7yJexH6Lv1mhb1Xsi9g8u&#x2B;99fUREhGvSpEmNr7jiiuHt2rXLTU5ObutyuWjxB4AQhgBmt9dfZz4I0GFYZxo9rtH91eLfo79/&#x2B;f10wYP6x&#x2B;joqOR&#x2B;/fpf2L17zth9&#x2B;/b9unXr1p&#x2B;uuurK19asWXNQFwQYdQfogwKPjXDAIebLAkK1naD4uE6khrYTTKcrAAQAAFAjRb&#x2B;dQCDUZ/vttPiL2N&#x2B;yLxRb&#x2B;DkvueSSrIkTJ3bt0aPHgPT09B6OUJzOAoDTgD/Ff/ltrW6vP4NvVsSbhRH6x6haoZ44&#x2B;1/eAeARXzMLTn3u6OjoFPWSmZnZa9GiT4Zv2bJl9ebNm9bfdNNNH61bt&#x2B;6Q1L/tBKtzcKAY3NaSd1dAwZZthAEgAABA4R9E4R9oi79RQe9v0S9Sta3faA2/VbEvEvj0fsNW/8TExPBRo0alXHfddWM7d&#x2B;48MioqKokjDQCC&#x2B;lnlswD3/rhZF0Dl7QGt6snKJ5v1j&#x2B;sxOJuvDwMqfSKTDgR9gKG&#x2B;jYmJSW/Xrp16GdWnT58z169f/8UjjzzywYsvvrhNqmc7QavdBMpvZ1Twmw0OtLudYK0MDmzWNKPiPnv27iMMAAEAAIp&#x2B;G0W/r8I/0BZ/CbDQD6TNP9iz/lXW9p977rmZ559/fp5S9OdmZmb25kgDgOCKfqO1&#x2B;1YBgdX2gfr7W6/9N34u&#x2B;q4E7/sbtv&#x2B;bfKLyq069NR5WGBcfn9WjR&#x2B;6Mxx9/4owrrrzyo40bNmx8/vnnV3/00UeFEvx2gnYGB1p1CJhdH8rtBB0mgYJRcuP3EoHkpETtPjt2sp0gCAAAUPT7KvRrusVfpOo6f6fB9XbW84tFcW9rkJ/61u12u/r379/o0ksvzRk0aNCIpKSk1pztB4DQhwDV9XhVz&#x2B;A7fIYMVvW99wDAijDA&#x2B;3T/yR0E1D/qcwGj7Qa1UMHhkYjIiKSePXuerVxk1KgzNny/du0XK1esWPfiSy/&#x2B;/N233xZJYNsJGhX&#x2B;RoMD9TMGvK&#x2B;zej8U2wnqAwGRaugKaNL41HaCW7dtJwwAAQCA067wr2st/nbP8ItUb4t/RRgwZsyYlLvuumty586dR4eFhcVwpAFA3WUUIlQuvvUn6c0HARrtBmBrloCPZQOGdzk5V0B9W/55EholtO7Xr1/rvn36HDtn&#x2B;jkbli9f/ulzzz639NVXX9lhUPzb7Q4oL7CNwgFfuwk0qO0EMzPStfts37GTIAAEAABOm6LfV&#x2B;EfSIu/hKDQ1xf4dgIAf6b3W07zV6f4K5cOI0aMOEM92x8REdGIow0Aauxnm&#x2B;1uAKPbWk3xt14K4PF/NwKvwt0qHTD6UKWAwWtZgePk86z4wed0hicnJXcYOWJkh7y8vHGzZs366O233/ry08WLd/&#x2B;wdm2xj&#x2B;Jfv7OAU6qe3Q9mO0H9&#x2B;95FeSi2E/RncGBAXQHpTRo7vL4nhAEgAADQIAt/O2f7a6PF36zAt7PG39&#x2B;z/pWuS0xMjHj00UcH9OjRI7dly5Z54eHhCRxpAFCzhX8w99OfuT&#x2B;1nr/yGfxTQYDxiWOjEMDq7L/hEgCvtMHoy9I/x0ohgLps4ORT03&#x2B;&#x2B;&#x2B;Ni4ZgMHDry4X/9&#x2B;5&#x2B;/du3fdl0u/XPjBB&#x2B;9//9///regpKSkTOxtJ2i2jaBROOAwKf7tdgaIWA8O9LWdoD&#x2B;DA83CAI8fx5J2n8I9DA0EAQCA06PoF/F/oJ9ZEFCdLf5mRb2IjwF&#x2B;&#x2B;o/ffvvtHadMmTKidevW/dQz/crL7ORoA4CaZXcIoNX9zH9&#x2B;Vu4AqLwuv/JJ46rdA767ESp1AOiKf7thh9lWgpXnDlRUsg6X0xWWmpLadfz48V3yR&#x2B;Uf&#x2B;MvNN2/44P0P3nr11Vd/&#x2B;vTTTwrFuBPAn8GBRksFfA0FtNpO0CP1aDvBlOTEisf68af1hAEgAABQb4p&#x2B;X4W/vwP9gmnx9y7O9cW83Rb/YNf1a63&#x2B;8fHxYf/85z8H5uTk9MjOzh7qdDrDOdoAoH4GAUa3M14aUDkEMKsXjbYYNDv7X178V4QAFdX6qTsYtf5X2Wbw5HOpCALMzl17P65oj&#x2B;NQw&#x2B;v09PTcCy&#x2B;6MGfK1ClbPvzwo5fm//3vX65evaq4pKSkVOwtCbAaIOgU810FrLYTFKnewYE1sp1g&#x2B;3bZFffZuauQMAAEAADqZOEf6EC/ULX4m7X1B9Pi7/cAP&#x2B;/runfvHjdr1qyOgwYNymvXrt2gsLCwhCB2TAAAhPbnns&#x2B;i3iws8DUDQF/AGxfzp2pIswDCahBgRfFvMPnPbBig2fMXXYVa5fOZpBFqB1tcXFzWlClTrh85cmRBcXHx7g/ef//Nhx9&#x2B;aNXGjRsPS9VOgOrYTlDEv8GBVtsH1rntBBunpWj32bKVHQRAAACg9ot&#x2B;fQEvPj4WbIu/dxEvYr/F36zQtyr2Rfwc5FceAsybN6/tjBkzRmVmZnZs1KhRa440AKh7yothfwcAGhXslaf3V54DUF6IV66hPbaKcqPiv/zsv/a&#x2B;Q4wrffG9DaD3Y5V3AehnF2g31Q0ONHktHWoQoF4uuPDCbuPPPHP9vn37tnyyaNGn119/3Tfi/8BAq24AX4MDjZYF6DsBjJYLWP1ZxHpwYOVEpxoGBzbNTK&#x2B;4z6&#x2B;bfyMMAAEAgFop&#x2B;u0EAqE&#x2B;22&#x2B;nxV/E/nr&#x2B;kGzd17Fjx5g5c&#x2B;Z0GTp06KA2bdqoLf78uwkA9SQICDQ80Bf9lQcCGq3/r1or6otzX4FEldZ970/m59fpXfzrf0hbPZz&#x2B;OXgHHerPv6SkpA7qpXXr1iNHjxnz1ZrVq5ddeukfPti/f/8xMd9O0FeXgFU4YBQKeA8OdIj1TAHvYCCUXQH&#x2B;hAG2D8SWzbO0&#x2B;xRs3UYQAAIAANVW&#x2B;Afa4m9U0Ptb9ItUbes3WsNvd6BfoC3&#x2B;lVr9s7Kyos4777zmM2bMOKNp06adEhISWoi9gUAAgNr/uRjwIMAqZ9JNBgOateLrQwB9N8Kpt8b1vf7MvXF7vv6Mvo2A4eRTOtWoYLz&#x2B;wLsLwejTe7&#x2B;mmZmZfdTLylWrR6/7Ye3nBQUF2&#x2B;fOnbvEKwzwtTSg/CJib6mAUwIfHOhrRwGROrSdYLPMjIr7bPqtgDAABAAAv9zU&#x2B;tl&#x2B;X4P8/C30A2nzD/asf5W1/bfddlvHwYMHd83JyRmqFP2tONIAoOEEAnZYnqH3uRWgd713okb0Ls6NtgM0CwGsn2PV&#x2B;xiGFLouAH3Z6jCpRvWfv8rz071GiY0aZfft2y&#x2B;7Xz&#x2B;HDB8x8vtlX3/98Y8/rit48sknf9y2bdtRrwLeuztA3yVgtVRAPyPALAAw6hCws2uAVeGvf6lCtZ2g7TCgRVYzB0EACAAAiv5AC//abPEXqbrO32lwvZ31/GJR3Nsa5Fd&#x2B;Xbt27WImTJiQedlll52TlZXV2&#x2B;VyRXC0AUD9L/q9i1WfA/JMz/Q7qhS&#x2B;VQti/Y9Sj&#x2B;Vz8S6sve9f0XbvXbibDAI8tRWhcaeD6VaAJ/&#x2B;jnuf3mJz9r7R0wGzHgvLX82QaUf4qpSQndx49enSn/FH5x84977wfFy5c&#x2B;NYL//d/axcvXlxoUPSHcjtBj5gvCzDqEPAVDIhU73aCfi8RKA8CVAUFWwgDQAAAUPgHVPRbFfdGBXwgRb8/Z/hFaqDFX3172223dRg2bFiPTp069UtKSsrmSAOAhqFyq335WXuPz8BAHwKYLQXwDgKqFskewxDAurPgZB1tc6WZp1I24DAuzNUfdFph7hCX82T1W&#x2B;ZR3ndKqfLxMvGcqIYNBgEazQE4UesbDFc0SgiUm6hheuO0xt2mT5/RbfToMRuWLl3y9vsLFqxeuHDhrq1btx4xKO6NugP8GSBoVvh7LzFoMNsJNmvWtOI&#x2B;vxEGgAAAoOi3UfgH0uIvISj09QW&#x2B;nQDAn&#x2B;n9ptP8lSI/bMqUKRlnn31275ycnCHx8fHN3G53NEcbADS4n6G2Cm&#x2B;rEMB4cr/xdnyVf2JbF/&#x2B;WywikcjHu8ZTpH7zK5zYKPbRf8JVCX333wNGjsnFfkXy/a48cKimVzimJ0iktSeLCwyTc5ZJjpWWVHsi7C6Fq4OCwTjB0v2aUnZx10KhRQuvRo8dcO2TI0L1FRUW/fv7ZZx88//zzq9esWX2gsLDwmBgvCajN7QTFKziwGhxotl2gmIQERgW/6Ip/vwcHZp0MAzZu2kwQAAIA4DQs/O2c7a&#x2B;NFn&#x2B;zAt/OGn9/z/pXCQFuueWW9hdffPHUFi1a9FNeYhdHGgCcHkGA1Vl9M/pi2iwUqFr8i2H95&#x2B;tHe0WB7b1tnxg8uFehbTacT31bVlYm2w8eka&#x2B;37ZBvt&#x2B;&#x2B;WrUXFclgp/tWCfNGmrdKyUZy0aBQvY1pnSfOEWOWHpVP7WGnZiZPknkpbGdp4ofVLG04&#x2B;htNRuYqNiopKioyMTJp61lk9xowdt2vX7p0/ffj&#x2B;B&#x2B;/&#x2B;4x/zf9iyZcvvFsW/VXdAINsJmnUIeAyK71BuJ6gv9s1&#x2B;VwuoK6BVi&#x2B;anthPcxHaCIAAAGnLRLyZFvdnH7A70MwsCqrPF36q4d4jFAD/vt/Hx8WHnn39&#x2B;00mTJvXs0aPH8Li4uKZutzuSow0ATr8QwG7hrw8BjIpr/x7LU&#x2B;n2lbcXNPvh7vA5BNDX1/uVUvi//XOB/FC4VxIiw7QCPybMrX1SNRzYWnRINu4/KGt27pHujZOla1qKtE9OkEZREVoxX&#x2B;qpuszB9Es2mEjoMfg6vHcsUP8YHR3VuHlW88YzZ87sO2Xq1I1vvfXW86&#x2B;&#x2B;8vK6JUuW7JOquwT42lbQYyMccIj5soBQbScoPq4TqantBFuc2E6wTF33ARAAAA2u6LcTCPg62x9Mi793AS8SWIt/sOv6tT8PHTo0ad68eUPat2&#x2B;fm5GR0d3pdIZztAHA6c3fZQBG9zHqAjAbkKdfBmD2I99kJ76qIYDBDc0Kc7XA75XeRMJcbkktiJTl23dLSVmpHFXK1ijXiQa4cJdTIpTLwePHZOGmLfLp5m3SND5GuqphQGqyZCcmSHSYSzzKJzleWmr4OlTpiKj0/MojAOMww/t&#x2B;Lrc7LCkxsd2FF1xwy&#x2B;RJk7YU7tmz/vXXX3v/mWee&#x2B;XlLQYFVV4C/b2tqO0FfgwMD3U7QOF3yQfk9qOKx1m/YSBgAAgCgHhb&#x2B;gQ70C1WLv1lbfzAt/gEP8lPfNmnSJOLOO&#x2B;/slZ&#x2B;fP0ot&#x2B;t1udxRHGgDAu9gM1VaA3jW5dW12qrYz6ibwrpl9bgNoESAYBRgRbqcMyGwivdLTZMO&#x2B;A7KucK&#x2B;s2bVPVu8qPPH5lTtGut0S5nBKWNiJoYBbig5plwUbfpNWCfGS0zhFeqSnaO&#x2B;XOcqkpLT8eTkqByLeAYXXrxYewxPhYvq9cDid7vj4&#x2B;Bbq5Zo51/S/4PwLNuzctWv966&#x2B;99slDDz34owQ&#x2B;MNBqRoDVbgLltzMq&#x2B;M0GB1bndoJBDw7Mbt3qVBjwC2EAAQCAulz06wt48fGxYFv8vYt4Efst/maFvlWxL&#x2B;LHID/vEEAp&#x2B;JP&#x2B;&#x2B;Mc/DuzRo8fA1NTUzsrL7ORoAwAYFcX&#x2B;BAbet1fPqJef8dbX5FaD8M0&#x2B;f&#x2B;WdBYyLf8Mz55Wm9Su/wLvUxn6HlJR5lEtZpcdWC/rSk8&#x2B;rbVKCtEtuJKNal8q63Xvlp70HZPmOXbJx30FxKzdQH0d963S7Tla2Htmwr0i73YcbC2RI8wzJSU&#x2B;RprExEh0epn3u48rn83gtE6gaUFTezlD/OlXpptC9CC63OzolNbWLemnXrt3ICy64YPkHH374wY1/nvudrvgPtDvAzuBAqw4Bs&#x2B;vrxXaCWhjQ5kQYsPFXBgcSAACoi0W/nUAg1Gf77bT4i9hfzx9Mi39FCDBp0qTGZ599dufevXv3z8rKynO5XLT4AwAsi3l9UW&#x2B;n&#x2B;PdudTcq3o2CAPMazvz&#x2B;Ve/pqFQ8e4cI2g/Dk2fdf9lzQA4eK5H02GjJiI&#x2B;W0lKPVvirn6PMa1DgcU&#x2B;Zdr8wp0Ny01Ole5NkGd2qmawr3CeLC7bLip275chxj0SFubRtA9VQIcLtkgjlPgePHZc312&#x2B;SBRsLpEVCrPRskiZtkhIkMy5GW0JgHlA4Tla23rMPqu6EoH/f6NVzu91xzbKyBs&#x2B;aNWvwiBEjPtm1a1fBsq&#x2B;/XnPbbf&#x2B;zSvwfGGhV&#x2B;BsNDtTPGPC&#x2B;zur9erOdYKuWpwYHbtrM4EACAAC1UfgH2uJvVND7W/SLVG3rN1rDb3egX6At/pVa/VNTU8P/&#x2B;te/9h48ePDQxo0bt4&#x2B;Ojm7MkQYAsPEz2bTItLq99/R/o9t4D8jTd7&#x2B;fuot167vZ&#x2B;n&#x2B;jDgCX88R6&#x2B;sPHS&#x2B;S3/QdluVK0f7J5mxQfPS5psVHSNz1NWiUmSIeURhIfES7q2LfSslLtraOiZV/k6Mn1/HERYZKX2Vh6ZKTK&#x2B;j375eutO2XZ9t1yWCn4HV5PSl1KoD7GsZJSWbGjUNbt3i9tkxrJ2R1bSeukBC2M0L6msrJKQwlOfQ2VX4PKIwPKt0P03UZRftsWLVoMbd68ufTs2bNk/JlnfvbTTz&#x2B;tWfLFFz/&#x2B;859PbCgpKSmTwLoDyp&#x2B;kUTjgazeBBrWdYIvmJwYHsoMAAQCA6i/6fRX&#x2B;gbb4S4CFfiBt/sGe9a&#x2B;ytj8/Pz/5kksu6TFkyJAz0tLSunKkAQBCEQr4CgOszvobtfDri9vKdZfx2W9fvzmcap/3SEHRYVm2Zad8v3uPFBw8JPuPHJVw14kz9juKD8ur6zdJhNMpTeNipW9mmmQrRXpWfKzEhrulVF0i4Ck7Waw7tcdT33crty88eET2/n5E9imP5/D&#x2B;uk/W4keVwt&#x2B;l3KdxTJQMT2sqXdISpXl8vPa46v0rFfBeL4jDY9T94OMb45WIVKp0vUpZLcw48b47KytrmHIZOmzYsNJzzz33/Y8//njxfffdu&#x2B;bw4cMlPop//c4CTql6dj&#x2B;Y7QT173sfEPViO8HyHQRUe/ftIwwgAAAQRNFvVejXdIu/SNV1/nYH&#x2B;tk56&#x2B;/r7H&#x2B;V69xutysnJydu1qxZnZTif2Rqamp2TExME442AEAwKhftHtu31V&#x2B;n7xDwLv6rnsB2GD5O5XDBPEAo7wBQ/xuuFNtHlGL80PESOXj0uIQ5XdrjqEW4y3PiAdQz9b8dKJJf9x2QyDCXdEpJkjFtsiQzNkaSoiO0&#x2B;&#x2B;4/ckx5LIdsL/5dO&#x2B;u/Zvce2VF8SCnyXXKio9&#x2B;hFf3q51QL/9aJCXJGq2bSKjFeUqIjTyw/8Ii2xKB8mYFWDTuMf4XxGoPoeztBrxewUmTiqPqaeC3rcLhcLnebtm3HtWzVavikyZN/fPWVV15cv3797tdff23L4cP/n733gJPrKs/Gn&#x2B;lt22xv2lVvK2mlVbNVbNkW/hyKsSEYMMZgk8S0P0kcEkIIyS8fJCSkACkfEL58tCTEBmNhG2PLVcW2ZFm9193Vrrb3Ojvt/s97puztc2d31c8rr2f3ztx27p2Z8zzv8z7vWAzW2gkatRG02jkgDuvKAOA6aidYGAzydU6fOSeIAEEAiBAhgP9lAP1WgP9MSPytZviByyvx54/k4v&#x2B;Xf/mXqzZu3Lh23rx5G/x&#x2B;f4m400SIECFCxEyDf4vf8wZgXTLY/tSPR29GofYAoCx/acCHh5YvwPvDsxnAH&#x2B;Jy/d2t7Rgcn4CH3PwZqCdwbnc44LTFEYlLeIe95kRPP2ryc7G0qABn&#x2B;gfRPRpirwPODwxxUoHOj4A&#x2B;eQeMhaOcWKjM8WM&#x2B;A/5k/LeYrRf0ukEKf6IFEh4D0CVD1CA&#x2B;VQaQOis91UM2nRnkJQOafZOqweHwlZWVrfrs5z63KhQKdf/RH33x1DPP/OqZ1157tWXHjh090FcCTLedYCZTwMvZThA6y2GBCNAjBjLGooXzRQcBQQCIECFAfxagPxPwn4rEHzMA9NUA3woBkI17v6Gbv9PptDPAX/DBD35wwUMPPfRIQUHBXOHiL0KECBEiLtP3eNbtAPVeZ2YCqHxKP9lqRijQUxyMk8M&#x2B;lF4AqYx7wO3CirIiLGc/66tKcbijB0e7&#x2B;9A8OMJr/n1ONq2329jkPqEOiElxnOrpx3H2Gtqzx&#x2B;Hg5QPkAUD7yWGPhQzgh2NxrGLbrC8tQVWeHwUeD18/ztan5/SIDrlJohyIK0fBoKOB0fqyAbUZIFO5qaORMsPr9ZZUVVeXPPaZz9zysY9/vK2nu/vkk0888ett255ubmxsHIO1kgAraoBs2wkC1o0D49BvGygH/FfFODDVQYBicGhYkAGCABAhQgB/i6DfCNwbAfxMIB&#x2B;YOYm/lTr&#x2B;rIz8Uo/BYNDz9a9/fdWWLVtura2tXRMIBIShnwgRIkSIuKzgPxvgr8zQa0FmJiJAic/M90HrOO2O5MslNPUPozovwDPxEW7ipwTG1JIwnjyWFSWFDLAXoW98ggP8d9o7saulEwGXY3L77J/X6UgfDREA1AmgriSIkUgUK9n6XrasyOdhr3NywB/nEv94urWgZYJEZeaXNh&#x2B;EpDM&#x2B;0M3iyx81KNbgumQgVFx5ubm1eXl5tX/8pT&#x2B;585FHHz363//9X//1g3//99O9vb1haJUAl6OdIJCdcaAk27YR8M9GFaBXZqB7W2IKJQL5ebl8nQOHjgoiQBAAIkTctKAfBqDe6Dmrhn5GRMDllPgbgXogg4Gf/HH&#x2B;/Pn&#x2B;T3ziE3Pvvvvu9XV1dXf6/f5iKtsTd5sIESJEiLgSoSsbtwBurcvTjRQA2jLulAmfnQHzWCyO5oFhHOrswZ62LpzrG8DayjJsnlWONRWlXNpPJf5RysKrfAyiSZBdyMD75tlVmBfMw972bsSk5Be17KAIkQ5NhLGhuhyfXVMHn9ORbBc4SSqEolGNhN8KUaLoAiA/RkUJgNYnQaPIUK2vplDUoN&#x2B;ykoM7GoJKBNxlZWWrv/CF36975JOPtDQ1N&#x2B;9/afuLu372P/9z8VJr6ziyMwzMtp2gfJleWYBaCaAuF5gJ48CpeAVYJgMaVi5PryP8AgQBIELEzQb6rRACmbL905H4y8G5GsxblfhPt66fS/2DwaD729/&#x2B;9i2/9Vu/dX9JSckycaeJECFChIirBf6zrTVXLyOgbLQd7SI93DcZPeMhvNnaiSNdPTjfP8Rr8/3cWd&#x2B;BN1rasb&#x2B;tC3WlhVhdXoJFRfmYU5DHvQCQltTHGehmoD4cxtmuQRzr6sMRLvO38dclBQWIxGIIxyX4nU6sryjFx5YtoAoBbiiogXeynoYS27hcum/UslAB3lWDYVNNdWw285aKakdEPQWAEQmQ8RpT8wApsS2Hw&#x2B;EtCAYX1BcULFiyZMm7H/7EJ8&#x2B;1tlw8/n&#x2B;&#x2B;&#x2B;93tzz37bEdyl3rtBDOpBKwaB6rLAvSUAHr&#x2B;AFbaCcL0xrtCxoEpv4DjJ08LIuBaxT7ZmqNcBvB1zXxBiBDAP0vgn42h3&#x2B;WQ&#x2B;BvJ&#x2B;qcj8c8W8CuWkaHf448/vnTz5s0rV6xYsdXn85WI2n4RIkSIEHG9zfOy6RYgV79PPqeHtcCN9J4/dxG/PtuES8OjcNntvLbfbpt0zifp/1g0ypflsufI0X9zTQVK/V70jodwoX8IXaMh7G/v5nL9UfZaqtl387p9CePsbwLgs/NzsbK8iJcKzC/Mh8fuQDgem8TbqSMzOddEK0ItAWBkxqe3vjFRIgP2KRWBzgslg7HP6NEgG36JMwDKayF//ejoaHtnZ&#x2B;fxX/z858/90z/94wlYLw2Iw7iNoLwcQL4M0PcMyGQcKMG6KsCsBaF6uRHAN3oua9B08tQZReuM4sIgRsbGEQ5PIBKOoJD9PTg4zO&#x2B;XKN3PDgd/pJVcLhdyAgH09PZiyaIFOHe&#x2B;kW8jGovB5XTCxu57umfsDjtCoQmsWLaU9pcYZGqDGWPbY68L&#x2B;P2YN3f2dfuZJAgAQQCIuHqgXw3gkeG56Ur85SAesC7xNwL6ZmAfyMLIL/Xo8Xgcjz76aM2nPvWpd9XW1tYVFRUttV0rb2wRIkSIECHAf5YqALP1jBQAxm3utCCVwPnAxARO9Q7ybP/Jvn4O6Gllj9ORJgPob&#x2B;7QH4kiwECQ1&#x2B;XEIAM4HPSzZXluNzfzo2OkdahuP4cBnQXF&#x2B;Qz0F2NDdRkKvG72hW3j24lLyuPh&#x2B;FiSHaUM6Uua4zZpWajnBQBAr5rf6roALKkAMrZ4VOWwE4SGeju0LLGnaDQy1Nzc/FZfX3/nN//ub3&#x2B;9e/fuPhWAj2Fq3QOMSAIjAiBuAvwlC8SAETkAg9dZBfzTJwNOn5UEASAIAEEAiLieQL8VQmCms/1WJP6A9Xr&#x2B;abfuo59NmzYFv/rVr25paGjYUlhYuNBut4uSIhEiRIgQcU0TAdmC/1Sq3EZffUltfTzp1J8ZHGsVAKkgHwCb3YZwJIae8Qkc7erF2&#x2B;2dONMzgKjEzfwn5fTJEgSq&#x2B;yfFAD1FwD7X4yG5AJaVFXIFABn&#x2B;3VJRypa74XHYOeCPJSXympp&#x2B;SXZUesBa5eCvV8Ov2wFAp1Yg7SpgME76wF2SVSfYkmAuruvPYMXjwUpHB0lKnXkiGAAdO3nixHMdHR1tT//ylwe3bXv6EmaunaARCZAJ&#x2B;M&#x2B;0KgAWl2ciA7IGUo3NLZIgAAQBIAgAEdca8J&#x2B;qxF8P0GcL&#x2B;gGtrF&#x2B;vht&#x2B;qod9UJf4KqX9eXp7rQx/6UOVjjz1296JFi25lf9eIO02ECBEiRNxoJIBtcjLBwUXPWAjNDKCsLCtm4J2&#x2B;Fe0JIkBSAlstCaDFRuo6dv4lywBPKBLBoY5e/NuBYxy4QMfZnhbNys/BF9etAFXY&#x2B;VwO&#x2B;BlAotcTaUBt&#x2B;6Q06FcfhaTLTaR/1Wnjpw&#x2B;STcbUgEQw8hFQrK9bQpAA/gQCHWyMwuGwadZfH9gryQqj18jLNtKvSRIx4&#x2B;PjvSeOn/jNK6&#x2B;&#x2B;vPfb3/rWaQPwn606QMqCFACMWwjGswD/16QqoK29QxIEwJULkbETIUD/zGb7Mxn5ZQv0pyLzn27WX1Hbzz407b/7u79be&#x2B;&#x2B;9965qaGi4raSkZKmo6xchQoQIETfwXII/Dk&#x2B;E0TgwhAPt3dxkjwiA&#x2B;rJizM7LQUN5MZaUFvFMPn1bxmNSGuhawUK0DxuBFnpk61NHgK7RMfSOj3PXf14GIMtqxxiQCXFfADvurK1Cgc&#x2B;T3nwoEp0asJB0JjoylC5XAJiBaqPyikntgy25WUmhADA27UscAwF&#x2B;OwN3e97aw0DfOaxeswbV1dXwMyDHOyFEo1O&#x2B;vnokAu02zgUfkka44fP5ilavWf1Q/cr6377//vu3P/fscztOnjzR9cILL3Sy44hBawCYjTrgcrQTBKwZBxq1C1RfxsvaTrCyopyvcyLlFSDi8n7GCQXA1WdhRFwV0G8G9K&#x2B;0xB/Q1vlbNfSzkvXPlP3XXXbHHXcUfuELX1i/YcOGrQUFBXPcbneuuNtEiBAhQsT1Gla8AOhL8CgD&#x2B;wc7enCkswftI&#x2B;MJ4zy2CtXnTzDQSa32KPNeX1KExcUFWFIcxNz8PDiovV48zsG6Fg9NLiNwT9nKKAPugxNhHOrs5a0Azw0MonskxPdDa1BNfySewHAlPi8WFgWxuaYcK9h&#x2B;oVOjbzS3Vcv51TCNv0ydJTfBbuoygPS&#x2B;DGr45dszGnq1CoDMDIcGB5GXn4&#x2B;RkREcPnwYx48dg9fnQ2V5OVY1NKCouNjcA0BxjsZKAeV5GCklJpfx1onx&#x2B;HgkEhlvbr745g9&#x2B;8P2nz545O/jOO/sGTEB&#x2B;JnWABPNSARgsm8l2gpmMAzOpAsyeyxpoHTl6XBIKgMsTQgEg4mYD/lOV&#x2B;CMDwJ8K6M8mww9Yr/GfVm3/Y489VvOBD3xg9aZNmz7g9/vLxJ0mQoQIESJukHlDxnrxmJSQ0k/EErX549EIh89ue2IdLwMSiYw88HZbF9661ImA28lb9q2poLZ9hSjN8fFUMpn1kblcQiRgSwAVFn1j4zjQ0YNjPb042zvIywvIzM9BTv4MxETYxsNs/4UM9M8L5mNlSSHqK4pQ4vfBQzJ49lw22CEF/hUkgM2g4Xsy&#x2B;y5v4yeZqBgkbW9AmYJAi/30ygBS26BsP5EjcXZ&#x2B;MTZ227Ztw0Q4jHdt3YqysnL&#x2B;/LEjR/Di9u1wezzYfNtt5scjIzjU11z5t2oKmDQE5Mdq0yeRHA6Hj34WLlz43r/7u2/ePTY62n727LmdP/rRD1956qlfyL0CUj9W1QGXu52gpFpHrQoAzFsMAleoneCK5XVCFXC5PguFAuDqszAirijozwT8pyLxxwwAfTWYt0IAZOPeb&#x2B;rm/8lPfrL6ve99b93mzZvvDgaDc10uV46420SIECFCxI0WllQAshIAMucjNcDBzh4MhsL8i5My9JIM5JI533gkysF7WY4fH126ABW5AVSz353stZSpJLl/OwP&#x2B;h9p78ErzJbQPj/J6fdoWlRGQrWAkmjAXnJ2Xi001ZVhSVIhZ&#x2B;QFOOnByImU&#x2B;KE2hNh8wVABAMjbS0zMDzDiHNllfDshTpn6pbVCmPxqJoLC4CD6PF83Nzfj188/j7b17ceedd2J4eBhLly5F9axZyMnJ4T/y/esqABREgJkKYHIFjY8jlAYGei0gU8vD4YmepsbGN5544okXX3ppe0tjY&#x2B;M4pm8YaOYRcD21EzT73VKMj49LQgEgCABBAAjgbxX4W8n2X4sSfyt1/FkZ&#x2B;aUe6&#x2B;vr8772ta9tXrJkSX1tbe16BvoD4k4TIUKECBE3Ovi3Mu&#x2B;zJSYfaZTXOx7C681teOlCK1pGhhFwuPiL3ElXfikFAEkezh5z3B5srC7l7vwk428bGcOpnn6EojG4HQ647Im2fVQuQI/5HjfmFORieWkRNs&#x2B;qRGnAy7eXcPKPy5GzAnmqF0kGjv6Jc5IBeSiV7bbkhuSdAayYACr2p3L6m&#x2B;QYEjQAVB4JbmpjSNl&#x2B;9kP1/idPnsTLL7&#x2B;MWdXVXA3R2taGwYEBBINBPPjQQ1wGntonkQe0XiZzP&#x2B;1xJo9H516QdwGwKUgBZQmHEQEgfy4Wi4z09w9cOH/&#x2B;3NvPPPPMnp/8&#x2B;MfNuDztBK0aB&#x2B;r5A1zX7QQPHj4qCQJAEACCABCgfyqgH8je0M&#x2B;ICJhJib/NIsgHMmT31STAI488Uv3AAw&#x2B;s3rx5828HAgEh8RchQoQIETcdEWCVKEihPAIZBA37RkM42t3L5f9n&#x2B;gbRNToOPwMXTrtNARUjSSKAAD49NxaJwu9y8tIBO38&#x2B;hnyvG4uKClBXUoi5&#x2B;bmozc9DrtuVQIc8229YMK/7p1pen8nVP9nhcBJ96bxeP3tvsh915wJ7otYgnpb5A729/XjuuedQXlYGNhdBICcH3V1duNDUhGe3bePnvuHWW&#x2B;HxennGn2r9ncnSC2MHf&#x2B;NrmyZJJHlLQuM2gBo0Kl&#x2B;uaM1o3nJQSu4wFAp19ff3Xzh18uTb//Iv39l94sSJgbGxsRiubjvBTD/AddJO8PjJ05IgAAQBIAiAmxv0ZwL&#x2B;2Rr6TUfiLwfnRgA/k8R/uvX9nAxgX6CBv/7rv76tvr5&#x2B;bVVV1Uph6CdChAgRIm70iPP2fePcZK9pcATrK0u4aZ/H4cxq/ieX&#x2B;9uS7vy07fahEey51IVXmlrRx4CHUzaFsSURGPcTiCbq&#x2B;StzA/A5HNw00MfAymIG/Ctz/WwynkTG3IY&#x2B;ngajPMttkImXg209AsDovNLbUrUBhIy80G/HJ&#x2B;kJEPT3JfubAV1u3Of1ehCJRNlTcd7K7/ixE9i5awdC7PrMWzAfR48c5QCtbtkysLkKamfP5tvhY5Aw3bME&#x2B;A1LPCRFbl&#x2B;zjqRF/Ao1hFEJgPaUtZ0gpJTigP0bHh660NnZeerPvvzlH&#x2B;3Z89YApt9OEMjeOPCGbSdIqgBBAAgCQBAANw/wzybbfzkk/kay/ulI/LM28JMv27BhQ8FHPvKRRffcc8&#x2B;dNTU1DR6PJyjuNBEiRIgQcSMHge3hSATnegexr70LZ/sH0To8ylvrFXjcqMzJ4WZ99eVFXHLvtNtN54J6UnF7svUf/S8WjeM/Dp/AS42tHNzHVeuPRaMchPzNHesxj&#x2B;2PjOxcDgL7dkixWHqmMBSawJm&#x2B;IV5SQAaEVBJQFvBzlQCZ/iky8TIkLsUzqxkyEQCwTaoBJAPwb4CFleOSHEsp2d6Q3NtfeuklnDh5EuvXrcOiRYuQk5uDgf4BXGprw47XXsPRY8fwwQ9&#x2B;EHPnzkVRUREam5rQ3dmJJXV1XCFA4F8N2c1q&#x2B;TMvm9yanCzQlAhoIKj&#x2B;9jJ1X9C9n9jj6NhYW0d7x9ELF86f&#x2B;Od//s7uw4cODZmA/6moAawQAFaVAFaIAWRYNh0yIGuQduz4SUkQAIIAEATAjQn61QAeGZ6brsRfDuIB6xJ/I6BvBvaBLI38UiTA0qVL/d/73vfuW7Vq1d2BQKDCdq28yUSIECFChIjLGKORKHZfbMfz5y&#x2B;icXCYZ&#x2B;m9DJR7eD95GycBolKcu&#x2B;zneVwMkOfh1qpynpGvyg3w15gBzBTApWx088AITvaSQWAvr&#x2B;2Py77MJ2LJjDX7ozIngPcvnI275sziXQH4&#x2B;knAyevch0fwzOkmnOsbRDP73ed0IByNg5wFlpQWYF1FKe6orWKvtelNXvV&#x2B;tTS/NVQCyMkFKW62S0309/fB7XJzh35q4dfU2IRtzzyNhQsWJRAhGxM/A2EtLS0YHx/DkiVLucR/wYIFeG3HDpw6cQJlDPTn5OaiYdUqlJSUpDP/kgZEy40JrRACKeJC38hP4aMgG5vJdZTEgdm4GJEuylKJycEfGho639zctL&#x2B;jvaPlsU//3vZYNBrLAP6NlsMCOWBGABgZB17X7QQPHDoiCQJAEACCALhxQL8VQmCms/1WJP6A9ZZ9M9HCz7527dq83/md36m77bbbNs6dO/dWt9udJ&#x2B;42ESJEiBBxs0Xb8BjaRkexv70bh7v60DM6lvgCZtOPVLafvjzDcYlnl&#x2B;kn6PdieXEh7l1Yi1kMfLqddt1tD4Ym8FZrJ/a1deHcwBAmolFOJnidDv48mfkRyUDt&#x2B;ohUWFVRjBWlRSjwkqEfGdbZ08oBLvVnx/Pk8XP4t31H4He5kO9xISZNGgr2jI9j86wK/NmGBn7smoyyBTM6U/CvglWSkcZftk5iGmdLEyHyDDq59v/4Rz9CeXk5uru7eV1/Q0MDHvnUo5z86OnqRSQaRn9fP6/r7&#x2B;npQVVVFfLy8tDW1obhoSEsWLiQO7uTwZ8e&#x2B;J9ULBiZ8umXAKgJACMSQJKMPACUSyVJyjjuGg8FSVKWW2iIBWB4ZPjCoQMHnn/5lZcPs7FssgD6s/ULmAnPACvEAHB5SwSyBm7nLzRJggAQBIAgAK4v4D9Vib8eoM8W9ANaWb9eDb8Z2Aem7t6vK/Wvq6sLfOxjH5t/3333ba2url6ek5NTJbL9IkSIECFCRCI6x8bROjiCnS3tONbdi76xCXiShn3yIBBP/d55fX5RAW6pKsOaylIO6McZyB8LR7DzYjuO9/TjfP8gXEQmkKqAiIRYwuyPvqHL/H6sY&#x2B;tura3k7QA5aJcS/eRHIxF0jIxz88CxaIS/1uOwozI3By1Dw9h7qRPtI2N8ewU&#x2B;D8kE0FBegq1zqlDI/jaqR1cTAJl8AOSglE8ZJGVWXK&#x2B;DQOr15NqfaHUX5o9ery8N0lPLOjs7ebs&#x2B;Gp/Ori6Mj40hFBrHu&#x2B;6&#x2B;m5cEpI719ddew7lz58DmMli3fj3vAkD7jrHxNvYhgIF7v0l7P9XkL7OJoIryULRLNBknHRgRVykoUvJ/SU266BxPODzRd&#x2B;TokWf37tlz&#x2B;M033mx98803&#x2B;nDjtRMErpJx4BTXEQSAIABEXAHQnwn4T1XijykC/anI/Keb9dfU9n/uc5&#x2B;b/fDDD9&#x2B;xePHizXl5ebPEnSZChAgRIkQYBwH0poFhvNrUinc6urlhXzQah8flgMM22caP1ADkIUA1&#x2B;lU5AYwyMOpiIP7i8Aivtaf2fU5bYu4aikT5Y1nAh7kFeVhRVoT60iKUMuDPoCzfZ5zXwgMHOnvx/w6dRM9YCKFYjG&#x2B;DSveptp8IgA8sqsXmmkr&#x2B;JU/HlseANpUtkLKAXkcdAwwmr1DzAmowKq9Hl2ejEy728eQymR0AAVt5Zj&#x2B;5Hv1HgP3I4SMM5HegoCDIa/Zzc3NRVl7OZfy0PQL&#x2B;8SRAdrHfh4aH8UePP4777rsPd269i417NHFNkm38HA6nEkwbtTTApGo&#x2B;RV7oy/kNTAChNTg0Jg5s6QFNOPlbKzHQkg86XRRSL04TOUiTRIohsCWkIGycIqHQeNeBAwd&#x2B;9dJL2w/uf&#x2B;ednuPHjw/DWklAtmqAmWwnqH7OiBwArrJx4NUiA64m9nSKrwUR1wDoNwP6V1riD2jr/K0a&#x2B;lnJ&#x2B;mfK/usuq6&#x2B;vz/3whz88h32B3jVv3rwNbre7QNxtIkSIECHiRg/KwJ/qGUBNfi6KvO5JlJtFkPx/bjCP/SzFPUMjONU7iGPdfTjU2cMz8&#x2B;QTQEE1&#x2B;X5XAhC3MNBP4J/a&#x2B;HkJCDrs/PnyHB9GIjFsYYCd5P01eTkM9HvhTnYWIGAblU3saVp0pneA1/gH3C7&#x2B;pU6Wfh6HjXsOtAwOo2VoLOFTwJ4jL4JEBwCJmwEmJh82U/m/HC8ruxfKjkM2LbLb7ORGj5/8&#x2B;MdYu3YdVq9dA6fLDZfLyduokWt/hI0LZeUps586rx/98EfsMYaHPv4wPG43P7dTp0/hiSf&#x2B;B5s2bkJhURFWr16NvPx8hCcmuNHfsaNH&#x2B;EFNsL/lMzPyU7DbHSoDPkn3&#x2B;krqWaCOaiET&#x2B;EcSU0NvLGXXSsEBIJmxV7eENMn&#x2B;K45FNYWVtxCUVNcufWK2FEGQHieX3x&#x2B;o2rhx02fW3bJ&#x2B;ZHx0rG3fvrd//dOf/PTtnTt39OqA/2yJALvsd5sO2LcpR17zY7Rcks2F5QDfpgP49ZbJl9t0tmEE5G1TAPVTWef6xmtCAXD1WZibGPhfaxJ/qxl&#x2B;wHqN/5QfnU6n4&#x2B;tf//qyrVu3rp8/f/66/Pz82eJOEyFChAgRN3pEGPCltn0HGUA/zH5OMQBdHvBjUVEQqyuKsZIBbwLT040Wto/vHTqJ830Dk90A0iAt8etAKIyHli2A3&#x2B;3E/GA&#x2B;l&#x2B;MHPR54XM5JzMDb1UnQM&#x2B;Sn6dEwA7/UjeBETz/b5ygH&#x2B;9QIwON0YE15MRrKSzksjevJ&#x2B;HWyyGZOfHo16WSAZrPbuIohxgA8PUaiETQ3NaGishJejxcnT55ER2cn2i5dgs/nQ1lJCXIZkCeTPhcba5Lv79ixA0cOH8bmzbfB6/Ois6sbe954g5MEH//EJ/Dcs8&#x2B;iv68Pv/t7v8dVAsePn0BVdRUKC4K8tp8jS9X46s7HdcocJAvzdrkngRE0lDLU86d8AFJifT72Uhx63QP019USEeprxwmFuKToSKjoSJDer3L9VIcCet34&#x2B;HjngQMHtv3iySff/NWvtrUje8PAy9lO8Lo3DrwSZIAoARAEwM0K&#x2B;jMB/6lI/DEDQF8N5q0QANm49xtK/T0ej/3DH/5w5WOPPXYX&#x2B;9LdkJubW&#x2B;1wODzibhMhQoQIETd6kCP&#x2B;ntZO7O/oRvdYCP2hCThISk6ZeKqLjsY5yppTEMDykmIuuV9aGuSAOtugzH/XyBj&#x2B;df8JtA6NJFrzJb&#x2B;UqXY7FI1xwLW4pAB/s&#x2B;UWJS7gaM&#x2B;uTblzU0FJBTQTCgS7w5ZoaRdPwLswA&#x2B;JeAubstZFozBTXp2X7eq0AdQCofG5LMvtnfvUrlJaXYcniJSgoKIDP7&#x2B;Og3ZEct9OnTuNb3/pHLFlSh3Vr1iAnLxeDA4M4fPQI4rE45i&#x2B;Yj9qaWixavAitLa0YGBxAT3cPN&#x2B;6rr18Bn8&#x2B;PtvZ2PMv2Qy3XHv3U72LWrCrk5&#x2B;Xzc6bz5x4BKim8TTJp76dTxy/JYZktQ&#x2B;2/SUtHdemActnkHtXS/En1QVyXADDdNyaJjclyB2gUDXrnI2nIisRKUlySotHoQH9//9mDBw/seuqpXxx46803e8bGxuiGipmAfattBM1KBYCboJ3g5SQCBAEgCICbDfhbyfZfixJ/K3X8WRn5pR6dLP7iL/5iyX333bdlyZIl72J/&#x2B;sWdJkKECBEibpagzHDn6Dj2tXXjleYWNA2McPBP0&#x2B;&#x2B;Ax5lCfDxxOsFAJnEBVF&#x2B;/tDiIZSVB3mavxO/NOJM/2tmLk70DOMoA7IW&#x2B;Yb6MTAFpHhhJyu79TgcqcgPYPKucbbcauSnzOp59tWN4IozTvf240D&#x2B;M0oAXg&#x2B;xvn8PJ1Qn5Ho9hdtsuN5NLAsG4hTp&#x2B;NRFgyhaonqJM/9t792Lfvn2IhCPIY6B89ZoGLFy4CAXBAi7F7&#x2B;7swovbt3OZ/oYNG6gtHQf0l1pbcdddd2EvW3/Xzp34/T/4Ayytq5O1B7Th0KGDaG5sQogk/izq6&#x2B;sxb948vt14khSRqxgU56iCV0YEgPoaSpCM1zMF4cbbVpICNgUJoBSISzIFgMSbOZh5L2iuW5r8kBTHI0m25HYkjZ&#x2B;AvgpEZoqYIK2ioVCoq7e37&#x2B;wbu3e98pOf/PjI6VOnRiyA/lgGwG9EDpgRAFeqnaAZSYAsSIKrQgYIAkAQAAL0T93Qz4gImEmJv80iyIfOcofR6z0ej&#x2B;PTn/401fWvXbVq1V05OTmVDofDLe42ESJEiBBxMwc54Z/rH8Txnj6809bFAPsgJwP8LifPJqdQJLXcI4M8msER&#x2B;N9SU4X68kLMK8jnhn2poGz&#x2B;Gba9nx09y2v7xyNROBx2rizgLQGp5Rx7LPf7sbKsEGsrS1Gbn4sCr0czP/z3gydxpLMH3WPjXPYvJckLJzuePPb6Dyyeg/fMq&#x2B;UdBMxwRKZ6dWXLeJUCQFl0rmsGKH8JyfdHR0fR1d2FEydO4OyZswywh7Bs2TKsXbMWxaUliIQnMDI8isamRoyzc5tgf1OpwP79&#x2B;3k9PykIfvsDH0Rufp4i6z04OAg2f4HH4&#x2B;aGfiTD574BaoVCGsQqQW7GebheWz6YZ/8zzevNuh5M7lKW2Vd0AVCWApiNe0rOb3g&#x2B;kt59oXMuMG5XCD3zQUmK9g8MnDrwzjsv/PVff21nZ2dniF2TuAnoz&#x2B;YRMFYJyJeZEQRGYP&#x2B;6aCc4U0SAIAAEAXCjgv5MwD9bQ7/pSPzl4NwI4GeS&#x2B;E&#x2B;3vp&#x2B;TAQ888ED55z73uS0LFixoKCsrq7Pb7QL0ixAhQoQIEQZkwPbGVrzd2onD3T3865Tq9Un2T5n7VAY9zIAntfMjQ7/ZBbnYNKucg3hy/ycvATLhG4/GkrX&#x2B;EgPoEgfpbvZ3ZY4fy8uK8O55Nbx9nxxtpRztUz3cP7rtFV4&#x2B;QFshkiGelLjT64bY8geXzsejK5dw6buk6SOnxA5G7eTUGWU90zoyJIzFYoakQYowsDvsScM9e3q7Y2MhtLe3YcfOHejp6kFJcREWLVmM8ooKNDU242JLM1ouXuSHuum2zVi8cBFKyko5sE&#x2B;1/ZMmTerSy3Tn1Jo6fn0H/UwEgALZyaT7akBvOreX9EG1chvKI7XJVQCmJQf6BIDZ/pSblIw9EVTb0PgYpMYvfZ8mx0eyoaun6&#x2B;joyOilY8eOHvjDP/j9HQbg/0q0EzRSCMxEO8HrkggQBIAgAG404D9VQ7&#x2B;ZkvgbyfqnI/GfSk2/YtmXvvSlhR/5yEfuWrFixfvYF6bowCFChAgRIkRYjAgDmUe6enG0s4&#x2B;7&#x2B;J/o6eN4h&#x2B;T6Dg5uJyX1YwyIe1wuXmMe5/LqOFwOJ5fgj0VjcLPXFvu9qCstxMqSIiwozEdxwJdGckZ16bS/i4Mj2NPWxX0DBicm0Ds2wTsMjExEsHFWOdZXlfJyACuYQa8G3QjMy4&#x2B;KQDdl6XNyAtyt3wiAut1u9PT2orurk2fnPbw8wYaKqgo&#x2B;HrRCS0srdu/ciddffx2rVq1CUXER&#x2B;vsH&#x2B;O&#x2B;zZ8/mrf6orj9GngiwDnh1TyJ9HpP19aYEgF72P23mZ0ykZJrTKwz3NOtqcZ1ykWSwz&#x2B;wJALWiALAZkhjqsTce3&#x2B;Q9nG6niCRJZUdvX&#x2B;&#x2B;xzo6OY/v27Tv0/e9992h3d/cErl47QbPfp6IKMPIKyLY8IFtAOGUAKQgAQQDcCKBfDeCR4bnpSvzlIB6wLvE3AvpmYB&#x2B;wmN2HysX/Pe95T/Hjjz9&#x2B;18KFC1eVlJQsFYZ&#x2B;IkSIECHiZooUIJnJ&#x2B;d5gOIJjXT3Y39GD831DuNA/CC8D/C57Qh0gJWuzU7MD&#x2B;aRhTWUp1laUYD4D7cV&#x2B;n&#x2B;y4JGSaCtJckZcgsB8CxBNJBUGcLXKlSAi2LK5jDGeEFSwBSVUNOGXi/&#x2B;Wfv4O6pcvwW&#x2B;95N9&#x2B;nfH&#x2B;JQ7TjlVdewUvbt/O2fLNra7msPxgsRDQaRSAngIDfj&#x2B;PHjnOSIBgswEc/&#x2B;iDYXCXhTxCLcRVDSmWgBbDGfgUKJ38FkFfVsNu0Q2KuHtB/rZ4rv9Hc3rjkQsfNn8Y9dZyK47GljQATJIKOakMH/NM1jEuqTgVqh0GdbUgGqon0uUPHV0C&#x2B;b0mmHkisFOvu7jp45vTZt378ox&#x2B;&#x2B;uWPH6z0w7yKQrRrASueAbH9g8W818DdbflWJgKuJPUUWUoD&#x2B;mQL9VgiBmc72W5H4A9Zb9s1ECz/7gw8&#x2B;WPnAAw&#x2B;sXL169YbKysrVItsvQoQIESJu9CD3&#x2B;/MDQ&#x2B;gYGUWO24UDHb0IuBy4ODTKH93U8529jtro&#x2B;ZxOVDAAmuN28uw7TUeymZDks&#x2B;1vrK7ABvYzEo7gzdZOvNbUirN9gxiVGLhNeQWoZuc2BtJJSbC4qABBnzerSXgKZMaT4JY8BPwOe7qtm1YGb3kuZmHiNQn&#x2B;ybn/0MGDaG9rx&#x2B;23bUn0mqfx48egJFpiDOh3dHTgE5/8JBYvXoyx8TF0dnZi7549eO3Vt&#x2B;H1ePh2H3ro49y4j7YzQfX7Fk5Cz&#x2B;hQDsRN3QxTxIxZFwCdCaWUYQwzgf/0aNqMn5dfDkUTekm5VA7iMykh0gaI0PMcUCoArOLI1DmkLTFoTdn7SKFukG3TlljZUVpatqakpGzNylWr7tu1c8f/dHV2dv3Hf/zfk&#x2B;x&#x2B;CcHcMNCe/Fv9KCV/l7/eJgPdNtVJTkUVEFetD52/1cskHZxh9Hq53aMtS2BvwxVoHThjGFAoAK4&#x2B;C3MdAv&#x2B;pSvz1AH22oB/Qyvr1avjNwD4wdfd&#x2B;Xal/IBBwbt68Ofid73zn0VmzZq3y&#x2B;XzFYjooQoQIESJuaNDP5k4nuvtwuKsPx7p60crA/0Qkxr8hyU2fsvEExHn7u&#x2B;RXOK3jcTr4VNnLHqn&#x2B;ftOsSlTl&#x2B;rCoKMiN/qYSY5Eor/V/&#x2B;UIrLgwOc6M/l8MGObVAMz0iDIoZ&#x2B;P/D9SuwpDiYnhRYAf&#x2B;ZjOXkGWFzDCxl3LZeCQDJuLu7uvBv/&#x2B;df8dGPPIhly5dRP3gu9R8bG4PL5eYlAURGUIaflAK7d&#x2B;3mBoC5ebl4Z98&#x2B;9PX1oaZmNpazdT1sve99/3t433vvxfvufR8i0WgS7CpT2nou9JZLABTbgQIXyscpRV5oMuMKI0Hz&#x2B;btZWYB86CXFMej7MEzqLqDsBJA6lyxKAAzr/6Fub6hVAKTvKZj4G0jmWEZKnafsGirKCMhQMxodGxocPLt//zsv7du378yTTzzRPD7O2wmalQZc7naCVr0C1K8DrHkH6N1W0/UIsAwoRQmAIACuB9CfCfhPVeKPKQL9qcj8p5v119T233///WWPPvrouvr6&#x2B;nXV1dVr2TA7IEKECBEiRNzAQcZ8R7t78XrzJexv78E4A44OBk4d9kQWmgBFJBbjy&#x2B;JIgB16juTySLb2SwGRiVicz8G8TjvKGWhdV1nKW/stKQoyAG/P&#x2B;thoq8e6&#x2B;vDUqfM42TPASQj5DIh8AAZDEdTk5&#x2B;ArGxtQHvBllbbTk51rwacGu2bECHoEgHx9Gi8C7N/59ndwobERd2zZAif7&#x2B;/y5s6gor0B3dxcKCoKIRMIoCBbC7/ehoWE1gsEgQiEy/Wvncn5vUvnQxLaxY8cO9Pf346GPfxx1S&#x2B;s4UWPKQkBpRGdKAMhfoOoGYCR31xAA6g4HJuA&#x2B;ow&#x2B;AKqerRylMkjcJsDyZbpYmAXrKaM&#x2B;QODC4njotHNVtCVOtAPXOwbAMQJK0p6fadzzZttGMAJj0JACRAcM9PT3H9u7d8/Ivn3rqCHvsx/QNAy9nqQAwPRNBMyLgspEAggAQBMC1BPrNgP6VlvgD2jp/u85yK/X8MAH3lo386OeOO&#x2B;4o/MQnPlG3devWewoLC&#x2B;f5fL4iMR0UIUKECBE3Q7zR2o5tZ5pxaWiUgfcod92n6UaIO&#x2B;zbUJOXA5/LyR5zOdimWTyVBYyEo2gcGObkAUErqlGnbH&#x2B;qXp54gwjbHr3e73SiOj&#x2B;ADVUVWFiYj0VFBVkfZ8foGP74pbcQg6QpByBiYXQiim/edQtm5&#x2B;dYn9UbgEyjDL6WAJBMt6cL8KAkAJqam/HG7jfgdDpQVFgEn9&#x2B;PQgby/f4AB/&#x2B;hiQmcO3cOv/71c3jggQewZcsdHPjb7YmpEBn6vb33bfh8XuQXFKC4qAh57DEajqgy0kpXeU0fen1&#x2B;wORc4rrnpyA5MpgIajPmanM8CzX/vKZfUmTNzUsIbDICIDN5Y&#x2B;QBoFVQ6J2r/r1gBOD52MWlpCkiJtUK6n3YoCDd9I7VpktCSdLw8HDjyy&#x2B;99NNdu3eee/2117tkqoDL1U7QCilg9rsa6Mdh3jnAzB/gspIAggAQBMC1APyvNYm/1Qw/cHkl/vzR4/E4/v7v/37VnXfeuWnBggWb3G53AUSIECFChIibJGiW9GrTJXzvwHH&#x2B;N2XWHcnpBmGQVWVFuGN2NeYwQF3g9fCMfyoos0xO/af7BjAQmsDe1i60j4ziaHcfb&#x2B;fnc7sUYI/KBEKRKAOtNk4G3DOvBlvnVKE04LfsFfDShUv47oFjmpICAkGDExHcXlOB31&#x2B;7nJv3WZkfmoHEFIjXusnr4QFlH3m97coBXgoU0s&#x2B;pkydRVl6OwsIgl/2nYmR0FI0XGnHwwAGcOXsGLjaeq1auwu23b&#x2B;HO/5K2PyDcLjdfHpNiiEVi3OjOJm8tr5u5l9WzS8bjZOTor8z&#x2B;2zK37VOsC811hGSNoNG7DJmJA&#x2B;U1S7xGR5Vgct3lJQBK8C6ZsBrK8ggjFcDk5VG2ApQXok&#x2B;2L5SfumRIvhiQAPQTYzHa3t7&#x2B;9quvvvLSnrfebHn99de7cHnaCRoRAGblAUa/W1ULAOadBMwIAUEACALgugb9mYD/VCT&#x2B;mCGgny0BkI17v6mb//ve977Se&#x2B;&#x2B;9d&#x2B;E9LCorKxvsdrtLTANFiBAhQsTNFmcYeP&#x2B;z197mMn67DNxTrf/K0iJ8ZdPqrMiEiWiM&#x2B;wbs6&#x2B;jGrovtGiPAFG6JxuKISHEU&#x2B;bzYWF3GyYCygF93u0Qc9I6F8PNT5/FWawcHN3ZugpbYXjge56UJS0uK8OebVsHrcGZtAmgkP9cDv1ZUAEZz0VRrPALzdA6jI6N4&#x2B;ulf4lJbOyrKy7H17nehra0NRw8fQVNzE3f2JyO/lStXYvbsWu72H6asfiZX/BSQtul0pbOgApAfq37NvYkUXv8lhtvQHt7kuJPvgb4Sw6C9oKoUxVDKn4D/yitngQCQMpx3&#x2B;thVm7TSBjAN&#x2B;GXIXqPeMCQBMrcTND4G8mqIhcdGx9sH&#x2B;ntP/fsPfvDE4UMHey9cuDAWS7SLUBsGTpUMMCMJgMyeAXrmgcDUuwjA4DXTIgEEASAIgKsJ/K1k&#x2B;6&#x2B;GxN8I4Fup8c82669YFggEXN/97nc3rV69euWcOXNu9fl8hWLqJ0KECBEibub4z2Nn8OTJC8hzK3lwkv6vKivGlzas4iUA2cbFwRH87937MRaJpKX6tiSYdyTBO/1EYnFecjC3IA&#x2B;P1i/G8lJt9R0B/CePn8P2xlbu9s9VBGwbpEag7ZH53weXzMVtsyq5AaFZBt4qAWCWAbbLyBLyRkh0ClDXwKuPwZZs42fDwMAgtm17mjv4b9iwkZv6DQ8P4YknnsCpU6dwyy23IjQewuKlizF3zhyUlZXx/dN&#x2B;GFBLA3M9ckIPmCqwomkNvz54V4yFjgGgTbG&#x2B;MtOtmZMbeACoCYBJ40XJGgEgq/&#x2B;fVDMYkTo2JfGhQ&#x2B;RkInwkI/IkpWqQ5ONiy2hkOAn6paS7hmypqgxg0naR2hlqaAyZv0RyvZQHxGQfRGW5hMI/QEIkEhsZHhq8sP3FF/7na1/73/szgP&#x2B;Z9A6wYihoRBToEQRGaoDpkgCCABAEwHUH&#x2B;oHsDf2MiIDLKfE3A/c2mBj4yR&#x2B;DwaD7y1/&#x2B;ct0999yzad68ebeQi78w9BMhQoQIESISsbetE3/zxkHkul2aOS7D5lhWWoh3z6tBHXskWb3RRCXKgPDwRBgXh0awr70L&#x2B;zt6MML&#x2B;Ts3CKOMfYj9&#x2B;V&#x2B;IrWE4K0GuohGB2QR7&#x2B;6JZ6zMnP1Ww/FI3yfZztG0DL8BhO9/Shie2LjumPb1mJqtzAlOeAZiBTvZza9Z0&#x2B;fQb79u3D2rVrUFs7m8vx6XSi0VhyvbgC/Nu4G3uMvc6NFAZ&#x2B;6aUXsX37dixetIivf&#x2B;HCBfgDAaxevQZbt96FGBsraklICoBEEtYElMvgYkpvoVEAqCZy6oyyHmlgDrglE2SkVTxoxteEANAC8MzXZbKtX6asd/JMuTGfpCAFjMibjGMBGJcByF9hoiLQGvnpl0Jo1jEgcNKtI9OEhH4ZhZzAUYkKiHAK9/X2HB8Pjfc8&#x2B;cST2378ox&#x2B;eUykC9NoJTocMuFydBQB9FYB0OUgAQQAIAuBKgP5MwD9bQ7/pSPzlAB4wz/Abgf3p1vVzqT/V9v/gBz/YdNttt91RW1u7UUzxRIgQIUKECL15EvBfx8/gl6caeWbezc3/El&#x2B;oNKOOJMHnvGA&#x2B;iv1erK8shcfhhM/pQG8ohFK/H/vaOtE9FkLn6Dg36RuNRLiXQAqIUJa&#x2B;kgH0tZVlNEHFL06dR57HrTgOIgT6QxP4aN18fHjp/LQPgVGE2XGFonH2GGXH5TMF8tOdL6oJAMrS79y5E12dnfD4fFi8eBHql9djVu2shMs8z9QrzfGonv/1V1/D&#x2B;lvWo79/AC0XL&#x2B;LVV19GaHwC933gfvjYdpYsXoLc/DxEIxEdybdObbdB6YIGEEo6DdBNiAOzfRkRAHoKgIztBHWIACMCwEydYXa9jNswqswA9c4pUwtHPfAtSVpXiGzLADBpAqhYV67YkKF1pfmhlihJKzVUngtxSVKWKtiMOziw&#x2B;zne3t7xxuBgf8srL7/81ve/991TKiIgkypgKmoBIyJAgrmPgNXOAdMhAQQBIAiAqwL8p2roN1MSfyNZ/3Qk/tkCfsWyurq6wCOPPLJ469atty5cuHCj1&#x2B;sttl0rN6IIESJEiBBxDQcZAb51qQNvX&#x2B;riMnrqTU8y9xQGmYhGOWDgyzlRYOdyfAL4JNGnMoFUy0Cae5EXAJkGktN/fWkRVleWoJQB9b1s&#x2B;1/bvZ89pyUABkJhPFg3Hw8snadx&#x2B;M92zmeVCDADk0Yt4WgZjU1PTy/OnjmDkydPoKOzEwvmz8fatetQWVXJs/pEAqRc&#x2B;ilx&#x2B;rff&#x2B;AZGx8aQm5sLj8uNZStWoG7ZUlRUVPHOClH2mlS238BoIP2UmYmhEQGAFAhMrxNXKgZgvmvDdoCKfWpbAWrG0qCMQIG8DAgAax0WjE0D5V0A9E0Lta/NNB6T2fi4zFtBCRHNzsHIR0A&#x2B;nOl1UmNmYASoGXP1WWkUADIlQYb2j7J9h9rb2t7ct/&#x2B;dnf/0D3//dl9fX9gA/GciBrJVDGTjI6D&#x2B;PRsSwGp3AEkQAIIAuBKgXw3gkeG56Ur85SAemJ7E3wrYz0QCONTLA4GA87HHHpv98MMP31NTU7MsGAzOMxgbESJEiBAh4roLmsdE2Q&#x2B;126Ppf5xqdGMSr9GnLHg&#x2B;A9mDEyGU&#x2B;vzoC4Xgc7kQcDnhJAM1ajHncHJwLln4cowywHqwowc7L7bjeHcfxhjoH2c/Dg76E3O7GAP8BH4J&#x2B;EvJVnzxJKbzuRwYi1A9fy5WlBVhY3U5l/W7kyCYjvkrr&#x2B;1F68iowqXflnzOy9b/5p23oCInMGPzv2wUAXoZZsP16bxjcYyPjyEvLw9tbe146603cebMWfjYNVmxoh61s2sRZeNx&#x2B;sxpHDp8GHE2lnfedReWLq1DUXFRwhOBbSMt8YeOzF6R9c08z9VvTacE2GmpvMV2gKbjIOsCYIN&#x2B;NpvuFc210JXRm5yXhVaAuucmaWX9/JjS4NimMN1TlwHoH4dN0U1AF8DrdgHQJyOkDC0I1QoCRRvANNBXdnFIuRwoCQUDfwtFBwGbQsWgISySY8uXx2Phnp6eA6dOndp74MCBMz/9yY/PhsPhuArYWyUEpusnAANCIBuzQGAGVACCABAEwLUo8dcD&#x2B;dOV&#x2B;APW6/lnROI/Z84c32c/&#x2B;9nFDz744AOVlZVrxBRRhAgRIkTciEHy&#x2B;f93&#x2B;CReaWzDrLwAA/th9IxNoDTg5ZL7qhw/escneFu8cDzGpfdUqZ/vcWM4HEGhz4Pq3ACfl&#x2B;Ww1ywuDnI5fq7LhSB7ziguDAxx0mF/eyebzdtxaWiEYyqq86fMf0Gynj3f6&#x2B;bgY3VFKZfjU0u/JcUFmjZ8HSPj&#x2B;MmRU9jT1oWA26kwKiNTPzp&#x2B;qv9fWVY8Y/M/K0aA6telnOflc1n1&#x2B;lQGQEHt&#x2B;Z5&#x2B;&#x2B;mlUVFZh9eoG1K9ciTgD88dPnOAS/5xADgYGB9DT3Y3qqiqsWbdOZugXU7nS6xvK6eBtS/NctQJAFySbrZMVAaDYsrVjNZD&#x2B;pxZIyF7en&#x2B;k1Sj5Fgn4TB2MCQDIA83rXTFKPkQSVr4D&#x2B;sXNiwmZMAMhVBLBNgn/YdAiRuKRSJGjLCBQmjjqeERrPAFlZQfp0uf9FdIRUAWdOn9772muvnn3mmV&#x2B;1QT/Tb7bMajlBNuaCl5MEEASAIABmHPhPVeKvB&#x2B;izBf2AVtavl&#x2B;G3aug3VYm/QupfU1Pj&#x2B;9CHPlT9sY99bOucOXMa8vPza4ShnwgRIkSIuBrRNx7C8e4BBoZjWFISRLnfd1nmPjSN&#x2B;cL23bg0nMiap2T5CTm&#x2B;bTLjZ0sCjWTbPcrmO9jrY/E4b&#x2B;lHWXya5NNjEQP&#x2B;JP6&#x2B;bVY5FhTmM9BdBK/TaXoctA3K/rscdoyFI/CSyoBtn/bjcZh/FR/p7sO/vH0U/aEwfC57&#x2B;pjJ1C/Kxo/8BR5evhB1JYUzMF5a4J&#x2B;pXtxQRq&#x2B;zPj02NTUhxx9AYXERLl1qQ3t7G86dO4fBwUGsX7ce69avS5A3UTbuTgcikQhcLhcnFijbbygpVxdy67zISFZv6CoPmQJAJifX275ZJwDDObUkKagFSafnfab11eqUeBKMZpbxGyAySYvNJEnuS6BDVsjRrKyDAD&#x2B;euKTjiWBw/WQZchv0PQdSrQ3VJIIyiy/pQk15eYCi9l/HB0Cv7j91G8SpXEHS3ntmRpMKJYHsHOVkAj0XjkT6Gi9c2H7mzJlT3/qnf9jb29sbVoH7TESAVXLAiCQw8gbIlgSYkgpAEAA3GQFwDWT7Mxn5ZQv0rcr9M0n8s23dp1j&#x2B;1a9&#x2B;dfGWLVvqV65ceXthYeECMe0UIeL6jXAsnq4d5m282A9lKcmBfGgighy3k0uBPWzSPB6Jcomzn02c6bP82XMXUZnjR9fYOJc425MzWmojRt/q9PrqXD9aR8YwryCPgYkgByYpoDS9445xczQRN3dQjTplxvd3dONYVz/6xse55D3f48HWuVXYUEWS99wZ3Se9Lz79mx18P/S&#x2B;ofvQ73RhNDLB3i9urgig98MEucanZPpsck/g2udw8vIBuvtdbD2HLTm7ptZ17DX0ninwefn6n1i&#x2B;CKsqiuB1OGfs2M/1D&#x2B;H15kt4lf2Eo3HuLZCaMUf5uTjxocVzcPfc6owERLYEwFT9AIyCavnp&#x2B;Qj7fPr1s8/g8OEjWNXQgIULFqCzqxOXWltx5MgRrF27Fu97370c&#x2B;Mv3rzYF1APYuiSADKibGeuZEQByEkBPASB/LTcx1AG4hmOj4yavd466XQR02gFOAmkos91656jbCtCqKkDnaC2aAFoxXtTvBiApCABdV3/odCbQIVLUXQDk45bO4ksqBYDqHBUKBsmWNAHUjrGhAkRnvNSqiu6err0vbd/&#x2B;1JEjh9t&#x2B;8/zzHUlwrwf0YzpAPxuiQP3cdEmAKasABAFwExAA0zCZs5rtv9wSf0Bb52/XWW6lnh8wb92X0cgvtWz&#x2B;/Pn&#x2B;Rx99dP4nP/nJh0pKShY6nc4ARIgQccWDwAPVEg8y4EMZv6GJCQ5AesdCvF6XZL0O9tYdZMuHk/2&#x2B;2xkAz2eAvms8xKXJJX4fmgeGUZXnQ9vwGIp8Pr4dUieS7LebAfpCBkJGwpEEyGaTkPFIjEufvY5ETXHQ6&#x2B;HmYR6Xne&#x2B;PZx0ps0YO40lQRCCdAMYEAQ12bEQCjLJ1af8lfg&#x2B;ah4ZRk5vLz4OymQsLC9A8OIQ57HUuu4ObknWOjmFBMCFfJrBF2yGC4bmzTZy8ILDlYesXsvOj46vOz&#x2B;Xn7Gf7pXPxMRBTnuPn8msRN07Q/fjL0&#x2B;e5fL1rdJzPe4m8SvV1pwl9hC3MY4B8cVE&#x2B;6suK0VBezN3ppzsb6g&#x2B;FGIhu5/cU3bf0XiEpPznm&#x2B;1xOPs&#x2B;hdn0k5780PJI8HonX7jcPjGA8FuWGfKd6BjASYfcvu0cdshZ8dB/Te8fJ3gMbqsvwmYalnCyYTtA2d7W04UeHTqONfR7Q&#x2B;5d8COjYQslWeUQ6fGHdcqwuL7nsc0ArBEAK5MjBujzzSZL&#x2B;WbNqOLAfGBjEc88&#x2B;g5dfehlLly3D2jVrMDw8hHXr16OgIAin02FafmCU&#x2B;bepHelVUmuZb54mI60GkhoSQIUj1a0AJZiVSRjMrTXgXd9/QPe6GMgg5Cp7s7p/U/NGJLCsZGDoN8mpyFULMCi5sFbSoLcvhcZA0gfXRgQAXxbXSvZ1SRCbujxAtpqkVTmoiRU1HTI5fhbaKqb9HRKqJMUGk6&#x2B;Px&#x2B;LhaCwyfP78&#x2B;e2vv/ba7h07Xm89dfLkkArIW/ndiCywYiioJgWQgRAA9A0DBQFwMxMAN4jEf6qGfpdF4k&#x2B;Pf/Znf7bwnnvuWb1kyZJ1xcXFdWLaKULE5flcpI8wArQuNikn4D4WjnJpcRMD6hTs2xrdDMBPxBI1xe3Do7xtFwGMVgbiCXzkeVxs&#x2B;TivMe5hID6XgZ8Rti0O2hn4ICD9v&#x2B;ZV87&#x2B;JCCgL&#x2B;Ni&#x2B;wtwJnPZHUuVcBgJG2WsDLlfCBZtNJvycaAhzpUCex8PWHecg/ttvH&#x2B;EtxgispyTQtqTcOTXhoWUEbsiVfFN1Oa9PdrPXd7FtuGx29LBzqmAA/VzfICcW6JyoN3nL4DB/LcmjqYVZmd&#x2B;PpsEhBBjQz2XnSeREPzsHhz0pCSUAyH4nYEXHSevR1I3GtCY/F/curMXttZXJ5SKu9yAyaNfFdrzT0Y3zfUMM1I7y9w4RT/T&#x2B;SDvls/cLvzfYAnLAX15ShPqyIqwoLeR/X60gQE4lBHtaO7GrtR19YxOQz2JSLf&#x2B;oFv&#x2B;bd92KecG8ae&#x2B;PSMI3Wztwgb23Tnb3YXAiwl3SFxQVYPOsCqytKEm377tW5oLUfo&#x2B;c&#x2B;Kkln/yzkuKXT/8SLc0tqKyswIGDB&#x2B;HzelFcUoJ7770X1dXV6W3otQBUA1A5kNcF7SYdADIBUSMwL/eN0&#x2B;sLrw9koRkH4yzwpBWgnpxclwBQg3ZYawWYbecGNXEgh7sakK5WJRgSAJOA3tDET575p2OKWzEyVMvtoewEAKVSQuHgr2J5FASAjhJA99xSpURm1yDdolBSllzYbFoVBvldYLLcIBqNDUWj4aHGxqZd//LP336q5WLLSGtryzj0M/9q0J8NSWDVLHC6pQCCALjRCYBrVOKPGQL62RIAVrL&#x2B;Gd388/LynO9973vLHn744VtWr159e35&#x2B;fq3L5RLZfhEiZihCSQdvysIRYC3yeXnGnWJ/ezdurSrDS02t2FhVjgOdPVhSHGRAN4TavBz0MpBPZmEke67MCfBa3V0t7fj3gycZKHbzSS5lymmyn2j9NTl3ok/ez6yqw6aa8hk7l//vxV3oGg3xGmQrgO0La5dzF3IjgEJtzbxOFx&#x2B;jcLK&#x2B;2U29zdn4kOyaExykZvB4cKKnD8&#x2B;dbeaKAwVwkk2q6IfIByI/KAO7lI1ljC3sZePZwEBgDtve4sJCeFw2Lt0OuBJSbjofcknX&#x2B;4qh46R6a5qtkLrAbeHcRVzeOQXdGzsutuF03wC7L/rZ&#x2B;2OCv8c8jkR7vNS9kKi9T5S8VOfmYF1lKe6srURxwJsGe1c6SDnz5dff5oZ&#x2B;6rIYIi&#x2B;IvPqLjQ28s8CMjRn7R58hZ/sG&#x2B;VnTZ0yO23VFSE4rZQDy913rpUv4x29&#x2B;E5tvvx1VlVVYWrcU4XAYQ0NDeP7553H69Gnc9/77kcM&#x2B;F6nlX35BkH8ekJO/HpQ1yv6rCQAFmIO5zFr9lBU5utrczcwEUA3gjZQGRsdnRj5oCACjNoeq1xplvjO3A4ThdUgst2mJC1UnACtjrlFwKID2JMMmGbQn1O/cIOmyI8aSf0mffDGQ/xsRU&#x2B;S/YFPdL3o&#x2B;DOqBlmSyASPyQL3fiYmJronQxMX/&#x2B;I//&#x2B;70XX3i&#x2B;ube3NxJLtMSQA/64wd9mREG2ZQGZSgEEAXAzEgBXKNt/NST&#x2B;mVr2WQH7WWf56TEYDHr&#x2B;8z//838tW7ZsdXV19Tq73e6CCBEiphxUR09ZeJK8E1gt8HhxqKOHu4J3j4UwpyAXn15dB4/dwbPjVP9LgDKWzJirI1Wr3zc&#x2B;wTP8jQNDPAv/VzvfQfPwSLqtl1l8YPEcjEdjCDIATWqCSu5WTvX7bhCOJRUAfbzm8jrmhEKA6vsLKOsfSvwdi0k8exCKxvHTY6fhtDmStf/mEWPfyY8sX4Q751RjlI1NIGlYJs98ZROkFvjsCzsTBIAl0AOsYqCf5No0vid7B9hxhDEyEeWllkPsd14uEPBzoEjqi/UMIA6xY71tVkVipsP2NT&#x2B;Yhx42Zj8/cZ5fW8qYzs7L4TMYytJWs9&#x2B;JyKD9iLjyYJoIqTdaO3CsuxfHu/uTZSt2br6Xuk9IlUJEAF3P6vwc1DEAvLqiGIuKEkD4SsyWyBfjMPs82N3SgTO9/bx0wJacKUfZsY1FI1heWojH19Xz9/mNQtbIDfImQiH&#x2B;vqRafjLk458TDGucPnUKNTU16OnpwW9eeAHNTc247fbbuOTf7fXCxq4zufqvWtXAW/hVVEySiolsv5QJD&#x2B;gCLdP6/wwEgNV2gBoCYBKj6foA6JUOZNyXAgRPlpZIVk0AZSDVJgfZkDSu&#x2B;WZZf&#x2B;3fVM4hmTja2zTXS9JpA6i&#x2B;dpnOhZvrQatmgKTTPcCASFCSA7a0kZ/ScE/pAaBXRqIZfz3zQc31SxEjWiJET/0hJzrIiNAmKX0MUiU1Rv4NyWsbHujvPzQwMND81C9&#x2B;/uzPfvbfTTrAf6qEQKaSACveAMiGBBAEwHVMAFxhiT9g3dDPiAi4nBJ/M3Bvg4mBn/wxEAg4H3zwwar3v//9qzZs2HBPMBicBwh1rAgR04nvHzyBAQbST/QMIOB2cJftMCfQbRxY0huMMtifW1OHQjaxH2BAnDLU5/sHeVb/HHukbF9j/xCXwF8cGoWHTZD7J8KIMtA9wVtVxTnw9TOwMs4AasoMyyzoGCijOMpAfsohnIMjp4MDWZ8zRUSw7TIgPEZu2Qkbc0RT5ERc4hJ7kunTidAyS&#x2B;A7OYmjUgGq4af9k/KBQHex38vPjxQLVbk5/DxncxAdY38HEGLHlOd2ooBN/CPs&#x2B;ClLOos9TwTL51/YyUsUrHw9UMbzq7c1YH1FWRIsJiZsVDpB0mg6p5ahERzp6uWma1Snfbizl7&#x2B;WMsw0haIxp/KD8oCPey2QkoB/MNsSJQjkgUDX1sEmXVV5AeS6PVhWEsSW2irxwXqFg0z3dl/swCvNrWgZHOXvQ7fDxokAeb19iN1TBLhJaVKbl8tBN3kFzA3m8ft7Juc&#x2B;JLknYuJARy9O9fWjd3ScO//7HHbu7UG1&#x2B;EQ8FbP3Pyl17l84j7fnu5FCDuIaGxvx8yefBJt74FO/8zv8c6y7qws//OEPMTI6ylv1VVZW4pOPPMIl/eTcPzw8zMFLaGICE&#x2B;PjePXVV7Fq1So0rF6drrXOBP61TuqTBIDGaA/mGVb569NqK5nPQQqA6mXx0yDNhE3QdA7QUypkMPPT24Y6k6wAg6o6dC2a0pHFGx6LnMxA2qle7/WSbqeA5DJV3b0x&#x2B;SIpyjh0wbFKWm/mAwAZcZIe&#x2B;5TcXn5&#x2B;OtfM1GtCUpU7KMz/FFA/fbCSkcGfEfmTBP7aVpZm129yDFPlDZFIuGdoePhUe3vb4V9t27bjV9uebovF2BekNUIgk0&#x2B;AWatAtTfAlFUAggC4zgiAa0Dinwn8IwugLwfwgHmG3wjsT7eun//NwH7BV77ylc0rVqxYX15eXu90OkWqSoSIKQRloQn0nekb4KD2lcZL&#x2B;M35ixxEp8zA7DZ7OkMe45P8KAMbTu5cTWA2Bb7JIIxk/JQ9DjJwTNl4qlGmySOBZfomzHO5EGF/U5aaav8v9A9xQJMpSD1AUucFhQUcYIxxI75Ez/JiX&#x2B;KR5O80wyGQTR&#x2B;9dGykYCBSon10DGVsn2TIR1J&#x2B;yig8e7aJnaMDccnahzLtlwzZCLgTGUGeAnS&#x2B;Cbm2jY8NqRPIb4C2SeNARISfASA6fuqRHk96CiwszOcmcK1Dw5bOn6JvPIyvbFqJjdUVlq9viri5MDDIyQ8aN1JEtAwljN0OtHdjhC2zJVu9cXOlZGYsnrw/KO/82TV1uHN2NZeki7iyQUTSpZFRfq32tnWjhb1vqK6eyjy4C39ypkj3H5FCBC6d7DkypCTFyLrKMlTnTa8KrmlwGNvPt/ISBbp3Eq3/Eh03eNs9blbo4vtcW1nCCYgbUUEiqZQ&#x2B;owzkx9j7fJg9VjGgn8oq0zU4evQoWlpa0N7WhoKCAhQWFnJDv/z8fJIpY9u2bVwhsGXLFuTm5KCquhqZp5eSIeg1W1cDoiz4AJh1AtArK1A7xKv3b2VfapSvNL6Tsls/CwJALaE3LAOwADzlV8qwLEJlrqe7XKae4ASM2rwRxoZ6CpWD7Jprx0CpAFCMp01JfuiSFXJCQ8fnQFIyKLoyfsW1NvRL0N4BRpl/bbtIJRsWDofb&#x2B;wf6jrzy8stPfftb/3Q8WR4QUwF&#x2B;PRJAzx9A3VXASkmAXvZfEAA3CgFwFQ39ZkribyTrz0bib9bGL2uJ/7p16/I&#x2B;//nPN2zatGlzTU3NOofD4YXI9osQYRhkkudy2Hj2kLLDhzp7OFAn1/yz/QMo9/txvKePA4eE0V7CBZyk7dCRk5I8meTFt9dUctm4x2mH02bnTvdkXEbtv6hdWS&#x2B;X5ge4yR0RAEQM&#x2B;Lk8VuJgBdR3nD387ZsHcbCjJ2P9PYHY4oAP3966ccbq1X91phE/O36O&#x2B;w1k&#x2B;kRPTbLIyIxAPGX6iXAgYz9yISdFAgEkMhccY8vI1X8g2Uath72ukT1HjuVEGBCgpvEeDId56YTXad0ZnbL3s3IDPLNL9f99oTBq83M4CUH7IpKFrpHTbn2M/m3/cexuadct2eCXypbojkAgj8on5hbk8WMmyTnVnQe9Xt6hgMgFp118HF/uoAz7md4B9r7t5waCVMpBhI2bt&#x2B;Ozpe/lePKakSKG5PfUEo&#x2B;6CNTkBSy1xqP7nT4LzvYP4UBHNw539rF7npQ8Tnr7JpQH0QTRRqTYyooi3DN3Fubk51ny07iewb/6sbe3F16fDwH2eWq03o4dO/Cz//ovvPs978H777uPewAQeeAm345AgpxJ4BAYKAB0Yawm&#x2B;yx/G8clA&#x2B;d&#x2B;XSSnXWxUz6&#x2B;D07UqAFUdOjIAeHMQn7kLgF75gBGaMq7vl0zn&#x2B;ZnWMzYKTO7dRAGgPGxpslxBl7RR70OyfN0Uhn/qjoIKMC&#x2B;7583GXp7BT5EOKmm&#x2B;kgTQehIYeQCk10uVDtj0X2/YilFSdSFIX5/EdmPRWF9ff/87ly5d3PejH/5w1&#x2B;5du3pVYN/o0ailYCZzQMCaQaAgAK43AmCGs/1XQuIvB/HA9CT&#x2B;VsB&#x2B;JhLAoUcC3H777QWPP/74Bgb8311YWLhQTAFFiEgE77vNviMoi36SAQLK7BLoLmMT/jP9gwwcTHDwRvWZAxMTvC6eADRNDBcVFaCPAfVlJUU8Q/3i&#x2B;YvoIsLA4GOMPvWGGCB4/JaVuKO2ctrHTiqD7zLwmWehtR2BZmrttaWmckbGbYKNyePb32AAesIQ&#x2B;MqDwNSSkiD&#x2B;fNOaKTGORIh4OECzc9UDXTOq337y5AU0setk9ZuVskDD4ShXGZBbPB2Lz&#x2B;nixoJUakHXtyxJzJQE/OxvF2pyAyj0e1FISgxAc74/PXoWz51vNrzuqS8GApLU6YBKHbrHJhCKxxCKRBL7DPhQmZvD/Ri2zK7ksnNqYahWNqRUBXabTTC3MxBUEnKwswfPnmlEy/AYwtEobyfpknkF0CP3CuCKHgdq83O5iWVdcSFq8nN0t0vlMq82tuHlplac7h3g183H7iW7lCABaVvUyWJBMA&#x2B;rykvYZ0hiW3bbzXFV1QTAubNn8eKLL2Ljxo2YPXs2CoJB/plBzx8&#x2B;eBBv7tmD8&#x2B;fOYf7ChfjA/fejvLxckaVNvDY1jzTCsVZA6&#x2B;Q2LHsBKICfVlpvlP1P/a4oPYB&#x2B;JlgJQE0bEei2AtQ7fks&#x2B;AJKkO3J6GX&#x2B;z542ekysk4rK2dZJKo5/uwGBKHmjLL9Tnrl5uQ4YyCCjr&#x2B;hMdbmQgWWXkp28kqM296ykAjAgUZRcAGBsS6pA4mYgDvfNW&#x2B;i3I3juSMSEikVlAONzc0929q72t/cQ3vvH11y5evDhuAPz11AHZ&#x2B;gJYLQMQBMC1TABcgxJ/PZA/XYk/YL2efzoS/zQJcM899xQ//PDDK9asWbNu7ty5mx0Oh2iALeKmjniy/pYeSdZOmfOzDDxSlo6ygUuLghzkLyjM52CTZO4NpcVcCkz15gQa6xiIpVrxlCFX6tPr&#x2B;wdPYkfzJcMJPC2lbOK75lbjkfrFWYE3eVYqknT4J4&#x2B;Ab751CMMT4UkTPZPzLmVg9ht3rEs7o5cwwDnC1k0BTKqBJoBLKgY6d9pHhIEee7IMwCYrX3Bw2XsPvrJjL5co2yyO/efWLDN0/59KUEnA13cf4NJ8K0HAi1ogFvk9/FpQkOcCZWFJTRCKJGqvE&#x2B;cN7lVApRYVfj96J0K4tTLhG0DkwNyCfO4BQP4L1FLt9eY2UyIkRQBQC0QaB1I3kLKBxns/G0tSfhzu6uWECjkqONg&#x2B;ljOAWcr2ke9xYXlpEc9Qzw3mYjAUwXPnmvg9Wej1YlFxAZzJ6yRCTnpFuFKnio2TL4NKZJhd/5M9g&#x2B;wa9OBIZy9ah0fYVbCn/QLsyZlkNNlBwM6z9i72eVDIAHwx6tn1IR8L&#x2B;b1GpNux7j7&#x2B;c4Rn/8f4e4sMItdUlPAWhAT6vU7nTXNNJB2jz9SyCxcu4JVXXsHQ4CBm1dSgo60NdocTp06d5KTAXVu3YsWKFWBzmTQ5oAZsRvXxUEExKwSALkjOIP&#x2B;Xb0d9rmbO8ulj1wO2Rl0IDEC8cR2/lAbTlgwE1TLyjOSJlJlQkG/LMJM/2QUg/TKFeMNYLWCUwZcg6ZMaEnQ9AMw6OEyOrU3hrq&#x2B;o408a78lvO&#x2B;O2hdBp/adHGKUcFCROlmiOT1OekPQXkLcOtHD91F0O1CUI6hHVWy8cDp9rvHDhKbvd3v&#x2B;xBz/ynEUiwKhloJEhYFx1WpIgAK4TAuAqSvz1AH22oB/Qyvr1MvxWDf2mKvFXSP1ramp8f/qnf7ri7rvvvqusrGxxTk5OJUSIuEmDZO&#x2B;XGACgyTi1Bdt7qYu70I8y8NUXCvFMMNXuT0TjeNecKnx8&#x2B;UIOcKkePs7r9q19RB1igOErr&#x2B;9FkJviGWf/yTjui&#x2B;tXoosBAZK6Xxwc4gCveWCES8FJedCX7GlPHQJIlk6t74q8PnSMjSLgcqVr5VuHRrkcnrf5s3CMpFogYzqqe/a5nbwmndalbZAPAAHP8kCAu44ToeBgk5s8n5sbGVLtM8n1eYtBtrOg142T3f1oZMfvdmSW39PxUUb7TzasRBE7Bsqq0zc3yZzt0/heovKBP311LydwrN4PH1w0Dx&#x2B;um5cmUnrGQtyPgIgfGntSdNDY099E9NC2wzGJZ4aJJLDLjOOodpyApZUSiBQJsoSB9S9vaNAtMSBSoHloCGPhGDpHxrCrpYNfj07eKtLOfRlWl5eioaIY28&#x2B;3oGt8nC2TMLcgl5eV3FJdjqqcAO8sQR4KN2OQweZFbuLYh8OdPVzqP78oH2vYuK2rKkOpP3NNPalNDrP1j7L3NWXv20ZG&#x2B;XX3u5wKHEJEUTRp7EbbvXteDdZVlvDSHXVQN419bT2cJKCsf8B98zbYMWoBmHIlp5r&#x2B;zs5ObvRXVFTEf4qLi41BCjLJwY3gq76jvBG&#x2B;N2wDqK4rz9SezxCYQtcQznD/gGHtu9FJZCohUByzxkTQmGzQZpGNs&#x2B;lmyyePaZKsmPQASI6MqgyAt8iLZyBCoOM7oAL/gGTqiaAxUdTU08O8nZ&#x2B;egkPPvZ&#x2B;OW3VC6fORmfopvlvUA6AgWJL7g7J8wQp5M3ms5r4MKc8OenSw70Sn3Ync3Bx4vR5UV1XWY7IswIwI0AP/VpQAgHEZgCAAriEC4Gpn&#x2B;zMZ&#x2B;WUL9K3K/TNJ/LNt3adYvmnTpuAXv/jFW&#x2B;&#x2B;6667fZqB/loB&#x2B;Im7GIIB0fmAYFTk&#x2B;BtwiONjehcrcAF5uuoQ3L3Xw&#x2B;vxUlpYypgSAx9kk/uPLFuD9C2frAja7LZkRZu&#x2B;05sERnvGmUoEinwftI&#x2B;MYZyD0hQutXFGQCQSTyzi5eZP8O8flYIA/yt3wJ5JGgNH4ZJui1Nd5anniuG08M02KBAKdLgt16imXe8pyJ87DxqXqYV7nnjAfo0faNT0nlxjaUxMo2&#x2B;THYyoTQcSJ2yLwTQVl3juHxzEnmKiBp8MPON0oy/HDx8A0&#x2B;QDMCeawsXHxWv0gG&#x2B;McBroI3JJCgQgWG1cjJI6CfAI&#x2B;&#x2B;8IuS18qXMbNTvJLt6zE6ooSS8dLmV4yGCz2&#x2B;bCztR0OtpVWBgY7h8fY8UTRw4AikRBUduywULtPY0n34&#x2B;fXLuNO81KGL8R4cmJKWWm6R8gH4Xh3H5rYPU6kFd0TNIbhpDydfqiMge7zW6vLOBClHvfkL3GjBxlwHmOg/UzfIFfH9I9P8Imr0&#x2B;5Ivq8kTjyRmR/1u68vK&#x2B;KeEpkIGyKI9rR24p2Obk4iEuDnChm6B5NdN4gUi3FlQIwTevODBagrDWJjVRkvz7kZlRnRcAQndh5Gx4VLyC3MQ&#x2B;XCGtSumKcBgXqEgO610AM4MM4C60vk9RUA8u0kMqsmmf9M6BnWpPX629MBWBnMAK16AGjXtdC2z0gFIPvgkkzr8Q2uTfID2Rh0qlL&#x2B;shJ2I4M7o2uu18YvDbQ15wnTLLzmHKB0689EGsjNAHWVG2YEgHwsDN4HumUYitObJA8yewBARUxJmq4Jkgr8e71eyeNx23ICgbjTwWYV/PMxjvKy0gb6SIDSDNDIKDBTKYDcCyCOLH0ABAFwfYB&#x2B;M6B/pSX&#x2B;gLbO366z3Eo9P2Deui&#x2B;jkV9qWUNDQ97DDz&#x2B;84N57772npKRkEQP&#x2B;FRAh4iYMytrTm6KTAfJRBsyobRy1bCPp9JneQXzjjQNwOGy687WavBz8ya2rcKp3gL&#x2B;eSgIIXFGN&#x2B;Vm2bkWuH40McPVPhBCJSrytGGWFvQwEhJLAnTLZZvJv8hmIJTMV9DrKPpPhHJUUkPkXGfyR&#x2B;RyBCFIlEIHRy/ZB9eBUo0xkA6kDeLadbYNIDiu2d4lWfi4sKM7nx0ugKOhzo5vAERuLMNt/kIHyjpExTmxQppmfjz3RjozOk8AjZcZpbEJsXIhkgZG7s0FQ5p3GgOT0VO9O55IYCxo38HEgUBVPlhdwjwWAZ9fpO4vGimTSVLNPpReJ&#x2B;n07FhXl46dHz1hSIdD94WXb&#x2B;ds7b&#x2B;GlDtOJeLKLA2XsW4dG8K/vHLPWBSHZvYCOfX5hAYrYcdD9RaZveV4XqnNyMpq/EYlDxMfJ3n5edkCgVN7OLpYkAlL35uz8HHx&#x2B;7QquErhhiT/2vqFs/xstndwXg8aQOi2kTP1SM0B6XSxprkWqFyIDSIa/qDCYsc0e3XNU6rHnUicusWveMTrGL6iXt65MEGFEABChRvfXirIivHveLMwL5t&#x2B;UBMDY0Cj&#x2B;4YGvouP8JYyy3z/1rS/gtgfv1gBDW5afJXpgxdg0DmZYIKttGMrwJQNDPyjLAPSAoV5bNugAfyvSf7PzyKQkUPsVKMZYs66WQkmBT7Osvi4BYma4J01&#x2B;XiqT9JNjo&#x2B;4CoCQAJMM2jmqJu8IIANryDT0SgV8/SaGINycAUiCajjGu02ZS0akBivNLt4&#x2B;UtOBbTZyoFSBqwkbhIZDRT0A2jolaAsUtEY&#x2B;z72GXS/J5vTa/3x9zuZx2B5toqUmh8rLSNUlwryYBjDoGWDUGVP&#x2B;e0QdAEADXNvC/1iT&#x2B;UzX0uywS/2Aw6P6rv/qrFZs2bVq7cOHCTYFAoEzAPxE3SxDLbLfozk6ftJSp/9ru/fxvOUCXZP&#x2B;jTDaBU3L7J9BA/eep7Rxldv0uB8YiMQ4&#x2B;KXtIdcIEQAnQknM7/Z0pi0vZxwKPBx9bvpABAQm5Lg/7tksQAHZbor6YMra25OSAQHEOgREpkVWmfwSc3dw23Ia/e&#x2B;sAjnb2ZXSp5zXnDCw&#x2B;Ur8I98yrUYBXDrTZ&#x2B;rGk230CuMT5eRO4TABqiQHcCDeso40Ns99Jxt82OopnzzTzjKtVcoa6HdQwoEttBFuGxhjwdXMwRgCajpFKGwhQ03HR8dBzHm60mJzvaJJ2Ei9hoHGhDKuVr1X67p3FwPCj9Ut4&#x2B;0ACyNl0DzAKAoTfefuoZQXAOBtrOudUq0B&#x2B;7dmqZCJZEfBhQ3UF75KwsDgfPvYceTUYkRA/PHyam8zpk0&#x2B;JQaM69CKfDw8tn89JJvK5sNlvXAPBFgY297R1cJXErpaEaoNKNci3IXUP0T2ZUk0QWbCosAAPLJ2LWbm5XEFhfg3B/QHeae/mHiLnB4a4lwa1&#x2B;6QOAbdUlnLwTySA7Sb3ZOhq7sBwzyC87B4urimDx&#x2B;/RACsrBICZbFyvxl4OUrRZ4clPbEmKq4iIScCj5wGgV0eufmGmTLQpmQBVdtnQiV//GM1b7&#x2B;nV8mcGvfL2cuoeCmp3e72SAPWwG7XMU/6tzpDLlGhqRzwYlW4oa/qNrp9GbJAuKdC2AVSfq4IJkbTS&#x2B;PQ6stdKMGg3mWzfJ2nKG2zpVoA2mKgH9AwZdVoWasdBWxqRUmCkxiE97jIlAAP78Hg9Ul5uHpxOhy1FVEhx7T1UXla6TkYAmIH/mAkBIC8B0CsHACyUAQgC4NoG/ZmA/1Qk/pghoJ8tAWAl62/JzX/9&#x2B;vX5f/iHf7juve9978M&#x2B;n6&#x2B;YgaCbs8BTxE0XJAunCbfdYcOCgnzFc2MMNHJpNJuEU307gVKS6fvYZJ/q8kmiTyFvrZYyY6NHyqb6khJzLqlnYKAqx89rwKkPN7WlW1VWwgE/tWkbZWBqXkEu7/lONcK/OHHOvP88&#x2B;7wfZcf35xsbLMvOzcHNCD7zm50MpHgyftDSuVXk&#x2B;fE3W9ZzYD9TcYkBrC/t2AtLKe/Etx47/zUcdFMWtS9JtNDxE3iir0Tqz05AjST13GCNzpVdcxpbUiXQi8PJEgYC/ZSIsCfLILL6TuWeTTZU5Pq4wR857xNQI2f&#x2B;6vwcTnAkasRt/J6x0grwH/cewb5LnbwsIyOBxY710frFvHzgDANGzewcyfyvPxTm50GkE5FNNDZENFH9P91/hT4PlhYHMSsvwO5zLyemaFv/efQMfnOhJaP54Fg0xiduNOqkjrmzthKL2fZq8nMzmuNdr0Gk3gV2f&#x2B;2mrH1rJ3/vEIlHZS6kMInFJ&#x2B;uaiSShzwAqMWkoL8atsyp4q8hMPgr02UP36fHufn7fNLD3uMfhEB/aWYbV97CV1nM6eFeTGTYCT8au9dYVANMmASx4BxiBSCsKgEzlA0YEgJkPgNm&#x2B;Dc9DB3jqHUdc3UJPZQIoJ4b0xt3UAyBVa6cgmCe3o2e0p1AuaBgbg2usduOHTheA1H5MlBSSDqg3U15oVQWTY5D2ATAoYVC0AiTCmv3mcjsll8ttCwT8MY/b7XA6nWT&#x2B;b&#x2B;PlOSZtKcpKS26BVvqvVwpgpAQwIgEAa2UA1wQBcKOCthtZ4p&#x2B;pZZ8VsJ9Vlj/16PF4nN/85jcbbrvttrULFixYHwgEhKGfiJsmyHyLsqsE6MPxGD7dsBQH2rvZhHuUgzPKvg2FI&#x2B;gaDaF9dAQ5TheXrBfxDH2UTcSd/HXyvt68Dd9EGFtqq7CmopiDf8qKUq00mXRRrTcHiYCpbJec439x4rw5&#x2B;CfyIhrFb82rmRHwT7HrYgdXCFj5wKUSiE8vmD2j4J/ixcYWDDHAmmfBxIwmb2RKN5sBTXtSyh&#x2B;QgSqj7HZqUkMKhY7R8UTdNQPsl9i17w2F&#x2B;O/Pn2vm94JVeTX5L3B5PLsLmgaiXKp9qref8xgpB30qMagN5qX9Fciwz&#x2B;9y8eMn87a8ZAtIeRzs6Ep4J2QkZGKYVZCHrXOqEwvmI2E&#x2B;yM7n4tAoV0OcZfc8mdfRa8l4ju5XyvDHeMmIm5cJzMrNwTx2jLV5OWi1cP60DSqz&#x2B;PjyJexRwonuAXz/0Cm2PQcDrX6sLC9k1ygHm2oq&#x2B;L3itN8YWWtSZFA3D/p5N3sPvnC&#x2B;mfsDkI9CO5W8eL3cT4M&#x2B;H3LZPUmqkzY2ngToyTOESCHyT7i1qoy79usFqYfmB/P5z80SnY3tOLnzIMZGxlFQWohldzQgrzi789frBGDl9epsv7EyQG3EJ383KOVERgoCDYkg80DRgHaVCaARuFYDQ/n25JhUkm9TU4MvKXarty&#x2B;brJe8HgpK639skooo0SEPVPvXMePXjGOmD6SEO77NkHCZVGNMjk9abm/T7nfyPtAOmREunSR91OvQcaVIAJtO20Ab4oirxkePGoGiE4BNdsHUx6tQWMjnK5r3iZRhzCStn0Yyc89/tUFFSMjvP717P1F64PP7JC&#x2B;bJ/nYZ6YzMZ/gLCcD/jbFWKZNGzXvEYcKoMd1MJQke1RjLK3sY/J3fVOPazBuNALgSkr8AeuGfkZEwOWU&#x2B;JuBextMDPzkj&#x2B;Ti/6lPfWre3XffvWb58uV3&#x2B;Xy&#x2B;EpHtF3EzBMnQSb57iAH7Xa0d6GAAaCISY184iRrbr&#x2B;3az4D3EAdkNHGn9mnzuJnc/8/ee4BZclXXwrtuvrdz7ume6Z6cNFEajcKMJJSFBAgjRJCwDBjMj3/wwzbmPSPzbGywAQf47c/42WDMA0wwmAwChFCaGUkjTc459EznnNO99Z&#x2B;1q&#x2B;reCqfCnWlJ3Zp79LW654YK55yqOmvttddW6M3LFjPoh5T82QttlAiHHMlgir6PVVXl9OFr1zgM9BKRVKDjhFv&#x2B;p7btEmCSPPPwAX4Xi&#x2B;N7eM3yGeuj7eLcimP&#x2B;twPI&#x2B;a&#x2B;ur6JbmxtndIzgjP&#x2B;r0y0WEO/VoJy4obE&#x2B;b6m9sejBuCNibTSoMNDgIfCj42cDg3&#x2B;MRXkyTjFxHMPjU9QnQDdSScK6q7Lmr6jwmKK6Ad/YxWsvtXVypLiKq0IIzK67t7Mb/7waGk9nOEUkiOM&#x2B;/BNe12S1aUFEGj8LSvX8fAFUQXKg33a1d7H65fzgEJeywzmjbGDPyDjt6&#x2B;hil2UoAYL0AIiGDXVVrCC4W&#x2B;zjTSuaOT1md0cP7WjpoI6Rs/SfB0&#x2B;wymCN&#x2B;NzS8hJaLq4T4xpBhBxmlaE5mjgApcfvrFvJXhsglB47cZ6O9vZRp/h7cHJSXFMxTrGJxELZ1Iyz/YNMQj52&#x2B;jynTdy2sFFcUzVX/H36wuGz9M2//HeKxeKUKE7Qss2riPIkAOwpAPk2LxNBMzB2AmRFgiNkEmrXYi7yNADyxMxO0GmkIJiIAMdhqf7lBu3Haa&#x2B;oIFtQ58KjqvR4/asImBbYNuhlVxBIo61K7ovmfZrH0QrIVRMp4uxk&#x2B;9g5FQDu88&#x2B;m4Cd7&#x2B;ofX&#x2B;Gvb0M9BsZbIsyhKSHUwJ7J9ZNGsS4UMCxliGy/7NeFQb2SPU8ZMOQkELTUqTPF4XC0tLVEA&#x2B;sXzUnEd0yzZQKZKBRayLKSDfvNvu4Q/CBZzcFDymVggAOYq8M832n85En8zgCfyjvC7gf3Lzevnf994443ln//853&#x2B;rubl5TV1d3boCHCy013rDg&#x2B;SEAPQIqCKnHcC9ZWCYwQqk2LibI0LMtdsryzgXHaDk&#x2B;sY6zjVLRKIMyPBZAEzI8//P7oOcq24HZHg2aQ7zpfTxrZsCuefLQVya/mX3YZb1xzwk3wCPo2J/kHvjucTSdXEeKCtXmUpQlwAeZYkoH3MsFObShPgMjh1pCHjGAtxBEl8mFtptIyPUK76LEnV&#x2B;qgO8C9C6oKyECROUDYTzPAwA47rzfn2qSGx7jKOgIFJg9Bfl3HutIgD2L4sEb29pZ48A5PT7Sek0Q78Q3bpw5r1JAcw6hkfYhT3IgweLmf9x7VpaKIDtwPik5uYuzhV9AECIcUG5RaR2REnzIEBfaIaECkvz0fZ0dPOCBukDOy50cH8GJTfw2ZsX&#x2B;PeFQXgsKi/VyRyV1SnwqIDLPVQLMG1EGUuQEn4Be4wD1DEwlmRSRZzT8spy/nnD0oWcRrOztZMj38&#x2B;3dNCuji5ezyKffev8elpVW8HXJdJhQCCsqaniygxzMb8d94pF4rr4/U1XMaGCMpaPn75IB7t62Z8C3gsx3dAzJD4bj2j3jW1i3u/p6OEyoa9rapgR74hXsx3dvp&#x2B;OPX&#x2B;IJsenKJGM802jurGW5q9ZSEVlxVTZ4E50bLznOvqf//XXlBRzAWk41QvqLvn&#x2B;H9QA0B6ldwAjD&#x2B;k&#x2B;vmoGkzKs4NyeO/hzy933Qv6qNKdbtQFKG5oJ4P4v250jEuyI4CvycnRu5yNB0ip5kw6&#x2B;BA3p0WhVcZIqlt3aSIrscShZqbydODCfsnv6gWo7h1z03&#x2B;4/IFUBKHYiKdeJiqJI8&#x2B;5l&#x2B;fcyL0LHeFlSIYwPa/u1exU45oBOKHipIqzRf0WA/iglE0k1lUoqUXE/1N9T/MbUitaUrF&#x2B;BTnCFTKA/THIlgJcKQAbyvUD/rCQE5roHgHKZn1c8tvNKGPqFfP72k/h7lfHLW&#x2B;JfX18f/9CHPrTylltu2XDNNdfcm0wmqwqwsNBe6w315OGq/9S5i1yuC&#x2B;AKUVSusw0gL8B1Y0mK3rl6GTUI0IJ8d3Zt1x9qsqgvQOnf7NhDxwU4KorFHA8nGH6hPNdf3LSJpdxuQAnbxrbK4jEGRNhv&#x2B;/AYP8gAHAGCvnnwBBMMfndybKu&#x2B;KEVICQaIQHQZkWPOpROoDQRBsXjYAtghxxtRXoBuuPEDjJYnNaKgUhxLr9g3Phu03F3aWPjq5ZOm2esgzKX0YEhIXBYwwzLwuAA6IB8Q5e4TQBMgKBWLamMhjrEyFWcQWi3eRylFEBFBniMgbtbWVtGjW672NUrMt33muT20q60rUL419r2mupL&#x2B;5IYNUlID7yMPH&#x2B;QOKjzsFSAfxAza/vZeGp6e5HKNIKYQQcbUAkFQJvooqP4Q7wNY/v0dN3K6AYwLL7UhjQEpAY8&#x2B;9SKrA/zILMxrjN8fX7eOiRuoZtwarsOWoSFWB6DCwMneAVbVrKqpoMOdvXyyIJMgeb9jYSPNF2C6ODq34xq4V&#x2B;Da&#x2B;&#x2B;mpc0xwYYxBXOEaVW39DtLgrsXz6aHVSznVaC62KXEv&#x2B;cd3f4qO7TjEZpBF5cVUVldJI&#x2B;Ke3N/RRxX1lbRqy1q65r4bac3rNgYi2S6n74OSAEGNAu0EgByX&#x2B;3sJeIHjXD66fAduDv2u25HcMMwA3jCWy&#x2B;Vve4N4r/x9xbZv8ylkMqo7oWLbhurab8GqAGS7UHGvBiDP5VelsnuzBwDf99zy9/3OR/U&#x2B;B6eBnm17pg5VDfd&#x2B;ixeA6jlHzAaJFhNByzVjteBxLedo8w7I5TuYCBJE&#x2B;6NRNZ6IKwKDqPFYTAnp3jqupQW9SACymiHis7U11bdSzgTQ&#x2B;PHzA7AbA6pkLROYjw9AwQTwMgiAlxv4z3S0PyR5L1&#x2B;JfxCw70cChO2vRyKR8EMPPTTvgx/84F2LFy9eV1NTc5VypVsFF9prugGAIAq9p72HTvVrObhITUTuM8zPAGCM5/m4AF4b6mvovRtWcO54kAZg/jc7dnO0O&#x2B;4SmQMYf8eqJbSpsY6OCnADgH&#x2B;4p5&#x2B;d6fE9REGRM4/jaBNgoES8f3ZgkKoSCY7Cs4VaWmUwHfK5jzKFrT&#x2B;g0wJYI389opcJU1XjPc2F38req9mlXUY/ZoOUCJskhUH62/iucc/HfkKKZNFoiiwg4g3Qg3&#x2B;n9cUB8qhBHqAqAPoI6QcAR0Eb5PLLBViE1wJANiT8RbEw&#x2B;zOAcCgW4BKAcnhqkvsan0vrx&#x2B;92pgDqv/3jJ1iy7dcfnPYhJtsfXruWbphff0lzFz&#x2B;tw6NMkhzv66e&#x2B;sUnOEf3RsbOBTALJtEIBqQLy6Oq6ai5JiL6pF3MQfZGPeRwUIX/y6xdYCeOXBqERANpCFJ&#x2B;9el413dzUwM735R6O9yDNDnb2sJM&#x2B;cuY7R8eYEIKvBYisq2qq6BNbN3I1jNdKw3k&#x2B;fa6NfnLyLJMs0VDIAXTgO/KGZc30gY2r5ybhIcb151/8Pn33r75KSzatoj/46scpUZyktBjXjlPtNNQ3QE9&#x2B;9ed0&#x2B;Nl99MhnPkhb3n77K0IA&#x2B;BEBXo7/QYkAcoWwwb5vyb83QLiEBJBFou3naZb/y8ryKR6kgd03wJMUkZYUtKdAeJy/CxOiugHkACUavd53OvqbQayZwZDv1897wXJO&#x2B;t/2lAPzv&#x2B;1u//ISiqqDV1JtB2PI4s3pF/Z&#x2B;txIRkgoH&#x2B;v/Zh8DHbDFbmtH8Pvo6k8n6DqRSSSpKpSgWi6rm8n2epILtb18CT7xVW1t9B5YYJuBv/&#x2B;1mBuhWFSBtA/pzggCYi1S5chmfVQK&#x2B;7hXZdwP5QQ39/P5&#x2B;OSX&#x2B;WRLg4Ycfbnz729&#x2B;&#x2B;/rrrrrujurp6RSgUilGhFdpruEGGPjg1RS&#x2B;1djDIXlZRThsE8Ll1YSO79n/vyGmWuxsXJCLiWxfU0x8gP98DDGk5akRj6WnqGhmn/zx4nA4KUF/uEVUFAIJb&#x2B;r/vP8YADGW7Qgx2rTeaLDDXa7WfnRjK1phXAoB/3pdYYCOCjLriiLjjHBFZjXJd8hADSWwC/ZPm8n5hvRSe9nhAlBFAG2CrIhFn4J0veQu3fWMBiYoHJbEYy8iTeqpEUgDvNEv04WSeYUkzwGRGDeVuhGEtCooRCou/KyJxx6LDrw2NT9L2ix0sQ8xp/bTyQugHRMJRng2kAn43FKf4c&#x2B;j75rJS/vyKyjIeE/g3LCovYQ8CPuZ42Dfyjm0VRSKXBP4N4gg/TboJnBE9vzg4RD8&#x2B;fi74tcBRe5X6xbhAYfLDAc2/AHMR/YHyf1Xi57qGWt4HKgB4ycxRhnFCzIu4jxQd4w/ZO8iF80NDhCz&#x2B;Z863caS7ubSEGktTdH1jPacdQN4fM113mKtwtb9aN7D838&#x2B;8SCd7BtgUD8d5rfgpk1xz0xNTFIlH5&#x2B;Q9C8Z/77hqCRXFI/Qfe49yf5gXjAYZd6Czl6/zIJUfZt2CThzzbe&#x2B;&#x2B;ly4ea6EDv3mJfvVvP6bb33Mf9bZ20fEXDtGxHQfp6PMHxTUaEp85P3uOO0&#x2B;CwPpdClwq1HuBq1il&#x2B;5JafF6bMB&#x2B;fOTJsx6SKy3nLpPJuCgCrd5yaVz8H64scZa1FlFWpVN4XcHmQD5oZn7Qeo885kFTGn&#x2B;1rcz6&#x2B;mQ7RcxMURQ5wVZKBbsVK&#x2B;qhyXQePt&#x2B;LIjZeDJ0kKQA7MKw4Kx60MoGJTfwD8x6JRNRaPIdqfScbjIYUDERlpfr9biUfZesR1rHN2CyEdD8lk/3ZTQC&#x2B;sZyvcaHl9dt9755gC4FLB/ysF/EP08hj6XarE3yL1Lyoqijz44IPzPvCBD9yxcePGe&#x2B;PxeEUBFhbaldLGBehFuTOA4FoBaLB4Boj74q7D9NTZC1QswIOiP&#x2B;zEU4geWrOU69XjFonyZwBM5waGKCU&#x2B;t6&#x2B;9iy&#x2B;rKbE9LL6RR488cHzfyG2XgVOj5B/2DYIBRmYAxzAJ1HK8Nbm8trgnvZyaYvjmCCAQFUB8io3aEHn2ayPiuJFXvbishLrGxjgFAFUKALQ4Eit2VpGMc955kwBcSIeoE59BZYJa8XtcgLp&#x2B;AZqrUnE&#x2B;3tJEjL685zCd7B&#x2B;imD23UAZ4xT4QnVxXW0Xd8BtIJjhanBBABsBzeGKKDc9AiEDhAGf5tJpmsiEZiVLL0CDnt2M/ICVaBNCFEqN7fJxLnuUT8Z5k1/1cFDVi5DLqfyt63xu5iviNEoARdisOib5Kaw7EsQgvqvAe0hCQMpIJqIYAybBhXjX96Q0bZ3Ruf&#x2B;65PfSCAExBSuiBZML8QbQdZemMaHxMN6o01kcgflAesS6V4nmHa2ZpZRktKi&#x2B;mZZXl/Hn0ZdfoGD361E6el159gPeGJyfpfetX0Y0L5tELFzvo7OAgHeroo/bRUR5zjCf2CcULUhruW9pMDSVif1WljtSCHRfauVoGfBQc17qY42f2HBOAcjd1t3TS/FXNtPb2a2jRuqXejlqzsGFMvrr/KP3sxHkeX3vwGGky77xqGb1rzbK5TdBOTdO5g6fp4G92UdvJiwL8H&#x2B;aUgAlxT1p3x7V0x/veQAvXLuXXXtb&#x2B;zqMEoN08UPWIAvuDfvdygBZAJ8Wf3lFyryi08yhc3ON9wLtXOT/HPl3M/Oymd6pfCUIJuHUrIycbM&#x2B;c5&#x2B;kWZXXrJlLPOMnvpXJBsjzyi5pasDg&#x2B;DSHJLU1ClhIZqLxOo3/MzqmqrVKE6kaxUBaAaBgreageQziipG9JoDwH4KZ6Is8Q/hjRJVgKovnyKWwqARc3icw3X1lTfTVb5v1kB4JYOIEsDkJUGVD1&#x2B;HBd7IQVgZsF/PuZ&#x2B;QYC/7HMhuvRo/6Xk8&#x2B;dbus/y&#x2B;vvf//6m&#x2B;&#x2B;&#x2B;/f8OmTZturq2tXSP6vFAYuNCu&#x2B;LazrZO&#x2B;ffAEnRagHnnFxkUGUgCAdUFpMUvAz/UP07nBQQYgqBmP6Cmi14lwhD&#x2B;LaDBLa1CnHRE5F1CKOy3AIkA4wFJzeSkNCRBcV5Tg98oTkF0rTD5gW0vE&#x2B;zCDW1FdzgB9sfg33M8Rlf7jJ57jv71uijhORES/eM/NNFNrZhAE//M3z4sHeVozhfJpOI/P37GFPQUuBfhgD8gXNxY5MCWEMuHL&#x2B;46wWVqQCgQGETFPgEX8Rk415NRD7IOQ4Yg0qgloaooQjyFy6gFEMRZGVIyl7UZeqq6&#x2B;0NIUQoExJfbbUFpCb1rWpKkNwmFWVcAHAs/CyCWA05N9g/Tnz7youTUHKMEHYP/Pd22hKgHsYeB3RPyg3Bzk5t2Y3&#x2B;IYMT9J0UkBVZtL6IlR&#x2B;DSI/gIR1FxWzHN0Srz32MlzvmQMCJQKsej7gth3XI9UZ9hsUqWnzl5kQ8OLwyN0ho04tUDMpK7KgDnk&#x2B;zasomvmVVvmhmWMxbGd2Xuco8YA/u2nW2m4d5AB49T4FFUtqKGtb7&#x2B;drr73RmpcvoAN42Y78Ifnxg&#x2B;PnaFnWtq0cqCq1ZQdBN/W&#x2B;XX0oU3rZq0R4Lg4h5CY5xPDYxRLxSme8k/RmBT3vSkxB4f7hqgYlS7Ki1/&#x2B;/g6QS5zv54Pl8KuBt&#x2B;&#x2B;2DVcCwADJakAwJTH1y/5tPtoA/gGepINEvm&#x2B;YtAX1K3BLAZABz6Akj&#x2B;pjmOh0LCDXNABVYnYn3a6MdMjknPq1vxUzRcJmhZaxItWVRDDGy04amHP5LWUfbWkijrx9y7H7j5tBqGOVFIvH1KSe229I/BWXOaV6XXc2xYKs2oNXek5tTfXrSUsBMED/lAnou5EAZvDv5wNQIABmkAC4HPDvFfW/XBO/mc7nJ/Iu3edr5Ge8JgB/7bve9a71W7Zsub2qqmppLBa7cgoDF9oV2QCILwwNM6ACYAjbUG9GN80CqHuhtYP&#x2B;z&#x2B;5D/Lo51zlXlkjlHHxIogd1Ez5I1QHQDEk4Iqd4H/sJs5ogo0fs5TemabHhNy9vpjsWLaAxEAECyMPIDSZ4IBISumrAL4caZnN/tW2XAL/esmaA2PesW0n3LFkwY3389f3H6cfHz1I86g82cBal4tw&#x2B;d/v1gcv0BR3njzy&#x2B;nRUJQZ8MyBH//F1bOS2DzfPENuCjAEIBz0CoE0BuYHtIB0EEuk2A4s7RUfYHGBXfwfhNZ9IMhhHxAH7E3MnnCaoRTBmeO5ieUDmUCTANYNdQWsSSb0R5F1WUUbkY31p4FESjnPrgRvJ8ee8RAaBbHfNd1jDPbmyspz&#x2B;8zlnYBUoPeGMMTE7SnvYuAfbTtFvMNZhgThlpH7pSAPudymgqSRxbECVGn9g2jA/hWu9G0vSMjYtreJR&#x2B;dOw0DYkxgpoGKov1tVV0z9ImqpIQSRNi7M7tP00v/XQb7X7sBTaPwyoWaSKhSDi7zpgW82VaXHfJkiK66qb1dNWtG&#x2B;mae28UgDQ&#x2B;K&#x2B;9nKEH65b2H2QQSXQ3TTI0k0kgpKJIeXrec7l40Py&#x2B;/hstpkyMTNDYyQmU1lb7XXno6Q9//zNdo18&#x2B;e4z4H4TIxNkYb776OispK2L2/Yl4VxZKzr/8vVQUge8&#x2B;fBHBXDfv5B8hM&#x2B;GQftvit2cz1/IgAC5C0nYhhKmf&#x2B;jpffgFtH2KsZXIqCwI0ECEQAqFYZPpHqO7YSJOdCHPgQQzLlhwHOc&#x2B;jYsi3p3CLb&#x2B;UqsJaR5&#x2B;eQyx&#x2B;zReLfzMykAzB/LZDQ/PAH0CWX7SktL1Fg0yoZ&#x2B;5vf9iB3pFaK69JsH6Df3WW1N9X0m4C9TAsj8ADIkVwPkowKYVQTAXPAAyBf8&#x2B;ykAXgvu/a4kwLvf/e7G9773vbfccMMNbxMXXYoKrdBe4w1Rwm0tbVynfFV1Od27eCFNqQKoidt3vwAzJ3oGBOibpEPdfSzhx2IZZcQiet11426MWufYVhQRYHFTBggcFKAFDuMAnSiDlhJgcHVtBcv4k2I7SytL2b3&#x2B;h8fP0Om&#x2B;Qddj7J&#x2B;YpNsXNtIDKxZrebr6ohdkBZoRvfMD/5BJf2nPEd9oH84HSgF4GMxUg&#x2B;T&#x2B;iXMXxAM92C0ZIBGGejMNTvZ19TBgR8qG6yLCfBw6UYP&#x2B;QEsFICNUfYEBsz3&#x2B;vPj3kZ5&#x2B;TtE41T/IN1vMq6O9/a6kj2xMAJojDJjDeh9lWEKPRQDKvuHfpKsNYCqIShHI&#x2B;24uL6KFpWL&#x2B;6WXh1tVWog4yn9tzLe0sq/Rr&#x2B;Ehc7Pe3Vi6Svo&#x2B;UAMOED4DbmLco9dc3Ps6/USGiZXCYjQyNFIAgDeO0aV6tK/g35j68BvCD88N8w75QWtOuqpmamKKLR89x6bjDz&#x2B;yjlkNnaBTXdCwifqIOmTgbSAoAHRI/k2Pj9OJPt9Pex3fSj//&#x2B;23T3B3&#x2B;LFm9YRo2rmikyiyoIgAx6/4ZV1C7mxZHuAXHvGmS1B9Io4FHx/1x9Fd26sOEVPaZvffLL9Mw3H6ebH7qTVtywVoD5za4R/Y7TF&#x2B;mHf/stnptv&#x2B;uN30tpbr6HW4&#x2B;fo8Pb9rNB47F9&#x2B;QPd&#x2B;6AG6&#x2B;wP3zzrwn085QOPzslKA5r81g1UZvnGWETdv0w4SrFF53XzPXg7QpgYyg3/7sTnvUy4AzFCgmKThZAL/5prwHhjd3oEWEsHcF&#x2B;btqM7agtJKApcMqBTH3i15917PiVwWuLNcnq9xndu4qVb5fr4KAsUw2FXNygH5982eCW59bC8D6dinzbAQ24rH42oijmh/ggkAcR9QgsjzZRPIQY0p&#x2B;nGr5rKVeann3AKsIco5&#x2B;cs8AMjntTnlATDbCQAlz8/kE/X3c/B/JaT9flH/QG7&#x2B;b3vb2&#x2B;ofeOCBtTfddBOi/ctisVhpARYW2mu9AQQiQvlcawfn3wNgzy8poS/tPUynxWIZZnan&#x2B;wYYiCLqigsGufnsIi9&#x2B;KzaQuKyyTACfao6CXjOvhs3uEH2sEQtcBEwgRQYos0dav3X4FJcpg5Rc1pD3jbz63xWL&#x2B;csx6cKD8xenz3OteABBLwM8yNxfv7jZVyWQT3vy3EVOgQhSMg5gDpH2FZWl0lJ3l9Mw5hi/IOAfDZ4Pty/KTwWh6AuM&#x2B;SW5yg9b5mv1xa9v1H5/dsdeHttwQOk1ZlxcAEyQTPBvmM7o1RjEMEbCGuAPKWF9/aPw&#x2B;XUI8IfPn&#x2B;zrF59t43kI80aoBGAEOI2UhoxGWvk9JAcnp&#x2B;nWBfNoYVlJ4H6AYsIgke5avICP9ai41pAicKSnl3Zc6OBrK0gDYQDlzcqqCiZVvMiDsG5IuKKqPEciiHHsPNtBR7bto6M7DtD5g6epr71bLCzDXBouVhT3N&#x2B;PCokdcE/jB9dTf2Uvf&#x2B;sSXqKy2ghatX0ZvffQRql00b3YszsR1M1&#x2B;MMX5AnqCfce2f6h1kMhImia90A0lyzb1baNdPdtCv//0nVLewgW757bvpxgdvo6rGGstnG5YvoN/75z&#x2B;ir//pv9KSa5bTrse2U9uJi3Ru/ymKJ2NUVlNGY0MjXAYwmpg9HsRBqwB4ATs5qeDAVUQ&#x2B;BUndnM0thnImEkB6I/MpB&#x2B;i8RpyVABT9UK0l5dTA/emKnrm6imKnGoKRCPq52V3YvIgYP3d4VzDtkPMrUhWBx2FK55djn&#x2B;YPmyCkuQszGSvEdFV/kCkv35jP/tyT0wPA1s/mOWc&#x2B;eQYmKN8XiympZIoi0ZASCUcs5fvs/eA6LnbJitu4GX2gKL7VHmzzUBZETXvgPzfgTxLgbwf/s5YMmO0pAIrvvSoY&#x2B;HcD/TOZx0&#x2B;UX/7&#x2B;JUf58XvFihXFn/70p7esX7/&#x2B;mqampk0F0F9oV0obnppi1/HtLW3UNTauRffEfSQhQHGnAEzmBYEhTW4WoAeLZ1kxN&#x2B;SYL6ksof&#x2B;99dpsbnLQBgfzf9i5nyXuisvDHw7xH9m8jm7UAeSlNkRfP/rrHQwcvU1ytGjv1&#x2B;&#x2B;fuXJZIFGQZ35cgL9YgIh&#x2B;Wpcxfu626wWAmTmggoj0R365jSY5Jz1YGxXz5Qt3bc06589Eax8epf/xq22aK3uAz0NWf0dzI71r7XK6yPn2Y5xqgOnZMjDC8xZpCWNpLcVA0Sew4fKO52Qou6jTCKtp3Uwy6Hjgs/&#x2B;I3P/kzJTJgwnfF3cdCkyoQEUDBUJZIk4LyorYPwDA1qhk4HrsU2lqPdFC2775OO1/cjcNdvexAiAai1EoEqLLqVqrRWYzvI9pcXyVDdV08zvvpK3vvJ1zz0Nz0FX/lWjjQ6P05NcfozN7T9KBJ3ZRJp2hO3/vTbTihqto&#x2B;fVrKCYA/aS4XyHS/91Pf416WjrogUd/m9qPX6RUeRErBxasXsTl/pTQ7OnjfMoA&#x2B;hEAUtd21QN9uuAE1UXGb6iUzM801SNk7GauJzWsc0kBUAJ8x9OsUJVHulWXfpD6CKhOwKy69pl3Wb98xtE4Nsd42DvJdTvyeSHNZXd4CSgWEsC87YyacQe&#x2B;endmPQVMY2X4CKASgMNTQM2doEqmSgJ2DwD9MzGx/ikuKqJoNKZGoxHF0LsrJkNd7bQUrqQgmxfu5oz&#x2B;6R6ec9lmDoi/a6qr3kw5&#x2B;b9bGoCsNGCQkoD232T723L4hRSAlwf8B5X82w39Xi5JfxDQH/J6PxKJhN/4xjfWfPzjH3/DVVdddWcymawqLEUK7UpoyHc9PzhMz5xrpedbOxhAIfcYkW5IzLFQR0R8I9zmxcJzY301S2jx3Lu&#x2B;sZZeauui/9h/1BKlx0WF6DAkx39y/ca8wf/5wSF2505F3ME/JPu3L26kzQ01eZ/zZFqTWcODAFH3Hx07I85tXFrqzNzQD3Bsf/5ipzi/Kc7tLopEqW10lOaLh/SZwUFaXFbG7uEwfgMQO90/QPNLijknPixAVSykRfAhw0b/QIZ8qm8ocM47wGlNIsEGc/guGpznhwQYrxIAMKNrBnEuk5k0jwuALhQaiI5DuRAyPSVZDit&#x2B;XxgcoY7RscAgFuBuSUUZLSiZOfCPY3rybCt7SQT9PKK5dy9p5uPGz7ra3HvIyx8T8wS/D3b1srrjZN8AR/8Hxqfo4tAwA/ghU6lIqAASkUheB40ykD86fpauqqmgkmiMFgmAm7xE4zgoAL6y7yhfl37eA&#x2B;NprQQkiAqoaoaHp5jEw4iuq6uSbgOAsvdiFx3edoCObNtLLYfOUrcAkcjph&#x2B;IiURyZkZiKsSDk1IF4hIa6&#x2B;&#x2B;m7f/1/aeePnqUVN15FWx68neavbmYTuyul7fnF8wzcYdi38sa1tOGuzdo9WFyXg6J/2k5coIr6Snr97z/A49TX1kOPffH7dOjpvfTU1x&#x2B;jMjG/lm&#x2B;&#x2B;ig49u5dN/FCGcc3rNtItD91FydKiyyJsXgnwfzlkkiqRgMvk&#x2B;05co3iSAG7flYJ/EzC2f9/PJ9QgFKyydCv4pzyJEU/wb4kuqxZs5GoiaLWql/aeJcruM05BxtXYlZqNNlMWyDrG0Dgn1woOtnJ1LhH83Fgp2fKD&#x2B;K2lkridg&#x2B;L4J3&#x2B;PnOOmKtYUAAd3ZJ/P&#x2B;keMOR1F&#x2B;b5YVInF4moymVBCWtqBYidMzKesKDklhUXs4Ge&#x2B;KZvPLleMXyqOBBe6Rf29vN3IBWu6Rf4VF97i1QXZs1gBEJQACAr&#x2B;Z9LEb6ai&#x2B;4HIgKVLl6Y&#x2B;9alP3bB58&#x2B;YbGhoa1sfj8fICJCy0K6WdFIvIrwugfbC7l6OIqCGPXOqmsmJqKErSpoY6rtkOaTHK6SE3OmUCR5Asf2HnPjb1M&#x2B;fYwxgOYOvRLRtpaWV&#x2B;lxQA7p89vZOOiwVxykVmj1SDGnF8j269mioEGB4Yn&#x2B;DXu0bHBYBT6Gz/EHsAwDtgXkmKDnf3cZS6dXhMAKxJ9hZAKLhfLyt40sNjwN4AFCHXL45GuNxesThPkCUAjcgz1x7kufzLmOg/9C2AN0iApF6eELJ0/ADElRhlEoP2kTh/0N4YGwBZqCQ42iD&#x2B;g7EdSgxifwCAJfEoEx5MbiB/EKZB4jWYNqI6QiKiAV6kWiDdI6jjOc7zkbXL6e7FM2eEiH5BJYTesfFAn8dcRR77p193Xd77AhkCogblEkEOQNECQgVzp2VgiDJ5bAv9DLIlrEd1QIpsFtdOcSxMawUQLxXXleFJ4df&#x2B;Q4D/Hxw/w9/xPHcxptc11rJSB6k1SD/Y3FBLa2oqmViyt/6OXjqz5wRHlU&#x2B;8eJR627rYvA&#x2B;kVGQG01l8566Yd1PiuimfV01rbtlIW956Ky3dvOqKuN9&#x2B;55NfEcB9mHpbu&#x2B;j&#x2B;j76TVDEH9/zyBbpw7Byd2XuKImIsyhuqadUN6&#x2B;gtf/owxcSc6T7fQc9&#x2B;5wn6yRe&#x2B;Q0XivvzBf/sYjfYPU1Rcz2Fx3a/csnZW&#x2B;St4EQD5Rv/dZPoO4EpOgzzrnYo8vyt/XwL&#x2B;7SDb52Xf6L&#x2B;DdDAdcR4mfq4kgKMX1GDfN4FURdKTeasATFDNODc3I0dHb6nOMbQrBSzj5ZG/T2aSxb4vVT5fs8QpR/Zt4nxzRoGnmaFN2ZDJjZGRboj1U0Jc7/iJREAAxBSLGsBHsq&#x2B;6kFyBTB8t5hdycsI&#x2B;nm6VAqqrKt9C3goAr3KAbmUBVbIqAYx/E3kYARaqAORPAMw0&#x2B;M/HqT/fsny&#x2B;OfwyUkCA/dKHHnpo&#x2B;V133XXL4sWLr9dB/9wqYFxohXYpCzHSSpUhx397Szs9f7GDWoaGGMTCDAzRRwCWP9y8zjcajkgqcrUBvuOmGtpGJOND166lGxpqAx8XwDTIhe8cOUnfO3KKyQh38JMWwL6IQRCO85Q4lqpkSgC6cVLT4mEk7gJT06rOxCuWCAck3lA4ID0BkVOuOADQm0eEStGfPgB8hgTcauBE2bxAVZfUZ/SHvFGNQM3WZc4/6qPoz2osSsJ69QRjoTStp21M6XnwnNagv4fXJxEVVjTQyqZ4IW1biBQnAqoQjFSIJgE6ITPHfirY6C7B5AJMH6uTSXaW51KD4gsoV&#x2B;gXBQQJ8YmndlIiAKDBlrCf/3fTGrq5aeYM2/Z29NDfPrfH91gNlQv8MIxAT0ZfCIFcMKI5VbrPxbq6SqpPpWhJeRnVFie4FKbdmBKE2iefedG13KUxzFCPYLz&#x2B;9rbrqa44xQQTTAbtaTiIIp988Qjte/wlOrpjP3W3dNLY0ChH5RHxZxn&#x2B;q7FMwXUj7jWT41NUXFlM191/M22&#x2B;/yZafPXy1/b9V58fAPW/&#x2B;epjtO3bj1MsmaCGFQvomvtupPV3bKJff/mn9IPPfoM&#x2B;/NVHqet8O/3yX39MQ70DVN1Qw/3znn/4MKXKiufsuedDAgRxizfnkdummKnOe7AqAG4EgKeZnCf54GNMZ8ZgZuCfp4u/O/BWLeA/8PclaQT2HnQD/d5eAKplnSArxeigSowxtJRelJduNM&#x2B;JjE7A2x38FXNqg&#x2B;pOAMgAtmv1CVmqhEneIUtT4TkLw1exzkmmkmzqF0XJZD11Skp&#x2B;uZaIlAfI/dL8peNue9ZIw&#x2B;veBMADJvBvJgDMpQFlKQCyVAC/NIACAZAnAfByg/9XAvCHKFjU30wGhD72sY8te&#x2B;SRR14/f/78tWVlZU0F0F9oVxr4R6QQIB&#x2B;Rcrj3/&#x2B;DYWZZ9owQfAPiW&#x2B;fX0IQGo/NzcB8U2/ujxHbwNRLHtD4e3X7WE3rhsoV7jXKHBiQm&#x2B;H53uH2SX9kHxPZgIIlJ5oLOHy8GhXjpwz&#x2B;m&#x2B;YfLLGMCtDVHwHKAP8RMjYjzcdVm7SjnrWfMjMqNHNgz5e9CGXHJtIaLqINgA9MgF10CxxGeI/06rBljXyxGqmnFiKE9pLEBn2HgKim2iP1XdKAhng&#x2B;MJ63J2yONV0yoAwDKtExLZh/ulyk5Ji8BPAuyKvwHax6eQchBiCT9SLIoh/wYJITpnUWUpTYnPrq&#x2B;rZqUE0ifW11VRjQBASImAbP6zO/bQnvbuYCoEpDkkEvTpWzezod5MtX944QDtbG33Lb8H8mlheQn7DqAf0O8gVdDnOH82aMT8FJ&#x2B;DYTT6CZ9J6GO&#x2B;rLKctiyoo6pEkhpLUlQqAPznxPkfE2DPXP3AmDsA/XDgh2JjufjunYvm0w2N8koUgz0DdGbPcQH8d4mfF2hscJQXxLzAnGW59&#x2B;npaUpPptms7q2P/g7d8q67XtP34R3//TR9/WP/zEQMcvWvet1GWnXjGurr6GWF1Q///ps00NHPlRXGxbihpOK1b9pKq7eup7pF82ZVXv&#x2B;lEAB2MsDvOw4QFABoXk4pQDv4ty6QFakXgFv0P5AHQBZQySPJbt/xIhq8o8SX/v1MgFxwab9mgbC5tr3qSRI5fQDIVrYvGKEhVXAQOQgAqwdBgFKA5vPKkOfcMr5rLhGZEM&#x2B;uWCSsJlMpJYIAigtJIJ3/MumDB8nkRgSo7p0nfd57kUBGq66qfNAG/v1IAOPfslKA6QIB8OoQAPmCfzdDv5czsu/3Xmj9&#x2B;vUlH/zgB6/asmXL5tWrV79ePGDnQnnGQiu0l4UAUPXoM3Lfv7r/uAA6HfzasAC2iKJ&#x2B;YOMqX3d7yNg/tWMXnewddOQ546FTKR5smxtr2ZRsvwD3qMV&#x2B;UoAa5FafGxhm539I6CN6qTVFs4Vn8I7nI4CjFyhO6xGAEIN/lSX50wIUA3RBhq1n5fFiBcTAFFcmgNQeRAH2E9bLxYX4qRjE8Z6JBHFIyyrKudoAot0DAsCirxBhHxHAtyoVp9bBEWouLeYoe//4OFcoOD80TE2lRdQ1MsHnjmitQQLsaevkmvDhgIt69BW2mRLn0yv2j/OAvB&#x2B;PGi5hpud7c8lFcZwA2ewtoEcoALQRoYfUnn0ZVC1SUpSnBDyba0i5Kk0Z1ZbLSBpJY4wvlABG5MWIluN4kcKBHPz64hQTU0EKGyj6ubxn/Uq6f/nCGbtGQEJ9&#x2B;BfbKBGLeD4oM7oR4z/evVWM/SQfC0oZogRm98g4ewv0cN&#x2B;HuKycElK5xrwxlzDvedzE37iGEL0HCdY9Okoq5cpnYm6OiLEqE&#x2B;MDxcC1DbXsedFQUuw4vpH&#x2B;Ybpw5BwdeXYfHXhqN&#x2B;f54zUA6zDGOqTM6uJJyINHTvtND91JWx68lRZtfG2qAU69dJS&#x2B;&#x2B;zdfo6HOftr6zjvo5M4jdGbvCerv7OPUiJLKUnrHX/wu90dJVSldc&#x2B;8Ncxb05wvq8yUApNHYgCkAboDTvK1sGTQ3N3g1f5DlZgJILgSAGkDSnT8B4CPb9zGHU1U3JYPLNs0EgEKuRIHThJGsaQBmVYKHEaCFjJAQAKrlS&#x2B;458oaRYLYahCqZUy7kjXEcAP2qjlWR25&#x2B;MJ1C&#x2B;Tw1Hwoq5TKDM4NGXAPAiwUhGSvgTc27bd1UD2M67uqrybSYCYMoG/KfI2wjQzQxQJWsqgOryUyAALpEA8Iv&#x2B;BwH/ygyAfa9Iv&#x2B;w9x2tNTU3J97///Uve8pa33NnY2LimtLS0SZmt7jiFVmivcIMK4LPP76bDXYNUKoAOgNnGuir62I0bLZ&#x2B;b0iPrMEwDiIFJ3sXBYTrY3UfPnm9lcznZHQ5gHBF4RIORo47tI&#x2B;ppgHt2WNfBiJH/psnx/Re5xkOoTAfgMCPsE&#x2B;dTL0Ax5OD1xUVs&#x2B;AYQjtrvKyrL2QV&#x2B;VU0lGx3idTbHE6C3V4DNf3rxYKDa9SAdkJP9r/fenCMt9OPBYxxRecjnDdM1A&#x2B;QZUWQjcmLchNAHfeL4/&#x2B;ypndQ/MRGo5jui5gCJn7n1Ou2YxfairNyYYmyHvP8psX/4ASC3Hf09IV5DmgOc9ZFe0aVXawiJ/9pGhtnAsH10jJ4R4xm0rKFxbpC5GyX9QGZM8/GFswuKsK6OiIRCesoDORYUZjCNOYCSfUrAo8ioCm2sr6LllRW0uKKYvQ8wRpgb0UsETH/7/D567kKH6F9vBQKOFRH4392wUkqQoZ9P9AzSsd4&#x2B;nndQyoD0SuvVBfBfXC&#x2B;XiXHCfMA/orqahvtW9Et9SYqua6yjrfPrqVGAftk1AkB57LmDdOz5Q3TuwGmaQPUO9CVk/nMMOGLuTIjrMpFK0J0feDPd9I7bqbyucs7dY5F6cfDp3RRPJljmmxDjWCHmanGlVpVhXFyPp/ecoNO7j9Pz33uS&#x2B;rv6CfzQ4qtX0pv/6B2vaU&#x2B;EfAgAd7Bu3YZ3NQA5dFE9zOScAWzVVMIvQ15cQBbA2oCVdRsexIFLdNfPP8CPAPBSEQSNBAdJAZACQ5sU3g14SgmAHLr2HTtXMsKk2mB1oJQEUHOkjyqvJJAD/DlGw62CA8v4FZWi4SjFBPAvKkop4XBYjYTDSsaFnPAikYKXXHSr&#x2B;2CiBYKmkXgqDeTHWFVZ8XYXAsCrGoBbGoA9/z8zVwiA2Rhpztf871LBv5thXxA5v1S&#x2B;7/Ka5fuf/OQn19x5551Xr169emtZWdniAtQrtEKztouDI/S5F/ZypLNEAIRJ8ZBaU11B716/kg3QjnT1UVIASDjCoxZ5ZVKT6AOYwJkfDucMdiXg34i6A3TgDp0QIAry/7SSZjIB0eCxaTKBRmLAiBfmFSWoRzfy8wJdqB3/gatXU11xkgEVyuANCiBdKRbaU3rU263d0GgtFfgvuw9mCQi/Bvn1jUu078ui9QndydyIwJvLJPJN0sY/4r1zA0OBwb&#x2B;iH8OqqgqqTiU1ebnekhICA9F0c4MxnFvb09FNT5xpQXwiUF&#x2B;ADHnr6iU0gqoGIc108GBnL8vcQcaABEF5QNRWj&#x2B;sExUR6mgEv6WAX4xTjdARtPsCTIBZW8ghQa/PnhdZO9rFAb8B0EuQHzPaWVpQxoGosLqKVYn5zST&#x2B;xv5qiBBHJSYZzYn4f6uz1Bf/c52L&#x2B;37NEbn4I00X8LC4vpbuXzOdFyAVxvZ3o7af24TGxn0HqHBmntuERMWdV7heMZ5qVOFN8TSwVQHFjXTW9XuyjLO40DxwX22k5cpZ2//x52vmTbTTaN8SRpihSLlA2c47y3SyNLUpy2cCffP479Oy3Hqe3/dnv0LrbNrFz/lxobacu0rc/8SXa//RuShUVUUl1GU2MjXFpxcaVzUzOjIn7a&#x2B;e5Nupr7aEFqxfSre9&#x2B;PV3z&#x2B;utpyTUrX9PPHxmIz&#x2B;d75nkiA6BBcp7dtmF1TpeTALm7saymPUlrsZvr0stAn/lStWzZ5gHgg81JulFHKUB5GUApGSPZgVsdBQvRIasQoJj3QxSkGoMi&#x2B;8NEBFg9JZwKACnxYUoNJJfDyEX7XdQfvAGb&#x2B;70J9Bv7jEQi7OBfJO4BAvgruncBg3/zmJpJIcv5S5z8ZeSH33hpv3N7VCn4NeIob&#x2B;H2RVVaBSCfagBuONW9dMcsb3NJau6lCrhU8H85YD8U9P1ly5alHn744cXveMc77lu6dOlN4kJLFmBeoV2pLa3fnMOWB6B28SD//h&#x2B;e309tIyPZkn0A6xcEEPnc83uZABgXC2&#x2B;AM0jaAWqnMj2awZ8eAUe0UpafDVAH4BdjMBMS30tTQ3ExA9wNFVU0mk5zNB7qAwCbjpExLpkGLwCUbusSgOgfXzrguSjEg/O2hY20rLKM/224pFfqZeuieeQ2Q83wYmt38Ki32PfNTfNmdKxO9Q1yn8VD5Os4j15BqsDq6koL&#x2B;J&#x2B;JdqZ/yLfcnHmRAcn6jQ111FBSlH35vqXNHJ3uG5vgyYZ8d5SlwzFPTWeofXSUc&#x2B;GP9fWz7wPy5o9191OlAOtTYpvdo2N5P&#x2B;oVE/Gizf0MExCdo&#x2B;N0Ssx1eF1gLhYLMB5jk8I459mjJGO1&#x2B;BvmeauqK3hOo6LDYydbaFzM24gPeMY1tqqyhBpN5&#x2B;8HNCDfx49BJqFvUCZy&#x2B;4U2euJMK6GmQ71YKG6or6ItjfXUXF5iOTee/6L/LgjQf2Tbfjr&#x2B;/CE6e&#x2B;AUS/xDkRDL/F9LDSQGShKO9A3RV/7wH7n03f0fe4gWrV86e8GtuAfu&#x2B;9VO&#x2B;uZffIVaj52npZtW0p9896&#x2B;o80w7dZxt4zJ&#x2B;L/5oGzWubqZN991IC1YtpA33XEcL1y6m4qqyK&#x2B;L5dCmVANxIADPw98ZB7lXCZFFV1QMUuqJ9H/JBdTH0sz&#x2B;js2X2JPu2GwHKCAeHhNsAvRKTOtmxZrehuh&#x2B;frN9lJRodJIALuSKX8luJi2wpQ9W6D9mY2ffr6O8sIZNL8MgpSkhqzOtUbljs/xn4I00nHAqp8XhcScRjaiweo0g4kjX0U8wkhKTUpBvuNpNS5jKFDtm&#x2B;Sx1Mo2BgbvxMf3nMIbPK0bJ9S3lJBx9CHqDf73Ee9HNzghiYa7nmig8ZQJcB/vMB&#x2B;F6f5Z9EIhH5&#x2B;Mc/vvKee&#x2B;65YdmyZdeVl5cvKUC/QrvSW6cA1alYhIoEuG8ZHGap&#x2B;3MXO6hVAPxJAcK2CbCBmuiQjxs3btykUEaub2xSy8lWkJdPnLtsmNtNpdNZoz83bNRcVsIyZUjtBwTobyzW5MoA5cW6XN3rxrLjQntWHu1240He/dXzqmekr4509XI1BJyn31MEz0NE1EFozCRRA/PFaCgU6CmGsUgKQLiqeuarlB7v6efUgkDHLX4WlZSws725GdL0iqRblLZKIwqoOfsKvBBAHKEE4s9OnKPvHT3NaQRB&#x2B;gIgGp&#x2B;N6SAZ84YfHiGY75F&#x2B;LAlezIB4GE2rYrxHKD0wRPvbe1j5grmNSgWYoyihh1KR4QCRc8ybmxZcetUBEGr4ASGxpKKMUwZumF9HG&#x2B;tqHOQaQD8c449sP0BHt&#x2B;2jU3uO03DvIJfvi4nrIfYaA/52MAISQNx&#x2B;6LA499ZTF&#x2B;j299xHd77vjVr1glnWxkfG6Xuf&#x2B;Qb1Xuii&#x2B;z78VpoYmRCg/xe0/9e7qV0c&#x2B;/joODWvX0LXvmELveEjb5v1pfteFpLkEsG/FNi5ACEZePLCDEFUAFLgbnGlt&#x2B;Iue/TWHE2Wg1J3ssSL4JA54DvAoKUHVFtddw8wbnrTHjXPkhK6h04gk0bFWt7Qb/wsagXJwVrBqhcBZCUCLKlo&#x2B;i5yQ2kGxy4pAFnSIKNXzwlRMplUEwm4&#x2B;EfYaJX0FHD467BwwTwXTAes6CkJqv7cU3JUhwVv5zgdxdF3blUyyAXQmVUAsr7zVOhkzX9yJEAArOinArgUrDrrVQFz5e6uePztJtWQ/e0V8fcD&#x2B;mHbZxygv7i4OPLII480Pfjgg9dv2LDhtpKSkgXhcDhRgH2FdqU3RJGfOHuBfnm6hTbWV9MhAW4hj4f8nh3&#x2B;Q1rpt4RYNCd18A/gBck8G&#x2B;WFNWd41IcHadAvvru6tpKBE6T&#x2B;i8pL6ZmWNuoaGXPN0797SRPd1nxpoAjO&#x2B;k&#x2B;fb/WWLatayTnk&#x2B;l9uw6N2d3t3Li/d9/Mqragqp9gMRt7B5HeJsQmFlMAEQKUA3YvKS2Z8/iASHVQ9AZ&#x2B;FZZUlWurGZTaz9wJHxaem/X0g9JXL/SuaBVgPc9lAGBpOZ9JseDjOxIDK8ztuMpMMZ/PrQ/yQKdLHfgSGjJOacgDgP0hFBnzmxvl1MzQPMvRH1613XtPT0xw5fvobv6Sj2/dT&#x2B;5k27UErzikiFpiRPE0b53ITz3mKlKRosKuffv5P36NEcYJuefjuWXecUGFsuGsz/fr8T6jzXDvVLqrnsbrtPfdQ24mLtO6OTVS3cB7FixJ8TldiMwMYL9Di9j2ZeZwdwLvfOMxLXFUKtqV15WUSfBvD4DAPdKkG4KYAsETXDVJBAl79ztOLXHFzhpcRKrJyhNljNHWhLDXDy1RXydIQ2gZk88BhtCfxAPAiRWREk/ncFROZYM7EV9xSO8wKDH0M8amIuIYTiaSaSiaQ269w6qOaUdwqIFjMAo3fWSCt2PZIpiOzDoXizI1wJ9bspImrmaUV/dmVAJZ5ISHAFG/wLwP8QUiAyyUKCgTAJZAAQcC/vdSfH/iX/cgIgJD934lEIvzHf/zHy9773vc&#x2B;uGjRoteJSVhw8S&#x2B;0QtPb2YEh&#x2B;uGxswygEaU/3jPAEm0AevykBFDARRYL5&#x2B;7zmilfiG5aMI//fc28GuoZG&#x2B;f8ckRUceE1lhaxSzkAGVIHvn/0lLQsmqI/B1bo5laX0n5&#x2B;qoVTAoqj7qBmRAAiQ/p/uW1sclInAIIvWjfUVc9oXjXk6qjEECIKSAAQLS0v4zz3mWwYYyhHgqQAaIugEG0S82Wm22NnWgKlNsC8samkmB5Zu1LvR1UnU0ZpLJ2mC4Oj1Do8zGueF1s7mbAYn86w5J5TAljZgkoQ2rgCzMe5jGIegFR85zuHT9PiihJOYQApA3LhUuaH2b8BueE9LZ10fOdhOvTMPjb36&#x2B;/o4TQd5Pa/lpzg821YgELtAG&#x2B;Ab33iy3Tx6Hm654O/RZUN1bPmGBHRf8MfPEg1zfX07Ld/TcdfPEjqlEo1TfXUsKKJTr54hKoaaqioIkpXess3/9&#x2B;4D8sAo1clAHlFAFtuPpE0kuzzUJCmAHidg9kHwCHndwGG1nuv4sgTd007sEVq7U9te968oy9tkgZVBhIkef&#x2B;&#x2B;ZnUeyfdWNYFVpq7TBSbyQXX1ALDPCQfgtUo7ctBfJv3Puvhr5o/sURKLq9FoTEkmYuJ3VDEMH90qI5irHzhEH6rqSYbZx1zux5cbnezxyz5oIxvUXK9SRsmt5YisagP72Gbnh7svgCz674Y1iV6j5dhnG1D16/ggPgBeKQB&#x2B;4N8P8Gdfi0Qi4Y9&#x2B;9KNL77777qs3btz4&#x2B;pKSkkaxCIpToRVaoWXb/q4e&#x2B;ptnd9PQ1BRLh2HOV56MczQVsvslFaWc3z1lZuRVuLWn6SObr2ZQ69UA/nGz//ahk1m3e1UCTKvEPuFQfklAWBzbE&#x2B;cueEaU8dBBpHZDXdWM9Nux3kEmPMoT/rcUnC8i/5WpOFcXgFwbDzyU4YNPQjSk8PNveHKa/QSgvIDRHFIuhqYm2cANvgcojYhz0FIOBPgXn4fSIsgyOESaAmBxhUayjAkwCzIGwxqPhExjoQaKYJsbjOgwX5A64j9WxJ9bVTWzruxnBoaoXRxHedx/PJCOcsei&#x2B;RYwDn&#x2B;lBn3&#x2B;LSnPkURvXr6I&#x2B;wQKB6gL0G8wXuwW/X6ws4evCzanzKh5rUCgXPju0VOsKsAcqhJji36/dVGDOIcYLauEWiTMhoRBhqO/vZfO7DtBB57YxeXgkC&#x2B;eQWlIcU1HxbVVKF9jIl&#x2B;iYS5p&#x2B;MR//IzO7T9F937oAVp/57Wz5vgSxUm65eG7aOvbb6euM2206xcvsFnj4Wf20I7/eoK2/9dv6G2feDetumn9nKvQMOML0oAqAIeZHpGvI7rcB0Diia76RaE9oqYWnT9ZqtR5lQO0lxZ0Kg5ywDD7t7TknvW3Bbw6w8UOEsF&#x2B;nG7yfyKXxGtzmcSgaR0e4m3r91Vr4N9Az/pBy6oAuJ2LtPKC7otgFYQ4aY4MVywKQbGjxmIxKkqlEOnnaD8M/dyMIu37dH0OSKrj2LcnVYy4GARKyZxcWQoJ&#x2B;FOy1RYsKgkbEWC/9lT/i80LXwbFnXnMngIBMJNEgeIySF6l/rxIALcIv/n18AMPPFD7kY985I6lS5deXVNTc7W46Aqgv9AKzdYQ1Xy2pY2&#x2B;ceCEAJtJura8VoDLKdo0r5bmlRTRhAA7yC2uSETpfT9/1lKzHSAWRnrraoOB6YGJSTo3OMyGZDJhH0DtW5sXXfK57Onood5Rbyd8pCKUCmDVVFrCcm8oHCD3htM6ShTWppJMdNSKvoD3ARj7tHhOAIRPc774NKdJDE9N8/PjV6cveKoN7DdDkBxf2n2ESQqYxGFbIACQVjGdxt9hLjnYUJyi80OjtLC0mEYEwB&#x2B;YGuccc5ACqPOO7wFsxpk8mGbwGQSwZ0iTsO&#x2B;42EH7O3tFX2mKiGoBPMuTCeobH&#x2B;fz0fLHFTEHUlwiESkfkBo3in/3iT6uFGCSyxmKfgMxAQNGpIuEAkohQNZgjs20wfwTpzUCyO/pjveKozG6uSlYqomRYmBWjlyvV4KA&#x2B;gJzaceFNvrukdOBovdZgkX8lIhtY1ygKmBSSBzd3ue7&#x2B;TPzy4pofW01/d7G1TxX3Rok/tu/&#x2B;wQdfnovdQiwOIkqGCjtGItekfnhgZoOBorKiun07mP0jUf/lfvurt970&#x2B;wiKsS41y&#x2B;bT/ct08iqjjOtNDE8TvufeIkyKJOKm8oVjP/zTQGQRiHJmRNtB0heHgBBcuxlIFJKCKj&#x2B;eegOpYItHGw5OpkEW5IGoAYxsLGdQ&#x2B;Dvy1QOErDrNWbS1&#x2B;2RcMuYKpajVbMg3ZTCIZkLsmC0Ww6/RaWgmqPn1uMOcW5/Qk0lk0okAuIxohjve6VZyF5TbaZ7iqNPFOm4mbfnZgLp/NtWSsBOCDmIAMVBSsmuFde57P7sVMg771&#x2B;WEuBFCsypNhc9ANwGkMhbBWAmAcI2QiDsAvyzr//d3/3dmre//e3vrK&#x2B;vvy4SiRRRoRVaoUkbpPJf3nOYDgrgNk8Azk/feh2Dc1U3QTO3bx08wUDHACFTaoZB81tWLAocKUZ0dghSdcnnASZri&#x2B;L0xmX&#x2B;BIDxSEGtevgKdI&#x2B;OMyB99nybnhGoeH4X6Q1feHE/tQuAjWj8hYERNqI7OzhE9akUR7IRcZ1AffopjSQY0SsawOsAfZPW9wKyIRYOBaaSAepQpQCVDSJ6jnqn2CZq1nP5dl1ODqIEkXmkTABUIzoNt3vsD2UXw1rUgI8CW4nkYWSG1IyukVE6L84J3wOZcFYZYoLDICkgBkjrUZmQ3p8YNxw/&#x2B;g&#x2B;f5T4SACSq58dP62XoAj3QxDZGJtP0wsV2cTwRJhCg/KgR4wCJfU0ywaA4lkdkE6TCvs4eJgDUAJNobV0lEy6X20AolcaJzg&#x2B;OMimDEoRBnpRQeqB/k3qJS5hmwugJ866htIjJn/V11XRdQ63DxZ8Jtc4&#x2B;On/wDB18aje7&#x2B;QMYhsX1EBL7j8FAcc4WPXrlW1L092j/EP33p/4v9bV1c0pAWW3FrDzWukUaadW0tlCd2A7C8jEFlCkAAuBW21PI37HerQygqxqA/KuluRvK2fCaajW9U21l4/IhGYLXeyP3HHK3nfl8321c7bc49/F3qiNylvOqzxxw5v9nx86c/28xctQrKIXDaiKRUAD&#x2B;o&#x2B;Ihr29LMRMNQQgtt/KNij0lwPitv5jzWpCngWgb8S&#x2B;jKAXqLukBToLLlzdwrzoRDFeSBxEQZBsFAuBlIAH8ajeSDdzbSYCQDPhff/31Rc8///yk8Xo0Go286U1vqvnoRz96z&#x2B;LFi6&#x2B;tqqpaXyjfV2iF5t2O9vTTV/YepSM9fQw8Hly9NFvOz36nBEHw4xPnLa7igxNT9L71qx014r3ab862ugIkXMy3NDVy7jbA9pAAhCAc8AA5I0Aw6tW/1NbFJc1O9w6wazsi01EBjFoEcEf5v5O9gwwsvZYXANogG15q7WJQfV4AbQBGlBgEGAb4x&#x2B;soOYd9x3UPBM6vBjCOhhx9lC/GwjFEI9FstEFLj4ApmzMHEdEC44WIGB9VPxa8H8pGJfJcMOtgHmkGvGaIaNuJUzDMqOo3ZKgO0FesRiAtoh30KQufgENdffTcxXYBwqM0mZmmZDjKxpGTmTSbNI5NpcUxRlgNgQ2XxWJUkUgw4dBYmuLxaSwuYhd&#x2B;pE&#x2B;AGOkX8yYcxJBRbC&#x2B;ociUombbzYkcw74F0mksdzhcAv2N4lLZd6KDhqUlWmUBhcHV9NV0rQD9KA9orCUyMjdPp3Sfo2HMH6ej2A3Tx2DlKi&#x2B;sF8yFuq6ZQAP/5NbGYICUUpt989efUe7Gb7v/oO6hheVOhY2b7gtNHwu8J6HxqoquqG/Z1pgHIvu8G4uX53SYjtIBO9GZAZz40fp6oZJVtS03inNjcKBHnijQt5IN3GbjsmHiAd3m/qz4O8gZ2d68EYe373LNVsVUQCDJ33EwALX2iK3FAzsdiMXbyh7kfzDtJB/1B/CHMjvyqJHpvPwYnUKcsvFclnaKociJKth17N1nG1K4OkKgBrGQZPhZAdSLvHK&#x2B;IftBo/5wp&#x2B;zfXCAAlj/fdpBxmEsBV8v/4449/eXh4&#x2B;MKBAwe2i8kYXbt27R3V1dWbC6C/0AotWGsZHKHP7NgrgPYkRQT4/61Vi&#x2B;iGRrkTOczQvrb/OK8mjBs6cqfX1lTSHYsaPfeT5lKACruoQ1b/ggBIUReAhLsxSqf9&#x2B;TMvUZ8AOWzkF0ce/DgD9KmMytFnvkEoWpRaA3paucHWoVGO1PtlYHOpHfEZRF3xdyyige8IaVFjw0k/bPq84fBvXgNljId0nsAbzvII1gPs4bzYYBEAVvyNaDrIgOl0hnOT0cwLMXyW/RmgfAhHBECeogRc3ENKXvn6E1yxIaPV81VIJ2VCHIU2QL3hkaRF/bU&#x2B;574IKZboQr59YO0PlUE9G0xGotynnaOaieD&#x2B;jh5&#x2B;P2MzGsLumYgSCzocM/LmoWhAX6AUHkrdBZHgRxWNRJip9uSZi6zqiPk4suPIoJx547JmqkxqgP3epc3Z6glLKkqc0TkxAMj9PvT0HjryzD5qPd5CQ70DpEQiTFqxi38h2j8jLSTuBzHx355f7aTWky30iZ/&#x2B;HcVShezB2d5mshSg&#x2B;W&#x2B;XlGdX0OYASUT&#x2B;gMfjWeX3HbfIcG7VbQKCJt8A2XesAVgbeDeQswWAkoUEkVUr8ESTknFwi/xLDRvJlG7vAdhV40OKYqNKlKwxgJVwoLxS04z9CMAvfhIUjUbUSDiiKCE2IlRUjwkkI3q8&#x2B;sOVPLKhLC8TSDcyKd&#x2B;UEGnU3p0xM52nYiECfIg8hfI3&#x2B;3vNWd3MBQWAm/u/DPQTeef9y1QAIW09qiTq6&#x2B;vfiJ/CY6/QCi2/NjA&#x2B;QX&#x2B;9fZcAkVMM7tbXVdIja5a7fv67h05xbXeAceOijQuw9o6rlmrbm5jkWuYAL21DY&#x2B;ygjpJ0yJk&#x2B;2NnL0voTAqxMpVXOPXcDZzgWfA6O9gDDADYwW0M&#x2B;OqTgJn86U&#x2B;3Z3AMoFlACD0CJUoFcOkvsK60TCdO6QQ/AeET/d5Sl5CYAiig8PoOa8aIPwjoRELQBGl5bX03dYgwWlBSxpL9YAGBEuZHG0FRewlFs&#x2B;BBABaGRG4pWjx753OIcu0fGqbooQV3DY9RYViy2MczKh7QazHwOhMLqqnIqTURpcHyK&#x2B;xbESe/4JA1NaAaDwwJMG&#x2B;fVMzYhgHWMxxnAtW98kl3vQVJAHQF/Aqj04&#x2B;J/oTzl&#x2B;tq4hvT&#x2B;V3nMU3pqgxpyX0MYqZbwY2gbnuZzj&#x2B;ipEYmA&#x2B;e7Y&#x2B;7mBYSaO1tRUcjoDdghCIl9fAihVXmzr4HHyWzDBrPG&#x2B;5c0W00h4OuDH3qYnpun0vuO0/9cv0Qs/fIaGxTgzgSX6PV6UdLJLhTYDSFIrjxhPxqj9VCv96B&#x2B;&#x2B;TW/9&#x2B;COkhAr2ibN68RlQ&#x2B;q/6OaVLKwPIsKtKzieSN5i3g3YHkAtIGHhFhmWG/apZDu5hAmjfn6NcmwMZq459SgkEl52oknFRVXmOvTOdQL9Ws9FrJ3nj7EdTCULVi4SQjJnNdDGb2y8&#x2B;HIvHqCiRVGOJuKKXM1S0Z23GOZgBpB1uSgr7sTjSEczDYgq&#x2B;W0sEmggBmxrAy2zQq78cH7Z9AYGFjL5lI&#x2B;igSs5V5rkQANgHuTHP&#x2B;Zv3XPMA8MvDCJF7FQAp8NfXz2H1UqjeQiu0QmOg/jfbd1P78CgDpQoBdj60aY3bOphN3X5y4qylxjrnfosF8n8fPU2PnzpPxwUogZt7lwCwuGCHJ6Y4qo6IPSLTxjMvEgp7mvOpOohHxrm5VvB0tmyO9vCC3Dyj3xDgxI5jQ4Q6ETCXuygWZZk1AGOJ&#x2B;BsAF7nWXQKUN5cWUe/YJJdiuyCA9bySYiqNRql9ZJQWi9cQpcV30X/LqsroyXOt9NjJ84Gi7/AOWF9XRf9ry9UsAUekeJLz58OWxYTZtdlQUEjXXno71tNHf7ltl9OwR9JQpg9A93/euJH7K2QAb6RdCCAPVQSIB7yHcn7on0ExZ9DXIB9Q7QB563gd1QjQ71zNQHzmyXMX6eLgMJ9PEBIiKfoV86F7bIz7Bo73AxMT&#x2B;vGENNUH&#x2B;gdzRtEWJyGTMkHhKEKIoopWhk9Lz4jk4cVA9NV9x3ibOP9UJEIl4hiay4p5W0vFODeUpKg2laI6Abah3CiJy80eT/YNUivKH7r0P8YRfY8NLxDbf8PSJtc5My36t/NMmxbt37afzh86Q8N9QwL0hygs&#x2B;j2kFIDoK7KQEfMuUZygZ7/1K6ppqqXXPfL6QqfMNq5GUjc&#x2B;aBUAr8&#x2B;7Ofi7YwrVM1LtwIAeuf9&#x2B;gFAKkskZFVfcwJmjfJv3uTpL7zmZgpCSSzsPMGhS2kQW&#x2B;fcjZiwbyaNogOI4gGDyKTPBEItF1Xg8psRjcTWC3H7xKkhtmdGexS/AZ5y95pxFZUKKgwDK7cdKBGSNAu1VAmRz30Yo2L353FQeMhM/zAv2tQHZb6vKYC6fKeMPpCTDFdxmEwGgXMLnFAou/bcTAWHzj8GuFVqhFVrwhoj2VwTgOS7ACnK/IUF//9WrOZ8csuvzA8Mc5d3f2U3zioroSHc/nR8aEmA&#x2B;bKkvr&#x2B;XHT9HJ3kkGRfj&#x2B;4NRUFtyjdCBu9ildOg6pl9/CAABwmiPCqthOmCXg0wL8QRaOhwhADwgL3ASLY3FKxsPs5r&#x2B;sqpxd04fFcb/U3kl8pB5qyFGxzbsWz6d3rVmedc03QFs&#x2B;wGpVtWYOhvzzUB53w2o9amvIxI3flkWp6WkYlkQl7K0DhoKiL2JBgLcYiKpkkvvXOF8jZ71IL90HcM/nVqL5p8Lgzmg1qaQLeaPSj46fCfTAxlTAnPnTGzcyqYByk5qKQKHBsQk61N3H1SgOdPZyVLxvdJz6J6e4X1CtIRTSADXUIZoRZJqNAhOX4HSfiOTMAlHVAWQHKj&#x2B;AmHmmpY0VDiBMQA6gH&#x2B;aXan2C0nwrxRyACmJBaTE9ceaChawxxhHeBNgWpP5b59fQ5sYaWllZ4SASIPHvudBJR7YfoMPP7GXQ33Oxk/szJPoolowVbmCvykJH3IfEvPj&#x2B;Z/&#x2B;TJsXcu&#x2B;v37i90ymwaH0VxALN8QJwbwLKWCnTDvQEj1ZLvuhoABtBdy8C/WyUB6WLcM8/dQ3FgONQ6tpFzes/KutWcMk7q8O6iAPAjemTg36JSUOX5885&#x2B;0I41h/1VT/NG4z148EQj4UwqlQqFw1r5PnzMzVjRDtS91B5BiAAvo0uZGsDigUCaJ4QjJcC2M/vxBlUB2Mtr4lmIZ9/J/n5Wdt6xuFGs3xRLYUO7itNFIOHn9u&#x2B;GO19TOHE2KwD8ZBmKx2836b&#x2B;91J&#x2B;ZECi0Qiu0gA2ReACsJ85doMcFUCmPa5L64kSUvnHgGN&#x2B;AASLH09MsjYfb&#x2B;LTu9M7S85DTUM24wRdFtSg15OlTaU3kNQp3eyXEZdE0sz&#x2B;FwaXb8w7Ht7a2khaVl7IBHEBXuQA8MPhbU13JUeeF4j3IrFGpAMAvFY1YHtg/O3menrvYQaGIRyFY8VlIxiGvB/iNhy/f/X2ESwEGfM6I8y&#x2B;JzjyQQ/Q9qCYKqQvliciMnLu5QRnBhowBUgAQJaksSXGEXdZubtYczt&#x2B;6cnG2VB58IIyxhjIBr7eL39jWqb4h9pV4&#x2B;nxr4FKI6DCUXQQRYvgcRHmea9/VVCWa/wD6F8QYSjMe6e7jfRCdZ0IgrPsIwJTSqFaA99kUUfQ1CKKN82rozcsWUrXdoA99Ia6R7vOdtO07v6ZdP3&#x2B;OhroHaFycVzQR47z&#x2B;K722&#x2B;6xYeIl71&#x2B;ToJP3sn77HVQGue/PNhU6ZRc1uFudXEtAKOLyl435A3gK/FDkpEQDv&#x2B;X7ILgf3IhvMYW5FzeX&#x2B;m2XfqprxBHpOkOdepk617FSuVMj&#x2B;Lakdr8oAJEvGM9k3vYkdxXrarv4L5tKAtqCExMfGDErj8ZiaTCQU/Bb35JAx1&#x2B;xKET/&#x2B;xuqbQK5pAfYKEOZ&#x2B;9VK9eClLFC&#x2B;2R3rwqoNU8HLxNx8PnpsnxTPx56fOC/Dfz9WNEHixL4iM/jBfO17VEfLEoEHeKxAAM0gCuMn/vbwA7CSAnx9AqKAAKLRCC9aQ3/zPuw5yTj7AamkskiuhJ/6NuuNpHeyjnF6R&#x2B;EHN&#x2B;&#x2B;zCQfJQ5HJ44vMC&#x2B;3BuF6KZyCVvKivSXMyrytlnYI0A9V0CzKQEkPne4dNUFA1Lw9iK2OatzY20ZUG99ByMKgNFeoTXSEcwPwS7deM4xWehCNIC0nN1Bp4K2AZSEALfIMW&#x2B;ZXnel9v6IMXXoWsA/2uqTM28VyrIGVRNKE8EUCGIn6pkItB2DTBfafp8hZ47b6gw7likETG/OdcaCPxjHgCkL60oo1P9Wk79dCbNqQeJSCi7gIFJIOZU2EhjwZfDuacY0hhg&#x2B;ofoBtQXKF2I&#x2B;YXrAQaZ1zXU0aqqCqpIWg3kYFLY19ZDJ3cepv2/2U0th89Q59l2Lt0XFnM7WZIq3LhmFcIUAKAoQRPDY/Tff/01Jmeuvuf6Qr/MloVnnikA/oAyKEa3CsrzTUdQJQDLUarNaeDvJC08HP0NEoCyJrZKFmCbj8N&#x2B;brl9Ssq&#x2B;2f8mR&#x2B;U507FL5OFBfBpcVA3u5Iq1VCHUCjKix/zszlUCkIB&#x2B;PHtCYTURj8HUT4lGUb6PvWmUTEZuMutVslHKz2B75BLyVty73C/VxFmCT3VCYVtKQHZbUmJFkVYK8DrP0clp&#x2B;rc9h1lZim1XxPWStFg0Zn0RFMf/VVmpxssD9a8ZrBiZa/dlFzKA8iAC7PL/ggKg0AotYIOj/ud37mcQnhDgO6znUOP2O63nqhkO63CFV8UPcq5jkYhec9x5B0YE/ioBbpZXltOUmhFALk5lsThNCCDUXFLMyoFUNGIB2E&#x2B;du8ifVZWIk2UnLbd8Xsmlg1KcCyLEfrQxP9S5rF9oxp4K2HdQNgGPz6BGhUFbhgmZKT4v1Xf/2mKhJBqdeRJibIKj3kH6FYRTQ9HMgtwLA8M0PDlBpfG4rykj9t9UVkx/&#x2B;bpr6Wh3PysKusX8wffwb/hkYCHSK84JaQFQjcCTANMrrBsUQuGClAVDJYBR3VBXTVvm17OapVZCsvR39tG5vSfo4NN76OiOQzTQ0UPjI&#x2B;PsWxBNRAv5jrOZAxDXOUos9rb10I/&#x2B;9ptU01RHC1YvKnTMbBmffMG3DUDlowKQAx9VWlrQXkkge4iqS6TWhqDtUWA7UM0qH8gZAXZLlTeX8XOUlgtY8cAs4Tf76mfVAqrH91yQo5shoxnEu42HXg&#x2B;Q/2EY78n9BJSsl5BqOgFObxB/wBg4Go2q8VhMEX&#x2B;r0WhEzynMSKpD&#x2B;Hs9yIgN&#x2B;zg5QbriIANUx9sB/REkpECuz&#x2B;xFLPXt6GoRhYKW1HQqVECMj4jnJpSG2vNY9R//rP7OICV8F1ZX1ANzLhEAXuDfC/Tbo/4yUiBMhVZohebZEJX83HN7WL4MQG7URYcseWI6Q5WJONdtL40nKA5zPgFMmwSAR4QaxnffOXxCy7e2rTwQ1X/3upWu&#x2B;41JLnyAKrdScXjApOJRKo8nLvlcAcLxsFF8avdgXwBtON&#x2B;ZWXVqpnrBuWjFYqY4MwSEytL7bDUjPwIELvfxmVchwEgxqAoBw2T4C8xUOz80wt4RQRYsWJAsryhnEA/3f6rJvYfxnNINi4YmJ&#x2B;nC4AhfS0gB6BgZ5fPEPvBvmB/CS&#x2B;OWhnn05uWL2CgwJHFr7mnppO3ffZKBf&#x2B;fpVpoYHaeQWBhhsZkA8VWwtJ0bIFP8V4SqG8cv0A8&#x2B;&#x2B;w163z/9EaVKiwodMxsWnD4AyO3zsjrzntFVv&#x2B;iuy/NHrtQ3gXV5Hbsc0FY9zlfRDFHt25GY9UudZIMYEjrO27PEmw&#x2B;w90jNsH/HzRRQ7gWgZM1znduRLw34vDMs8adYNM6mfqEQCo3xvAipakB3QY9&#x2B;M5&#x2B;yb1&#x2B;7hL/diCB7v7gpQ6T&#x2B;BIoJlJk4G9Uyt6yGkeZzULLyEnsmg5Zax5WU8ugchWQTttDmGgHgVgrQqwyglwLA8fNqpADIDEIKrdBmYzvTP0SfeGonl24rKY4xQAZgMRzfP3ztWloB8zwBcJZUlLJrv7kkGdz8VdV5IcOorK44vwUvDNrODAxTLKS4XldF0dhlRcYNjwPf61N31Y/OWF61ao0m&#x2B;DR0QekMg2/k9MNoJxRSAh6DQpXJma9p3jsxIbatBpN4ivdri5Iz2AcqnRsYCCT/V/SFxhIX/wHMQ2MuwgyxQcz3zQ21OjmQ5lKJSEU5K64xXFOoFoHP2Hc93DtEZ/YeZxf/o&#x2B;Kn7dRFjkxFsdBMxK0uzbPt6W2TmWYwv8Jh9isIodIGomUhvYTZFVaQB9d7siRJB57cQ4998fv0wP/67cIDZzaOUx7lAN2izE6VgB37ekco5WXobNFSuxO/BwB0Bdau0XbJPxXFfd9uoNXsOeC62Jdb8TuBursJoAWUuxA7snW4KQnDmZpgM5jTcv9zkfx4PE7xWExNJhOKlvlonweyG7ViOg0vJYm9H3MVIOxkgGIyUkRpYmnY36UspSwCb5l7LuPsRfLkFBJu5SO11Dh44IAID0KSaYSB4sxrcflSvpUyCgTA7AD8QT5rJwG8ov8yEuCVP0mb8UqBDCi02bnwgfN4mv6/u7ZQPIoyaio9&#x2B;tROTZ4dVmhtTRXd3DRPdyvXZNhm8I92sLOH&#x2B;sbHtYiq6SKFg/684vyk25Cnt49o0VkXrEEVAhRFLgOUwwgOREOQvglzFD4/BYDh7g6TQzyQwmxwOM3R33xufyHxvWPd/cyMQ14&#x2B;vzRFLYOjfO7JSIil6E1lJXRucJj7&#x2B;YL4jXx3EDUorRfj6gtpjlAjRQOydQDpi0OjruXnZMurlsER&#x2B;sGxMzzuPeMTVCV&#x2B;Y80BwmhoeorL8cEMEo7/cOhXSKtWgLOvTCQ0SbwAyWb/B6hFoCKhgJJBNwPASx1/kFYRLiHp35DiwqX&#x2B;8mzog3qduIDM30F2DY9Ry6EzdFgA/iPP7qOOM600OjBMYZQ7hOt/SJm1gQ2Qe3iyZibTvPAaHRqhBAw3xVwpKi&#x2B;moZ4&#x2B;KqoooeGeASYxMnoKUUzMGSUaIuVKUWPq5AjSNp75z1/R8utW09pbryk8eGbLYlRR8lYBuL1u35YTbJk9AHJA0cuF3gHiyd&#x2B;8TU4iqP7bMYNE2xEHeVbKCJFg/WruLx/DQgnEVmzpEZ75/vZzciFwDNM/EOUxcT&#x2B;Ocwm/OFK6EO3XXPxNQN2JR81jnfttB//&#x2B;/eFNAGUd&#x2B;j3IIB/c7JnK4ukPYIyFsU0T8Dd/Cso5GDV3jI6JtWIvbZpXo5fq9SGk7NdpAKioUAFnzXYCwA7o7UCfXN4zG/6RB&#x2B;C3y/9fdQWA4iMztkuQCmRBob1yCyCiFZXl2X&#x2B;jNBvq2SNXH9H/HPh3bwc6e6Q3aESbqxL5SfV7xyY5DQHmgqpzLc0/pbEoO7BfSsvorr5KAGYQuwBYPNk3xM7xMQG68eCCQqEmmaDzg0Pid1IA8CGWqJ8XADwZiXIu2vmBIaorSlG7AHnoy9bhEaovLmJX&#x2B;KCYDsf4tQPHGHjDNK80EaV&#x2B;0T9hvQb98OQ0kxOongBSAMcKTwU8bAHQwLSjfB4iz5Dxo18B1vNRNcTFfn584iyrPoDXQ7wflccHYB/7K9VLRALQ45iRNpKEOaQ4Hhg6ovQdUhnwvWIBbEGGgJgoicUD9QXMJn91qoXmCxCOaDsWFNWpJPcJ&#x2B;rZUPyfOuw&#x2B;wPRAiIE&#x2B;CMmQpAVgrEjOnguhr7abnf/AsnXzxMJ3afZwl/sgphXt83Kx0eJXAPyL4SihMU&#x2B;MT2uIuDd&#x2B;CDM8prbyXSsnSFJvc1Yr7Q0hcF1tvvoOG&#x2B;wZp3vImqltYT0M94tpoquVzS5WX0M4fPk1jQ&#x2B;N0/IVD/L2JiQlKiGsH370SWkzM07HBUXrsn39AC9ctpZKqMiq0V5mbuYS1lrtTvPw1mfu//eIOAgTtoEwlmzxAYgZof9nTCNAkTlBcGAwZ4SBLNZCmRKiyp3nOXT/oMEiFUIp&#x2B;PqphCqf4jpOsxr2i&#x2B;wEY5fvC4XAmlUyEkOMP0G/3CvAqd&#x2B;eEMdajd5YPVFzTR2TzwNu4z/pFGXS27l6Rk1qS/dm/omZJTjMjkyvZB5VdFwP/HnryfCtdGBihjfVVZHF3UqwmlIbjoqYgkFwf0uj/q/rILBAAM0QKyEiCoBUBvCoDvKrMsgzg5/vwKRADhfZyN0SOf3X6ApXHYoQAHyK8ssiluQHMHezqc1y&#x2B;aZ6vIapN5UcADAhgkPaJAMCVHu8DxCGqjrxrgHUYFwJwA3wi2g0AChICQBmmc0XxCJ3sGeSSgT1BTABVVBKI0pf2HmbQOaFHt1XSyiJppm45szw87FARIaw/co/2DGgbgfyZZefDDFIjAckLkBWQlY9Pa2UMx6fSuopAy&#x2B;VHqcQ0A9Qw5zNGOcqOvhfHFNFq1uN9GMwhrQNO&#x2B;uiTfFIajJJ3cKbPmIrspnXzRh5rcSzRsGZwhzdBGGFe4HvoZ8Dy4akp7qv20VFWRGhyQCXwMXzj0AnefpE4/zGxrWRYgGXsX2wTUXYQEXDpxxyujMdpgQCdyM9HCUsQCBFxfFAoYJxAioA8CLL3jJ4CUXKZqRgToxPUdvw8HXpmH&#x2B;395Qt0/vAZzSQQxybGUXkVov28oAVRND6p&#x2B;WFwKS3RP0UJLi1Yv7hBHF&#x2B;YGgSonxD/Xn3LBvYkaN6wjGqb62lKfG/&#x2B;ymYmA7pbOvmzw33D1NfWTY0rm&#x2B;jcgdO0YFUTRRJRevjTH&#x2B;AyhW0nLtCRbfvooOiH488d4n6BoeGVUL4QlQFO7TpGR3YcoM1v3Fp44MwiEiBoCoAUTLrkkLtgFSvadolca2DUw1hQpgCQ7MzsrO8FNklGNkgqAZhzw&#x2B;3&#x2B;AUbFAcf5OIgEC9LTzds8iJaASgIvRYTr&#x2B;BppSzngrxaJ50Q8Htcfffye76MiWLECldy0FV7z0GsuBZa9exygomhZWk6cbSKyZJ4AZAL&#x2B;quOU&#x2B;J9J8Wz7/e8/mw0AlIlngGeUXrWOixFYcpBKdpmE8Z3CLW3OEQBeJQDdiIFQQODPP0Eu4JeLBPAC8LLX3NxlZX/L2NYCSVBoQZohUze3F1u7BIAeFUA5ypLu1dV1vuXXTvUNUu/4OEeK7duvEwteRKO99j&#x2B;hR68B2BHJPdLTTzHFXRoOULm/s5v2/aZbq52eybALO0BvTIA8RLsB&#x2B;ADwkmLfKPeGyP10WnNeh&#x2B;wbIDgRiVLI3wKAbyVwpsXRpEIR000o/IrgNaPqAboDsn6DFY9w3rnmLm98UvMeJiYYjIcmgLYRHc/wv0N552EzqWAqZaTyPrTtZIzjI5UMYbdWEk87BpAxWUkgHuhqyLbsDQie9DFIC1AfC0d4vIcYxCt0eHyC0yQOdfXysWCskc6C&#x2B;UE6UaHohooRLq0YZwVCEAICefzI249dAkBFDnzHqYss8T8mQN&#x2B;ZvSdpeGCI53DcToy9ApOJ1RvT01xJAKeeKElROBamZddfJUD&#x2B;AgqLvoM8fVxci8VlxVzDPqyTPPAh6LnYSau2rhPn1MpeBWW15fTUN35JE0NjdO7QaUoWJ6m/o4/VDBhzjBUIBmz309v&#x2B;harm19C8ZfP557b33Ecndx2lA79&#x2B;iZ74j59fEUAzxNdMhvb94oUCATAbFp6XYARoNwB0JxWCAkIXwOXm6C7zADDb8OsKHXt02ivNwPnMI6fju8TczfJ5rz5SnLV87LFpNyWB5ftePgAelRlk46xqDDufIK7LqAD&#x2B;yVRSwb1Z/K1kJASP23reK3KvvSUTNvunBdjr27ul&#x2B;Etz9mV5BMYYKu7jLsMj5k53lPjDb0V1n91ifYKSy4vKS8VzQDGpTBQbwNNlAIo/lpIeuKoGLhlZIADmDjGg&#x2B;BADMoWALBVg1jxsZDcMNzbZ/u8gQN&#x2B;PECiQBIUGifY0L8xz4Bxg6YmzFxhYZnRgvXXBPN9tQf7P9dBtryNq3VRayXXTEalHbj/mXuvwGEe1j3b3cUQWsnmUEkROOCL4LSyjj1DGZX8AbfgMZNxhvS6u4QcwMa1y3jW2h33gIc4O9qrmZ5B97IbzB&#x2B;&#x2B;K7bGdyT5v1GwdeEM2p5rAuBGRB9nAAFwJBZY7qvq4jIq&#x2B;A7BF6cWEXiaHx09sHPJ6reScwmOWEICtf3KKSYC4AMr4LlQDA1PTlBLfHRN9A6Il6B0gzWUDpykJYA1QlwH4J1ZVYLvYD/YHgD7Fed7EpA&#x2B;IHRAx4&#x2B;K7qFePcWFASFpeZSLPMcjetwzZpvgzqmg5/Cmex2IfIJuYKSGew1AlcL/gNfHvvukJ/nz7yCgfW5AxB6lxum&#x2B;I/uvwKSaXXr9kAc0rKfIkD7rOddDJl47S/id20dl9J2iwq4&#x2B;mJqa4Hnw09sqX70PfTYvxgr9AqqKEFm1YQhvvvp6WXrua5q9q5vnY29ZL4YhCR7cf5Nz99uMX6NTuY9yfnec7KC2&#x2B;j&#x2B;h9SXUZ9bZ2s6R9WvQHctuRYIfoPjwNoAIg5PiLF0NIERHz76aH7qKK&#x2B;irHcS29ZiX/RES//PQL36V4Kv6avu9iHOKJOB1&#x2B;dl/hITTLiIB8SQDZ99xMAN2fJt4Z9k7wT3rlFMWWu291DJRKxl2M53wmbC6/3LNEohXj&#x2B;8n/rVFrOdHhpQBwaCckKgdP8K&#x2B;TcbFETI3FYko0GlFNTv6Kmse8UFXVleeQf9XdCFK2bpeZBLrPKsWZEuBVDiDgMzdQab8s4DcUkSYgGtKUiRmXya3au8fwE1AUz7ls6f/LOM8CAfDqgnzZXZF8wH5Q6f&#x2B;rlgIQhAiQXWSehhw2JtLudOpHMtg/E4QwKLTX3iIUNdAXlpdaXj/dN0CHe/oZTHHkNhqlDXVVLOUGIO/To6wjAtgB0CP3&#x2B;rQA9y&#x2B;1dbHU3N4gnT/RO8jVBSYYpBKNTaV1oJimCANClQEkFjWIsPaOE&#x2B;e2&#x2B;z1uNBl9yLGEiuggP6RHyo1otzGn2bcspMnnQ0pwuxgG4TCyE9/B9yZ1GT0AN6Lyk2lI0qP8G7J0LQ9eZZA5KgBweSLKgLk6leASfEGBL/pmYXkJra6qoA7R58sry&#x2B;js4BD3EYz4zg0N09raKjopxm1xRRmdGxjico3j0xlOC0hFtXz78fQ0lcZiNChAKFQR3z92hgmaIC74IFI&#x2B;ev166hoZZwO/DgHyUPoRhE1RLEzdo&#x2B;OspugaG6OG4hS1ifeLxL77x6doZHKSysQ8Qb8d7x2ginicDSdBDpzuHwqcCqHq/QliZ5oVAJoiwsgxxDjklCbajMBnjCgO9s8gVVeWqAEeCcYYgtTAsbeOjNDVdbW8cJQdNaL9PRe66LnvP027fradJfGGbDYs&#x2B;iMRfXUex5MCpKfFHKxbOI9ufeQeuunhu6hu0Tw&#x2B;j9Zj5&#x2B;nbf/7vdGbvCZoSnxsbGqWBrj5KFhdxCgBAfkZcs1AJIJ0HJQgnxsaZBEA/JooSuecGCCIxJ9APUABMi33i8ze&#x2B;&#x2B;TZ666OPeOb6j/aPiO&#x2B;kr4j7L/oJ57vzR9to8/0FFcCr/Sy0r6suhQhwe80JjO2gML&#x2B;a6RkXGbblg6Yv5BMQtfoKUDavXpUgWbcqAK5rSEcEP&#x2B;fDo0pPQXEqCLzqwes16bKRcFV1BbO47yXiMTWRSJjL9ylu3wuyjpcZF7rn7ys&#x2B;4YXg89FtfJ1GfS4eARSsi&#x2B;14w16VQPPeUVgtZzlvE9ehumEgRdHLMVMuquJyrvap6KXCKLS5rQBwc//3Av8yIoB/vxomgDP1cHJnG503CfMDzUsh4PU9tzQD&#x2B;2uyB2ihzf4G9/MSARIR1YVMHsAJUeIfClCIqJ2RcwUs/fUDx&#x2B;lAVy/VCOB6UoAg5EEjxx4gGvnocHcHUSBz5EeEFA8ElYFwmJ8ApXENpCWQoM4W&#x2B;7m5DLAWCbgAw2eR3w15&#x2B;zT/1sDelA7McVxx3aSuOKqBcETQEXUeEMC0GoZc&#x2B;F6AeYvtzi8topVV5bwfAOxOAYLmlxSxr0BTaTHXewehApIE0fUyAZQ7BWBeVF4s&#x2B;mucFpYVs3s&#x2B;jAJ/fPws/fTkuWBmdeIY37ZyCa2vq/L83K1NDYHHHzn5vzjVwmMe9nHW1YigCK2qrqBr6i//cWKkfRzr6ac/e/pFiilhNpfzA/8w/HvTsmaeT5i/IDcw1se6B8Tc0lQAPeL1wcmp7KIEqSzJqDbPYJKIeT4J0kNXH3AKg2R/IIe0UokZMe/jtLGumrYsqKe1NZXSkowA&#x2B;qd3H6eDT&#x2B;6mEy8dof72Xj7qiJ528GpFJLDvcQHom9YuYdB//Zu3CkCfoAkxL5/62i/ppR9vo7MHTtKUuB7CsQjL9HHtlYp5noaCprJUi5SlQtn8WIB7eBWAUFD1pFEoG8JiDEYHRqi2eR6lylJUWlNOyzdfRWtvu4YWbVzmeowjA8P07Lcep6e/8StOR7hSHJyUiEK7f76D1t&#x2B;5yZkKUmiv&#x2B;HXitea61G26KwCczvDua0AnSJeCPDenOJJXAnBzerfvW0fFOYNfSf/YwWVQQKZIgKr5OB3bMY&#x2B;TGUYbwF&#x2B;xrkczprQITrmKa9H&#x2B;SDiUiUZjIWPbrpUGbOtreYUGn2oFLmX9nGch9wbwA7gSdb&#x2B;/C76sYoC&#x2B;S6ynQvr5cJAEqYQu5QLxlahe/hYVina2ddG186pZFahYJp39rPRzkfUZyyTd1wFKwOuu0OYWAaD4/Nv&#x2B;mowAIA9SYFa7C7lF9YNOdLebuhdhIGNqZZIpmVmh&#x2B;TUvNUOBFJid7YcnztJpAeYRle8VoBRguE0AWOAwo9ydwe/&#x2B;15FTHP0/LgAbIse40UfFYj8zrdU/j0firvNV1UkA40GT0W/hiNYaUVvOidXd6qEMGJ2GXD2mEQFeNzbxoFheVUkXB4dpcUUpR8fLxPeaBNBGlBsl8SYyaTa/Q7S5QgAfgOlmAcj7BABuLCmmbxw8QXvbuxjUe92YEHVuLiuhR9atyMs8b7nunYh9oVXpC/2V1eX0w&#x2B;NnWPHgd6UjdeBYT58vAZBPwzlAkdA5Nua7f5w/SCL07yLRB5fbDMKlSIDjBKcUZPxvzvr65LbmRseC2gDrmDv/P3vvAefIWd6PP6Ou7b3e3V7v1Wf77mzjirEBF8DYYAOhxBASk1D/EALJL&#x2B;FHfkkgCS00U2xCNzbGGDDu7Yqv317Z3du97b1XrVbSSvN/v8/MaKXRzEi7t4bdtV77PtrVSqOZd169z/N9yveL88TvUyrIH5wM8M8IADWOTNDI1JTazhASzkof&#x2B;YNhdnhinSlUSmSLdbQ6P58uryih3WXF/P3Q75M&#x2B;cbwLR2tZuq9BPPY1d9M0NO/FNbF83wIYkwL8X3nXDXTX5/6CMsS6R3b/qe88Rk/e/xsa6RtWMmFZXi7d15j9GdyrIB/AHmoAEdURDIjvPnr8w4EI69rnlubTSPcQbbl6J/&#x2B;87rJN4t9mMT9hysrPZcI706Ca&#x2B;C42n6qnh77wI2qublBK/19DfhvmvOl0I/WKdbNiy6q0UfozDjP/JtWgQTJAmIjNJdMgQKol15Zl3klkBI374eUEpCVRTDY&#x2B;5iwTQDuZ&#x2B;53Ra9Eh4DgNe4NAiKkPKcsJYDIK/OWZYITKkyM7XU5J2PeI1&#x2B;sVW5jwOhjQyrbZgsRU5B/N1o85gV/yNhCr9t/YANPFutrI39vUZErL&#x2B;LiwlQHaUVI0IzWoU5LQzuN03xAd7eqj80MjzMN0aXnhTBWGZBJ4IErgorDb7Nx6msgLYDBbJueSiuJaOgCw8IMAZkoAZBEASlb&#x2B;v6gqAFKJSM&#x2B;mL8kqGGDVfmAWATX60lmpHVgZ21T/lh7zM5DF/0NDKwNoaMwDiHeM&#x2B;xRSOT24FfcDknHYcd3IDopHu01BYxG1S25azcKbfSknQtPRyDKX&#x2B;gtEm&#x2B;WyU0gGIPYymzsI2VhXHhUCAphCcx6l7E4TgAwQd2VlBb1n&#x2B;3oCBR16y/FaW6prJ1&#x2B;R39pRUkgnevpYita6El2i9vEJ7mV3XiQTPAYY5VE94fYqUn3WhpnYuM7nQECnwOuhyOAocUV8kk05IK4b5f40j6plDmHwEUBCO4kteWMjBQUwN8oBYE051DKSmey80kdelpkRfd2Govy49wWPRuiF1i7xSqzFCK9jvP&#x2B;6ZZV02/qVtDwny9DYDHT00ZFfv0TVzx6j7gsdFJyc4sXjdLnI5bYtmP5D7KX5FYX03i/9dXRP/dYHv0Snnz3KGWfwECBYAQZ&#x2B;/BVtAp5ML1cHAMyjl7&#x2B;gvIhySvPII15fuLxEgP5MWrVjLflGfbR611rxXXDzMYrE31IdYwOjdOqpI3Ts8f1Ud/AMBwK8mOvX2LYPYsWR7gFqOHwuHQD4M/taWhY4VYI/s2PoAaH1ccyBb/zPxmA&#x2B;oaTbIEtOJoDJiAwwPpgQH7iQFTbZqBqA3mAYKQEkzIFZdcJM6MOaBNBiBrXXokpJVgn9hG2R3WJ/crlcmhk1DkxchG9u5WcbtQJYdzToyQHNAyqJ55CIsc0uLUE&#x2B;Uj2efzpCx7v7GNCf7hukdQU5XPkWNlFwxPkgKfDVo6dpMhjmY5ZmeRFGMEd2MU/A9rvUNk0kWAan/MIXG6Cp6XB8HErSztpa4eHVqOJJBwD&#x2B;fEEAI&#x2B;CfLMuvJwEkWiQVAKlsOPO9qK37ihIlbvTgX28s9UEBI3KcZIA/zU3w6g6UxP28tpG/EOhN1/RVIyqrvKwHfuEIb8BQA0A5PcqvUW49GQpzlhRl9Vkq0R4ZAnWit2xYSRVZmVSVk03dPh/LtI0IsFEqwD9KuDPVMmn0maOvHpn/n59roPMDw8w6brZuoCsL0J7hnDsgR3k&#x2B;s8mztq9JUIoUQruusUnqmpikDfMQAICqApvhSGo7IqQDUyl/S3WgbK9EgL1UVecCcoRVHuY7CIHWkfFAiCRHcjLAQDgyr5&#x2B;PyoCJUFCsu0xal5tDu8tLaE9lKUtW6gMSKG1HiT&#x2B;k6wBauxo6&#x2B;HvBjuYCLt92QiJSfEcdqmykJ9tNKwWAjwhnD1UK6NHPLy9kMApd&#x2B;izh9Lm9Llq/bwsNtPdT1bZVvEDAA2DX2hlmOQD4&#x2B;5q7qL&#x2B;tl048cYjJ79BygCqDzNxM7odPFgRbskEA4QDXHTxLN3zglrRxWgA&#x2B;1myBoXG2fzZr2Qjgx/s8Frg&#x2B;HtAZEA1YkaLLKZXyx7w3eszEqoGZrHuiD2ksNxh/UlHiulT4CrTziJ099XMcdjsy/pTh9UrqOUip&#x2B;Ldz9Z9nsx8aMfkbc0MYq9kr52x8Hcjb6CX8zOQC4&#x2B;Zc/RXEuY/Vt9JPztQzaS4nbFRlIbPOEnx2iJVeiBWWYmG6tjbi1qYU5fnnKr3fNbRSgbCdI/4AdY4rCZ&#x2B;O8Uly2hIrAOICPTFrxSzQkcYJiyMAIM3h9Vb/rMD/ol8Rr2aEy0qRIJXfzVhWzTbeVKoFknEPpMfsxxmUa3X2MfBDpFXrc0bmU5bluAqAkNikq3KzuNx/fX4e9UwAvOfx/ENqD6X1GhHeN4&#x2B;fiwYRYoEzyqlfv3IZ971jrC9UUsja7/rBJfHQdM/K5GoDmcydHmjJ4/MzLmI&#x2B;NhTmU5bTTsNTEcsKAFyzTwBVkO9tKMy76PuQJYAv2gEAfl0mEonaABhF9r1jfIKWq60E8zEqs1I/VjhM1DsxOb/g1K5kAVJJ/bLTEI7MaxAEvA3v2bqB9i4rpTV5OQmgPygck7azTQKwnuYsbav4OegP8gm4PK4F/13Hmh3uGqTv/d1X6Jp7bqI1l22kD3/r05yx72vp5qz9QEc/kwEajeIVZUmMBnFwAdwB4wLkTwyPM6EgWg1O/PEwebxuGhscpebqC&#x2B;I8&#x2B;mlyzEcSWg4yvUwcKKnknK9V8K&#x2B;0W9iop6mLRsW&#x2B;nFtSkDZQf877MUcuIyMFANmiBz/hSxSzy0EeMlEBygLomOm/G5DQmakB6MG8/vTi6hR0J6OXnkvC05cwGfrzj3IOSPGyhXFKAvElBgq7vN0W8Xg8oPNDUM2yWnguZI9WQQSjuTQr29dPgflS07dGKM8ZS/dJlmoTRqSKsfMuqdJ7PT4f22S3qjAkkXXgKQq2JEVimPTXL2sgTGL1mDjfUqxzKOrgAPB&#x2B;UNsHcl6HRFEJYbSE&#x2B;sO2uCnQEw/qvx9paLC4AgBmgYDZyP7p/2YzeZ1tKd3UPyfRRSqZfCtCQbP3GgH8VD4rPVIb6Ld/qrmDNgoQvm9ZGWfQAQIRBCgTTvn91XU0GQxFgRBysu/dtp7WCcALoxCOyIal/iCUwzFscry1wE/IrKO9wAzwmxksnA&#x2B;Y9SMRc73a0UCAOsYmKK/44hxnAPqXO3qjZeRmax6XV9s/TDetWj4v9wOM/ce6&#x2B;shF9qSbI0rkzvYNz2sAoCTLw9UXU0mIELWkRPf4/AYAsJYKPB5qHhrj9pJkg8v0I0q7x3yMt29aa6hAMCbm&#x2B;dAjL1LtgdMseTfcM8gM/sjWMvC30aLpVUdbwtHf7qdzL56iirXLmJBv&#x2B;&#x2B;svo6ptq/nvZuBf22PBGQAOgNHeEZ4HkP6hAgISgecPnSW3APnjQ&#x2B;M0IYB&#x2B;d3OXAP0eVhJAht/hcvB77ZCJFD9nQXFEsuarea0NSGMOdw1QX2tfOgCwQHyqWcmexfgsGknm7Hw04/L/&#x2B;HaEmQRq0sOZN5tb&#x2B;2skGwYVZLPjkwEHAaXw0QlKAjOwzqgCwEhJQJXvk11Op&#x2B;RyOWUAfnWYgv5U7&#x2B;FcWz&#x2B;s&#x2B;AHM/m4tF6iPYZiTReoDD/pAA2YXdm46EjG831othcbin3gKMwg7EWxLCRcEpRiVf4HPxy1s5x8a2igfSaaYQzMptHq&#x2B;Lq26QVIq83Amy4XPuFf4qU67Q5x7OIV7kbraRToAsPBA/8Uey6gKIK49YDGqACTbfJIB84UQGNAbnWSyOcmMllGVgVUUNt1GoAyUr5/s6ad/uGIXbS2JJ5QDOV5xfTO1BEPR5yIcxFUiwhpgM3RiEXWPaSOIHQgaDPoDsz7Xwgw3ZQnQgNYDp2Qz/ExULlT3DtLWiwwA7CotpkOdfUlDyMCoDcNjfJ22eVhDl1WU0MttXZTpSk4YhxaE6t4B1p&#x2B;fr7EhP098toum0MOe5HJwBwb8fi7dYx4HdQ4uJiOPdQUjf0A4JqmENbCWwOQ/XwGAWPA/HZym9toWqn2pmqqfOUZt5xo5Q4uyd5DkGXiti2LAucsuyOVy&#x2B;/aaFqo/UkvP//hJKl9TSRXrl9PqS9bTaP8oFS8vZoI//7ifQuKxo66VZf7OvXCSwX7vhU6aFo4Zsvix&#x2B;yv/s0nKPKEVQqwLp8fFLQNG50JpBy3&#x2B;e2Wzs6RiX1MnrbtsY3pCFoD/Mp&#x2B;94Ub67caHtiLAk&#x2B;NA1wyxugLAE4gAE7KxyUFvbCY/UT4uZtvTZe8NgwZyYtY56n8loF0jMkAiSY5ni49NEnncblkAfw7IUnJusJT9SrM5ms19T1YNYP5&#x2B;OUn8xpw00qxqFiX8SLqjyrBlFPxFIdpRWhR372QrSUmLwI1VtQF8QfgrrNIkbPup7gF6tK5JUeMhReUPMsB4nU09Z/hyWhvpOmGvwMGzrbhQ&#x2B;CcOrlQ1xA266hOr80oHABYH&#x2B;JcsXiOlAP6NAgFEiZUCS3IsBi1Mq2hlKoY4NntkRFA4myoDs8elOg519DDQB/mbfkDfHsz5zIYfI5uT0gYjqZrokrFwByoNZjuynS5akZPNDP2umMix3tiArOZdtO6i5mVrSQHzGPhDYcsyIZDWtY2Ok0&#x2B;AxewUWd6Dql49HgE48ehWfy/LymDyw1RK1/DZ6JND31xlTiZzAqBdIsetECaiwgLVEPkCeIG9d0bDYUY3elAAeNx7vHd9fi71ivuiZK1SA8vD/iD9&#x2B;8ETfM64pwVeL0fmwQUByUW0ioTDMp/DeDBEpRkZzMoPnA2HAJ89MDlFJZkeDgqhvQQqBKhCSGXHQplhn9qGkCPuFz4DPBYu&#x2B;9yKu8LinHube&#x2B;j8wTN09oUT1Hm&#x2B;nYaFs4KedCf63e22JQFYOWMmrsXmcJFT3Jugz0/1R85Rw5Eaev5HfyC7mEOHWEcg/QMvAJj/wW0g2RSzCXk/yS5xZiczJ0vt6dTJkSVrVE4P0wANymMHu/rTk7GAfKj5CiKYKQHMQGrJNKoYT8xs/tXSE7rp0ePFlkYnBHljjm8GIC2l/Ay9hPh2P1nntzmE/XAJn8DhdMh2m016Ne/3fAWA9MTayfzd5CA2NdlIzXfr8U3S4c5eJvVrGhmjm1Yvo11lRSRTPJFkkouKJxdIIBWIDxfBN3pYgP3yLK&#x2B;wz0Hhk0yy3C/kprXGDHBIbcjJZVJlraIPpMjgiLq8spS2FOaTxwkZ58gMIaCZBGNMAMkoIJAei48E0AzgzxbsW7UKvGaM2GIJBqRiTPWPZkEAs6CAGUuvlXSIWSQ31WDBQgkqTAtgBqmWQq&#x2B;bJfYS/h6RFelVeab0T5IlmpaTl1457BID1OlwOOFLBuDYMjI&#x2B;6/NFVnx1bjYd6&#x2B;413c4Rduj1TdGoALy5Hvec1x8ALHrAz/QPWW4TTpbIkeml9m4GnSArHBVGzm138Dl4nHYBUP2UK&#x2B;a4Q4DsDKeT5ebYOIm59DOLPTFxIp4Dcy6i4qEUyO3g8kB&#x2B;8cHT5zlyHuRyPpnnPayW9mGdBVWte78At/h8GFi0D&#x2B;A5SCECMIO451i3UvEAAkR7Cv4UjPSYuNYTPZO8RBAoCkUGWRYSVRrT4skM9dh2Vm6QWTEBzyFrj/uJNpGAmsHXsh4IhnhTIADkcxDH/fbJGr5ezDmuCde3piCX53RKOB9rC3PpDauW8byatTWM9Y1QzYHTdOa549R86gKN9Awo/dhgJc5wzzhFS82PUNiyyCbmzZuVEfc87ldmnlKHYZS9TwQbaUdrvmw15tE/NpmejAXkl8wWBM6m5XEGS0kp&#x2B;w2SASt/LPCJIwFMsQ0goZpSX9KvHVLWBQFkWQfWja9RlpP7ehagTQB9uyT&#x2B;j3g9HlsM8730at1zs3s2l7Vglliy4rgyA//xcykZBI4SqwFQHfFrAcSfae7kykUXAuU2e8Ix4z5PknRl/yb6gjEnNBWTuceA3/FUU5vwJSX2WdDCCV9Jk1kenQrSOzavobs2raHWkTH2G/D3XLebOZEiwkeADwGS6dhYlqxjN5SiXwSzQEY6EL2YAwDSLJ8zUwpQcMISbQGYTTBgMfdb6ntGzYgGjQIfySoMkska6ufPUD7HQAJoIYF/jI7xcY4Cry/II6/LbhAgUGTQYoPLeAgnx//M5o7srGSQakBfWe&#x2B;Eb07nvKk4j9wX7KbzCAMzOR2kYwLAbS7O5xNGxBiR5m7fJAP7NgHEkWmvGRimqpxMDhggew0W/nbxtyyPU5yfXzw3adkHr81HgQCIPzpdJz4nIgC2ncEtSBABRBWSJKV8kbWGVe10OcaRil1vCI7YDSR9zL/LFO2VR19cdI3ZZ7b4DBVMZziVe8J9duTk12U6nfycV3JEe/Rmsysgq4BjaFZZO44WfIEj4KEZMA&#x2B;iQzyXAfAv5gKtHAhKyGpGQVYnJtVzwFx1cAm6zAErDKhSHOvpZ86I7SVFLOuI1gK7QTkumOgvHKujF3/6NHXXt9OUz8&#x2B;SjnYxR0sl25&#x2B;Ko29kRaW0w/RndHYkCk4G0hOxQHyl2dhsM6Jjo7&#x2B;ZtwBYa8DP2nfTE/VJqa9D/WlppHySUko2E2jQkckZkbLp5zJ6LQYBCn4/bJKwiSjvR4&#x2B;/2&#x2B;WCz277U/hQRqpXc51/o8x/Kj64UcWHXjoweqfQdglyPTliGohFsB2VE26bpNpZY64GKTaWICfeF738Hq8H4fPAz7owNBIXALBx&#x2B;b8jejgt5gD/CL5HSaabbl1Xxa8DB5L22fgbev&#x2B;NAiEJLSikCwgYBqPSwenFEgCQZvGaVMv8JTKXEHxNG7fFHgyYrTFO9fWp/By7SRtVFlzMOb/aRu7C0JjYYGXKcjvJZvBVmJYjUYIubdNHdDYkpya9ViQAddf4RALwAjhG2Tcy1sjgBlk2Brqvspq5lmksOM0GQth8LhnL87i4RLx73EdZDidFLNa0XVwN2GTBGAsZQV8wxJ8RVgEuSs8A1BFRRsYegByGESARr7Or9xDANJVbgJcgg836tYRSdJsag7dHzc5sgfVcv8dscFUmdc1qhtVrCqktB/gbwLKT2w/C3BcIpwF3OBKTNUh19XFQCPOrEl451GoEOAEgbQypqhCY/4jK6oM2AWYAliQOMtlVDgG7GuKfzfcH8oXIMuA6wBEBAscrl5VxG0e&#x2B;rgoExx3tHaaGo7Vc4t98soEG2ntJK2v3ZsdnwZcqvJwYGWeyPpT2g4FfsqXB/oLyfiSF/T09Fo4PMTt5N8kkm5uqz5XYCmAFPONI8sxUAJLHBYyBpwmxXwLpW1SKL7EFwKzlQJYTeQq0eQMXhiTJEa/Xa7Mp2WLbn8IvShYAmisvRCotpVYBJ8kg&#x2B;Y5PB&#x2B;jH/h0WdrTD56Nct4sTMBRHr6f8rPXYxwF6kyDDDGKKLTWJ54TAX1TeBW6XPN07QL&#x2B;pb4nbypAQgX23qaR&#x2B;8A3g23mFb7avrIju3LSGqwKnVf&#x2B;BWxDJqhImZi5kA1NtICeZHosrAJAM7M8lMGAVMEj7HAZEelaZcKONfCn1ys&#x2B;27MsoCGDGIGxGUvinbB9A9rV5FGX4ityfZAKs9B19ilMaPwcRNUDAkWe1NDDEAA/PUQKfPZ4H&#x2B;P7a4TOcnW4dn6BsAbY7JnxsCHzBIMsNApxCS3ZoMkA5AsiNB4KcvYYhseIigJEbCwQ4SKBEkBUDCIAIgIugAOIMAOoRdT49Knj3SPZohkOe40bF91y79yb3TwPCyuwqJDg2tXotolYJsPxhip87zfM1LY5hixpSpwrEcX/HpoKUJwDfqJhDtzhuhtvJP&#x2B;e7XGrfvD2aQXdoEj4pVyFIlCvmFOcLYw&#x2B;ZRy7HF7&#x2B;jvA9/GxaPIO/BusM/9PhDxhCfg14/cE0gIDEp7jlaKvDaZEEIHAdBHlQ2IMt/aXkxXVpWQqV6gj4xxodGBdi/wGz15148ScPdgzQ1MUl2se4cTjtnL147gCZCl755Hw11DlLh8hIxL/XkE3uBzWan9FgIN0i5Rw6nKz0XCwD4G/lEs/UdjN5vvcUaW6DE6kOD0nojwG4hG2AE/q2OFXeIeHa/uABEHCGglGRu1XcyULRJskvYJbvSFrbgNmYzUr/ZkgPOhvvK7DXwdWBj4cudEuB7f1sXfXrfJbQmPydxDSXooyUG2yW9ZrMc/3oG/CASVOqnCQWinWM&#x2B;qu4bFJ/fTw2Do8ImK4kGvGRM&#x2B;BZXV5VT0/A4&#x2B;UMhttV5bjdtLsqn3cJebyjI40RTODLjG9skW/w56VtCdAGQaJeCnGzO0hUACy0AIM3D&#x2B;1MNDlhVCqQHWZOfSAZlycnA6GIOCqRCzGLmJOh/ThY0MWsRsCo/m02bgtHnAzh1CwCELGyOMLZDk1PkEZvzGPev23lTBYEcesR88nSccX&#x2B;htUuAtxCd7h1k0rZz/cNUmZ1BF4bHOFPfJt6Hkq8B36QhGRuuKluA0le6euOi0PiIEZJUu6TMSyAkAKw4JkAx3pNqxB39ZXaDrcauPto0KVlJijeT8owEzmzXb0RWAg54v02aqakAoEYbAGYCfXfgAGDQKwx3SYaHAXihVyHIQZZ&#x2B;ZV42dY1P0sCknzJcjqQyNuh1v6aqgtYJo&#x2B;9hYj0vk/1szM&#x2B;l5rFxJk7sm5xkwxtQe/9xzxEAgKFGln5CnAPOBfcVWfQfVtfRWWHUtaoGq00VZH&#x2B;3r19J11dVcmAD5JEeNSswyXwHSmsDCHxw7JFAgLwOJw1NBShLzEdE/DctPmRQrMF8D8gAJ6nX56df1TZyQCii&#x2B;zw/z7HC03BpRTFnEMqzMrjKQP/98g1P0Es/e5Il7zrOt1LAF&#x2B;DgCkr8Pcj2LxKfAFkRsO27xXdBEnPrcDrmvK/llxXQ3V/4IJMAguzv1//2Yzr4yAtkc6cDAAtlYP/ILMhKT8QC8YdmawtSSSBYtFFb&#x2B;gtm2vGxJG4JoefYF0pKK5rR55mxquuPK&#x2B;l5CmPS01rlij54oJfyk2dYAcnpdJILZH52u8odvPAdR7OkzlyqAuQkvAxG9wZJkDPC9/rZuQbhq41TUNhX2PFI3Oti&#x2B;AFkIr3oir7iQE7SImIXNmNyOsxVlT2TPjrY3kMnewaFLZ/iz0USQFPSmRC2H&#x2B;2ln9qzkzrHJ9QCDyQk3MyJBJsWmA5bB1YM1p8&#x2B;hhEX54oJVMikrzBJ72kLLQAwX0ECyQLsE71GFQDmOxigN0JWTPtGvfRWx1kKQYNkhtuIIyDV8kCzKgKjqg2jHjv9I7LEAIAAeAc6euhodx8DqMngNG/ydpVgDht6bLbdIf52SgD/gx29/LcDHd0MKM/0DzLYbx6VWQGApGACINMPrTddMggQRL&#x2B;sNinBIGkktLYU9vSweq0KiFLfq7YCRNTDI/qMa8S1gaQO7P&#x2B;&#x2B;6RD3qyvtAo6kmwXOI8/torfv3MjgFYAUwRRwDaByoTjTK44d5sw3AKibWwZsHIBxgrRPVrL2XvE85nPEH6RPPnuQM&#x2B;ruJIz2&#x2B;DuUDz64cxOfqzIUSceVnAkgNSMQP6ASoB&#x2B;l6lOXV5TQ2b4hgnm2JZ3jCK&#x2B;fW9auYELB&#x2B;JGYjS9TyeYQPDIe&#x2B;dQ&#x2B;NsHqBrJaEhjiskGFHGhzUQFnD8BevCIn8Rh&#x2B;AZSbqxuodv8ZqjtwmuXrIlBeEPcH/yxIthfs/lFQVkhv&#x2B;eTddP7QWWo93UijwvFT&#x2B;mNtLLfH2bIUyvixxnyjk/SVe/6ZildVcDuEb2h0zgGF9Hg1briyb&#x2B;WVFqbnYoF8/4xscrLXJwsCJEj4xf1unv03VkKiBOAeB8B1mfq4gEEcmaAxq3rsYxRPqrw2sfJ8JMuGHADx/etaiT&#x2B;riMgeyPc5HIsuMWfku86GLNKKBNDo&#x2B;ImvI2bTPyfsdLbLwRWbnHCRLIJJCaUYGumowblJijSf9hb4SBcGR&#x2B;lf9x9n/whVlpATRLDSqfqJ3MqJ9j/xetjpT&#x2B;7ZzoTD5ZkZ0aWD18DPMrO/Rskt03Wti3GoYjRxi0iO62lIj8USAJgvkG5WJZAOAswyGCCDMVEMq6y3WUQzUf/WODiwVCX3zObMDNSbtQdY9RSaGSejfkSUaSFzDIMBgCpxj3iYGeS5w0sm/ltILSePHQD&#x2B;LpaqkylD3Vs9dvus8RSXu8eAcUkF7Chr08rYUQ6uuR5aT3kgjAwzSsRlrlAw&#x2B;1wA&#x2B;&#x2B;IMDxWJf0P&#x2B;KarMyabhqQBVCgDqm56mIq&#x2B;bP7MoI4NZ69cW5FILSBEL85gUEJl4lKm3j/roZ&#x2B;fq2ciZf1aEpsIhWpWfS9evrLzo9VKc6aF3bl5L95&#x2B;s4UBJ2MKhQBABkf&#x2B;fn2ugD&#x2B;zcNC&#x2B;b2iWlRfSUAOito&#x2B;PRbL7ZPcS9qBWA9EB7D92watm8fF8QQLliWRn9tqGFJQaXQQ6ovIguqyihqtzshOBSYHKKOs&#x2B;3caa/XoDkzoZ2AWzHBTi2k8Pl/PPvK/ieYC3b5tCTKF6OXv3KTSto1817aLRvmKZDYb7OrgsdVP3UEQqL9RsU32MQGDo9TsvgRsDnJ//YhJijDnKjqkYcPx0AWFDGgtxeF1WsW5aeiwVkt&#x2B;cqBWfuVyW2ASTqvCePVJoTCZIh&#x2B;I8lAjQmlDPwM/SAi2bKrmWDkzduG1B0hBwC7NttNtnpdEhqwmJROn1W1ZhzDSakKj0tqYz8aLPzcMJGiu/4N1pHMYz&#x2B;Rg0mcb6mCpgHfFNxCSAkhbrGfRxswD1GwF9W7z38SfhBhRlettPv3LSGAxNh1XeLXX8adYTJ0kwIglhJ/SWsybhjq9UAUpoJYLEFAMzAfLIIoVl/v/QqBRheS4EArTwLWTlZr6BgBk6NMtBW4NiIQd8qMrrUWg2sAgZGQYNZ8xUwYA0zQMZLNGALEKBsmja1L32GsV4P&#x2B;kA4gymHxjuyAMiw4rXo5wIJX1ieIYlxO4wBJI7vFp/pF&#x2B;AVffkoLSvxergfvCI7g8&#x2B;vLDOTy8gBCAenpmhdfh71Tk5yWTvK1B0uu&#x2B;mXGEGEVXk59PE92wWQDzCQDCITbJFRv6SsKP6JXAHGxTk9et4hAH7YVBUAILxfgNBHai/Q3&#x2B;zeGpOJn/u4clkpPd3cweVzbosAC57HPXyutYtuXb&#x2B;SSjK88xCA8NLeilJqg1xjEj4AzUF4qrmTdoj5A/njRRsocT37KkvFPQ/Q7etW0obCXK5W0Q&#x2B;Q2R1&#x2B;5EWq2V/NmXHfmI8iYDp2O8md6VkY33Hxb2p0knKKc7n0dnxojEvvXd7UerzhukyMTtB/vO3zVLlhOW3Ys5VK1pTRqh3r6Nq/uJlu&#x2B;qvbabC9j&#x2B;qP1VLLiQt04XgtBz1cbqfhfbM5bFz&#x2B;j9ekx8IbCIZm5GRS&#x2B;frl6clYQEAv1SDA7FoFjPv4zTgAkpPIqaDeSArQIC1sFHxICXDJqrqNYsgNz5hJZdXKNlQowWF0gXNFqRJb0Nl&#x2B;TY1GSmFtWD2XajDAFhPQjkvcRCJkTRVpzO1g1U6iFw3UnlFUiGzR867rH6S2GBJnbe1pbYl4FgmioEriC9WlKyvLaFtpIVXmZAnfMDyTuDDgiiC1ikF/vmbnHsUQurtixBEQ5XGSTIgC0wGAxbsfz/Jv6fL/VykYoM/2m2X9zYCqWR&#x2B;7VRlVMvCfKmnhYh7JAihWAQPtG4ByalndGbFJK5IrYe4hR19WWNVwR884ZN5iy&#x2B;0B3JngT/zsFcZAWCmW6UEpekTsuIj6oixscjpEhQJ01wyOGAJnALq7N61l/oBy8Q/R5krh&#x2B;I5NhSgfuuPSDOGMXSWmiz1OhzBO4CNwm2SocT5n&#x2B;oc4al2g6pi77LPnFKrIzuRydZTE2y2AfbbbTYc6e7k0/fqVyy56k4GU3ru2rqP/8/IxBvjJ1jL68l4Rn3&#x2B;bAMzzMW5bX0VHe3qZwCdDzHHEAuDiXBuGRuhgey/dKt43H986sPhvF86EnvAR8mg9TZ1M5nfmhZPUdPx8NICFf5LbuWCsPVexiPvy/v/&#x2B;W2bDPPzwSwy&#x2B;c8sL6fjj&#x2B;9Vy3BRK98X15Bbn0WBHP&#x2B;1vfVZZy5luCvmDtPtN&#x2B;6hweSld&#x2B;qYr6PJbXkfdF9ro6e//joY6&#x2B;433wLQntLD3d5TMrl1GWfnZ6clYAN/fZLY2FRtt9bz11z85Ha0OU8WV7MeDdjmhXECWra9bjpF&#x2B;M91CtCyrQTuiAP4a6JfUAtIFfb&#x2B;7JibpRE8/29EvXnP5nNeJWQDJEJyojezwf0Dmh&#x2B;pDtNXtLCmi5bnZ3Lsom7x5rvMZ1UOXFOJFAkGy&#x2B;BxwB/WKOTjXP0LPt3WqMtBaaT9UfMIc74H/NyX&#x2B;Bv/uDasrhL9TwWX&#x2B;aOdAMigkfMiEIJTB&#x2B;tMvy8TAmGQ6l/p1Hvt1kaREQJgGfUsjADBfwQLFr9JlsdNjdhuevsw8FVK8VH5OBuStgg2mRmwOrPtLKWAQ23uo9GwpXxD0pa/Jz&#x2B;XoL8uzqBn7TIeDRkIhermtm5nktU0bQPBL1&#x2B;3hjHep1uOe4WESmlyvi8vpIUMDw4LXfGH/MbVXLH6&#x2B;x8T7GofHhAFRSl0LPErGlnXlDYY&#x2B;iHDNigo61NFrtUhZSeBs/xBdvaJ8zvOH875FgOq6odGopJ3h60gh/PttfSu3ESzPvngSL/S6X7uijF5u72HiPquBOX&#x2B;qqWPeAgAIrLxpdRXdf7KWr9thpUqA4Iy43y&#x2B;0dNCeyhIqzbz4KgSHbp676tuo4Qjk&#x2B;05Sa3UjjY&#x2B;MsXPkBDGeXhtp4WyU/B1rPdtIW163k2780G1UuWEFPfPD33MG3i&#x2B;cLThMeJU7y0PR9IWBJcP31&#x2B;WdkTWEwwYpv2O/O0hBf4Cef/AP5Mny0lV33UB3ff699MAnvkFTPn/qot&#x2B;L0g4RTU1McUUTy1&#x2B;GZbLZlaolV4Y7LrO2KK4HcpliPazbszntZCwg&#x2B;zmb8n&#x2B;zRIZVgiPx0MY9y0bv12dMTfPWKVYAxF6HkaRfFHzGnOWM4g3sgF3sTeGI1&#x2B;uxxZb4L2x/S6aH65q54g4l7pnzVB2V9JpZsShITzS20ZHOPgbgUEFyCNv7e08r3b11PRP8ympLpCwnMN7F30wpUXkhCrDl&#x2B;KYS/DwqPqttdIIVmJqFL3a8u5/Jh32qdB98nWnh14UlmT6wYwPVDQ4rXDziHq/IzaKdpUW0qiCHJLHvQiI6iN5&#x2B;HSg3DALoz9NkLVsFUWLXpaxXO4i9SJ1KQHosjQCAWYm/ZBH4SWf/X&#x2B;VggPZFjRj0js8VuCYzyMmCBno5PjPJQ6vPWmoDZfleu4OGIgHedW9dW0VbSgoUzXhVRx7XPRoICAMxTh1jvmhZO6LCqBLYpZXLZ2UkAFFtgGju8vISNnBQBoidSfSR/bGxnW5YWcGAebbzvio3h7xOO/lDEdPdHX95rrWDy&#x2B;ntFwEGIDG3p6KYDrT3kktSSssMN1ZhuJtHx&#x2B;gPDe30wV0bLeUKU93k7ti4hs72j3BJnRWYg8FuF8b8XP8QbSkumJd1cuXyMjra1U&#x2B;HO7uVAIzZ9wRrSsxvk1grL7V30Z3inOdjjA&#x2B;OUu3L1XTupVN04VgdDXcP0bRwMhxuB5eSSvaFy&#x2B;4Lp8Q/MsHn&#x2B;swPfk&#x2B;DrX20Ysca&#x2B;tk/fY/aa1ro&#x2B;vfcRDtv2ktt55ro2O8PUlddGzndTgHyPSlZKQ3cerMzuGR8OhQi/6iPHv/GQ1TwUBEF/IElL28Ynpbp2vfcTMWrymhErI3lm1dSX2sPZeZl07M/eJzGxPpZVPs3Amlib9567a60Y7FA/Zy5ygBaywhbBQFmqgBmHYy4yM3RSNKPn4/lX1PISGWHjfE&#x2B;JPyQWLNpuH8x3Fuo3/yyppHJj3Pdrou228kCSFrm/3BnLz14up56BfCHDC4&#x2B;F5WEqLKEdO53Tpzj6kM92a3hniYrfEmJibCZDx2cCvLnaE/tb&#x2B;&#x2B;hp4UPBvEFf3Caq9NYFtmhtFYC1ONvf33JZrq2qpKTNbwaUAXqUCSTp1Um/7gq/1jFCH2QIvZ8DQIWppdm8R2MbQOYCTjEf43S&#x2B;H/xBgDmUy4wHQj4ExhKW0wvEQMxNSAwV2cslbJ3/fNynMRcfBBA/5pUuQtSOf/FEDRAZLcsy0utAqxCfq1FADcEABgkayQt4hG9&#x2B;VcJ8PyD6vpoAABG6nEB6D9WsM2y1UCbgzs2rqYX27q4VyyWSA8l&#x2B;j5hdB6qbWK2WC9zECSSRJoR7UAr/trlFfSTsw1UlOk1XBNYhZDKeaq5g964ZsVFzRnk5loEoENPvlcjvzHYaNA6gaDDJeVFHDi42JWAQMdfbFtP3zp&#x2B;lu&#x2B;Ble&#x2B;XJQDk90/V0j9ddSkF5DDlC2cC9xcSipDnc0pKlQck&#x2B;ODoQKrHoeruTkXCfO79Pj8FxGsKxN/94nFFbiZV9zkVTgjrLz6vjYNtPXyfURGC6hIEizI9LnHcSbHmMjnIdLW4b26HzdDRwuX1N3XThRPn6eBDz1LjifoZSUWxHh0uR/yLF9jAXoc2BZzc3juupbGBIXI4nVTzcjWdfOYIeTI8lFuYR02nGmjLdbtp18176ep73iB&#x2B;r&#x2B;ds/isPv8CBALvaxy&#x2B;nsN&#x2B;wfjJaYexYA9k0JeZ6qYN/LjF22eiWj91F2YU5CYvo7PPHaLR/RAkSLZaARihMJavLqWLDCkqPhbPOZgu89f6GWRWiHgvNPK0XZE8EfkZVAMmkBE1iToagK7bnWh9IkDWgKUuy2y2sil2pz1sc2X7j4eE2N3neTYpkPLn06Pkm&#x2B;pXwfSBxDDsZifVz4KMJgB0UNvvXdU30ib07o/J&#x2B;pnOrEgMarVEkB0DSh0BDdA2Kf35h/8HhhKy&#x2B;O&#x2B;rfkfDVZJY0RuXnRy/dRrsripV2AHF8m/pZoRgJP6O1p5fwSwhI6SsCLKUQU4OBsVUH0c&#x2B;zCCykAwCLfG9OEiBI3/I/o9HUbVZxCgJmJH/JwLNZqb&#x2B;ZyoD&#x2B;s/ScBUYGebaMrFYOw4I1dsK4lDMYA9FfhDPMiO7qy67Ry39ZeQk9VNesAECVKOZM75AAwj6qiMn&#x2B;mwVpQL73&#x2B;lXL6PGGVuCT6JcSvWTozUfP3cGOGQZ5K3lIvdThG9dV0Yvt3Qxazcr2nOK1P69ppG3FBbQsZ&#x2B;5l&#x2B;cuys&#x2B;i29Svpgepa7odzmMiuAfxCZeDh2gu0Jj&#x2B;bte1hh5ggESV/waAA2k4aFSA8WwC8Af8Utz0MikeAdcjkNY&#x2B;Mc4ndhaEx5kiAikFFVpZ4jd8yO4G/9Ii5&#x2B;PyLR5hUMUccH4YbrRAZ4jOggiCpnAqQOIR0YZ/4TBD3gVwxX9wr9CICnEOvF/q&#x2B;OU4XO0apZEXQPtI76acHq&#x2B;vYqQChpB9cEF4vbRKg12N30jVVpZxV0B9vqHuAWk5eoHP7q6lu/2mF7R7lkC4XZyZSaIddEKNoWQntfevVFJwK0eW3X0VtZxtpYmicTj55hNwZbvJP&#x2B;MnlcVH3hS76yj3/QvnlhbRs4wp6431vo7d&#x2B;6h666h030LHfHqSmU&#x2B;eps66NCQ0REEh1P9HkAZf6kJkTxEatZ5rEnBeRM8NDo2Jfyi3OZ&#x2B;nH3qbulKQRF9KYEt/Fq&#x2B;68gby6qqr0WBj&#x2B;zFz8gFQUgJK7ucZtkrEALPYxAWwZgS6TFoQE3ywmq6rw&#x2B;Mvc2&#x2B;90OCRbCtw06ZGYYPpdQwv9&#x2B;GwDt9lBfhjBeSgwhcIh8ohHLYEG1SNI7GLm8UwkERUbrjv8hY&#x2B;h3ma0GSBRorRiJgJm2OKIKpmMQAFIl3eXFXE74caSfAqrYB8JIkldE8KdiQtA6ZeYFUifIewzaf63CATEylXGPjLhpK4SID2WZgBASuHn9FhAw2azxSkIGAUDrAyl1WZq9H6jFoRkTPlWci5W/XvJqgTMMtjJOAlezSACNvJVudnCkCsbesPQMPe&#x2B;VeXl6OZJppLMDNpWlE9n&#x2B;4e5dQB30i8M1f62brpr89rkqEwc77oVFXSks58GBKB0xFxTRO0df6y&#x2B;lXaUFHIm3&#x2B;heGFVt4LkCAVj/csdG&#x2B;uKBE&#x2B;abnbjWgDCwPxUG8GN7tpuSBsaOSIxRQb0/Pn50KqjyDvRQdd8QOci8HB6Z9CYB4r93opamwtNUmpFBnROTaouFRBPBafVR4UYAAWNEVqLuCM5MhKY5I4HsOc4/qHIzpALC8RoEE3D&#x2B;UFDg50jpNdT6&#x2B;INqoGJUPJfldHAlACoCQmGZCjI8fM8QNNB4B2wpbq34miOohPWFrMa6wlzhSKB9ooTlGPXn7x&#x2B;bpIajNVR74DQ1Hq&#x2B;nrvOt3AONk0Sm3xWrKLAIwD/36YOTQFx/yapy&#x2B;slnv0N1r5wF0ybdeO&#x2B;tVLF&#x2B;OZWtrqTmU/UUFPfeNzhG7TWtPAf/dfc/U15pAd36sbvo2vfeTG/469upu76Nnvj2b/hREo5h2sLp5lt8L37w0a9y3z&#x2B;kSSfHJsgjnNexgVGunlhs4MThsHEAKD0WHnibzVqyyvgnayWIkcwz9AeMj5kI5I0y93qQZcTLlhC4UIgFZYeDS2lkp9MZm&#x2B;V/ze9ICKRnJlH9ib1nUCT66bkG9hHwLNSFdgrfZ2tJEdvcxxuaozeE5ZlDMjWPjNLqvLzEyZaM7T8C5sP&#x2B;IJ3p7ac24ded6xum&#x2B;qGRKL8T&#x2B;wCsamRj/hS7pPgWmwrzuV1yS4nC5I9zmI4B/w2DI9Q0Nk47igpYKUjvR1sITpgHAfSLOMUyFv330aZWMlqu/fRYEgGA9FgCwQCNK8AIyBsZWyPQbVW6n8wwmwUcZsfgay1vqC/ZS3b8VIIH8zWQYUaZ92ggxMyz5wZGaLnY9OPBNnGp/b7KMs7Uw9AhSoxN&#x2B;umWDrp57XLKFSDRWqqGOPO&#x2B;TxiWxxpaFE3WGM8DhDL1wyP0rDjeHZvWRKsQjMC/0RxcKsDlm9as4DYDh0mfOsDuiZ4Bery&#x2B;hW5cvZwahkapRADS&#x2B;uFR5kIYDwWFwQxwcAAZcYDzUfE7&#x2B;twCwsADxHeMTlJlbqYwggJcpJBZxLGOdPWpUfghBfxKamQ6ynCrlVIyES8bZL8wuHgv5tmlliV6HfaU76tEMwR6Dk0fGOXSshT9uyLLqwD1iOo0oBQRj/hcSY2fh9Wy/zAp7RSKAkRidhmgX1OSyPO6mR/itnVVtEE4FEYDpdmNR2vp2Qf/wNnaqXGlZB0s/s6FKE8Xx3hl7ZR01rdT44kHlVYF8VqU/OeL&#x2B;bj7X&#x2B;6lw795kVrONFLH&#x2B;VbKys&#x2B;hzVdtp&#x2B;ve&#x2B;2Zyep109LH9dPrZY/TDT3yDKtYvo&#x2B;IVZXTZrVfRnZ97Lz3&#x2B;1Yeo&#x2B;WS9UgmxVIcUq9&#x2B;U2ltAoBgOTrO8IoJJyPiDN8LutC869w/l/6t2rV8w8pXpQQYAJ7V2ALOWQ3M/wjiLH1/&#x2B;D4ATsfBtYt9lQMJm8MJUOhpdLqeEpA16&#x2B;2mBy/f9qUfryAR96ZWTdPfWtXTVsvKU1tKp3kElky5uAwLw79yylt62fiV5VPJjqCh990QNt19yEEDsaT0TU7Q6z9gs6dcRlJvO9AzSL&#x2B;uaqGVkjNss0ffvVYMU8Ln909P0wV1b&#x2B;HkEMLLEZ68U9mit&#x2B;BejJclOCVIGkI59vqmTHjhdx8mINXk59Lkrd0WleeP998R&#x2B;/mhwyWrZJJEbTkUpwIgMOF0N8NoMAKTv&#x2B;CIwrFoJmVYVEDFgO7UyonpQbVb2r/2crOXAjCPAysDrX2dUaWB2TmZMwUbnnmrQIKW/i&#x2B;cB9qtyc4RBGuDN9KR4vG5lBWee9fvyrvJiKs/OpKHJAFcBAMCjhP2JhjZ659Z10Wi11fncsnYFVff1C6PpY8MTu5HnCmP3&#x2B;8Z2Jq/bUJjHYBItAsi6g&#x2B;hvLBji9/T5/JTrdlP7&#x2B;DgHHvD3oHgtAD562a2&#x2B;9QD1j9a30B8a27g/Ha9Fhl1jicXPICqEcUSPf4Cz8ZBCjLALhes&#x2B;0zfFkXs5xe2Fe/ZT3axUg&#x2B;aSlCw9jCsqBlxg4pVnSgDxnFPRVU7uvanHHpsCszCy88o8IJfDBD8kRc/Pztn7CP8NZl&#x2B;7RKX8UFLbP1CtEGE5RZ4zSP4IhwPOxbq8XNpdUUR7K0qpJMur3I&#x2B;YAUb6lpMNdPalU9R47Dx1ChAcEg6QTcwrg54FjNgi4poBNu1OGzviVgMkbpBw07SkkaUe7h4Q19tGtfvPUN3BsyQJC1y5ropsVzsoqyCLXnn0JWqvaaYP3/8Z&#x2B;rfbP0OjvcPUUdtKtQfOUNW21cx0v&#x2B;TAvypZhvJSOGihUJDcHjeFpkLkyvSk1syMwNYsgmML2RYGpqZox42XpR2DhbxkkyQJzOy&#x2B;mS2XTTPxkmEEUt8GJ&#x2B;vk/PQkbIbg3yLDqm1ZSNLY7TbZLuyMer629N2PH1DG&#x2B;c/Dp5i5/3&#x2B;OneN2vTs3rTZVMeIgn3Bqnm/t5HlGBv76lZV0z5Z1cdGf169aLoD2&#x2B;eiCwP2bDE6ndE7wV1DqD4nkoFo9mOVyRHkFgmrC7e2b1tKbhP1RjJusNP4j2x&#x2B;ORH0ByAHWDo7QdVUVNCr8PnAQse8gjon2T9h&#x2B;JCpk3RpHfk/5nQzX5syKjieYjCNWtmACtOoaMOSNSkPB12QAwCookF4RC8jxYesyUxUQbQ&#x2B;IN4rGoNrIOFuBbqPS8lQy8matAak6DGayiVZBgFRaB5K1H5hWFJBS0rWzrJBOC&#x2B;APAFc/MMxs/&#x2B;sKchOuAzJ/YKP/74On2DlnAi7x79m2TrphdSX3eE8IMAcDNDDpE/fTLoxJWJGGUXvQAapBaNcxNpkQGgbYhXzgV4&#x2B;e4axx74SPQW7fpJ/lCEFah3McmpxiojuU0WW7XAw&#x2B;ERxAUMCRJCtvU&#x2B;cIEW&#x2B;7mvF2aeBBnIbbbWdb6Pa4lEeHWynpdtgUY4WfkZFXjWlsQtgsaRn7XEQNMjD4jig2V&#x2B;NVgDPBMoJ2G78G/fqjwSnuycccoNVhTJw3uANyxM/dYn5yk8gCavfbLd7zgZ2rqVcAcPALhCMKmU&#x2B;WyynuWYiKxP1EKwI&#x2B;Y1w8lmR6uRIBChAFXg8N&#x2B;6eYLwL3YHlOJj1c10RPNrazcwF2YkgVXlJWRJuKErP908Jx6ahtobMvnBLA9zSDfv&#x2B;4nzO2Lg96212JE7XwvH7yZHs5I48sfNSIivm3O2yG&#x2B;wFXN4mbHBRzBuAOkPudD3&#x2B;J9r7tGsoty6NlG1cp5aC9Q/Tr//gJBwxABIiydaWEU2JSv/zyAhruGuDqiKUWAEBWCesDPfvhafFYmk&#x2B;DbX1UsqqCOutbyeVyvyYstRoAp8zcbNr&#x2B;&#x2B;kvTTsECvUepEgEa&#x2B;Qqpqw7FAhprKUAzEJQsYGb2eUjGRCJhBv1OBcSm/WRzk0A/E0AbNhUJAVTIPXa&#x2B;mavn7t25yfR9HRMTLLUHXiTYXwb/6n3R1oVL7P1ovUNrgCZfh6REKgN&#x2B;DdoF7MKbcKss/fC/wmpL38q8HHr7hlV09cpKiojfo75LOAYcCjsDNaEvHzohzneSq04g5wyArrUQesTe7YoB/0Z&#x2B;rH5tGqvbSqlVqxj6&#x2B;wZBhVn49&#x2B;kAQHqkxwIbdvsMZXMwGJQdDodk5mCnArytgg5mRnW21QepOAOzaS9ItmmZBRWsHBGzAQAHoA3QgdLzX5xroI1FBTQlwGZFlod6JgMCgNvJNx0SwDTCfV8gs2OwKowBAOT/ffk4A8QLw6NUnplB9UOjDCpBvtcjwGuOw0XDoQB57Eok2pa4aytGRRgekNQc7exlkArQg0wzeteRBR8XjyiFh0HLFg6KrJajF2d4owy5qThyTmmG&#x2B;Cbq5UhqINymROkZlIvPQVAB1QIw7MigB6ZlJsjjXn1xPSDvQVuERo5jes8IvAB22l5cQO1j47QmP1eA&#x2B;Elam5/HzLzrC3LZ4KO1IEMYf2TP7TaZAT&#x2B;CFOAFQAAFEXcY3x9W19GJnkE&#x2B;ppwk5DnO4N5Dt61bdVFMuCspmx8/sGMTX&#x2B;uVy8r4OjIM&#x2B;h8nhsfpxBOH6NRTR6i7oZ2GugYZwALUokd&#x2B;MQ0EigDQP/L9z1Jfazed&#x2B;MMhqtl/mrrq2ygwESJnhptbF&#x2B;K9EZkKlxVT&#x2B;bpKDnh0N3RQl/j3y395gLKL8sTzFVS&#x2B;Zjld8ua9dPvH38nBsuZTF&#x2B;j/3fZpGujoI3eGJ7pw7M6lZ64ZbIjv19/&#x2B;8B&#x2B;ocuMKmhyfZP6Doa5&#x2B;Kigvogc//g068fRh7utf&#x2B;mBCJr9wuN/y6XdTxbrlaSdggQcBUnmdVSDADCQl4hy9oPnsAxKG2X/dS1SfS/W1HFEm//QwHxeGx&#x2B;iPTe3sn2CG4Q/BD3hKPHdNVQWty881fN/Pzl5QKijFz7CdJWofvX5AIWlKrU6crYSd06YkNfyhMGf084Ut2ViYR9dVldOmwgLK9ji5Ko2UjsS4Y2u0Dl9&#x2B;5RR1TfjZ5zjVN8SJCPwJfhb8o&#x2B;tXLlPL/&#x2B;PXeLIggFGgKmmG3pTsMPFnM4LAdBAgHQBIj0U21J4zjStAVr/MklFgMEn7kCUAt9bnlQx7&#x2B;c0kfsz6/lMF5EYBCD3ot2o3MHrOiqNgRW42G6GuCR&#x2B;X/qPP/7j4B7k4XyjE5WwT/KjI1OD3WCI3RJx7haHoHFd0bM8HR/lxcDLAsVyYuonpELkkpZxdk5AxanoEN4DTppqEGLIajxppdqrXoJEIog1BttmUYIHKYsv96uprZAvNWW0A5KNKIQTJG2HkRqaCnAnHNaPqAUQ6ZdkZlO10UTA8zZF7ZOsR9YdRRDBkxB&#x2B;gQ119Ss&#x2B;exT3FcT92&#x2B;TY2eC7O5s7UDczW5/rk5Tvpa0eq6WjvAAdHzMgBlc8i&#x2B;trR06w&#x2B;8Oa1VRf9vYRz8uFLthgA5Qh1nGvmsvUzL5yg1upGzoBDAs/ldS9atmgELgY7&#x2B;un&#x2B;&#x2B;/6LNr1uO13x9uvo2ve9iYbEc4d&#x2B;9Rw1VjdQV10b2cWaQN8/&#x2B;s8j08r&#x2B;8Pq/vI2rHMJi7SC7PTnuY2LDDVdsoYycTDov5uqx//4F1Rw4TT0XOvi5KPj/Mw9ULQCoa/cwDNIorQoB7SDcCjM3B4vXgvh/2eaVlJmXRVkFiowfCBLZic1wz17PbJEOqEJUbKiim/7q9rTRXyRBgFTWvJXvMDtwkhopRkJpdAywUuTQ4p0lCP4iuKgyzmvEfmnwn8L41wPHFXnb2BY/lsG10f8cOUv/&#x2B;LrdTHqrHy&#x2B;2drG/hT79DQW55gCN74lxBUjC2ojxp/AOBA7w04aCPFZWgvpRqaYqgtdEFJWYaSgPIIARmWkjQYn/haERahT/CtTECvyaPZWl9ExTB6/VK5aX0VvWrVSbBxN9mNkEAeJ&#x2B;1rWt8KNVW0AKSb5U2mjTAYD0SI8FbnTRIqB9mcESrrUKGG0uxgDM6m/Js&#x2B;1GG5uZJq/&#x2B;vbNh90&#x2B;lpz&#x2B;ZUzIbhxzM71euKKefn2vgbTwLhH7qe70q6NcezdwQpzAiTt3GYueotVEfo8XGHTvX6u/4XIB0AA9kSWFgUQGANuyIWsoO/dqpQJAyhKGChA2k74YDIc6OOy0Y/2FmLqsopl2lRbw2QEbImXZxPGTiM91OfhXK8bSIPKQGFSZ/WzSYAQnC9olJ7pnzmPQjA6C3j03QN4&#x2B;do3t3buT2gpl1aaxwYEU85REg88O7t1L22Xp6srnDMvjA90hc27eOn&#x2B;Oo/fVVFXz&#x2B;8wMSp6m/pZcajtbSmWePcbn/oFqyDjK/hQJmL34PIgHSq6nu0Bl6/Ku/pLWXbqJNV26nm&#x2B;97GwNlEBk&#x2B;ff9vqVM8&#x2B;kb8zGkw0N5L3/6rL9F0METFVWVUsrKM3vefH6GR/mF66ju/pf2/fFphY/YFyOV1cSn8QslUIDuPwAcey9YsEyB1koMb/jEffydwTT7xM4IdYfGdw31G6XCqRcP47kbEvD36pZ9w6XtQfH9D/iny5mbRSPcQNR6vE8d20lIfuNveLC&#x2B;998v3kXORVca8lkaq3ECpBAxmV54cCwJnLPBs7LxWBSBHIpzlp5msfxrvz2HA/7h1XRVn&#x2B;wcmxZ6lkr0qdlaizgkf/aKmgf5G2OfYwHzr6ESUNA8VhXlej&#x2B;la0Urtk/UshyLheL9MvH9zUT5dI3y6a1ZWMjeStt9G3yNe87vaRq7UfM/WdSz5F0tIjIpBSW2RROvB2zeu5mTHF6/dQxOhIG0szOcES5jXnmwKvvVBgVgMb9WykpS0z8KZN1TDSK/xdAAgPRZ/EEB7BBjUNkpkpZSNM35v0O8R&#x2B;qij1Z5itL&#x2B;kSvYXSwxopQxgRGIYS1Jo5nQYEwjJ0U3erELAVNJQ/H55WRG90NJB3eOT3JemzQGy25qxgkFC5hsGJawSdRvNY1i9/rBaKoaIssYuH9ak9dTzVPrdbFxFkIgQZI5O4/MKcjwsa1dVlEcjgWlam59NbQJMbykq4PMNqszzCBbgd5DejEyF6EhXr7iuTirM8M5UA8TcXFD7ISu&#x2B;b3kZZ/STDS2YgDL22OOgLeLdwpD&#x2B;56FTHKxwOYwJ&#x2B;pBp2d/eTX6xZu&#x2B;7ZAvle90JoD8Zh0PseskVgOHeXZu5DeEVlI077aZmE60MCGR858Q5Luu7SlzzxYypcT&#x2B;devoInT90lhoO19Jw7yADQSb0w3UtIaMbnAoy4PVkuMVjmEEx2PqP/u4APf6VX1LVtlW0&#x2B;dpL6IP/8wkOBKDtofrJw8JRDFJAOIiYia6GNqp9uZr729/yqbtp9y37qGb/KRrqGCBvTsasQMWfYqAS4W2ffTfllRbSqh1rqbeli7ILcplhH3vuxOAY9bX1MFEhnms51UBjA2PR7y5UDewW3ynee/B9&#x2B;MVzHFRAwARBAI9YOyFwXQinFG0VS7p0UyyMyZEJuudf7qXVl6xPG/lF4H&#x2B;YgfrZBBKSgf/4p81ZZozOQa8EoL5VdgDwi&#x2B;&#x2B;jTbExaUR0EQM&#x2B;yx0CFF9eUULfr66ls31DzH2k3SEkAV5u72HOpHIt8y5G08gYtw9qbZDgMTJbZ4oSz8wacJskFsDTw1VZqj&#x2B;S43bRJ/fu4EpFUn2x2PUBH&#x2B;SBY&#x2B;fomdYOgnuHYAHUeuSYwOzqvBxaU5DHCY1b11dRvvCfsOevystWWiVVxZ9k6zOZApaRUoC&#x2B;aiWhisXAgZdsidGElDkx0gGA9EiPxWeMNSMGvkBUB2BT0pQE9MEA/YajB/3J2gdmY9iNDLTZ363I/MzAX7IM8VzOF8QwN65cTj86Wy9AC3rcleOEZGWzh/FBOwBI94YEEEcWHGAbRHGSbj7z3W7eqEFiB4CK95VlZNCAf4oNS/PIuDAuudTnU7LlaDeYCoYVwxgbSBC/ucT1fOGaSynL6SKnw86keTAIqDjQyPOsxhXLSqlnfJIj8s7YjHdUK5boeFc//fRMPX1QAGmthG4Wkxj98dKyYnr/jg30cF0zS/tkGbD/S6pzcLpngL5&#x2B;9Iz4zE1UkZ1pWWWiD&#x2B;LoA0CoVECmoTDjAj1c28SG32hWZDUIIL4h9KPT9bRDALvsWcrtAfgOtPdR04k6OvTIC9R4XKwXf4BL3GGEXV73rCTcFsFGQyFxfQDoN7z/FipaXkRrdm&#x2B;impdOUfnaZTTaN0wXjtZR48nz9LuvPUTVTx&#x2B;lNQLIve6dr2eyv59&#x2B;5tssd4igSCQYoctuvZIuuXkPHxr8AG7hWIEIb6ENrKttN&#x2B;ymPbdfrThXYqzYspof88sLDV8/1N1PE0MTdPjRF2mwo48ajtSRf9w3Q/Joso&#x2B;j8gHgHz2pmGcmh9TKWZe4BweejCvvuJ5u&#x2B;Mtb0kZ9EYxU&#x2B;XySAf8UzIl5xIhkC5nkeODjsDvQehRxuVy2mAOkxzwNqCh9Zu8ueqC6jiWINUZ8BUjL9GxzJ71727qZ73swRFphv1v4I4c7e&#x2B;mWtVVxVYOoMny&#x2B;pZP6hb9kj1EByIix1bFrcEDYJ7t60/FqJBVQ1WmmKtUxNk6P1DdRiVfYHrvSAqmp1WjHzRXH&#x2B;NyVl1DXxARtKS5k8M8&#x2B;GSIGslEvv2QQsDL&#x2B;7hgnxcxWu5QQBIgjCdQnddJBgHQAID1eW0MjDcSDtl8iDmAG8pOo4CQYU7NNarbcA0bPWYE8s0qCVNUNrAIQRs7DjauXcVT3p2cbyOVw0sq8LAFoN7HUH0BljwDRMC6jUyEusX&#x2B;&#x2B;tYueaGynfI&#x2B;TInL8/v/3&#x2B;3ZxzxlI8kYDU5Tr8bBCQJYwTP5QiLwqgR9A/G/rW&#x2B;jnNQ1cVueMYTmHUYPE3y9qGukvd26aMZIqnawtpufNLAaNSP3nrtpN/98zh8gfnlZ4AXTXjb78Z5s7aEV2Ft20doXCKzCXDVUApVvQFyc&#x2B;4xfnGoWxD1C2262U3sXMt4P79WU61TdAXz92lu7bvYUdiVQlJY2eQ8vC&#x2B;7dvpJBwHl5o61bUDkyCAChBHAkE6B&#x2B;ee4U&#x2B;fcUuqszOVKs5JFNHdbRvRAC6Gqo7cIYuHKul/pYece8i5BBOiSfLm/ghS2RAonD1zvX0l1//qLjODHr2B7&#x2B;l9po2ajtzgUpWlVPAF6CCikL61EP/l07&#x2B;/iB97&#x2B;&#x2B;&#x2B;Sq2nL9AzP/w97bvjOpLFmgCARin9de9/M&#x2B;UU5lDrmWZ6&#x2B;N9&#x2B;TOMDo9TX3LXgCP5w33HdcjiS8DefcB5PP32cGg7XUG5pAd/7ivXLmKgPvfuFFUV01z&#x2B;&#x2B;n1/bdraZfvOln1LdK2cVgkSrvVYtT9V6UZe614Y5npqcoi1X76R7vvjBtBFfRPdtLgGDZAEBo6zozNcgthDc2AeIf4ewLuIL5XIpbDp2uyst3/cqDhDg3rtrE0vivdjaIXwjt6qwJFH98IjOTtuZbwghUVQkoiUAFXnor4e/c35ohI529rOsoNMen7kqV8kCY9cL2h37JvzR1wDMry/Is0wOHWjvZt4CViASvxeq3DxxakUC8IOnoETYPPgveqnJ2J8TAwHGHplZ8oohvSSb&#x2B;9/yTBBEopgKSdmgIsAkCPAaMCnpAEB6pIcmJWhT&#x2B;8NlNbRptIGZ8YkYlSVZbSTS3FqVEmKdZsjJKBtsFElNBhpjj6V3TNDTjtL5N65ZzhHip5s7GUR2jfvoqhXl/JpV&#x2B;Tlxx1omQCsi2i8Lg4L&#x2B;sIhSv0XD/gB971Qd/cvVl/I1Afzj8yDdh3vCfAIgA5QUPdlbBWiGIfrluQvRloGocXU56LmWTvF3me7etJYqxGdGtHOPucZIjLShfv4LMzx064Yq&#x2B;vnZBja6Dl3vO2fGJRvdf7KGQgLUMoifYxAA441rVvB8fE8cb0jMBYgF5ZiSFFm9Dxl2B10YHKH/PlxNH9q5iTYVF8zZEZXUe/ihS7ZwBcfLHT3ci6gfmCfWAZY5cEb9wtFABYLN4NiTYz5qOdVIZ188QecPnqX&#x2B;9l6aEusB0ncAtE6HY0mB/bh5gi69uEb4JTf99VupoLKYHvjE1&#x2B;nlnz9N4bCib5xxPJO2XbuLdr/5CvKINRaAQoWYSyYAFI7Ykcde4gAJNOqnhaN28KHnuI8&#x2B;OBngrD/K49EqsdCy3DgfZO3PvXiK1wAI&#x2B;rTnX/rxU/S/f/8dys7P5jJ9XN80yvaFs5hVmMNVER/8&#x2B;ifEz9m0Yusqeutn3kX/ccfnVNKpdPJRGwGxBgqXldB7v3RftP0jPRb2MCP8nc1&#x2B;baYEEF9VYJVdNT8flHaHxebkdLJqki1d5Z/kftL86cMj8/93l22lxpFR5gTgakMx/5OhUNzr1glwPhmcZiJlRVLYRvuFrT7U0cvnM636PwjSx54ZqglW5mUnBJUah0epdXScWw7xjG96mm5cuczSXwDHEwgInTZFTWhrSaFOBUCKJmf0VVhGibTZ&#x2B;LRG5Nl6zG7WpqvdK1QjIPlgN&#x2B;J2kuWL8MHTAYD0SI&#x2B;lFAzABiMpmwYIA4nbBGL5AvRAPlarNHbjMKsYsFIiMNt4TJR44v6mnKc5mLcC&#x2B;8ZOhWzJR6CBQ0SG7966jhntIbmHaoACj4s2C3AajuEXwCNK3O/bvZml7NCPn6Fm6FGJca5/iH5ypp7es30DLiZuriJqlk8zMErmfAUHBX5V18R/j5bri7&#x2B;jb/25pk7WsP2bS7ZSrscdR2iTiuMGwh4EAv715RMc8bbrgwViCtDm8M2jZ7kKAmV5tllaDUn9LLzvimVlLJ34vVPnWeLPw&#x2B;0NUtwiw48IhsCAf&#x2B;tEDd2zZS3tKivmvsBct5NbJSDR2DgyRkVeD0ssAqy3jU4wMc9YIMSHGg0G2Ji3j09QRVYmtztwcx/ZoyYYr8drcY07xL28ekU5Ez8i8CHHLEj87BueoLpXzjFgbTxxXgBWP1&#x2B;dA1KEMf2MSxb8i3UGYIss&#x2B;PjwGA129vG8tFQ3UnZhHuWVFdLuN&#x2B;2jfXdcI34uoJ7GTvr2h75Mx/94iDKylflBgCSW/BDgF8dzieM6QSwpWwfqFsKAHN&#x2B;vvvggvf4DtzBTP77z4DnYdv1uajpex1l9u1jXpSuruApg63W7afv1l1BGbmZ0T1m&#x2B;ZRWVr11OnXUt5HA700ZJDASAsotz6WM/&#x2B;hwVLS9JT8giGckkd&#x2B;dyLL0NNj&#x2B;0bAiqkOAAENLaIe2qREca/JsP2M&#x2B;j3f10/cpyyvfMH0EtEgtv3bCafniqNiZsE38fqoQ9r8zJoLGpEIN2DE8MkHWpHKrTzH&#x2B;k&#x2B;Km420gooN1Sf2&#x2B;/cews8yTxvhKO0NaiAnH8TEu7ctXycqofHGGOpBtWVzJ/kZ47ykjGcuZ3a5/YvB1A0vnKiS0KscfXB8O0pNdzzz9HW7dspZKSkmgFQLQtwKBk16oFOB0ASI/0eA0YbQFetCoAGXJcAqRKsiwlCx7qVeoSggWxP5spzpm9zqoaIXHzS&#x2B;15FEDoy8jNsg1Gf0enV6kAkXsrS&#x2B;m55g7u9/9h9Xn6&#x2B;OXbqDI3O2ooogEDt5v&#x2B;/opd9I8vHmEpPDZqsqKH&#x2B;4fGdnqTANLFmZ4o6DcEXNzHbqe3b1zD2elH6prYVDg1FlzxS7bbRSe6Bui/Q6fpw5dsovLsrASjZdUi4RDHv3p5Bfkun6YHTtdxpUFsuwGDNvG6QgG0f3iqjtsdPrRry&#x2B;w4FVQTh6g/&#x2B;A9W5OWw5B/mJlrKqbNGeDrT4eAgyv8IY45yfHAlwOB3jk1SgdfFVQReB8r2gxww8E&#x2B;HuRfPI66JI/l2m1o5YaMzvYMM8jXCRsgUIZuwNi&#x2B;XLq0ooV2lhbRWJz2Ea0Smt/N8GxPbIdvf29xNUz4/OV0O8c/1mukcxZpSMrN/w7J/p54&#x2B;Sgd&#x2B;8Sxd8&#x2B;430F4B&#x2B;FdsW0Mb9mymyREfyxwe/8Mhqn76CMe4svOzLBdHtEJlkQROvMKRPPzrl&#x2B;j0M0fpzX93J&#x2B;18wx6qEoD&#x2B;vu/9PT34ia&#x2B;hxpX2ve1aWrljLeWXFSYw2EM68PjvDlLrmUbyZHrSxki99/nlRfTBb36CySDTY5Hexjlm/pMdz4qkODYQAEVkBGS1isf0SD5gY19o7abnWzuoaWScrl5RNu&#x2B;fAXZ8VAPA9sKvyTAg7nv/9k30n4eryUnxhfJ4PYD/lPBPN4njdAibjHWAsv43rErM6j9yvpn6Jv2UpSqlwBf4kPCNkq0zJFA&#x2B;umcHJzo40ZICn4WZlKV&#x2B;rZoHBGTSSxoaBcGSVdVgzT/&#x2B;29/Sxg0bU/nyxZ1YGvynAwDp8RoPBiBYbrM5ZO5zDYUiksT9cmoAXaLEfjujn41LlpKpEMTuScn4CJJtVkaVBspx5IS/6zd3q4oCjaH/5tXLqbp3gMYDIWobG6fvnqylf7hyF4PJ2PejKqA0w0Mfv3w7/b&#x2B;DJ1ieUdUUZhbbrx85Qx/evZmBbcSi&#x2B;kDLnN&#x2B;xYRUhMPNUUxu3F2SovcMoZ7dJdjrV20/fOS6LY26hsqyMBF6D2MAGjheJ3jWZ5&#x2B;SNa1dQpgC1Pz5TTz4Q8iTWmbGCwC/PNXGp3HUrKhWZXfFfQBhmgG9URqBqoV0A9Gxxfg2coXdT4/A4v0ZSuQtkSRVBNLpZMaUmLAMGiUNkmUfHmaegTcy7yy7RIPTXxd9g3EG8iPdkqXOC63RragMOJQYuiTnyBacZnJVmepmYEP2FyDx4dH3YAQHwe5q6qPbl01Tz8inqqm&#x2B;niaExVjiwOZHBdi/ZLL8VQAPj/8sC9F9&#x2B;21V04723kkvMQ8AfpDfcexsdE4D/Wx/6ErWebqTxwREutMjigIo807&#x2B;&#x2B;ZDZM8b3zusg/7qdH/u0n9OR3HuPs//p9m&#x2B;meL36IMvKyo&#x2B;0BvBeI7wbWz1D3ALWebaLqJ4/QhaO15Mn2phsw1fkcE/Nz5z&#x2B;&#x2B;j1bvWpeejyXiU1yMHKAVZon1C2DWVN5jlu/jFro0&#x2B;E95AFj/lwDdbcK&#x2B;Yv69XDI//9MHQl6NHR&#x2B;fub00kTB137JSun14JT1xoY1fY7NL7DehHWBZTibdJHwvcCd95Ug1t2UisL&#x2B;jtCj6fn9omp5p6aDHzjcz&#x2B;Ie3BVWh29evpKrc7JSCTbhyh2E5vpSgGGBNUJ2oPmGc6IrnsDAiszTmu5o5ZnNzE61evYayMrMsttgYgsD0SAcA0iM9DAwxbytOp9OmbICSHAgEIuJ3e2LJUjzwNyvFm3nOOCigx35mAQOj3/UBgmTH0IIB&#x2B;s9PJQKqbbxr83Ppzo2r6YHT5xnk1/YP0c/O1tO7tq5XggDaa9WqgU3F&#x2B;fTZfZfQP754mJxc1m/j6PfZ/kH62tEz9PHLtlN5Tgb3Rms98PoyMwQIED2/Z&#x2B;taAm3RI3XNwkCGlTJ1SWLSGhi8swPD9OVXTtFHL9tGVXk5CU5WbHACxhMZ&#x2B;UAoTPkZHmodGaWrl5fT0KSf2frNjEhZlpcN7EttXRSYjgiDbONgAsr5M50uDgJ4xHJBgAQBA5TfKeR&#x2B;yqpgqSX1fJw6zgHDPjVSSA8dqsH12JVssVPCdYSZCAdzEX0rJBr5c&#x2B;JbKvB520sK6a0bVtKGwjyWJtKPoH&#x2B;K6l&#x2B;ppRd&#x2B;8iS1VjewlntYXAcyuE6VEChuqS9hsA9nYWrCT26vh4MeKN2HpN2Bh56lF3/8JOWVF9DyTVVUunoZXXnndXTgV8/RqScPU1Z&#x2B;DrdDsLMyi3aUPwc4kVUSSlnV7rTFVL5YAhhN19rr4uDGxPAYPfvA7&#x2B;ngw89Rrvi&#x2B;F68opY2v285rM7s4h04&#x2B;cZhGugdpXIBcBEfwXQc3QBr8K3vc&#x2B;MAY7b3janrd3a9PG&#x2B;ElAPxj7WUqNjX2UZ/xnAlex9t4MPg7nS5bJBKWHQ6HlqVIg/85bPbDUwGW8X01RWoOdvQwi79Llam&#x2B;3qAfH77B3VvW0rKsLGoaHWV/o0DYH0gbA&#x2B;gjyfC3T74clWMuFn7LzphAApSaHhW&#x2B;C1oZcazRYEjY/AL2zaQ5Bqb0j0bklVZy1NqaVXgoIilzBGh/x/sQ1EKGf3p6xp5CJjYYDLIfV1NTS&#x2B;vWraPSstKoKoFE8QSBpoGAdPo/HQBIj4XmFBG1jI1R&#x2B;6iPM58RNRoKeRJsbihVRin0q23IERCATA6rB8qyFApNR9BLp4oMGgQBzJlO401L4ntNfW3Z&#x2B;Hej6gAr/oK5VA4YtSUAI9y4ajkNTYXooZoLAvTa6LnmTvG8nd67fSNJSH2qYFUzCJuFEfrYnh30g5O1nP2X1Wz1&#x2B;f4R7lX7yKVbmMRvZp5i5ydmjsR779qyjiXqflXbSMEYZnAmzxNGolmAke&#x2B;erKE3rl7Bure1A8O0PDeL6vqHKC/DS00ChACYo98vWwDbAfThO51irY1TvjC2/T4/Z9bNjCTAODLhI/4gk/Kghx4jh1n9ZcoDKBJv9WY6GHh7neaKBFzeByOnPiIwoQRRZIN7K8evIiT3xZzjfFBWCGdAWEUaCUzRhoI8GvQHqCLbS2LJUqG47j2VJQz8XTqCHGjR97f2UN3Bs3TmuePUUdPCZf&#x2B;4RpDUOVyO11y2H0RCmXnZtO/t1zG5XySg9P5jjaF/3&#x2B;URTqMAtKM9wwLQjtO177mJbvnI26n&#x2B;0Fllvmjh9vBzW8f4JJMZQpoxHJoW1&#x2B;NiUO4Xz8PhwjVw5Y34Hjg0qT7DPii1jUbMTW5JvjjmNI0NjtJo/zDVHjjDPABwv8LieQb8Yp26xR4u2aQlL&#x2B;OXkp1DK85kgG76q9vpbZ99d9rwL4Fgzlwy/2bgSp/xhJSxDY6QeFb4JZyvsC1ErdDFBnhYsjj8qhwbWf&#x2B;D7T30kPBXUK2Iu7mzrIhyXcYSqEh0vH51pfipMs5DxHG&#x2B;ffwcs/vD5g9NBemTe3fqYDOxDwS/BNV&#x2B;l5aV0Geu3EkuNdEgJxD3pR6smstaj13TCjCXLJS2JMP3a&#x2B;2cw8MjdOpUNV1//XX8twP799P6DRspO1v4dnW1lJeXS8FAgHJycuKTZDrwbxgESI90ACA9Fs74fWMrPSI2zLFgmLOc2PCCAFPCIQWAKc/ycjkUiNHQm/1qDk1KcGZPkuRp4dCi145jAQrtfBKwb&#x2B;A5m1YRSCn9bLVnW7UhGFUQWPEYGL0WAPm2dVV0fnCIzgpn3yt8kKca2zgoA5I7yAMCfKNMH7r3uEerc7PpPdvX03eFEdMqBbLdDjrXP0hfPXqG3r99A5PelWVmUMPIKBvCDIeTuscnKFMYSxDYoaweffDInLvsDgqEg8qsaLJ/4hEcAxeGRukbQ2eZHBDzpWTdlRI8jeTPzm0AskKgoxIO9vkEAJJs1j1v6qPGE2CL4T2IcLm30uKA57mMD8ZPzQRz24EkE1TUcA3o4UPbwRQi3OJ1CEC0DI9xYALXTyaKA3gO/Anv3bGB8sC8L44FwiCU/eOYIO&#x2B;ZAuhyOEzlprob2qn&#x2B;aB2dh3zf0VryjU7QNLL94r7F9WwvATsJJyISVhwJm1pRAnCLIAdAaWK9jkQh4WDtvHE3XXLTHnrk339MbeeauRogIvajgsoi7v3fcePltPaSDdRwpJa&#x2B;&#x2B;aF/Y8m7V2sARE8HpvneAEDPhcyLJeZ8U7RsUxXtvf1qrurIys2kjIIc5nSoP3yOsvKzqeal0zQuvkNj/SM01DVA08KZhKyfzW6zBLPIyjDxlJhQZ4zetM3mVX&#x2B;2L&#x2B;jgyJ8yCBMKBiks7NtNH34L3fHZ96SN/hK5r3N9n1n7HQfilCyojEe1jS6dtlzgY1TY0rqBIXqpvZsOd/axz4PijKlQiO7auCZO0ch0XcT8/N2T5&#x2B;jltm72F1AJsK&#x2B;ylHl7Ysfmwnx6uK6JfZhbhH/2js1r48C/EeCf7V5stsb1z4OAUm1HoYb6eqqtraPbbr9NVeAy5wdApp9VZITvMjIyTF3d3bRxwwY6eOAgxVrqXz/ya3r/B95PTz5ZTVPC33z00d/QLW9&#x2B;ExUVFlJoejqx0jXGPY&#x2B;tCkgHAtIBgPRYIAMA7fmWLvpR9XmW&#x2B;ASogeQWfvaqIAuvaRZg5f5TdbQ8u52uWVFBN65axiRor/bQggFOJ2cDJZ/PN&#x2B;12u&#x2B;0qQ6mUWP6vDwxYVQikEiAwe13qwyg4YLyhmxMPIdMN9noQ&#x2B;dX0DyvKBMKg/fRMPT1W38xGZ1JswuWZmdQhAHyJAA8grgMTvVsFpdrIcTmpaXiUvvDSMc5ka/KuEXmGAEfLciOCHoooEjko2bPFnmjMCbtUkkCX3Tkzw2p/GzdMxkjuxU6BTZUr1I4nxwDwZMz/Nl6vDq4IKM3MoDHh4C/L8HKbwYrcHPKLx02FedTt89PW4gLqF0BsY1EuZ&#x2B;pX5WazVjDaC4529dOvhRHvmvBRrgBRNkMJQ5mGJgP0y5oLwplYSzuEI2CPaScAGDMC/8jwVj9zjOoOnKYLx8/TcGc/hUNhsqms7e6lRsgmLh2kfC6vizIFsA36ApyJAJBF5jUkHAf0qtt0VREaM/&#x2B;37v2SAGhvpXd98a84q71h3xZWP1h7yUbq7&#x2B;il3sYu&#x2B;t/PfptOPPGKAMnhaPZ//i9D4uDD5qs2UM3&#x2B;0zQ17udgA&#x2B;6ZZEs9AQjyvctvu5I&#x2B;8NWPGjpyG/Zt5cfX3fMGduBA/og2iCe&#x2B;9Sg1iesOTE2xY2a9wSQ6helsf/yYmpiizIIsuvsL99Jlt1yZnpAlGAiYSxWADpSBj0gS&#x2B;1VEfOeUTMMSK1cOBAK0f/9&#x2B;uuGGG5bG9QjbguTD8Z4BOts/RK3CTw2zLVbsy7jwCf76ki3C7uelvlcIsP/9U7UseZyp2hcE&#x2B;O&#x2B;7dEvCa1eoff5vWLOcPrBjY1LgPtuKFaN1a/R&#x2B;gP6&#x2B;vj4qKiriv7d3dFBBQUHC62bIb&#x2B;Uo&#x2B;K&#x2B;urqYdO3Zwef8DDzxAe/bs4df1D/TT1m3bqKenl06cOE6&#x2B;yUn69ne&#x2B;Q8sqKulTn/okTYt5ys7OZPBv6MfK8fZ0PqUe0wGA9EiPeRjHuvvoh6drOBsbC2gkHQjj6KL4VrePTdCPz9bz&#x2B;968diWXOf&#x2B;pDDxGZmamIxQKsdyOyhVgUyP1kqFHbFopIFl40kZVBWbBhdkEBRJfl2pVAd8DyUZ7K0rpI5dto&#x2B;&#x2B;frKFQGMRzNtay9alZd2jfItPdNeZjEN89McG97Pqz8Kr3UyOu0&#x2B;5z7BV6SKka8OpnIpaIRgX4GtjXZ9ARPEJVAEr&#x2B;QmplCWoE0Jtm56CBYhaUKgGZAwloD4ARR0DDbtS3r61NgoxOGe1dVkrLs7OYhbcyK5MrIEoyM5id354CWLtZGG/07f2qrpE1gH2hEFdA2GLnQ1zHxHSITvUMirmdpL&#x2B;5dCvtLi8mu259ao99bT3UeKSOjj9xiGpeqlay4eKADnFtdufC3&#x2B;6j91crHU/VX4nIdNsn30mbrtzO5e6TYr8ITYW4HH2gvVeA6Wqq23&#x2B;G/OO&#x2B;hHngzxTT9/jXfkn7f/ksVaxfTif&#x2B;CKAfome&#x2B;&#x2B;zjVH62hoD9AduGUARS/auBfzdq/45/fT9e86yaqPXiaumrb6MhjL1N7bWs0WIUgRzKAABLDldvXxb0O7R8HH36Bq0DAPt99oYPyywqoqKqUbvnbO1ma8L4ffIaOP36QHvz0N00rStIjNZvhn5ik0pXl9Bdf/gitu2xjemLSY0Y9B5VKYgDwa5l/tCCaAbjFPh577DfU1ta26AMACPq3jIzT7y600Zm&#x2B;QSYphg&#x2B;LJAVkeHEvkbXfWVrElaupjgvDY/Tg6Tqq7R/makpFSWia7tq81rAFNlvYoI9dtj3pZ&#x2B;jBu35tzZYjQH/cwFSA7r//fvr85z/PAffY&#x2B;8sBeJsU79urv44L//CBHz5Ad77jLnrmqacoKyub3B4P&#x2B;XyT1NLSwv&#x2B;Gh4c5mPCZv/8MjYyM0ObNm8ntVuSftWPrCa8Nea&#x2B;seAHSAYD0SI8/7RicmqIHq88zkPSoJeKxm4Qmk4UvqgakXCpwRBn6&#x2B;eFRerdvHb1BbH5uA4kVBQ/Is9ZwTzYE6OcDejwejtD7fD4OBCAIoJVAGQP7ZM&#x2B;l7D7oggRSEqA/f1UD&#x2B;Pm6qgqOcN9/ooZGg0GWrtOO71Yzq1oW26E&#x2B;amA2rs7BREs5EkMEiBFS72E4pndhWlaOiec0dQB9o5lNJdIDOeCwf4pW5GTRmDDU0MYdFL/vKi3mdoNtJUXUIwzOpqI8GhGAaZV4/ZgA8Y1iff3vmfpoACFaialaGZD9PdHYzp&#x2B;Vs8pFq/MVSb0SpxrU0IyfQUZffzfBh/B3l22jyytKWZUAbQ&#x2B;SinunxDHy3C7aXFxAl5WX0O6yYsoV4A8zra01ELONiO9E4/Faqnn5NF0Q4B&#x2B;a9SGU&#x2B;LucClhNgfHIKjz1pxxBf5ADFmCd9&#x2B;Zk8DXEOin4ngHs8zyL9aepXngzM&#x2B;jWj95Fgx199M17/50rHPxjk1S5qYrL37des4vu/Pz76L/u/j800NJLDk883wEqAxAsAHHduZcGKSLmHrwICKCACwBl8dEWlFdpYM14xGet37eVP3vr1bv433V/cTOdeuYYtZxqoJoDZ6ijplnhbAD7s9NmeG&#x2B;94lqOPXGQrn3vzfxaVEHcf99X6MQfD1JBeTHzPxSuKKGyVZV02e1X8jyTuq5237KPmsVnvfyLZ9IFyHMYWDOj/SN0/fveRO/4p/exlGJ6LH1gnwrzOhMMKURDWrafFmu6H/vV&#x2B;fPn6dChg/TGN76JKioqGKjl5SVmvbdv30H9/f2L/j5/&#x2B;3gNHe/u4yo&#x2B;Jjl2OlTOBmIFHyQQLqsoofdtX5/S8aBC9FxrF/22vpmGBJjWqlth&#x2B;&#x2B;Eb3Lq2yvB9IAxE6f9cwLteKnk2a1tP2tzZ1Uk9vb38HJJj/f0D9PJLL9LNb3wjeb1ettehUIh&#x2B;9rOf0ZYtWzjLj3UzINYCHh/99aP0&#x2B;huup8zsbDp14gQ9&#x2B;cc/8uvwKQUFhbR3717KzMqM2n605Bp9z1Lhv0pXA6QDAOmxAMYfGtqodcxHBR5Xgu8KzXJsfsQZWIkCYoPMdrkI9DfgbsWGC73zB8&#x2B;cp/Zx6LRv5gisNgYmp&#x2B;jJ5nbqEX/bVFRI11SVc6/4fBt7jMzMTLvYxLhfLxgMhhUFgcRNUv/z3AH/bJ8zOo7&#x2B;&#x2B;PpggXFLAjZOGLkrlpUy8L&#x2B;/uobJ9fIRkVWz7&#x2B;hJR2mcI0Y2RgPvkkqNj75hZNv1MzENoCWACrLgBR43jYemqSQrgwZ9fi6zV9QBbOJeOoWRVJj36wRYw71HCXwsB3swEmaw/IGdm7hlAWV0QwJY54pztdttBpZCvVY5QuXC2Gwoyqcy8fh0UzsdFcbeISC9I&#x2B;bldpXd/3f1LfRiWzfdsXElXVe1jLKYRC0SDWTISQwuB0ZUDoG9laW0viCHnm7ppN/UtdCa/By6XFzD9tIiWpmXrUbSZ&#x2B;6Jf8JPzSfr6ewLJ6npRD211zVTJBRWVAMEmEMWPPoOOXm4SEohrDT7cNKsvlQkizVQuWEFrdi5mnLyc&#x2B;n47w/SUOcASeLLj950zBWuK&#x2B;v/Z&#x2B;864KOqsvc3k8xMeu&#x2B;9EEIICb03qQqKKCJ2XF3X3nXVdfW/rrprV2Rd116xgVhAmoUqPXQIgZCQ3nudZCaZ/z1nCjOTN5MBQwnMgfnN5M17b165797zffec7wT5iOvhgpqSCshcaEbehdXpf373Bwy7fCzntlcWliOybwx8QwPQf1waIpJiUHIkX5/S4yKzSYi4MmmiODsgQq7PLHrv7lcx/pqpGD5rHPzCApjAGD5rLL8otSPjpy04tH43Dm8&#x2B;iOb6RijpmN0shabk4hnJ35eDb5//DLMemgcPX09Mv3M20qcMRvLoNATHhsErwJvz982N0iGOi/ZUVVThnP0/BSNCjkohzv3bfFx6/1W9IurGaad4rx3Mr9bpjYG&#x2B;kbgl8N/bz59Cv&#x2B;&#x2B;66w4B6kbhz3&#x2B;&#x2B;DS&#x2B;//JIAel9g/PgJehBHkYClpXjmmX&#x2B;iX79&#x2B;2LBhfa&#x2B;/50drajmSkCZCqLtu79Cxv6qQyRHj54lpcVGYGh9t4ZPasnLh27y6bS9y6xo42tDdkHJFqQAk7vvQqPQe5ZutRSd7Yl9c4UhxYrx86cUXUVtbg6rqatx&#x2B;&#x2B;&#x2B;1MCqxcuRKVoq38XluL4cOH83rx8fEYPHgw/Pz9mCw4lpOL5T8uw8BBAzFv3jzU19fD19eX/TcK&#x2B;TcfsG2VDHSo3LYT/DsJAKedPaMyLOsLiuEr4WSTmJmHWD4pIhIhnm4scJJdU48tReWs1k3gn8Aliaq4yV2x8lge2jWdeHBUmt55FQDim0M5AkQVMlT5TYCzbcVleGTUQM6xPh1m1Apwd3d3MSig6lpaWjrd3NxczJ2D7sqn2HAdJNaX0hPQ2QH21rDO1naybiEhfRKnh4FhgXjScyi&#x2B;z8plHYAwT08G7nOTE9Ag3iO9PVHc2IRoH28xuNULwO&#x2B;KIAFiCKSvzS9CVbOayR1jdAfNqE9LjMZlfWJQ2tjK61KoXQiF1avV8FGqWESQBkYiHyhcmxh4qqG7Ib8YR2rqEOLhblZLQMbheS9s3o1b0vshyNMdAfS9IXTMvnXwPoaEB6OvAKHrCoux8mgBKlpaoHIhKsAodqYnoyhM7&#x2B;N9WdheXImr&#x2B;iWw6i&#x2B;1z06dZX1bKRbeOHAZyYtADw/ME9eQ0i2ifby6pBHQANZYVYf8AzlY&#x2B;&#x2B;kqFBzM5XJ1rOKvIBV/JaRkKmGHLrJFBKAbuujkvWX9jBHNRkvNltFxayi3L8gP0X1jGaAe3XEYxUcKuYZ8v9GpGDB5GMITIhDeNxrF2UVoqqzFl//3AUcE0OzA0hcXIaRPJB788hnsXr0VdaU1PHNfmVeGZa8vRoG4bkQguNiIGjrdYKG7Z55nKMR5kN7Aty98huVvLMbouRORPCYNiUP6wTfED&#x2B;7eHlxCbvy1U7F/XQY2f70WFXmlKMg8DlfRHuXsmOpJLlJK/n3xbxh08XDO&#x2B;R9&#x2B;2Ri0tw5F3v4cFB7KRZ/hKUywHNq4V7SjBgb9FBlQcCAXCnfFaRU6PB&#x2B;NUk60ov&#x2B;bdtssXPrA3LPSzpx2hkk7OzP/Wq2WZ/kpVdAM8J83CIQA2kcffYLExERs374D5eXluOWWW7Fjx3Y88cRjDNxIsG3btu346qsvBCC8o9efM2n/yHXtXJWIfB7SOhoZHMIE/oiIEJ4ccNQI&#x2B;Bc0NJmAP02e0ETInJQEXJ2SyNGxp6vNnkzbPnr0KBISEhjMW49ntExmaP9Lv/0WM2ZegtjYOCxYsACtra0cBXBg/348&#x2B;fe/45NPPmVgT&#x2B;r9ZEOGDEFpWSl/TkyIx/898w8eu1atWoXffv0Vzz77HFQ8BtnW0HL0XJzSNE4CwGnngB2prkVTewdUBJLMlrdqOpAY4Ieb0/siNcjftJyA1J7yavx6vBC7Syu5k3Qz1HElgNTU0W5at7FdgwNV1QzMjOH/Bypr8Mq2fXh&#x2B;4vDT7ggYCQGVSiWjXGHSDDCI&#x2B;&#x2B;iMRIF53V8pRtMeUDyxrs5uXpf91AMZpCsX2KpqYLk&#x2B;fSJClga&#x2B;e4cPQE1rG/aWVzGgz6yqwZ3DBjB41SPRTn3AlewEuXBRTDhW5BQK8J7PobIKQxk&#x2B;EtIJdnfjkn4qQ2kyAnZ&#x2B;TNzouB3Q7L/xOlAbuEoMlCPFoEs1cTOKy&#x2B;FpIJU4319sSxEKr27fy/l4tw5M4ZKAUiUQpa4UzeJ5Kl1wWVI8BgQGYH1&#x2B;MVbnFvL5uJqJBlI7VshdOXfvX1W7cN&#x2B;INIyNCuNIByJLrOs/2xu0Og3kBM34m/uJVKqv8FAeDm7Yg5yMLBQdyUd7SxsDDBWVXLNxZ6VoHVt0kFQdCnvL7EUDdJHBpOvV2cEh/ZV55QKUu&#x2B;kjFOSGUkHQz5y6KlwE6D&#x2B;Efb/s4DwPEvMbevlYDL1kJMITo5C3Lxs7l/&#x2B;OrK2HOLT/vg//hs2L1yJbXJP4gX1YAyB&#x2B;UF&#x2B;0N7eKfezE71/&#x2B;IgCzJ&#x2B;fv06y&#x2B;SvzuGU//I7KqWc3nSaXzKG2B/iAg3wU4GJIk6TvSH6BqAL&#x2B;8v1yc4zp4&#x2B;Hpg0NQRSJk4CAmD&#x2B;8I32A/pk4dhwIQhaKxpQO7eo9jw6WrUllWjXjxLXn4&#x2B;GDxzpAD94xHeJ9L0E1RZgKIj3rvrVa4Q0FzfzBUACOx3dOgVmUm0zpkmebL3uA1hCRGYfMulGH/9VIl0MKddCOCfwL5BxI/1gbh0puv5U76PBNuUhrJ2Hh4eiIqKxH//&#x2B;x/MnHkZ/v3vFzhH&#x2B;/vvv&#x2B;N0gIaGRrz&#x2B;&#x2B;usMIMePH8dRAb3dCPS3CN&#x2B;gb6AfZiTGsK8aYjYGn4wR8HcXYzhNgNDkRorY15XJ8RgWHnzaz8PoN3Yn3rplyxYcPHiQSR4b/q7JiSovr8BVc&#x2B;cyyKfllMNfVFximvX38HBHu7h&#x2B;Rvvhhx9w66238Of9&#x2B;/cjIjISdTW1KCstxeWzZ8NdtC9jSUEpr8W2/2vp10npAjjNSQA47SzYsdpGnkXtNIMPlOvtIcDZvcP6I8bH22J9AvJDw4JYLG1LURk&#x2B;2pvFCqsURk55ULcP6t&#x2B;F6TPP/SfQ9/PxQjw9bogpT/10m1HMh&#x2B;r3UgdFMwGiI5MZOky5VOclBejtLbPX&#x2B;Vl28vgD5ABswEnoSzaKe/DYmEFYeawAizOPYXd5FSv8U5rAdalJcFO4cgiXTneC6qGw/lsGJnN5RyIBCKR7CpBfXN&#x2B;Ij/ZlMRFwfWofAYJ9&#x2B;Nfod2BdxsUQ104AO8rXC/cNG4BXNFomlzoN5ABdF6WLDK1i&#x2B;drjxahuUeOuYakI9/ZioK1D1/I0FkUGoK9OIH4E8f4&#x2B;hpcv3tt9SDgBWk5XMOocyDg1xYXJqXfE94erankgDxXnag29KcxdZ9ujNAEHEnEjZfbs7YdwYP0e/txc16hPoxBgVuGuNF0L012RKLejM3yps7q91gBe1g1F5Ej0gNT69Cw2NzZh5OyLMO32y3Bw3R7sXPY7KvNKGRhTeDuFoXO5O1pfnD6F8A&#x2B;eMQKjr5qE&#x2B;MFJqCqsxNf/9yHKjhXyeVNOIc1mk0269TKx39kcIUDEwNJ/f4aj2w6KdYs5moDL1JFoHs58PXp&#x2B;/jpl6DsqlUXgynJKEBgdwtoEWxavhaubnrDq1HaKVweTTnQRWhua4R8WiE65jjUcSNGfvlv97g/Y/O1a&#x2B;IcHImVMOibOvwRR/WI5MmDw9BFIHT&#x2B;Qr2HZ8VKExoWJ/assRJjoeIg4OrrtEOel15RUc1un603fKWVK212E0yTvL5FLLeJ&#x2B;zrjrSsx&#x2B;9Fp4&#x2B;nk7L8wFaETyC6DPZD&#x2B;N&#x2B;9QNuric&#x2B;xEgWq0Grq6OpTzl5ubikUcexvz5N&#x2B;PKK6/kZe&#x2B;&#x2B;&#x2B;y4qKys4pLu4uBhvvvmGeC/BF198iY0bN2Lbtm2cAtCnTx9s2rSR0wN6Ea&#x2B;nT2E0s/SQICQIX4DE9xwJ87dnlEbQ1K7lFNVL&#x2B;0Xj8qQEeKvOTPqZlKifORFAf&#x2B;/Yvh3ff/cd7r3vPpNfYr2eeRv3Fr77F4sWobKqComJfRi8FxTko7CwCP9Z&#x2B;Kbwh1VQKZW8zd69e9HU1IiYWL2OwScffYQHHnoI0TExuGn&#x2B;fCai9aH/sOtt2KpQcKoVD5wEgNOcdtocJnDIk/VDTMIeVwvAaA3&#x2B;zY1ypKgMYB8Bwl7bvg85NfW4Y2gq53ebOiDReRIbe7xOY/GbUV6eOFBRc0aYVamOltIBdIbeqKWlpYNIAOpQDWJAFg6lNUNr/W7dsdnq/Kw7edsRA/ZSCexXIyDBG8p9myPAbqJwfD/adxT5AsgvF8D&#x2B;WF0D7h06gHPqtWYEgNag73BJQgyH2BM5szq3iAdBgh/7yqqwV7zmp/fFuKgwBLi78&#x2B;/oJNqSfn&#x2B;d8BLbPjZ6sNhXAb7POs5h&#x2B;UYxHUoZ8VbJcaiqBgt3HsT0&#x2B;EhMiovmHXQYjst6nLCODNBy5QAZLoqLhJ&#x2B;bEt9m5nDZH9IaMFYK4GgAMaBrO3X4KTufSQA6x8FhQdzmPcR3OQLApwf78zVRGiIfjJ4Gh20LaxbrFuzPwbrPViP/4HHUV9SyKB6VgOOQbAm5B505wy2zIgXsIX2zZZKT0SdBDcEK9BsjJPSgXo6y3GLsWbkN6dNGYPy1U1AhQOqBtbux7fsNXHaPiBEPX29o29shVyqQPmUY&#x2B;o1JQ&#x2B;bmfajILeVQeDrG0PhwhIiXl78XDovvSBCP2vOvHyxH9s7DXO7PzcsDbj4eFs31bCj/0j1rFP3OFY9dj8TByabnkIiPjV/8rI&#x2B;madfwrDydU0BkMDy83THw4pHwDw1gkL7xy19weOM&#x2B;VBdXsh6ArkOH2tIa/PbxCmz5di0GiXWn/flyxKTFQ&#x2B;4qx9HtmWioqEOTaGu0D1KiJ0G6A7/tFtdJh4JDeaJ9HYPS002yjJ/THOvTiURso7Keg5Iw4frpGDtvsvPCXGDkj&#x2B;Gdh3YjEDKS/73BSkpK8OmnH&#x2B;Nvf/u7zXXeeedtxMbG4&#x2B;KLL8bLL7&#x2B;IgAB/PPvsM5g0aRKL/VEpt8jISDz&#x2B;&#x2B;GNYs2aNAPjj8e677/G2EyZM4NeXXy7CDz98jylTpp5zAF8m&#x2B;Xzrx3xKQ/RRqSz8gruG9Wdh4J4wmv2/vG8sRxIEebiftdwQa5&#x2B;QPmdkZGDZ8uW4//77GaQb1yHg7uXlxYSOsd0bt4yJjmb1/mnTpuHHH39EWGgoAgIDsfa33xAl2khcXBz3m1u3bsWizz/nfZNR&#x2B;t5jTzzBpQRpfzpDuqDxXuiPUSbhnei9Dlv&#x2B;LmzcWycv4CQAnHaWOhoqmWYRniNeJM42NjrMoX1QfvnfxgzhGeexUeEWXQGBscmxEXiltAqB7kqT/08ztaSwepadRj5UEg7UaDSd9HdTU5OWwgPJaZDqvKTCx6XYTVsKrfY6eluRBt2DAas6xtBxuP1AAXSf9vHGUgGOfzyWxyD&#x2B;qfU78JfBKRgpgHwnz3zrTGiTwDfNqt8ZMABqbSd&#x2B;LyrlXdOg2CqA9af7jmJzUTluTktmcTy5qTpA12B2mqn3EqDxyuQEDAwOxIqcfFbpJ1LBmF9H77k19VgogHmmAJwz&#x2B;8QiPsBXP81P2RmdHDpiiaKNCFosb27XQunaiSQ65qGp&#x2B;O5ILnaUVPLgZSplqNO3NUpbOC4A2Nu7DoptXEVbVGFoaDD6iPOgqBUiEwgcGrcjAqwgMxfHMrKQuWkvju/NYVE7yul3VblaDs66E4AftngcKY07XddBUCeT9oqkiASdHSfKxEeQAJoAtOoWNYf408x&#x2B;pxys0F9ypADHd2Vh/aI1iEtPRN&#x2B;RAwTQHYEpt8zkEP6f31&#x2B;Go1sP8TYdjS1Y/Oyn2LxkLbK2HIS6uRVJQ1Nw0fyLGShTDeEvn34f6z5dzUr4lHftIq4z/abS7dyaxaYIh01f/oqtSzYgVoD0stwS1JXXQt3UKv5OQMq4geg/cSBiBiTCy8&#x2B;Lz8FoFM4/&#x2B;5FrMGn&#x2B;DGz4Yo3Yz8/iXDvQ0aZhsmDApCFImzgYgTHB3J5chfPUUt&#x2B;CDx54QzxvOp7ZpwiC6uIq3i&#x2B;RLCwQ6eHmnOX/A&#x2B;Cf7h1dz8semIept14KD18v54W5gMwQ5q8nO&#x2B;XyXsGcFRYWIjrasmTcNddcjdtu&#x2B;4vNbe6&#x2B;&#x2B;y7s2pWBq6&#x2B;ex&#x2B;rtlLv98suv4qabbsSRI1k4dCgTVVWVOHjwAKKiovD888/jkktm8OytuSUn98OVV15lSh04V4wnYeTWPpJemT9YAHIC5pTbbz5uuqLn&#x2B;J0oby/MT0s&#x2B;J/o0888HDhzAL2t&#x2B;xn333YdQAeKN/iGRPZ98/DH7LU8&#x2B;9RQDdrqnarWat&#x2B;2bnMyz/4u/&#x2B;QbjJ0wQY42SX8&#x2B;JdtHU2IjvvvsOOzMyOK1gwsSJSOrbl/0n2n94eLihNKbOdK2twbrl3/ZjD6X8aSf4dxIATjubA6dAL81tmi64JFI4UEECGDlqwcKBvYPU/126dsaT4iKxrbgCW4vLOMSK2NoSASAiOBz7HAEFCgUfuJeXFwsHNjU1aTw8PFybm5s7PDw8XaVC0&#x2B;2xmt2xntJlU2R2B4OTqVqg1wXo5KoOdwxJQYCnG4f3V7aq8c6uTLR2aDEpNlLP7HZaEgdktw/pz9tuKCxFdWsbvEjoTwEcqqjBS1v34Nr&#x2B;fTCD6t0acDpMpVxkZv2&#x2B;Pt&#x2B;&#x2B;T5A/7vb3wsjwMCzNykFuQwPcXRS8DbUXeq3LL8Fv&#x2B;UX4y8BUjIgKQb26ncP5yppaWD9iX3m1AOoq5NQ1MErWdGrFd63cnii6gEoJyg15AtalJkkRmIiKME939BPHMiQ0iAUFvcRAaKxbS9dVI5yM2tJqAXAP4PDv&#x2B;5C3P1f8XcX7IOVwEr6TAmk6GbqPu4d9tG6rHoQUsaCTSPw3VhUwjw6gc6Yc//QpQxEaG84pC7tWb0VHewe0lCPd0srAs7m2EQfW7RHnfQjLFy7mmfFRcyfillfvQVVRJfb/koHcXUdQXlyKwoPHMfjikQYBu7EMiH/7cDk2ffUr5617stYEoJK5sRCRo2O7lLbBaWI8WaNh&#x2B;3cb&#x2B;H4TSUGq/dHJsbjr/ceQPCIVAVGWUUkUHVCWW4RtSzdi9Xs/4pGv/okBEwfhohuns95BWHQY&#x2B;gzrh8EzRiJlXHqXXPMBFw3mmX91cxsLClLIv1&#x2B;oPzg3RgZnWOQpe8n68n4tdc1IGNIXf3rtXkSJ&#x2B;&#x2B;gUlb5wQD&#x2B;Bfa1Wy3o&#x2B;vSliZs2a1Th2LAf33HMP/93Y2CDA/zW44oorcMMNN0pu88svv3Dfsn79Ri7ft2TJYsyYcSl2797NgO&#x2B;6666FSuWO999/n4EgzQhbA3&#x2B;jDR067Fx6jE39PlX26TKbL9dhTr94niDwP80iqC5niDui&#x2B;&#x2B;Xm5ph/TTn6H3/0EW666SYG/&#x2B;ZGav733Hsvli1bjv379mHylCloE/tua2vD2//9L7Kzs5kkGjFiJKZO1Ud7ZB46xBoC6zdswAMPPMBigsOGDWMBSXOfs&#x2B;uM/wkSwNwX7nonze&#x2B;ozqbva6tSgJMAcJrTzqBJZfUEubt3UTzvtuG62F7/oZFpCDygwvaSSjSIDmpAcABSAv3PvYfPVV9cTnSGik6mPkk4SKZTq9tYPVgvImTZ&#x2B;Vnkqdupe&#x2B;oIGWA&#x2B;62&#x2B;vpJFUZIBUyoGxHODV/RM51H3Z0TxsKizHy1v2okIA6MlxkQimmq5UT1BuQPMskiTDDQOSMC46HF8dOsaq/pRP7y9AeJMATp/sz0KbVovp8VHwUCn1tVzNQKi2swMN7Vr4qVQobWiCj1gn2tcTdw9JxccHs5BVVQeFIUSTjpRC9Ts7Zfho32GsyslHrbodSlc5alvbxXoyngHwUCjQqtVwiUEtpTrIXfj8CPDLZTC8y0zkB9UApvXSQwI5VWWAeA/z9pAIwZfh4Ma9yFi&#x2B;BccyMlFTWg1Nm4Znal1VihPXuDsphpNZbj1eWof7m0cDSKn8dREFkLGug4ydJ31lXZ22gwkOmhkNignF8QM53Ea8g3x4tjo0LhwN1XWc715&#x2B;vAxlx4v4macw/iPbDiAwPBhjr52C4ZePYzG/nN1HoBXXJSolDk01Dfjsif9h/y87OaSdhP3MZ11NbdgGsLcF8rtb/2TKH9pah8skuSvholQw&#x2B;TFu3mRc8dcbEJZ4QpiPxP5y9x3DgV93Yc&#x2B;abSg&#x2B;XICW&#x2B;kYMFdeCogToCgdEBGP&#x2B;S3exJkJAWJC&#x2B;ZKDRaWttQ3luMXL2ZGP9Z6sY/Ou/l/EMl65T132bcppNQpSuX0tjC0doTL5lBmbcMweBkSHOi3MBGEXrGQl78zG7N9lLL70kAN18fV8jxtW7774bc&#x2B;Zchdtuu83mNr/&#x2B;&#x2B;gv&#x2B;/veneIY3JiZG&#x2B;Cg&#x2B;uO&#x2B;&#x2B;e8W42UFRjAzmaFafvutNZj7OUVSgykqfkXyIGwb0PZ&#x2B;IK9ZhuOiiixxav6S4mIUeFy1ahB07doh2MgfBISEs7JeSkoKkpCTMu2Ye1qxajVb1CuTm5GD&#x2B;zTdzysCNN92E9PR0i7KARCKRfzBz5kwkJ&#x2B;ujHQIDA/UpgmaVkrqmq9rqj23N4ktVuXJqATgJAKedYz1wV3BJs789OaoSaLt1YD8GnHXqNiT4&#x2B;ZwxtvVUjcC&#x2B;n5&#x2B;vgq4HdZq1tTXtgYFBSo1GP&#x2B;NAXIA5CWD&#x2B;bosgMC4/GZJACvwbO1FbqQIWy8U7ibckBwXgXh9v&#x2B;Lu5YXVOAT4/eJTLOd45pD8CPdwE2FbDWwB1Ur8lcK6k2XHxj3L/iTggwUfaH&#x2B;XyU6TAe3szkSUAJFUf8BMgM18MSO6uCk4paRegslrcZ5p1P1pTj2DxfVFjM/zcVGjSaFgHQOJ6g7I1S5pboBQoiSpTkJAfTZTS/ulUVK5uDPpp5l9nhqFoGZ15q7aDy1P6u7shJdAPQ8KCmcRQkf6ADibCgK5HXVkNjmw9aJrxp7xsAvxyFzmr4p9RcCaz4RRJoVrz9cX10rZpuRY9ldcjAkdJqTbiGlDd&#x2B;ea6Zvz6wU9Y&#x2B;9EKBrU&#x2B;IQG45bX74Ecz0i1qNNc0cr47lSykknN5e7OxY9lmVBVW8P4o7cEn2JdV8LcsWY&#x2B;jW/bDTYD9qsIy0ayo4oEbvChtw2y235H6F9YihrJuLonMxvspd3kdevHHez54DMMuG2fxbJHGw6q3v&#x2B;fyjnn7chCREgNvcY5egT6Y99SfxGd9ySS6bsMuHWPaVqvRIn9/LrJ3ZiJ72yHkH8zlfdG1dZbv6zkjwomiWPqNT8NVj92EhKF9nRflvHdRdKYwfyPg7y2h/lLm7&#x2B;9nGr8WLfocFRUVmD9/vuS6VVVVPKO/desWbN78O6enPfTQw7jmmuvg6&#x2B;uHiIhI/Oc/C/GXv9zBVQB61X0FlRzWT0FRQqI/idK5uNobGnu9tTQ3Iz8/39E2j&#x2B;DgYBZ4bGltxcb16/Hmm2/iiSefRN7x4xzlsWfPHmzfto1n9SkNZNr06az7MGbMGFMEiLkP2S8lhV/my21VwDL/&#x2B;4TPiVOYtbecsXDq2zgJAKedAyYTSEMlAI9aa/mo6tX5e&#x2B;YhpRljYnYJ9JFgYK&#x2B;7RqKz8vBwd6GXvo4wlVOpa/f29la6sHCcTCY3lE&#x2B;z3M424D&#x2B;1ThTdRgd0Da8yq&#x2B;wgHAe619cN6IPK1hYcrqrnMoHPbtrFQnp8n8R976CZdN5ZJ9SdOp5d96FweZmhTKQYlKisHxEJu8uqsElTCiVtJ37P1aALoGDVf6C4sYm/K2ho5pD&#x2B;&#x2B;rZ2E7tszg&#x2B;fCD6QmSpDKAxryIzXS7y3CeDOAoYGMO9iiEnzVSqgFoCOygsOCw/CgKBARPt5WbgQneKtsbIeObuOcF4/zWiX55awmruL0lUPoO2h1rPWALt6QnSdKM&#x2B;ehOUGTSVxvnQB7v2x7pNVKD6Sb8jbE/fB9UTqQltzK4vWRfWPx/t3v4q9azN4NklHopgeKgyZOYbD/iP7xaGhvAbjb5jOeex7f96ORU&#x2B;&#x2B;i&#x2B;wdhzkVQlNdzyQAz2hLiPnpbKQ&#x2B;dFfs0tFlMgkeRMqxtFc20Sim0GnGtFA4OZ0TtQPSNghLiIS6sQUq8TcJJbm4KixSf&#x2B;rENdIrzjdjz&#x2B;rtrJdA5fxa6pqgbdcyOULEidN6hqMmMUm6P/GD&#x2B;2LCdVMx9NIxcDvFcl9O6x2gn9T8DLH9prK95zqk3blzF9zEeJqWlm5zLQr/Nlbi&#x2B;eCDD1iZfcKEcXjxxZctZoYJ7C9bRqXZbsOTT/4du3bt4tnaY8eO8Yuei9tuuxV33XV3rwP/RqOSezLD/Q72dLsg2rUjie&#x2B;k&#x2B;E85/P7&#x2B;/phiCN&#x2B;fMmUK3n7rLezOyOCZ/3/961&#x2B;8PDEhgUH/JTNmcCg//QaBf1sTSo7MwlvrEJx413XxcaX8W6lRVyrc0RkR4CQAnHaWjGbhaXaVgJn0A/zHjcTkSKF9IJdr8UYIaQv0UgbQWD84KChQSQ5JY2ODlkrfGYUDzTtGWykCUt9bEwNSKQUnQxpIVSVgkCNeHmJgeHTkIOwqrWJxPhLgK2lq5igNmv2nNqEH&#x2B;jqeDadwW7WmRQB4FxOaMu5dIdYNcFPpZ&#x2B;BNJfhOfE&#x2B;kj7GUnPnxaHX6fAEmDcQ&#x2B;1MLRIaKAfp/EA60ZYmOJQGo/A4KDWO2fIhRifbwRIcBonbodoQKohXp6CNDrYnHerY3NyDuQi0Mb9iBr60Ge3W6qaWQxPxexrlLRu7pcnhkQTtO0P1&#x2B;GpJGpXHLu&#x2B;N5jHM7e0tCEyORYDJs1BofW7UbewVyom1o4NYDE74oO57G4X59RKZwG4B3sK0BuK7wCfNB3ZH&#x2B;OgvAL8UdYYoQA/e8gc/N&#x2B;aFra0aHR6okEq3QIi3KHuhNkjT0ORaJoQhfgfhJciOV2RjFFAwGiMzQcnczoaOjXkVG77tDiy6ff48gI0jP49t&#x2B;foUBcr6DIEKhb1Rh79SS&#x2B;RtEpcRZ5/VQ6cOmLn7G6v2&#x2B;QHyrySzkKgxT/SQCRSgmywJ/TqekRIxFLTbsWKRMGYty8KaxpofJwc16Y8/V&#x2B;iwGVxlYK9TcbU3uFw7Bhw0YByp7n3P7uCACa3SV7&#x2B;&#x2B;3/ITv7CDZu3ITbb/8LPv30M4wePZq/ozJ/RkE3EvOj14IFb6BfvxTs378Pn3/&#x2B;OesG3Hrrn3vlva5tbeMIACL9qcvuH&#x2B;R//jdwmV5w2JYVFRUhLCwMe/ftM83Uk1GpXdJ&#x2B;oHaTmJiI8IgI/Pm22zgNYMXy5UhNSzOBf2sf0J5/aA7wbZEDUhWwpPdr7aNa5yzqbJIMTnMSAE47Cxbp5Yk8qmdu9lA2aNoNmcR//AElQbfVAmhuLizjigFpwQEcjj40LLD3EieG2Qhvbx9XEiHq6OjU1dVzVICCwId5XqI1&#x2B;LcmWKyJABOA0kl/b6uzlfrbNN9pNihoDWHwo6JCkRzoi50lVViVm4/Chmae&#x2B;afv9DPr&#x2B;rldDfQz&#x2B;zRQ66MA9CiK1u0w5P5T7rhCfqLUHPMHnXpwb4wAaROgnapLUF5&#x2B;kEofph4u2sPxuiZMjYtCfVsbvJVKbCws5d&#x2B;iUzHqBNBvtWk70SqAqL&#x2B;bEqMFSAvw9DCiParvxgJrMOhQECFB4esUwr3pq1&#x2B;QvSOTxdy4TI7SFe7evXfmkJ7PduEUFh8pZCCbvf0wcvdmo6W&#x2B;Ca7iuqaMDsKMO6/E5JtnMqA9uuMwDq7fjbz9x7je/YqFSxCeFIV&#x2B;owcgrE8kxsyZxPslYuR/t7&#x2B;Moqw8Uz11Kt9HVQAoZ94CbRs/WlcmkNkgB6yIAZnZdtZEgM4BksCaSDDOILU2tvIP0cx7h6YDbuKdRP7kMhcO0ae2QmWNiLSj0HxNixqfPPQf7Pjxd&#x2B;TtOQrvQB/EpffBsLFj&#x2B;RqReJ&#x2B;5E/TTm0tY&#x2B;K&#x2B;qoIyvTVVBOZQqVZcQfyf47wEgKO5Xa1MrazPMfXI&#x2B;C096&#x2B;nlJOrNOR7L3mvH&#x2B;EfDXa&#x2B;zo72VvKt9nNArVpxn9mJhYu&#x2B;upRJ9hJADSBHCj15w5c0Xf5Mogz2ifffYZ/P190dzczHnjb721EFoxDn766acICAgQ4P/KLqKjvcl&#x2B;OV5kGhcooGxIWNAF/SwQyF&#x2B;yeDEeevhhbiMk5pefl4eDhw5hV0YGp4pQaH9kVBSvGyjaAGkDlJeV4aqrrzb5B6cy/tgqc22LDLA1zklNcnUlBJxEgJMAcNo5YVEChOms0GNdD5boo1lgyuuiUK8j1XXIrqmH9kgufrjq4vPjgRVgX&#x2B;BbWXBQkKK9vb1TrWnTCWdG1qpu7fTz9VMwJNZ138HZixKQAvjW29iKJLAmD2gZgXgKa6ac/OnCwR4Y5o9tRRVYm1&#x2B;M4oZmDrUlVl4mnJR4Hy&#x2B;UNbdyGcd60S583fV5&#x2B;ATIKWSvSgBrEgisbGlllV6ZQb6eBvQbUvsIwK9DnwBfVLWqkSScmYrWVvT190NFSwvP2IOBvlxf/U9sNDU&#x2B;EhmlldhUWIaSphYuJakWgx2V7xO4DWVNzUxi0ABIA4dcHCcREzLx3ljbiOKsfGRtPYDMjftRKYAazYxTbj8B//NloKGw9P3rdmPPLztYyV7hpoBvqD/XQadzJftpwWJxPRowYNJQnt1vqq5H3oEclOUUI3XiYKRPGsIk3&#x2B;7V27Br1XbxvhVtAkC7&#x2B;3rydXInUT&#x2B;dzhKJWyfsn6giaTHGy8w2M/9sTQZIxulDIqrABhlgnPUn0UaahY8ZEI&#x2B;LbrxEr7Iv2pK7l54IqCuvRvnxUg7Xry6uRH1ZNQvz1RSW83VTibZ913uPIzQhHL7BlrNQJNJVnlOC5W8uxqYvf4F3kK8Aot7cZ8pd5M4BpIfBIAF/Kpmo9FRh1PQRuO7Z20y6C&#x2B;ZOpyPP8sms67Szcr9prOQx1Aj&#x2B;Zb34ZqWmpuKnn35iUB4VFW2XAHAxkNstYhz8/fdNWLFiBfLz8/D444&#x2B;b1iOtgKeffhqffPIp6upqcM899&#x2B;GJJ/5m&#x2B;t64j1M1Lpl7lgiEZjF&#x2B;/5SdzwLAdMNDPd0R6X1&#x2B;l&#x2B;8kMT&#x2B;p5l0mADyF&#x2B;jc2NqK2rk7fLpqa8P5776G4pAQ&#x2B;Xl4YMmwY/vSnPyEmVk8uURnJzz79lPd3/4MPdQHUJ0MCWIN96/euOgDS&#x2B;7Y&#x2B;NUsfVtYtEeA0JwHgtDNs0QLguVg9uQT0OgwzxX94kDc87gTuXOWuvN9aASi7DEY069jRaRoQepuR4yIGdhca3EkrgFBwY1NTu4&#x2B;3t7K5uUnr7uHh2l1Eha0ogZNdZk0C2CICtIZZiGB3d1yeHIdBYUHYX1GNFdkFKGpsQqiHOybERiA5wB9BHm5oIQE/Aj20ra4TXgolWrValAqgviq3ADnVDahRq/Wkj7iPK3IKMCIiBP4CYFG0AYH0UAJl4nejfbz5nQ6NRAXp0LTC8SeByIQAX4yNDsfavCKsyyvBJHEMY6JCEC&#x2B;&#x2B;86bwSa1GADwXdl7aRVstFKD/2I7DyNy0D0WH89Fc18gkBn2vOh/zCkkQ0YNmnU/MPFPkSXNNE8ZfNw2bvvkVq975nme5j&#x2B;/NZhBF5fvqKmo4bD0wMhhL/v0ZRwXUlRIYVsNDAH9FoM&#x2B;JwV2nsxyr7Sn1WSXam/NdOsA&#x2B;iWC93CqB32J7mRVJQG2nXctpEJNunonx10&#x2B;FB1W1sGOkHk/AnZX6jxUhMCYUPqJtuioVFuu1tbRxmD8RI4c37Ud9eQ0Co4L5OhsjXWxVMrB1uZwm0YTkelV/SlUhMosEKlPGp2P03ElIHJKsT0PSSQtImTuqXdKGJJxaWzNbToLgzJI8OsPFpzHTCGLPh3uwd&#x2B;8ePPDA/TxL&#x2B;9lnn0soqev/9vLyxk8/Lcfhw5nYunUrqqurMXz4MDz33PMICTlRzeKOO&#x2B;5EaWkZEhLiuYybWox1PQnad&#x2B;zYjlGjRp/x60RaPm/uPMgENCUJtotzmhgTySV/z2fwv3r1asy45JIuThvN&#x2B;lM5v4KCAtTX1eHV115DeGgoVOSXzZ7Npfqo0oO5xcXF4c677uIyf9b6D93N0kv4rpLEgS0iQao0tWXaqXQKq41fd3aKTgLAaWfL4v28uVwY/es0PKWFwkmm0O3TUXeVhi6lBHNNed2fHchGnK8X&#x2B;gcHIFwARZderBXg7e0tN3aKarVa66Kf5ZCbpwcYCQHrdAtb6RfWy6X0BcyXW3batqMIaEadShrE&#x2B;HghVlx/mrFfdbQA20oqsFAM1CSud2mfGPEeAF8abCjsvlN/PD4qBcLEvUoL9kdxYzM2Fpbht&#x2B;NFqG5Vo10M9Iszc7Ahrxgp4p7SfifHRXG1AdpHp7loIU6kKJA4JUWmzE9LxhV947mMIMxEn&#x2B;WuCgHkmgWAzcHmb37DkW2HGPST&#x2B;Bqps1uU77uw3GsBbNsR2S8Wj379LAvaRSRF4cj2w/j8yXex/fsNaFO3QyPAr4vSRYBeJWshePh56gX9/mjour1yiFJx/mbb2NAOlCYbTBxFJ4PHR75&#x2B;DsHReseZ6xeLdfL2HUPGT1vQWFGH8OQYBpjhSdEYMHEQfIL84ObhBm9/b84vp1SKdnFdirPy0FDTgIIDuaJNHcTx3dlQN7dyzjm1q05D&#x2B;T57wN8eCXoqxOn5TCzQ9Wyl1BUB/BOH9sOIK8YjbfJQ1mGAzBLkS4F5KYBla30pZ9cMkHbr4DrtDwMgLt9H4L83K/jbMwrRXrFiJa69dh6Ki4sRFRVlaOedPMs/btx4Bu9Uwm/37l1oamrE/Pk3Y8aMGYiN7Zo24OXlhVdffRX79u3F888/x6kAS5d&#x2B;31MkDNeRP9MEAKWEvrs3E3vKKuHmoq/yQ61hTr/487r9Hz58mIX9Zs2axVGL5suzsrLw8Ucf4fjx4xg8eDBHN86&#x2B;4gq&#x2B;/zb9aNGOSCtA6t52B9C7IwPMt7NFYtknCGzt25ZAoLOPdRIATjsrFuDuhnh/XxytqjWVZ6N87KPV9Rh5JmsrC9C3p7QC6/OKBKD0RFpIIGYK0Bnq2bvztclER&#x2B;2m1wro0BUXFbWEhYd7dGg7OpUqpYueepGZwL09MsB6PeNUq74MnswC1Ju/W3&#x2B;2XmbsmDUd&#x2B;ogACtVPHD4Al9U34ldxPzYVluKFLbuQ4OeLWUmxGBUZypUD6Hc7DSHeFOod4&#x2B;uNa8W9GxsVim8P52JzcRlHAjRqtFxykPaTUVaFsRGhrEHgJ4CVRnwnlWemMZQH8qRZAbl&#x2B;FrBNrUZ5binPzGb&#x2B;vg9FB/NYCZ9OnQXYKPz9Ao4qo/D0b577GP3HDeTZ/oDwQI6IqMwvR7t4pgnIunu569XpzYHPmbhmMvtEgU4K6FsvM48UIBX/9k5c88yfGfwbSzzSjGLp8RI8N/OvaBOg38PXi68LzSbHpieyQB&#x2B;VipTL5Fi&#x2B;YDGXghSPItpb1GgUfR5pRRCJ0tGh5Tx/Y7i/1KHrbJySDtJlDqVAvcwBksCR9XqTG0UilqTJQP3jsJmjMe322YhNS2C9CZOzquvq2Eq9S60j9X13juypAn570QcXuun0xiX7SDent4f42yezOtHa2gJ34U9RH1RXV2ciAGpra7lM24QJE/nv5uYWfPjhh5g2zbE0SNp25MhRuOqquT1AUpRj3br1uOaaa7gKzJm0PWLsX3I4B4eEr&#x2B;mtVPAjTlGF81L6nLfPQMbOnUgfOJB1kkiniIWJW1qQk5ODDevXM1FEav9EHt1w440s6tcTPqf151PdR3f9mVRU1Yll0v7miXXgBP9OAsBpZ9suT4zBk4VlDLbpmaS86x&#x2B;PHD&#x2B;zBADAYFGnBvIbmpBTW4&#x2B;a1jY8MiqdnXtijqlD8RJOomsv9CH0WgGusoSEBE9KEWhub9eJgUDT3NLS6efnp7QQDoTOBPhNYB&#x2B;wnP23Wm5PtNH8O7tEsIGQ7ezUg6m&#x2B;/r5ICvDFlJhI/JxXiB0llRwRsPxYPm5M7cuiPVQ9QIdODt/XGgY4CuN/dNQgTCmrxLbicvyaV8w7JtCVVVWD/aVVWJadj&#x2B;kJUfxyFcvNQ8U4IkW8XOQuYr8dKMstRnbGYWRtOYijWzN5tl/T3s6AwVXpKo3ILkBTCKeKZvd3LtsEucIVRwXIotJ9rgoXU8k0R8sQnT3U4BjClXUCUSlxGD1nIjvfVNlh/9oM8fdFCI&#x2B;PwMTrpyEoNozTAwZMGIyAiK4CU0NnjcWKt7/jihf6lBEX0pNk0UOV3E3/5Fh4LRL6BXYIAZ3Ed1IihzIbHIfODoHQ3Wepy3hWSQKZPl2jvU0DlZsS0f3jMP66qRh91UWWwP80EbHmzqmtSAFzZ1cqdcAWWWCLUJAiIy4EYoAU/Gm2nwhvY&#x2B;Wc3lHGr3uyh0rziXMzLWtqakJNTQ2D/T179uLNNxdi/PgJ&#x2B;kgkg23fvs0Uwk1kwLFj2fjHP55x&#x2B;HdvuOHGUzpeEhSkOvJkJSUliIiIwLJly8V56I/Nq5t0qZ62ZzdlMBD2NqRbkdhvqIcHLkuKPV/aPbcNY4QFvdavW4cBaWk8m0&#x2B;lmMkoZP/NBQvg7e2N&#x2B;TffzCX9rCOaeqKt2uu3TqavtY4KkCJXzfdr3d&#x2B;RP2mPDHCakwBw2lm0YREhXE5NTYI8hlrsh6prUCSAeJTPmRVmIfDnLrzwdtFh1La1oaChESuPFSKntoHTByJ8PJES6I/RUaGmgaQXkgFyX19fOTlKHu7uLg1NTSS2T2Xp5GJwcLUG79afpcC&#x2B;eTqBNVlga7lp3zqzwQEnogradXoVtr6Bfoj398HVKW3YW16F77Jy8cq2vRgQEoipcZEYFh5syt8jEqC9Qz8YDBXLSVdgXEwEthWVIbu2HpkVNXAT942Yf1IAIDFBEnymSAICXxQeR5EobW3tOLY3C5uXrEPhwRwWcesU61K4NuW2uyndnRoyEoO&#x2B;3NWF1e/Z3FW9b6SVObac2m5bcyu/KJ0h46fNWPnWt9i1ahuGXDwSo&#x2B;ZOgn&#x2B;oP4fuE/gnkqCmuBLN9c2oLavG4Y17cXjLQSjdlJASF9BZayBYoWtbAN/4hU6CBJAuhmQbxMtsAHqp6sqOXMazgcCoH9CKZ13dpIZPsB/6jU/HyNnjmZTx8POyKyrVk8&#x2B;F1OeTJQ/Mt7fnrNsKlT1fiQHDeehodt9Yxs84zp1P/etbb/1HAOhleP/99xEXpw9Zf&#x2B;SRBzFz5mWIiYnB3Llz&#x2B;X3fvv0M6oxGIm8ffPA&#x2B;2ts1WLVqBe68826Hfo/IAuq3AgMdr5hEv0Wh4Zs3b0ZlZQVXCqivr&#x2B;dUgtdffx3vvPNfsb9gLFr0BV5&#x2B;&#x2B;eUzev1Iw6e0uYU/k3BwhJcHHhs1uFf5cUTsFOTnIz4hwWL5nt27ES3uPVWCoIoNQ4cO1ZMwVVXIOnwY9Q0NSE5O5mWU1z9hwgSEh4dz5OLp6net&#x2B;68/0s9a90/2yABrosGRClZOcxIATjuLdm3/RLy3J9PUIXm4KrBEAL37h6edlVx8KgFXKQaLV7buRWFDC3cYNM&#x2B;dXVOHLYWlWFdQhHuGpnGueG81miWh9yCVSkk5kk3NzR3VlVVtXt7eruStK5VKF1uOoXkqgFTEgDlx0CV1wIwIMF9m44eg0XXy2iEe7rgkMQaDQ4Pw49E8bCoswb83lyE50B9jokIxPDwEcb7ecHGVW&#x2B;SUU33ftJAANLdpsLWknMmFIWIfIcIBIMKAQCtJP3Z2dqCqqAK5GUcEONuPzA17OSyb6ua6qBTiejln&#x2B;0/SMz9/z008FxV5ZTi0aR9HAQy6ZARSxqXj4Po9KM8t4WiA9pY2lBwrQtzAPqgT4L&#x2B;hpgna9nY01TWL71rg7uXJ1SEsGpMMktP0OmuhQ4nqBby5eeEEqbKIdn4GkG7eUuvZKocIG&#x2B;vAQfJAZ&#x2B;P4TmYEYGG/Dn0pSRJTpHKTU28bj4FThyJhcPK5CF67BfNSaUq2SAJbs23WQoS2wmeliAbrbW0tO9NGqW0E&#x2B;I3HcD7M9EvZhg3rsXz5jwKU17Ey/&#x2B;efL&#x2B;LlPj6&#x2B;&#x2B;P7770nnh5X8jx49IsD26xbCbIMHD&#x2B;GSbm&#x2B;&#x2B;&#x2B;QbmzJmDiy66yKHfvPHGG3DbbX/BlVde6dD6FE7&#x2B;&#x2B;eefcaWAVatWYubMmbz87bffxtatm8V&#x2B;ZmPEiJEcZk715imt4ExapI8X8uqbuEcZHx2OWwf1g69K2avawZEjR7D4m2/wzD//idLSUgbxdC2/&#x2B;uorPPPss7zO119/jSFDhmDVypX8bFI5R4pkfOqpp/h7mvmn15kbKrvP2&#x2B;8JMsAWAWq&#x2B;nlFHx2lOAsBp55CNjQrDj9l5DNIoE5xquG8rqcS4skoGdmfcvxcvyh3XqjvgJZx0uaF4OJWCI/X4YwIYvr3rEO4dNoCZ5N5uVPc4QLw0Xl6dNItSUlKidnNzcyWSwNvHRyEzj5E3JO3rJGZFu15HaT0B3UkiaFpbIwC6rFOGYE933JKejMuSYrCnvIa1Gz7dfwTLs/NZsZ/K&#x2B;1WrSQSwE0pXOacEDAsLgbvCBdMTovn4WU2dzkO0s7qyGq5Zf2DdbuTuPoLKwgq0N7dyXXulh5vz4XSadB/hIsfKt5ai76hUBBpC/MP76PNu21rV0KjbkX/wOPas3i7arQ71lXVobWzlEphegX7dEyT29AjsPCeS6QEyw2Ir2QUdToIVkFjNFglgD/zDDuiXSitwZB/GFamEX0t1Az/XCYP7Yub9c5E8OhWeZpFkunOcmLIH9h0hCaTCZe1FEthS2jZGR0iFB9urjHC6yQBK7Def7T&#x2B;fc/s7OjrR2NiA119/DT/8sFyA7CLcfvttpu9pNn/GjIvx&#x2B;&#x2B;&#x2B;bMX36NKxYsarLjD0Ju61cuZrL//n5&#x2B;dn9vY8//gi33HIrf77rrrvEvmfaXZ9yyTdt2ohhw4bigQceRFpaGi8ngcFff/0V//vf21xqsH///kxWvPHGgrN2LSO8PRDsocJ1qUkYHxPeK0WeKaXipptvRrEA/YsWLeKZ/C1btqCdKiTJ5cjOzkZTYyP&#x2B;/uSTEH4b/u8f/&#x2B;D0i4CAAI4OOKvjpQ1Qfqr9se1ygDKbvyFV3tppZtfqbA&#x2B;Ohptn7fKYv&#x2B;Rm78bPLobP5u/mL1ezd&#x2B;uXwvCiz0rjsrKysudDQ0PjnE3izBnVgf9PxkF4cV63PpybOrVXp4xmpfdTsW&#x2B;zcrH0cA7nfhk7jRrhmK&#x2B;61nJgU2s78MTarahsUXdxaKjUHAF/mltwF8dG&#x2B;6JZ5BZNB2J8PPDPiSN6HZPsiHFUQFOTVqPV6iorKjR9kpK8TpQQkEnXW7HsoW1LsjpEwshsphRwByCne&#x2B;LCxMCR6jr8XlSK47WN2FNehQgvT0yNj0RSgB8GBAfw&#x2B;gq5C4fvE5lD4n9Uou7Abxk4sj0TpdmF0LS18yErVK7isJ011p3WvWnaNAgID0LyyP6ITI5F0phU&#x2B;Ib4wy/IrwvIrSut4oiAJc99ipKcIijdlZCdrax4qwgCC&#x2B;wvoTRoDfJ1VkyAzAE9R3tRCID9CAWZjR0Skdehodz&#x2B;dp719/L3RvrUoRh22Vj0G5sOlbuqV4D&#x2B;M&#x2B;FXSUUNSItn2V63OxLgdIgSGrc3z&#x2B;0/X2f6ze3o0aOc309l&#x2B;qjiyKRJk/HIIw9jypQpuPrqebzOkiWLUVVViYsvnsHl2v6I0W&#x2B;NGzcGmZlZ/DeF/x84sF&#x2B;A&#x2B;nRT6b/169dxetzFF&#x2B;sFBF9//VW88srLCAsLZzJix45tmDVrNr79dgnvz8/PHwsWvAl/f18oFGfXRyppbDYQAZ69vm2QuB8JOZK2w33334&#x2B;FCxZwWkB5RQUumT4dbRoNhg0bxmX6zkWCUyqEvyeiA6z3ad332Nq/q6vrfBrOye01vGsl3o2fOwwvrdln81en2bv5S2f2bv6yGG3P5ljljABw2lmzybGR&#x2B;OLgMbSKzotAGokBtgpg/uKWPZwKkOB/ZjszAvltHZ0cOkY16atb1CwQqJB3coqAh9IF&#x2B;fVN&#x2B;G/GITw6aiCULucXaOSogIAApXAEdIEBAYqKioo2EhCk2ZaQ0FA3mJMBPQj8T/SGui5/mzQC6K9OmeiBtZCLfwTyU4MD0dzejsLGJoR5esDPTaV3HDs6uMY3fa4pq0ZxVj4Ord&#x2B;DPWu2cz42qSYTMUC12J3q2U47GVO4KUQbqsKGr36BykPFbSgoOgTR/RMQEhfKIed9R/ZnMUT/8CB&#x2B;RX8Vjy&#x2B;eeg8H1u7Wp6v0VJtzJDnfDDzLjKkFZikFOkggbrPvZbquUQPG/cgc9Fu6Lblom6fgz&#x2B;xBESmr6YBWjA9BkcGIHpCAgVOHi9cweAf6mJw9qdn0sx22fracbnt/my&#x2B;zta51WoC1E98TVQys/yawT&#x2B;MPAX/RT/c6QT8Kzae8bes66o7Yd999h&#x2B;DgIKxatRqvvfY67r33Ht7fZZfN4u&#x2B;pLN8TTzyBrVu3ISQkpEeOldLgyBoaGnDRRePR2qrGsmU/saZATk4uHnzwfoSHR5oIANIf&#x2B;PLLL/Hf//4XiYlJHEGwadPvWLJkiTimUA5RP1estwN/o8gfGeks0HPy8iuvMDlzxZw54rpvwtVz57Lq/7lORkoRhz0N/qX6KKc5CQCnncN2XWofvLF9P/zdlOzwubm6cH33f23ehT&#x2B;lp7D4nusZKuNLgHN&#x2B;Wl8uOxfkruLIgS3FZfjyYLbeKRUH6Ckc/p0l5dheUoHx0V3romZW18JPpeIKBy691OGkMkr0ioiIUDU2NmqbW1o6qior2xgAKZVyH29vV5llry4dHdBdxIBxHQliwVyA0HpZJ0j4Tw8rqJJDcoCfXkTQqIQsPh/ZtBe71&#x2B;xA4aEclB0rRYcAELS9StwXqVlGR8uiOe0CN9EYCPRTugiVWaIZ6dKcYtHO8vTK/qINJ49NQ8KgJAQIoJo8Og0B4QH40yv34H&#x2B;3v4LsjEzevmc8KweAv/mh2yt1KEUUmL2bPzRG0kAntR9dVxJBqpKBXfdMrk/ZoZx&#x2B;mY7SsHTwC/FHwtBkDJw&#x2B;HElDkhEUHcpaHTozZ1IKWFrPctuarbansn8&#x2B;EwP2nPbuxAxtVTfoTqNA4v7oDH9biPmd68RNTs4xjizr16&#x2B;fadkzz/wfoqKiBXi/z2LdvLw8RESEQ6lUWSyncH9vbx8TyFu4cAEr/V988VTMnn0lXnrpJf7766&#x2B;/4pn36667/qTAP5EGRHi7uXVNbXMVY6dKpV/&#x2B;yisviWN/FitXrsCWLZuZAPjHP54SwH4pz&#x2B;4TqUH7oXOlXP60tIGsO0D555RnfejQQbz88kv44ouvnGNED9nSb7/Ftdddx589vbz4HhojM8aPH49Ro0ZZVIjoTdZdKpKjRKKt2X6pft9JCjgJAKedYzYhJhxrcguQW9MAD6UrO4tcy71di4UZ&#x2B;7GhMAhXJyci3Nud0wPoQSZFd6rxOjQsGP7uqh5zjEhZfkZiNJQuLrws2MMNs5PiEO7pgWd/z0CAAPbUhSjF8ZGAoRQB8HNOIQrqm5AeGoC0kEBWog1wU/Xa&#x2B;&#x2B;MtwD69aFaGQgSPHDnSJECOW1tbW6eXl5erGJRcLAC&#x2B;OeA3X2ZOCJiDf/PvbJABtsga433rtNpOq9ZwOCOtlbP3qLhfSrQ0NsPbmIctl1kgkO5KnMngeA11p10oRIABmMj05RCVKiW3OWqPWVsO4NCGvfw5JDYMfmEB8ArwRdnx4p4D/z3miXUlOHTdVUYwfxCkYvolUgqMxEGXaABzUqCjk69hS2MLC3AGRocgfnBfxA/sg7j0RPQZ2o8FPE3PPT/j6DbksztlalvLHCEPrH//QiEKuosw6E6jgIxSzmimn4T9zMv3SRE656I98MD9Aji/arFswIA004y90TZv/h3XXnst5s2bi9deO5ETT2JtJJxn1GeLixO&#x2B;RngEpk&#x2B;fjuHDR2DMmDG8nEiGnTt3YtKkSXj&#x2B;&#x2B;edP6hhXr14ljikdycl9JZ4LOYN6Mnd3D1x&#x2B;&#x2B;WxkZWXhwIEDLCJI4n1JSX3FOgq6V2Idd3R0aFl4kMD/4cNZaGlpwsCBg5gkONXygU7ralWVlVCZkTak5xBsIH5Ih6GqqgrHjx/ndtVbTQqcnyxB2Z3Iqa3fcZqTAHDaOWBKAer/OmoQXt22F0dr6uFpCN2m8HoCdrtKK5FVWYtIXy/4KZVcOrBBDE4Uin9zejJm943ruQ5JJ&#x2B;3MjYgIwYyEGPyWV8wkAR1znVqNjYUlmBAdYbGutlPHaQMF4rWxoAzRPp6YlRTHJep6s5toiApAamqqN4F/pUolKy4qahVOiydFCfh4eytkcrkluLfssaWXW5MF5lEDXXt9afLA6jeprnrKhEFIv2goJt9yKQr2H0NOxhFs&#x2B;W49Otq0DHB4FpcIp06dTbBvT&#x2B;wMdsgAnZ1tncTB&#x2B;coHnHBCVCQkKdPrWNRV1KC&#x2B;opZD10kDQC4/x9OGZHYAv1UjttAPkCobYEUUmNY3phdQJQ5dJwP/9tZ2LpHoG&#x2B;qPUXMmYNhl4xAcGwq/0EDxnLro9UHMQL8U&#x2B;DwZMT1HZ4hsKfLbE8o73wiBk3Wa7ZABLOan0WgI8MukZvzP5etH50Cz/pR7T2J9pIKvVFrmuV9zzXXYvTuDw&#x2B;IfffRRXvbkk0/ihRdexGOPPYJ77rnflLufmXkQ8&#x2B;fPN23b2tqCBx54ANOnX2yxT39/P04JOFn77bdfuYTg4sVLbI3pphnk8vJyXH31VTzTTyQGnV929jFcddUccVyt4tgf4/VmzbocN92kP&#x2B;YlS74R66Zi6NBhePDBB7tENzjNvlEFGSpVGpMa3&#x2B;W7Xbt2IdFM42Hv3r1IT0vj/u&#x2B;br79G/9RUi8iT3k4CmD/3J0MCSPUXUv2wVJlCpzkJAKedA0bl3p4cMxQvbdmDo7X1AmDLWHiPQui9BODW0MxzVS1cKb&#x2B;bhAIppM3VBb/kFmFmnxjWDuixQd7G8hsHJOHn40WmdbzFwL8mp7ALAeAi15MXFArcrNHggAAAFAVAteuppODhqjoEe3qgj78PRxj0RlOpVHJ6&#x2B;aSkeNXX12saGxs1tbW17T4&#x2B;Pgpvbx&#x2B;F3rmDJDi34111BSI62I8QMNVOt0wz4BkkAbja0IGIPlGI7BON4VeMx&#x2B;CZo5kIOLR&#x2B;NyoKylBbUs1gTS78TxdyhOQn9ulIWrWjaQPmhMLJtkUnYdBbUZM&#x2B;SkVB0T&#x2B;iTbmqFOfHeZlzcDIHyAOLz4bKKgJkdLRrqaQblCoVVJ5uAvRPxICJg9FvXDrcPd0tdktOLxEF9srY9RSodcQJlUoZcOR3uhPOOx/JA&#x2B;O5GSPIaMaZxgcD8JfZItLORcvPz2dQ/803ixk4U0i2qcqG&#x2B;PDNN99g0aLPuFybr68vr/vDD9/jr3/9K0cFbNy4HkeOZDEB0NamRrOhRr1G045ly5bhrbfewldffd0jx7p27W/8&#x2B;99&#x2B;u9QkDEcz92&#x2B;99R9OT&#x2B;jbN9lYRpG/o&#x2B;Pbt28vCgsLWXzQQ/hko0ePRm1tjThPd6xbt5ZF6EpKijF//s28zf33PwhPT71Y84UK/mtLq7Hsja8x8YaLufyro6ZRt2HJc59wxZLrn7&#x2B;9y/ek8r9t2zZuZ2vWrOE29ahoR3TPbv7TnxAREXFe9BXm/XlPiYfa65Od4N9JADjtHDQ/NyWeHDcE32bm4qecPMg7hfPsoicBKPTfWyXnwdbdWJJObJNb14AjAlAPCAk47cendHVFsLsbRyDogb4cRY3NqG5VI9DdTdJPJmKCXkRcrM4txOLMbE5tUAigGenthYkxEZwC4dOLKwoIR0dBr4aGBlJLlVVWVrSKz9rIyEh3Ly8vhb5z7yaiXyoqwCI22EY0gdR&#x2B;rCIJNO0a0&#x2B;f&#x2B;Y9PRb2waJt8yA8WH83B87zFkbd6PquIqFB/Jh1KANYUAanK5i5kGQfdEkc4G7oEDJII9oC9zkgLnA/q5sM/foNzfSbP8LW2sxeHh7YH4wUmI6heLkLgIJI9KRVT/WAYjxll&#x2B;qVl5cwfPFpi2p3Rvz0mUEr6zF1FgvT&#x2B;p47SXWuAI6O9OMO9cd&#x2B;zNCBwdzTZLAX7r&#x2B;3Munx8B6VdffY3DscnMo3neffcdLFiwgEP0p02bhpUrV/LyX375GYMGDcGLL77IYfyvvfaG4TzlyM3NEcD7UqjVrSzIR/smHYA/anl5x1k7YM2an016AY2NjXjhhX&#x2B;huLgU//rXv/DBBx9y9AKV7CPgv27dbww4k5KSOfWA7sm8eddg9&#x2B;7d2LBhHQsCUknBFStWnvDZ/Hwv&#x2B;O594c3PI3fPUdaAeWzJc13KCGs1WrgqusKshuoGqJtbcfEdV0jul9rBip9&#x2B;opRL9OnTB0//3/9B&#x2B;FP8nfCtzp/hQeK5P9VZeql92EoHcJqTAHDaOWbeSgVuGZSM5CBfrMopQGZlnXhgSejN1QwL6kwAiNb/6MARvD5l9Gk/Npoc9nFTcqdtPI62Dh0KG5okCQBz21VWhQox0Kq1nVAZUhuIvDhaXY9GAVCvTe3T60Edzf4b3l0pRaC4uLhVOEqyoqIidWxsnCelEEhhd1uagXTDZWaFzLuQCNbFXc0jAqz/NnwmVV3ahbsAIH1HDRDAIw0TbpiOlvom7P1lBzJ/P4DcjCz&#x2B;W0ezI64ukFM0hwAmnN4g5dDb&#x2B;NuW8rlUaoBUCTSpfGmnHoHTznVnzuh0EdAn51fbpoXKyw1&#x2B;IX4IigpFyviBGDh1KAKiQlg7wTgDSaCfIgNs5YPaAvndgWkp8O9I6bruZqTsAX5bEQqOltyzVcqqO1G8cyWKgMr3US6/IU1CJqXi39OlA8&#x2B;E&#x2B;fv7cw32qKgonv2ntms8ZBLPo7rrBNK2bNnKM&#x2B;LPP/8cmpqaBRBfjZqaWjz&#x2B;&#x2B;BOkqcPrE/immfSlS79lMbebbroJYpy0&#x2B;duUk19UVIjExO5nmV944d&#x2B;oqCjHjh3bOZ2AfotCyidPnobLL78cd911O5cSJMBPYJLC/JOT&#x2B;&#x2B;HOO&#x2B;/CjBkzmeCgGWciDNauXYu33/4fJkyY6OzgrGzDojU4lnEYPkF&#x2B;yN&#x2B;fw&#x2B;WF0yYNMX3fVNOIjx5agMsfvq5LdEBgRDAe/vIZ&#x2B;EcESe578ODBmH/zzdyeUlNTTf3khTiWWPe3jhKQtqoPOCs/OQkAp53DNiYqjMu8rS8owYb8EhbV6zA8uIZkQX7XimWHKmpwrKYefQJOLxtNIf3urpadMNWjL25owqDQILvblgkngI6d9AMIRNK&#x2B;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&#x2B;SI7c0JgLdvfxG7V25D&#x2B;tThXdMDRJMPTYiwDcxEWzGKQF6I1hOifbaIVKc5CQCnneNGYfGXJ8UxGUAkwBEB8uvUbWhQt3PuKYXR&#x2B;6pU6B8cAE/F6W/GHNJPjD/MZ3BlqDBEBNgzF65eANYv6KA8SMihorxzsaf0kECbod5U1o5K7LgrzsxjSgKGPVlykUI&#x2B;hZOhpBcJBVZXVWlLSkpbyDn09fVRqFRuLuaOopT&#x2B;nzVRcDLLrIkFyRl8LuUmwItMC6WHCvHpiaw6PuLScagoLEdtaRWnChRn5WP/2l08q9muVsNVoYBc4SIcQFfQKTgMLBwgCqQAv72oACmAbyuSwJ5oIZwkgdMc6QtFe9cYKm10ij6KQvx9An3Rd0R/ePn7cMm&#x2B;/hcNRuKQJM7xP9HOdCyGaKta6Mk6d7aWOQL8bYFve&#x2B;r19qIQ7AlZSR1XdykHtqIg7EUWOHLM1kTJqQJ043IWhFUq5fQ3V4TR7192KvfvXLbFixezQj&#x2B;J6hGYJgKAyugdP54HX18/fPXVlwKkr8CcOVcJ4DaOr82VV15pCtu2ZY6AfzLSDvDxsT/J8f3332P27Nn45z&#x2B;f5Wg3Uul/&#x2B;eUXUV9fzykGt956qwD7FVAolBxxQORATEwsv6yNcs&#x2B;jo6Pt/h6lFVC6QVpaerfHv2PHDo5IsC6PeK4Y5eR/8uh/MOGGSxxan/yCgkPH8dLW9&#x2B;Ed7Iv9v&#x2B;5EofARzI0qlvSfMAhj501xDhonO8ZIpHpJ9ZPdbW/vs9OcBIDTznELcnfDVf0S0CocxxYBvqgEIEUDCOgIL5USXmewDqrMChqR4F9Fi9oh8oCOnfQM/MQxN4rPNW1tSPD1QZiXRxcQvqWoDJlVtUx4UGdHFRDifLwwICgQ/h7KLsfRU0alFfdVVGN0ZAhifb3h1YMly6iUYGpqqg85jPR3ZmZmIzmKAQGBTBCQErQt8G4vGkBqufl&#x2B;7FUdlFmpm3dqBaAxxAbQQEEMfXhiFOsGdIj2V55bgkOb9jMZUCgG/4rjZWhvVaND0wGFm4IHfBe5y2lB0N1pEejsEAbm7dBW&#x2B;0Q3pIPTLmyjCBh6BqjvaW1q5dKGQdHBcPf0wLDLx2LQ1BHw9PPilBljzmsHh/Ub8/lta3h2&#x2B;2xCuoKoFOF3Kk6mFDC1nnW3XvdUHElHSgpag31buaxSx9kdaLeVI2tvG6nvKKefIjcMKvL8xclUt&#x2B;gJEcdTtYyMDAwbNswBwH0ESUlJfF50rtu3b&#x2B;WZ9JKSEgH0V7KIX3BwiAC0d/M5uAs/5cYb5&#x2B;Puu&#x2B;85LbXZaZ9SQRVUnq&#x2B;hoYFLBf7tb48z6WAkFsLDw5Ca2p/FNq&#x2B;&#x2B;eh5HBcTFxWLDhvV4&#x2B;OFHukQknKytWPETjh496hABQCkFcvm5O5IQyV9wMBcuCheLTqa2jISC3eHh62mxfkt9M1InDoZPsJ6UiR&#x2B;SzFWkzO2&#x2B;j59EXWkN6wo57Q/4PicJ/rvre53mJACc1suMwu/pFehuX22201DWTYaTC5N2xDqtnTTxaiCRuW6M8vyjvb1wfVofRPt4I6&#x2B;uAUuzchj8W4PsjYWleG93Jto7OmGsn7W9pBJuYmCK9fbGoNAAXNY3jvUPetoahTPxw9Fc/F5QinBvD8xKisWwiGAo5T2Xf0bpAfQ&#x2B;ePBgXyID6urqNMKJaPT09FSEhASrlEqVnKICTjimlg6/rWW2QIIUGWAbYFg60VrDvWXCRRx1eFI0opPj0K5pR2NVPSryy1F2rAi5u45wVYGakmpUF1fxfkg3gICQXj9Adsq5bI4SAd0RA1LAXooIkNnYTtbNZ9hZ5rRz36iN0kw&#x2B;t0/xv721Td8GaJZfLKcwV3/R9/iG&#x2B;CMqJR79x6XB3d8LbqI/9vTx0vdUBiBqBP3Wz5fUZ3MywLwiqD0izx7wl9o3Hb/UPqUAtT0H1B6JYEsU0BFxK3uaBsZ3irawpRfQ3THbcn6tUyakjoleBPiFyeidwvvpWKwF/U4mlP9sOeEElFesWN4tAdDU1Mgz/k8//bSeyDJoU3z22ScoKCjk2fQhQwZjwYI3DeJ4vpgyZQoTAqfLSIlf6rpRnv7s2VeyaJwYQ1FbW4vVq1fjxx9/wKFDB3HppZcJ4B8o7mGHGHMH4fHHH8ODDz7sMPinc9VHExxGSkqKScOAbPLkybjkkhmmv7OysvDtt0swceJEpKcPRGurWmyXiUmTJnFkwsKFb54TfV1lfhlKxLg9cMqJdkCaJSzgZ3aJ8w/m4sP7F8A/KgR3v/tXfXlX43VpakFgZDDWL1qD7O2HsHXpBjy14hVLX8fdzW6Yv9McJwyt&#x2B;5hTjQhwRgA4CQCnndedBVDb1g5PAZBVJ1sekOrD25oFES9tR0eXDdq7LOtqEd6e&#x2B;OvoQYjx1YcDRom/U4P9UWaVPnCgohYfCPCv03Uy4Jeb/TY5XTl19cisrkahGHweGDYAKteeFYahKXhPhQJtwlk4Ul2HnNoG/GVwCqbFR52We0VkQGhoqCogIEBB5QSLi4tbCPlrtR26mJgYDwopPbWZNksg4QhosNYMtAATRAx00owmaQdoGSz5CjDkFxbICuZjrp4MdXML2lrbkbHsdxQfzUfh4Xw0Vdejpb6Fa5zLXWR6UkDpyoKCpvM6HUzVSZIIMhPVZH8bmY3tT1ZjwEkSnDtGehjU4NtEX0T3RalSclnM0PhwxA/qC5lotyMuH4fIlDio3FRQuitNglRG0E9h/bZbQfd32/z5s/UM2osEkgL3tggB6332BEi1JepnnbcvlYZgLzzVWh3/j&#x2B;TL21PCtpfGoNFodQI86pRKpSmv3xFRP0ec8TNtBIJJTM9oFMJ&#x2B;7733CLCajoceetgUxbBnz14kJiaa1qPZdMrHvv7669CvXwqX&#x2B;HvggYcwYcJFmDZt&#x2B;mk95jbhy6hU&#x2B;meOfACj5eQc45SERYs&#x2B;Z/G&#x2B;335bi/LycowdO5rT0qiE3xtvvIGpU/XH9/XXX&#x2B;PLL7/ArFmXsxCgo7Zw4UKkpaXh6af/jiVLvrUgAEgD4eWXX8Idd9yBiIhIPPzwgywu&#x2B;PXXX3Hboes5d&#x2B;7VTADs2pWBuLj4c6LP2/D5GhzbddiCAFC6uXXpD16//hkW8svdl4OMn7Zg7LzJJ3wXLw&#x2B;seecHePh4oqqoEsMuHYOEwX2dA8oZJAKsI5&#x2B;c5iQAnHaB2/iYcNS1aZBZWY2ChiYB2jvRqtU61LloOnSoalEjxKoONTsPoqNp1mi7QBmFA7PjQ0IDEeVjGULmLwYcehmtuV2Lzw8cEb&#x2B;hYf0Dk9vMM1j6EEtP4Xe5CdC/s7gcz7e344Hh6Qhy7/n6u0SCuChc0SYc&#x2B;7rWttN&#x2B;zxQKhTwoKEhFLyonWF1drSkuLmpuaWnRCSdH5e3toxROkFzKee3qNHfv&#x2B;Nv63h4pYAFEOgXo6dC3BTnP7gMe3p7w9PXCjLvmoF3dhpbGFtQUVaCxthHH9xxFUVY&#x2B;qgvLUV1cjbbWVmjbO7jKAAtbineFIaLjbISqOVLq0Lp6gS0tA1v6BEDX6gdS5RPtre&#x2B;0k/WYTqQtcfi&#x2B;aKsk0MdhzdoObrshsRFQt7Si7/AUJI9J4&#x2B;8ShvZFWJ9IePl5s&#x2B;YFhR93Gp0tBvxaiRbhaIKJNDEgWQnUxvNoTRZIfWdNEthbp7uUA3saBcboAmugbSvE3d5MvPWy7tIApEgHW8Df/HvzaALp9UD3WKdX8j8RtWXPET8Z5/1sCf9ReVdjvfqWlmZce&#x2B;01iIyMYnE98xSG7OxsLo03efIUDv1funQp9uzZhddfX4ArrtDn9VNJwNNPWHTiww/fx4033sRVB9TqFtN3t99&#x2B;uwD4C9DY2IQ5c67k2f&#x2B;PPvqYqw1MnDiByQFzu/XWP/N&#x2B;qJLBydhbby3Es88&#x2B;i4UL30J8fILFd3T9Dh8&#x2B;hKKiYtxyyy144YUXkZycjF9//Q3//ve/mHCJjo7BJZdcjIKCAhw8mHlOdIsBUcG45bqpFt2QQkWplSfawM7lv8M32B93/PdRfP3Mhzi4bjfGzJ3EfSgZpTuFxIUzWTr5lksx7fZZzvHmDBMBtvpOpzkJAKddoBbm6YHbBvXj/PnMylrsLK3ApqJyh7bVigH3/b2H8fDIgV0U/0l3oEbdZgFaKNvA24H8LiIJunN39ldUIau6Dr4G8G8kHZraNZxXrhGAU7ht8KHIBnFs&#x2B;8ur8cLmXfj7uGEIcFOelmtJEQHyM&#x2B;yoUTlBelHMaUdHh27fvn0NlZUVbUQCBAUFKY1CU9Kg3VFhK9sOvzVYsBx4us5IWjj8FCWg7WQnwTvAGz7BfsKlkCF98hCxXId60R4pp7AkKx95B3NRnVeO0pwiaNo0qCmpYkKAqhIQwUAzrbRnyqnWdRrOy5b4wRkmCXQOkAe2SIHufkNmB/jrHICVF6A3ZIaET4A7eqcUFo14UQCLu6&#x2B;neJchNi0RocJxbW5sxtCLRyEmNQE&#x2B;Ib7wDwuwcIBJsI/2QVErJ2b4u6OD7FE31hECjsSMSJMEtsg9W4&#x2B;&#x2B;NWFgvY3UdvbSDxwhEW1VNTiRjmBfBND8O2uQbysNwJGSh1LrGsEmLaY&#x2B;l/RYjLP9xlB/e5EM3fW51sfxR6MZ/sijYgx9X7JkCSvh33//g/rxvaMDGk07h9rHxMTgyScf53B2mu2fMmUqPvvsCy7NdqaMjofC77/44gvMmzePAX57u14T6Ndff2VBvTvvvB1vvrkQdXX1uOKKyxEaalthn7an18kazdrHxMRxKbq8vDzExsbyffvoow&#x2B;ZALj00lni&#x2B;kziCghkWVmHOdLgf/97B1u2bMbbby8U30/HggUL0NzcCDGOn/Uuc9w1U7BnzXaseX8Z3L08cPVTN8PVTaEnTA0Af/X/fsBd7z2GoMhQxA/qA62m06K9BkQE45FvnkVQdAiP2047&#x2B;6SAkwhwEgBOcxq7jP5uKoyNDsPoqFDM7htP2AzdJQRQJ7KjpAKvbduHa/onIs7fGwqZfqsVR/MYjHuYKfITKRDq5d79YO4ABNpWXMGVDUxusUwfFTA4NATjokOh0XVie1E5DgoQSerDpAFwvL4Jb&#x2B;7Yi8dHD7E4rvOkQ5eR8zl06FA/4Qh1lJeXt2dkZNT4&#x2B;/srIyMj3YW50syULVVse/f4xMye9QyW9IzkyegQGMGPVtMBmbbDolX6BBHQ8kefwX0xjiJK6hqhblIz&#x2B;K/IK0V9VR3ydh&#x2B;FulmNozsPczh2U1WjcE5cOdxSQDKOFKCZLArNNs7u9raBz1Egb0uMUGcTItre9/mQdsBtXKfvyHQd&#x2B;qQNntGXyU3l9FTuKp7d9wzwRlS/WLgJB3fk7HFoFW0qJDYMEUlR7LBShA&#x2B;BIX0YfycTV8xgdQGHjtapkKJwYAX4bd1ZW0SCLZJA&#x2B;i53F/Vja5m96ABrEsBeJIK0zoCjZIK9qKbuqwPY6gfsRUyZK/m7uiqoVVGbkNM1tRZssycg2D3hqpMkAc6GZ2AkAEgM0KhIf&#x2B;zYMbz00gt4//0P&#x2B;W/KYf/gg4&#x2B;4nyXgS6D3TNvrr7&#x2B;CO&#x2B;64G&#x2B;Hh4UzARUVF4osvPsfXX3&#x2B;DpqYGLFr0BVpbWznE/nTWiKfyhTU1VZg&#x2B;fSpaWloY2I8bNx7r168ToH8RrzNgwADk5OTg3XffwbZt2/DUU09h4MCBHA0wb941KCoqwm&#x2B;//cbRB9dff8NZ7UNLjxVh8bOfYOeyTZzTTyQ9EQBKNyWDfyLCWhqauaQprUdjc&#x2B;nRwv9n7zoAo6ia8FzKJbn0npAQWui9g1R/qggIIio2EBCkKCBi7yhNRVQQC4iKqCAoTZFO6L33TiC993JJ9n8zd3vZ23u7dwmggjt45m5vb29v9&#x2B;3b&#x2B;b6Z&#x2B;Qae&#x2B;&#x2B;41q2kIhy&#x2B;WSWn2D98PAbjtVTVCQCMANNOMItg1/LwdXh&#x2B;B9eHEFKqBbxYWAOFeXpCSlw87ridS&#x2B;j1YuaYCVPfxvul9NJaWwaWsbNCz7RNRwTZeyBzy2gF&#x2B;ML5VQwgyi890rx4JMdfiYN6h0&#x2B;DFHHgDW/9IUjr8cvoiDG9a7649hxj1Z06YR1RUlEdubm4JczbyiouNQmZWZkmrlq38mZPirBRRc8Q5VqonU2q1xXNulRx8q0hgmQDGojLTOqgc7YNlA94QGBkM9do2pAwUBGOoMJydkgXJV&#x2B;Lg8pEL4Kx3hhunr0JKbDIUMsckJz0bSvKN1IINt0OADscmPnd2JqLAyVya8m&#x2B;/IQq3cH0lqKoDZbHCfwMxQOeG/UNCh8YhmMYigXwBLOAeI/o4dhDgu2I9PnNaq9SpBsHVQum812lXH4IiwyA/J5cUqpEs8pCVM5Wx8QWmzZK4F6/22x44Uwd/Yoq3kwpRIFed0HFIAKUzCQ6sCw5QP6blciJPTQ9ELVvA0ZIiHilgSyoIqiBW&#x2B;ruVUvnl58n0R/zNAqrHl7m66knQj/11Mn2vaS0pQarkbDsK4P9Nolu4L&#x2B;7msjtscTd06JNQq1Y0kQGTJ0&#x2B;2rIclL3373p6UbrGOXyw5wGsbOwvg/qBIIUb5AwICYcuWbTB8&#x2B;EgwGDxIg6BZs&#x2B;YEvNPS0iiVv0GDBuX&#x2B;g/k6vllVf575MP9m1arVMGLESNi6dSvMn/8F7QfqAmAZAu4zin727t2ThP/mzp1Lf833bXBzc4fVq9dAnTp12W9o9o&#x2B;e/9TYJPjg/peguKgYuj/TDzy8PSHpUhy9p2fHGefVw2t3w6G1uyCsdlU4uGYHOLOxULdtA2j8v5aaM30HkAG8eVAzjQDQTDOHXEVU3/fUuzBQXgp74pKgyJgArsy5xraD0nR49JXcGciq7e9709&#x2B;bWVQEeUVGEIMu6DwXlhRD1&#x2B;pVIFCiPOvKnIbuNarCnvgUOJGUBnq2T95sX9dcuAqdo6pAtL/99LpSc4qw0x2ohor7je0EmSPhi1kB6enpxqtXr&#x2B;Tm5&#x2B;eXBgcHu1etGmVQUtFWuzHwRLAcVQi3BdZSwG0LLix/US29rBTwH&#x2B;6yUQIKPLyx7ZAXRNaNgpa929NYxHaDxsJiyhhIvBwP&#x2B;dm5cGrbYXBxc4O02ERIMDsyBTkFUMbGsLHEaAGPGOkgQMnOPYJGNnjZf8K/MoNALd5sL&#x2B;4MMjip1hrxnxArLAdPpr1Bh5Oi7wzoC&#x2B;ZsEay5d3HFDA8nclCL2bwQ3aIOFGTlQkS9ahAeHQF5mbnQtGdbcPPQg3&#x2B;VYAb0XUhcEoGLSCSIpAGCA0fBvL1x4Cj4M72vVihSmdcVKR9QKyLRcUYJX0dE6blcoFCtKwkP4MuBv5qIoS1hoDyf8UubxC4CpvcYwETgz/AnCfnpMNKvJIqoVGtbWVD/T5MBSJIlJibCjh3b4cSJ4xSZxij18uUrCND&#x2B;HTZ58iR49tmxlhaDY8Y8C0OHDiUCAKPqWIJQo0Z1SEpKhP79&#x2B;0GXLl2pDAH3ffLkF222Z&#x2B;ps8Ad1IQgJqXwXAuXWkUD7OmrUaMqMmDv3cyoFQMHBVat&#x2B;J50EFAbEbIB27dpxNC8AnnzyCdr/v/P8ow5PelwqhNaoYknr//mdhZCdmgnjv30NWvfrALMfexsGv/k07F2xDQ6t2we1W9eHs3tOgrOLE7y94RNo0bsNBEaGQLXGNTXn&#x2B;A4kAzQSQCMANNPMIcN6e6ytr&#x2B;rjCZfSs&#x2B;m5CzAn3NnW7cLpJa/YCO0jQqmV381adlExFDAAQB0IdGbQxgBALX9frov7QO3qsO9GIuid3cjZd3dxgcXHz8E7nVsp3mSv5&#x2B;TB8cQUiMvNBwws1vDzgVZhQZbsgjvNMCugSpUq&#x2B;HBHMuDUqVM5Fy5eKMnOyi6tWbOmZ0BAgN503sS2kOabApQDX3tAiFe3quQQ26vX5dXiKrY6LBMYiC8xKbSbt&#x2B;fqhhFfN/AO9IXg6mH0C9oN6EKCbEW5JnGojIQ0iDt/nQBk4uUEyExMh9zMHLh&#x2B;4rJJzM3dFZIux5u&#x2B;GyNQZSZlbCdsV4ilEU6mqC21LjSDEtQgsOy3YG4XJ0ImJBX&#x2B;QV0CR4C7vSRyHSiLEdp6FmCJ0osHiDLyzTX34hchAYNtpcQe4qThwP4Z2XWOYlO4DkbzAyJCcGvgwpaF1awCRcxpbdSpGeRl50PVBtUoPdUvJIAyRDBq5e3rzZ23RHG&#x2B;YnOGAA90qgNM&#x2B;9kxSqSaWlsmNVV7NdChTDLYIxbk6/FKEniEggCOlRuI&#x2B;6eTROptAY8j2gBKBAPvnPG0R5SIBPkyrOnXmRAQyqpQtN8MhnXSfXYUIDpKANkTQ/y7DYmwLVu2wLlzZ2Hx4h&#x2B;gbdv28PXX35CKPxJnf5eFh0eQxgCC4sjIqmyfNsPYsWOp3n/RokWQlZXBQH0OPP/8BDqH/fr1U0zxxzln0aJvITc3F3r27FHpfcLWgdu3x8ADDwywec/V1Q0ef/wJOHBgP7z00os0x2CnASROVq1aQ6DfLshw&#x2B;XthRmZSOvz81gK4cvg8DPvkOWjQsSkUFRRCytVECK8dCQfX7oRjWw5C0rVEWu/SwbN0nX9&#x2B;5ifY&#x2B;NUqcGbzcXh0JJuDa4Bmd46pzU1aSYBGAGimmbLTAib1&#x2B;xfaNIUZe47AlcxsAtYEjGTrIlh3ZzflgXVrgKuz001/d5lgduTN34XaAh7MKfF34yv81w7wgRAvAxSbo4a43&#x2B;cysuACe9QJ8LNZf8PlG7Dy/BVIYzdBzHAQf9NWfx/oVqMKtAkPBT93tzv23CEZgFoB2EqQOUOle/fuSatZs5Yndhfw9fV1DQwKdOMDxXJyQBDzohXAkSOZBEo3H544Fw9glat025IHgjmii2n/1irnOlP/YvbRKvWqQVR9k96FYO7fjk5iTmomgVAE8yg6mBqbTM9vnImFovx8yErJgszENDoSRXn5UJBbSORDKYrIFRZTNMWZXQtYN44g1kXvSttHooA6GZh7yFNNuU4wfRcDvyYROZOIocMI6SZAP&#x2B;&#x2B;1qhChBC1LYSJdh1iOYT4X9K&#x2B;UZPHYX6Aa/BIGKJx1ztQNAsX1MH1Hr3ehel0PHwP4hPjRsdFjL&#x2B;jqYUTGNO7WEpKZE9qoa3N2nAuhTvtGkJ&#x2B;ZB36h/iRChdelgV3Xpew7nc1EC557POcergYCMY4Ce6X31IgApXGvpFLPIwPUWuCpEWP2ROvw7KiTAlLqRrBDCoACOaBTIQ2sv4cH/uWAXmm50jpK55UnUKpGLJiPmVBOGtC&#x2B;66QqOPaJCsEugWNv7PyTFht7jQFtU&#x2B;0&#x2B;Cua98MIkBq4zYeHC7yAoKIhA&#x2B;N8NTNFeeukl&#x2B;vvTTz/DlCkvEuh&#x2B;&#x2B;&#x2B;234fr1WOjUqQubN6uT6GDfvn3tbgtr8vERGhoGBkPFBP7y8vKobh&#x2B;PBUb0UaRPTgBkZmaCM5u/MfX/66&#x2B;/hCFDHoeCgnzKBGjdug2VJvzbLIPNs&#x2B;/f/yJkJqTR/erPuStMBEBeETz71RTY/esW2PDVaiLO8R6VciUBfEP84ZF3hlOmXN9Jj2jO8J3qwzvQcUUzjQDQTDNFxwVT7t/q1BKWnLwIu28kkvCfi5OTJT2/mDnjDFnCsKb1IDrA99ZchBhllUSsygjUO4G7K5/51zPg1Sg4EA7FJ5nrh02p/fviU2wIABQXnH/4FLmqmNVgMNeKI&#x2B;FwIS0LLmdlQ8zVBJjQpomVxsGdaAj28TFo0KBw5hiVXLlypeDYsWOZ7LzqOnbqGIgHl4QDVbIC5O/J37cHlng3H0fqdHntsXjRUpEcsNqWuRuBUGqEEulnzanYvqEBll/iH8YOQ0fT9yHgxJpTBAYF2XkE7tHS4lII&#x2B;COAvXLsErgb9FRiUFRQBAUMsGJWAW6/ICefShFQtFCvd4Ws5Cwqa8B2iHkZOaD3dIPc9ALQs8&#x2B;XGkuJDEBigSJaYoaBOQVZV17/YiIXLG25ZDXPTqZjQARDiWmbGHHH7AWdOfpOInll1lkKOkGQdNdgn2PgHYE1bg8/K5SUgQt2XmDfjb8d&#x2B;zuXFpeAwd&#x2B;b1vP086Y5wODnBcX5RVCzZT3ISsqA2m3rQ9y5q1DvHuZkFhaCp5cXcyj9ILxOJOSk5UBItXAoLTFSlBGPp2C&#x2B;xnVgIv0gMtgE7LA0B3QUYaMsoBJlikMttVxwgGuxJ1RnC1wFm&#x2B;8oL2Xgd8SwRwIokQKOkAXW14TkKrXzvjptxHuuRAjICQe1kgR7WQZSUgG4f3kkgNIcJLbvM19bOidLm1qdFedlz4lWmocq4oz/U&#x2B;3&#x2B;kpOTYM2aNTBu3Hh6feHCRVLwP378JLRp0&#x2B;YfuTcVFRURYBaPR7t2beG1116HixfPw6xZH8HIkc/A2LHjKrRNFAFs27YtdO7cxWEyIzU1FRYs&#x2B;AY2b94E586dg1dffR3uueceiI6ubbXe6tWr4OOPP2LHMpkIgq&#x2B;/XvCP1/A7Ykte&#x2B;5LI2tHzX4Q1s5fC6ZijsOvXrZCdnAGXj56HszuPU7YVkuUuri7QtGdrqNeuEXgH&#x2B;YJmdy8p8E/NRRoBoJlmd5Bh9N3PzQ1GN28AnaqGEQlwMSOLRPmwFrsWA/29akZC4&#x2B;DAW/adPm56kwCgVaRU&#x2B;eJ0RmFDBrL2xyWBi3lOQ32AzVduwJONym/k6QyQfHfsDGkF6BHkyLbh6eYCiJdOp2XAzD1H4Z7IELhbCFODweDSsGFD77p163ohGXD58uXchISEosiqVT2rV69uoDZXOj4JIGYESP86Qg5YPa&#x2B;AhoAasaDEavPIATnhIJj1HkrLytEkag5Yf7cJlGBfY9ECMTXdDJzrtm/ExooTGEtKTL3kcXtGIxQXldDnyhiwz8vKpYfew43IA3SssGY9IymdRA5zM3IgOyWDgdsS8GLAOpWt42ZwI9IhLzMPvAK86cglXogFnyA/KGYAHIkCrwAfEm7CZQW5&#x2B;RQ19wsLgOzULMJNBl8D&#x2B;44MCK8VQSRERmIqVK1bHW6cvwbRDKDHX7gO1ZtEU9Q9ICIIjAWmbIZqjWpCekIqRNSNgpTryRBZLwoyE9IhMCoM3NxdIT8nD&#x2B;q1bwyJl&#x2B;KhWtOaFL0PrBoChTkFdJzw2Hp4G6CE/R53dzcoKSsFFydnK0iHqf9e/j6UEYCRqBKs9S8u4waXbcZVBa5BJfE66Xvy5bxIMy/FXC27QOk7lUgu3nMlhXpHSmscAZm3zuFTa2tor9gEZJ/VKSznkQv8cy09DybA76LD2n4kNxH8mzOMdPYGkokjtF/bX1Hn&#x2B;e&#x2B;KvK1btw4aN25EqfRS27BhIwP8LSyvH3roIcjOzmIA/NaXu8XEbIMLF87Do48&#x2B;Dl5e/Cg8ZkKtWrUKBg0aZEnnb9GiBc0RLVu2hs8//7xS9fvBwcHsc6HUKhB1BOzZkSNHYOzYZ6Fhw0YwbNjTRDbWq1ePRAf9ZVpGjRs3oXWqVAmHzp27UjeAf7ulxafA5UPnof&#x2B;UIdC6f0e4cOAMxF&#x2B;MhZ/e/IaEdY0FhWw&#x2B;j4bR86dAeO2qgDqlGii88&#x2B;3GjeukmxUREaE6f2kkgEYAaKaZYxcGw4dNQgKhMXuksxtHDgM9ep0zZQi43YK0f6n5uenB4OICucUmoIb5AKjWXaLiRAUZPMhZ1JlzBzCam1NcDEl5BRBqVv4&#x2B;EJcMCey1j5urNQBgD9x2CUP/SAx46V0hlgG2tMJCcNZVXJn9X30eXVx0Pj4&#x2B;rigcGBoaWpiRkWk8eOBA2pUrVwv79usbxpxmZ1dXV52lDEACyARp1NUOESB9ragzwFmuVFqg1PpLSeCGF3VVS7&#x2B;2Ib4kLQulz3F9I2YLOJVrBGDNOj5EMTusVacyALZe9ca1TCBGMH0/jbXSEnB2cik/nmw9rHd3Z2O4ML8Q3D3coCC/gEoFsHYeo&#x2B;zZyZkMQHuTaBN&#x2B;F6aiIuAmfQy2fk5qNgPlQZCZlAn&#x2B;VQKZg4cEQQH4hwdSZoKntyf73lKTw41Rfbx&#x2B;3dws2Qe0GzrTtVbKrjVnnTVBhstCa1Yh5x1TRDGzADMbqJwBMzGwlMbFGYqMxXROi8zkiPTYikJ8AliXmcgJJGXYySehFAkogT/OVMUogR9plpMBahkGSroDcvBqu75g9zrggVAlUsCe1kZFgS0KNFq/b0&#x2B;sUArg1TogqH1eZ5d8KM8GKhNMmQ9lGF12sgbx6voE8laoakDeEaeZR95UxFCJH9PyHQXCcXFx8Mgjg&#x2B;HDDz&#x2B;C0aOftXpv166dJEyHtfE7d&#x2B;6A2bNnU439li1bb/n9Zd68ubBy5UpSyn/vvamUaSC33NwcIgmktfz&#x2B;/gGwadMGOHToMLX1ff/9D9gxq3gG3owZ06B79x42pASKB4qGvx0zBObN&#x2B;wzS09Phgw&#x2B;mgaenJ/vOqTBkyBBYsGABkQJSq1GjBj3uJFs5awm0HdgZTsUchf2rdkJWUhplZl08cAZqt64H7R7sAi3uawd&#x2B;low4ze50K2Y&#x2B;L5Ja2DEjImKg6tykkQAaAaCZZhUynCoCPdzpcbsMo/Fhnga4YMym78P6X2OJAPnGEsoO4FmAuxtXdfpQQir0iTZFRLbGJpBWgRz8F7DtImDzZYAolQEv/D4vV1cGZhhgcnK6a89leHi4Oz6io2t5NmzQ0Hj0yJF0Xz8/fWJiYlGDBg18IiIiPFTToTkAXkocyDMHeCSBHPjZIwoc0R7gOdz20qcdBUVl5iwCU3aKYBe0Ku1biVBULizI/mJUvLioiP1lIBrF8fSuZrziRuUCPsG&#x2B;UFZSRiULprIHEc&#x2B;Y9AawSwKWAARFhjCgXQJefp7gHeBNBIKnryeVxCBpgOAISwJc3fX0W3DbPDRUwpF4L5W9tnpfsoy&#x2B;w07UUzoulM49b&#x2B;zIl6mZuK7Sdh01wUHJBjXiQGmZmoid/f0SuACVN27VRAmVXsuXVT59VA7aBVDrOmA9O6uvy8a6gMCfATosdKEUfz6px9cnkJ4bJyed6jGtDJCvjJONTnzfvn1gzJix8Pbb7zj0mZISIzz55JPw6KNDbN6rUqUKjBw5nNLa8/JyYeDAgfDiiy9VuuYffw&#x2B;SedLPl5rJxdTUNBITfOWVl&#x2B;DNN19nYHohhIVZ94ffuHGTBfyjuv&#x2B;MGTNozsjMzIa2bdsRaeDkVLnyOxcXVyti4cyZ0/D666/B9u07qUwKOx3gsUJiBbsIoAjh4MGDiAjA1P9evbqDj48vLF/&#x2B;2y27z2JpQVBQIAQGBv1t93ZsjXv4r/0w5L2RsPS9b8E7yA&#x2B;6Db8fBk4eAmkJaRDVqIakrEyzu8VQvHLjxs0obgoDBgy0ex1r4F8jADTT7LYZCvNhP3cX6sfuuDUNDYKz6Zl0k0JAnlVshIzCIsUuA3oXJ1O0VxJsQiIhOT/fss6plHQbAqEQBcXcXGBc80YQ6mmAEylpsOnqDbiUkQ3&#x2B;d7AQYEUMo2UhoSFuPXv2DMEOAgYPD93lS5dyEhMSCwICA9yioqIMUpVsk&#x2B;o72IBfOShTyhyQgj21UgMpqeAI&#x2B;VARcCRfxx7ocQRUOXozLf9&#x2B;M6mAh9PcD1sw/0VwLsXYJcWm9ojYvYAXZTaVI5T31UbtAUEwR9zLTH9LxRpwgUNaKOW885CtHAkrNYtXQ8jScaHTKRIpvLGjNM7kY8ge8aBU2qI2xtQyueXCdLwUdXvbcbT9nb0MAkfGuTxTwNHxXHlSQHDgudLndOXkEnteUlJS5uJiSj0zgX9Tu1g&#x2B;UOdH/nUS3Q1xHyor9Kd2nVe0ZSBG6Pv16w8LF35jQwAgYJ40aRKBbC&#x2B;v8jKlatWqw2efzeUq5D/zzCiqj8cod69evaFVq1Y3db&#x2B;YNu0DeOihwaR8bwK4Z9nzevDnn3/Ciy&#x2B;&#x2B;CH363A8bNqynlnjHjh21IQBQcA/T/PFzJ0&#x2B;ehIYNG8KXX35Duik3C0pRV0A6xn18fNg&#x2B;HIdLly5C7dp1ID4&#x2B;npZ5eBggNDScsixSUpIp4p&#x2B;cnAI9evQiEgXXuxURf9QM&#x2B;OST2TBixEgrAgDFCg2Gm&#x2B;&#x2B;YpGS56dmQeDEO3D308Oi7IyCsZgS06tsBDL6e4B3spzmmd7CJc7V4rVy&#x2B;fImuf/Hax05GWLLiCDmpmUYAaKaZxU261VOCKTUfIBNTnF1dqDbfESKgUUgA/HSqjDoPoNOHc92NnHyoH&#x2B;TP/0CZYJNpimUAmYWFJqBfUsLAfhn4yV1PNpEOb1wP2kWG0usa/t7QOSocPj9wAg4lplI5wH/JsINA48aNfRs1aiRgF4GVK1cmJcTHF3h7&#x2B;7gGhwS7hYaGuYtjxZGWasouvTKwswfoeABQTijYpn07Tj8pASm5Iy8HTvZTqJVr73i7p1TDLn8tx&#x2B;GO/07O&#x2B;mr58DxSQIkEUCqq5/0wB4Cfo&#x2B;vwCCSl8aNGKIiZA/aIKKVzqMSTqJ1jJR6FB/zlmQSVOd9KmTBq47myGTeVdHXLp/cyU/s&#x2B;bOPn5OSsczanZqF2ifr2dYpkTfnxV97XymY9yNf/8MNZ8MILkx2Kuv/44w8MGJ&#x2B;GBg3qw759e6hFn2g//bSE0uR5&#x2B;6LUHi8sLIyB9umK34dK9giIHTXUGqhWrZqFAPjuu0UwffpM2s7Spb9QW8EGDRpQ9L1lyxY2n7/vvj6wadN6yMnJgYkTJ8KgQYNJO&#x2B;SWOPAu1hl&#x2B;ERGRlPGwceNGIgCMxmL4/fff4OzZs7B79y4iH9atWw9Vq0YRoMLjihoCfn6&#x2B;t4QAOHz4MHUWOHHiBLRu3ZqW4fd//vln7Fgth&#x2B;Dg25MVgJ1pvAO9IeFSPDz85tOac3uX2LZt26iUZ9mypfDDD4tp2aOPPgKNGjUmkgnHOOpTPPfc89rB0ggAzTRz3ApLSsHIQLLrLVS/f6R&#x2B;LWgSGgB7byTDmdQMSMjLh&#x2B;KSMruufbS/D4R5eUBaQTFF8lGt/2BCCnSrXoWAvdzy2b4L8i2yl/h70HKKS8DV3EpM6l9GentBq3DrOktsATipTVP4aO9RuJCZrbqfZlFwuJ6TC&#x2B;fTsiCzqIgirVXZdiO9Dew3eJLo4B1HBjHz8/PTDxs2rGpKSkpRTm5uyd49e1Kxg0DLVq38PT29XAL8/anwXaeA17ipzeA4y2QvI0AO1OTPlaK6joA5HuBR0xmQgyc5iFATa7NHCMg7HfBAoXw5D4DKLxu1lnhcvG6lIq&#x2B;CgNVIBHvkgBXydWSs6Bwml3jnXK51IS0ZUBtzatu0IiIE64uDp0dQkWQLpefS17xMA5E0kGcMyDsYqJXY8MY2T0dDqreh9DlHgLWAkw0zo9GI4J8BXIx6OetErQ3lbSgLEFaEi7iZCJn0sxh9XrFiObz00st2PxcTE2NJ3e3fvz9s2LDJigB45JFH4YEHBlI0/1ZYdnY2TJv2PsyYMcthMuOpp56kGv8nnniSXsfG3qCIObbRQ3IAU&#x2B;lReLBRo4ZQv35Dm&#x2B;0h6F24cBGl699MdgWWSrjJWgNjdxGxSwdG9jHVf/z48TBlyhT2vSHw11/r4OrVKxAYGEgZE9jCTx6J7927N2km3JrjmwU5OdkkeEh&#x2B;Sn4&#x2B;/PTTT7Qva9euhqefHn5b7t/unu4QUCUYkq8laI7tXWI4jwwbNhQaN24IderUtSw/e/YCHD9&#x2B;nI2nNfDkk0&#x2B;x9xvT&#x2B;NZMIwA008yxge&#x2B;MSvo&#x2B;kGNMp1Z/mHbvfguAq5ebK7RmALtVWDCkFBTC0cQ0kzNq53MI8gfWrQkzdx8lET9sCnY4IRlSCwoghJM6l8yW6&#x2B;RJAJTeafoNxrJSkP8apAaQAPDUu3D3u2v1KnDmcDroSbBNGX4sPXsJdsQmQEpeIRSVlYAL23dUQfdz10Mtf19oGRoELcODwPcOLSkIDg52w0eN6tUNBQUFZceOH886d/ZscVFRkdCpU&#x2B;dAH19fvY4DQnWgAP4lumACcJTWzes5kvKtBPLsCcY5At7UliulV9sjBNSAv5rCuzLeFlvS6bjkgRI5wAOPSuBf6bttItSCpNqb26Je&#x2B;gUOpI9URFVPjnY5DJTVuDG/x8s2USMJ1PQslDINdJLcKltyoVxlVHHcCco/UXqYHOlkoPS&#x2B;EulQGS0C3jLeOFca36jkjzXg2K0D21Oiqr8yaSWokkEkDKvT2Snd0FkRF/JrW05oqG2H95sKCwtAr7ee&#x2B;9PS0gh4ytXkT506wYD1E5bvj4y0VvKuUiWi0vM4trzz8/OzykKYM&#x2B;cTGDxYudc7lhTt27cP2rdvT8/xfvrggw/Bxx9/DImJCey3FVPrvs6dO4K/vx/88stSEuHDfUehUXd3vlYQ1ijfjH300UewcuXvbD9mQ7t27cr9GPptOti4cT1lRHh7&#x2B;xDgxtKAyZMnwQsvvACzZ88BX&#x2B;brKJk98ITnE7UE5K0CeTZw4IPUahHLHnx9fWHr1q3w2GOP0fKZM2fctnu2u5eBusX4&#x2B;Ptozu1dYNh6ErtWPPzwYHj//Wk4R1quz0GDBlL3im3btrCx/Qn07NmDsgSkJUKaOWaaKoZm/00CQOcEz7RoAM&#x2B;3agS9alaFUOacFKBq9y1qX4ROUYjBA3rWjIRu1SMccqi6VY&#x2B;EeoG&#x2B;DLyXWfqEf37glM0u4fIrGdlUJiDIlvtYUvhtvw87CwR4uiuSEU5UU2p/SsCOBWdSMgATJzxdXalsAX9eWn4h7I1Lgq&#x2B;PnoZpu4/CuovXocBYeseOEYzGMafVuX27dgH9&#x2B;/cPa9mihfeBgwfS165ZHX/w0KGM4uLiMguAF8qzI6ywjlBOzkhjdFaAQ6F9uCDdlh0ygNfFQHzOE6DjAT7BAZE/m&#x2B;9X6Vag1r1ArR2c&#x2B;D4/OssHJ0qp2mpBefvnXz2zQOCsZ9WnXfoCn5bJVrJ6n/Ncjl65X6LAUCiRESrnkrdcSadATeySN5Z0VsJ2FReSlP983nmUAn6lw6j0OaXOBY7tG58Q4I1h8T10ZPFRUFBIKpsY/Hd2cuGm98sJNGulfwDZzKJaRsPbR&#x2B;k2KyP6d/LkCQbkT1mWubm5m3UGym3EiKeZI/8eCXZaATcGmDdv3kzAfO/e3bcsQoy/65NPPqa0e9EwXT82NhZatmxpWZaYmEjLRENxP0xZR/vll5/pL2YNIPjt2/d&#x2B;6NKlI0yfPgMWL/6RgdsYuP/&#x2B;vhSVx99RkSh6fHwCZGZmOLTuggXfwPr166h84Nq1q7Lj7wQBAX5w/vw5GDXqGRg27Cnw9/eH5cuXw&#x2B;7de6Fbt&#x2B;4wefLESh9HJG4wA&#x2B;L8&#x2B;fOK6/z111&#x2B;wfft2M9HhSutji0KRcEES57fffqOWgrfLXN1cwS88AKo2rqk5t3eIYUZLZmam1TJ8PWbMaOjfvy8RALNmfQS//rqMrkHyUZnTi0KbL7/8CrRp0w5efHEyXL9&#x2B;Dfbt268d0MrgIO0QaPZfNX8PN2gTEQotw4PhWnYObL8WD2Vw64VCnCrgVA1vVh&#x2B;m7TpiAtp6FziRnAZfHTkFD9ePhgAPU1Qlu8gIh5NSbRT70dcLNEdYXNh7ZVYgz2Reri6KYa4yBz3efrWrwYozl6AIxQ6dxIlEZ6pHBJP42oX0TLiYkQVJ&#x2B;fkwtHGdO16ABfe/VnS0Fz4SEhIKjh07lr1///60lJQUY4MG9b2rVa9hwJaC0u7gEu3AchddpwxIdRLSQAfKgWBedoFgiYzLgJv4GRVQpyRKqBQJ5gM7WT26LMrrqCaBEnnAIxGUarkdBTL8/vXKkWMe1uaBSK46vlp0WVEhT/q&#x2B;TsIKKYN6m&#x2B;W8LAH5ekpoWC2jwPJaOauAN87sCRpWCuyZ207adN&#x2B;zc5i51xXnmgOwJ0ZoP3NASgYgcYjtSXGQ6t3M7fuI2LL9DiJ5K0FKy/exYsQCVOhaPXz4CHTs2LEcjLnqzfX5pvGxZctmititWLGC1PgRoIpWu3ZdGDduDEWLMZp&#x2B;qwyB/M8//0Lfh7ZmzRoG2heTmKBo2eye36NHdxIP3bv3IHh5eVrmEYzmI3jdsWMH7N&#x2B;/j8oZEAR36tSJ6uwRkHh5eVd4nxAo33vvvfDBB1PhrbfetlknNvYa3LgRR2UFaFlZWbB27VoGstdTCQHuF6b6Y0o9WlFREVu3A5UelJSUMcDfjVKi0Xx9/WDRom/tqqOrGUb/EWhJRdYwOouZHKGhoXRMXnllCnTu3BU6dOjA9jcTMjLSKWL7xRdzaT3MREhISISYmO239R5do2k01G3bUHNs7xCbOHECXQuDBz9sWXb&#x2B;/Fk4ffo0jB07jsi1ixcvUukNimyitgcazi14XV6/fh2GDRsGW7duhqZNm2gHVCMANNOs4oZAuiaK4Pj6MD/ynwWqtdh&#x2B;BDGgn1Vk6i/urXeF9ZduwOWMHOgQFQbVfL1gz/VkSMotAE9XF2uswPa9YYjJufLSu5hbt0kB6K37bU83rQez9x8ncgO7HqBuAZZR6NnkjCUB2OYNCYjVF65Bi7AgaBJy99RohYeHe&#x2B;AjPz&#x2B;/JDU1tXjv3r0ZZ86cyWZOmVvd&#x2B;vV8Av0D9DqzBy6OJ53oMPPOgWBNEugUwKYF7&#x2B;usP6qTpzHbkAMOAChQF4uTlxMoATZHyxPkQMKR12rrSQGMUiaCUuaAmh6BvRZ4SoCfF5DXqRAI/DR2QdavXQXRKgkNqjEVauvwlnPFFdTLVXjLHRG55JEGSuUs5WUq4rC31R2wd37VdCXkxJD8MKoSdabzSE8ZWCtFktDZDP65&#x2B;6/jnSqdinCfde0/7/YlB/pyfY6KkKC8bWA7PkwR37VrF4FAJAB0ktQmBLCYqhsbe5160ksNiYOlS38ldfpbVecv7isCerTr12PhxRdfYPvxJ7UItJDtw5&#x2B;G119/HebNmwe//bYcnnpqKEUYa9WKJmCNABfB7MyZH0L37t3pMzt37mTA/U0Gel&#x2B;t8D5Nn/4B7N69h0APHi&#x2B;eiOHcuZ9DQEAAEQAJCQlUB42pzXi8sXUfptHjvvTo0ZPWf&#x2B;CBAaS2jw/MEJDbhAkTqQtAZQ3JDux0cN99vWHdur9o2RtvvE7fP3ToUJgzZza1EFy4cAE7VhmwceMG8js6drwHiouL4PDhY3D58mUCb0jy3E67b8xA0BvcQbN/v/3xx1rSCUExTCSoTFoWAE2aNIOff15KBFLVqlWJtOPd&#x2B;7HNJ2beLF78PYwYMYqEJzXTCADNNLspp&#x2B;GfjlN7u7nCgHo1Ye6BE&#x2B;DBQLSeOSRYs38pMwsuZ2UR0EadPw&#x2B;ZunIpW&#x2B;jvroe6AaaWN5imX1ImWAXF0CcrpDIHuOn2B5g1EeXjBUHshosigqijkFVYBFeyc6CoRAAD23cMbbmx/f947zGY1a09aRvcTWYwGFyY44oPAzr3J0&#x2B;ezNm0YUNiYFCwW6NGDX38/QPd3PSuTlKCRpAgChNJIFfdl2B3wTqTwHLa1Op7paSAGDQWI9AA9kUL5dnFUiDjINiTAz17AE4tnZy3Ph&#x2B;QKwsWSrsXqPWCd0yoTf21HFSqCd6pZewrgTklgUOhTODXuauRAo60YuC9VjowCoPJXrtD&#x2B;TKdQlaBPVJJpzBmlMab2vlVIgEcPYy4rIwhIZ1E8gDBPz5x0jnp1A67vHMBD8yDAx0aTOSE7ZiWi3M6SgTwMhFSUlLgq6/mw&#x2B;rVqxnQuwKpqWnMMddbWhRiW7jU1BSKRCcnJ9loAOD31q9f/7bMzyIRcenSZXo9cOAAAskjRz5DkcVmzZpSCzxMO96xI4YIADRPTwOBi19&#x2B;WUa6BdJjg7X0qAdQGW0CTKd3MQsOY7kA73iOGPEMdRtYvXoVA9BGEug7d&#x2B;4MESVlZSVQr15DIllEE4kJJbsZ8C8aZnAgESJaXl4ukuBUwoClEfhIS0tnQK4/Hav587&#x2B;EpKRkts8dCNiJ3RNut2ng/84wzITBVpWoU4GEmwj&#x2B;0bCUJikpiUimP/74k8jF0aNHE0EoGhJNWLqD4&#x2B;r996fDqFGjtIOqEQCaaXZ3WM8akdQ5YMmp85BXUkJgHh&#x2B;lZkff1UVnA/hQ9G9wvVpW2wnzNlBav07ibKXlFzgEqOwZtguc1LoxRPh6U7cBI9uvvKJiOJOeCWvOX4Oz6RngxSZ2F/ZenrEEfjh&#x2B;Dia3a8oth7iekwdVvAxEbtyphs59y5Yt/Ro2bOgdFxdXuH379tTCgsKyoOAgfdu27QKxg4DO7N3TOeNE5aTn0&#x2B;JwSwGrSBjI3X8RpAt8bsCynBeRlggT6uT1ChLtOjWs54gptZ7jRXMVWxtWcNyqibXJiQDpueAJuKnpDjja3cAemeAIppa/56iInTW5U8E8eekXOFI8f5OmVK6i1OFCTbCQRy452jnDxJwpcyS8Q4GPkhIjvYMt&#x2B;&#x2B;jw2On1rtYl0nZMKtc58LIS1IiEirb6k5fcnDlzhurOsbXcu&#x2B;9OpVpdE&#x2B;j0pjTxbdu2wtKly6ju//vvv4PHH3&#x2B;CRPluxt57711u6jwXEJrFbhs2bEDiedgK77PPPiUC4Ny5cxThnz//C4iJ2WoB9Bh5ROV6BCVSYCKaI/3GRZCSm5tD7fZEw&#x2B;dBQSHmfdNz5ycRLCckxMPJk6fgwoXzkJycwoB/fYrm9&#x2B;nT52&#x2B;9rxUUFMCGDRusiBtsa4jHCXf/2LFj0LVrJ0rxHzToIXj22WcZWKumOXH/YUPSDyPyTpx5D0txmjRpAm3btmHX3jzo1as3Lce5BHUjMPvl22&#x2B;/tWiIoNAftgetXr28RSXqeixb9iu0a9f&#x2B;tmeVaASAZppp9rdbn&#x2B;iqEOLpDkvPXIKrWTkE4txcnGhilOK0EnYXLmI342ahQdCxapjVNpqzZfvjksDV3N0AP4fK/cIt2seaAeWTr5uzDtwM7tDBEAZNggPh433H4Fx6JoF6dxdnOJyYAol5BQT05fbloVNQw88HmocFQk321x9bHd2hXIC7u7tzrVq1PPGRmZlpPH36dM7evXtS4m7cKGrQoIF3gwYNfdlNTg9yoC&#x2B;&#x2B;5gAqq0YCFjV3KQq0PlwWiCDIlvEilTI8IeviBjqVNGg1dXUrMCVjLHiChHKgpgT8HCUFrEChIHDSwpXbFyoBH0czCCpKEqgRAmpBeh74V6pNtylHqOj1pYR2pe/Je/DxGAh7zEUFMwkcIQ546yl3LwC73TLKBJuxRKe1tLRUcHY2ea6U5s8D0QpdD5TlHGzqPkBtcqxo2z9HSADxfeztjvX7kZGR9HratA8oA&#x2B;Ctt96CRYsWweefz4Vr166RaF3Lli0oTbd58xbU/x1bw92ss45gePnyXxUJAPwtBQX5YDCYUv8xAwCXYb1837796IE19GgoBPj994uolr9Ro0bQokUrSE/PoHp2BLI3a5jijC35pAQAHseSEqNIGNt8ZvPmTSTah4baCJ9&#x2B;&#x2B;ikp9M&#x2B;YMZOB7vvBz&#x2B;/vBzsrVvxK5Qiog4CG5/vatVgCXzgWsH4bMzyQEBg27Gmrjgua/bcMSz5wbhoy5BE2lrfavI81&#x2B;xMmTKCx5O7uYZ5XTHNv//73w9q16ygDYPfuXVQa0Lt3LyIRv/rqK6vuGpgNIM0I0EwjADTT7K4yjJS3qRICtfy8Ye3l67DvRhLV/ZPD5gSWntvolDYNC4JnmzektHupNQkJgAPxSVbLrmTmQF6xEXzc9Ldt37GMYVyrhvDUqs0Q4mkgUcCi0lLYfSMRHqpnq9Ibl50H59IyYdf1BKju5wPVfLzg8ca1wdXpzm5S4ufn58qcpwBs85WXl2fcvn172oYNGxJ9fLxdmzVr7lelShUPJZCkk4B8eUaA5bYp6gyIAN/B9GyrshDBmiywSgIQFECjDaAHm3aHNoyEAlCTvlZKC&#x2B;eJEcqFC&#x2B;UAS639oaNaBLz3eC0Pldq8CTfRUcTRID0vQ0BJn0CO3x3N7uftgOCoqCEPzPM6G6gh4UqzFrZjSIkYUCORlMYWA3Nlzs4uTtgeVK/X6yzg39m5QjvKS/l3NDqvlj2gfgorJvyHdfyvv/4qhIWFw5o1aymCjSn11atXhz597qPI&#x2B;HPPjYd169ZBly6dqa4fuwM0aiQK0tmCV6yzxzp33IZjAMOoSH6govjo0aOgTp068Oqrr9mA7OvXb1B9OiqLo2FN&#x2B;rfffkfpxg899CCMGjUann56GGRlZViikjdjCORFJXwJOUyifmjyDADMkGjatJnlNabuv/nmmwxMPf6P3b&#x2B;wU8F3330HY8aMI2HCCROeh7/&#x2B;Wgf9&#x2B;j1AUVzsYtGqVSs4dOggaRpo4P&#x2B;/a9gFBEtcMIK/Zcs2m/fPnDkN&#x2B;fkF4Mp81JiYbVQ2guNfr3eHS5cuwcWLV&#x2B;DXX5fChQsXobAwH&#x2B;LibrD5oZiyhoYOfVr1uy9evEBilH363K&#x2B;dCI0A0Eyzu8cCDR7wZMM60CMqEo4kp8CljCyIy8lngLoMQg3u0Cg0ALpWiwBvTrpio&#x2B;AAIhKkYCXXaIQNl2/AQ/Vvb7ucYLbftQN8IT63gDIAXJyc4VhiKpcAcGPvYwlDvrEEzqdnws7r8dCndhQEM4fpYmY2CSKi3gBu806sEkDFb&#x2B;YA6/v16xeO52Hv3r1pa9asjmc3S7c6dep6hoeHG5iz6KaTePOCCnITJKjBUt8uiaAKOnnTtfLsAqsotwys6qQaBRwcLy0dkKrbSzsXWAL&#x2B;UmFDnR29AaUv5AAxOSEgB2i89ysjZmiPGBCzCmzaNHL6wfNEDJU6FvBIBNuygvJlZWUVyyhQWm5P5V6&#x2B;nsMK&#x2B;EolBfYk&#x2B;e3tDA/5qpQk2NOvUCMGpGMGW6nqCPyXkbqGyYnVOykiejskg22ihFLJiY57gSjpBtgjEJTe43XT&#x2B;Oabr&#x2B;G9996DL7/8CsaNe5aANCp09&#x2B;zZm0T9vv76KwLxGK3G9F0xii2CfyX76KMPSal&#x2B;7Nix3HRhzjxKAEI0BA4I5FE8ECPu&#x2B;PzAgfJ2YCkpqfDFF/Pg3LmzDKQeYufJDV544QV678aNWPjxxyWwZMkSeO65CVC7dh2bSOPNGAL8Bx8cCF26dIHJk1&#x2B;0LBPbILrJCPjZsz&#x2B;GY8dO0PO8vDz47LM58PHHn/yj9y3UHoiPj4fly5dSVgQCrfnzvyLNBsykwFKJmTOnw65du2HVqlV2t4fro6aCZnef7d&#x2B;/n80P8yk1X26YNbJixW/QtWsXmk&#x2B;wYwR2skDSrnXr1jQmkER89933SLhzy5atdO0GBQVC48ZNVb8XM09QyNPAfEMk7njCmpppBIBmmt2xhnGlKj4G9qgGpcwBzSoyQinzP33cXMFNZcIL9zJATX8fuJieTbX4aBj5/&#x2B;X0RfhfjSoQIHN2XCoQccfvP5uWSbX&#x2B;KEDoyZwb3J8avt6kPeCic2Kg3RsuZ&#x2B;YQAYBlCLFZuZQN4MyXqmbr6GgfsJMAOqGogbDtWgIUlJZCmKcHtAgLhu7VIyBUUkZgZN99MjUdUvMKIczLA6r5eYOPXv&#x2B;vPZd4A2zfvn1gu3btAphzVbht27a0TZs2pUZFVXVv2rSZX2hYqLuvj68rN9VdsPX8BRmqthACPPggJQ1UgK4lCskjDqy6GliXFggKeN5uGz2O4KBV5YCdDAL5ckfFCXkAT/4&#x2B;77UaoFM6pvayAcQOEXLhQt654bU/rExNtyPYXKEjoGKtuRJWrxBZwAP5SoIItv3u&#x2B;NtVqlWxs1PiWGLAX8CIZxmb&#x2B;BgQxfJ&#x2B;Zi5qeF913NmbIxyfT/ifVWv7p/a9CKoRzIuONALA3bt3w/jx2JbrfkhKegdeffUVaumHqbwIurdti2GgsEGF58Jly5ZSdNlRc3Z2siIKHn30YZgz51Po0KEjZR589dXXpKKPWgQHDx4kgTzsUR8REQFvv/0O9O//gAXgC4IOatSoCa&#x2B;88jIMHvwI/XaxzditsDfffJ0APwJkFO3DlHn8blEc0c3N3aquHkXNfvjhe0qNXrJkMfj5&#x2B;dtkEPxddvz4MRL169SpMyxa9D07TtWpywAC&#x2B;CVLfoRPP/0E5s2bT8cVQRteQkrlHTgnoYBgQEAgrFmzGh555FHNobsL7erVKzTD8eYYJOUiIyOgVq1asGfPXrouUAugb9&#x2B;&#x2B;FkIIgf///teNygewbMhRi4uLI/Dv7e1DRMOtvIY1AkAzzTT7V5kzcyAC3N0cXn9E0/rw/PodpNQvAipMrZ9/6DRMadeMgW0ns4MrQCq7wZc6oBCAkfplZy5CDAPnmFEgmPUJsMFAgIcbRAf6QIvQYMgvKS13SPFzJSVUCmBQSRUsZU62t5seFp&#x2B;8APvikgj0YmbttaxcKl/YHZcAb3dsDSGeHpBWUAjfHT8PW6/GgYuzjv0uZ6ju4w0D6lWHDpH/7hsBwgfmQHk8/vjjkYWFhaVnz57LOX/&#x2B;fPbSpUvjmjdv7tulS5cgb29vV3sK&#x2B;nLQpAQ0LdoBnBR2OaIQZIBJJAzEv1bAVCxJsAOkpESANFMAJCBfDjal5QmqmE3SBl6tRJqXFaBEGlS0c4EjxIDlMyodC0BQIAcknQzk4J933m&#x2B;WDODhZh6g5wFRJe0BtWoA7rl1tOWCGsOgtIyHnmXrCiYmTVdUXFTm6opSpzoC/&#x2B;VEjH1ErjQWeMDdfsmIjrsN/k&#x2B;0Vf1XE7TEZQhCsZ7/&#x2B;&#x2B;&#x2B;/t3weo9FNmzaHoqJ8&#x2B;PDDD2Hz5o0QHR1N606d&#x2B;gGBbFS0r6hhyi625MP6e170H8EmAmRxX1H875lnRhEJUE4IOMOWLVuIAEBF&#x2B;qNHj8Iff/wBx44dgXvu6UhRR2ydh2nJcsMWY4888shtmdt37NgOderUhS&#x2B;&#x2B;&#x2B;JIB5HdIxA&#x2B;Vz5GUGDZsOK2DHQikbQ/xOL700hQCyuyeABMnTvrH7k1Tp74HDRs2pnaFbdu2tSy/ePESFBYWwaRJkwn847nx8VHXJcD2gOSHjBhJ/d01u3tMOsdgVgiWg2RnZ9msFxsbSxk67du3J&#x2B;IQO1xgy9A45suhYQnJwYOHYN&#x2B;&#x2B;/RVu57dv3z4i&#x2B;QYOfPBWgX/hv3QONQJAM83uYqvh5w3969aAtReugrc5Mo6A&#x2B;lhSGsw/fAruiQgl5/FcWhZsuRYHrjon1RkQiYJfzlyCVeeuMNDvQmSCpX2dk0CgPCE2D/bdSAZ35qBJSxME8&#x2B;ftzb64zf03kigTgPQOBMxOYJ9l72UWGIlEwAzcr46cgs2X42Eg&#x2B;31dq4fDpcwc2HM9EWbuOQJ9alWHEU3rWgQQ/82GwoHMIfTDx4ABD5TFxMSk/vrrrzeysrJK&#x2B;/fvF1azVi0vXg28GijlAVeB0pd13NR1JUJBKR1dWoYg8NCIDD0KnDR2Kz0DsG1xKE94sNE/F2xFC220DcC6VIE74HTKz5XKD5TAvxqJoEpKCDJSwU5pgRrZIweUSlkF8qwBR7sYOLLMXvmBvYA9j2hwiCjgsRJKpQIK4N9oNJYh0C81loITmz/0rnon83HROQL61Yk/3u4oRe11ij6pdco/2AB9RzIAxPOPivXY2s1oLIH4&#x2B;DgCq2I9N7bIq1WrJsyYMY0BdWcYN248PProoxUmmOSGWQY//LDEIoontUuXLlKrvS&#x2B;&#x2B;mE&#x2B;vEThiJP3pp5&#x2B;2RNDR5s6dRyn&#x2B;aBkZmfDYY49A3br1YePGzZbyAx74V7y3lZXRX0fKEbA&#x2B;&#x2B;fz5s1ZdAcQU90WLvmP7O5OyKbD0AHUGENwPHPgANG1qWv&#x2B;BBwZYpSsjWXD8&#x2B;HGoXbv2Px7FfOmlVyg1W25NmjSG5s2bVWhbM2fOoNpsHCuaRsDdY99&#x2B;u4CN50EkBCmScTiv8VLwUYwTy4b&#x2B;9797iThEAb&#x2B;5c78Avd6VOkyMGzeGyIOKgn&#x2B;0Ll26wsKF31I5gQb&#x2B;NQJAM800k9mjDaLhbEoGxObkEijHWQ4j/5uvxMHO2ARwZei6iDm7OHnrndSduvjcPNjCPueFPVyhPE0ca/gxvd&#x2B;JOa0e7EaPQMbIAKeTU8WdRKqrdXUm9xdLDXSis8octEhfH6jq4wWHE1Jg69V4eLRRNDzZuA4cSUiDzlXD4f5aUXAgPhnm7D8Bhcy5nNimyR11rrCeuEePHiEtWrQounz5cv6WLVuSd&#x2B;zYmSowRNvt3v8FV42K8lQEkZzlaq3TKpLCLn9toyUgWy4XMJQCMcGKVJBHmcVMBT4M0qmBRMF6RZ1En0AkBWw2pipWaMsZKHUpsJdBoETeyHvcq3U1qOj5kmYN8EgAmxaUDmoRVAT8VVSHQA6Q7QX91ZbZ/XKbEguBAdJSwUnnpMN2q84uzjrb48AB4TyCAZQV/&#x2B;2ds/LBaDtI&#x2B;dVTOkVNCfk5462L6fOYbo7RXuxzL32/sLCAor2rVq0hYTq9mUTW3aQYC27nt99WEIB4&#x2B;OGHrd5DYUAsD0ASwMPDAF5eXhQZxzRfqbAfpgpj9gEC919&#x2B;WUqigtjWz572gNJ18/bbbzJgPpDAiD1bsOBrArevvPIqjB07jvZh8eIfKDsCQf7Ro8fY9t4gogM7Izz//POUwWBxvF2sNXswhb5Tp07/insQD/yLIM&#x2B;eoSYEtk8U10U9iDZt2ph/s1affSfYypW/Q0hIKHV/4BkKPo4Y8Qy15sO0fXE&#x2B;KCsr5Y6R5s2bQ7NmzWlcPP/8RBgyZAiRAE888TisWbOKWk3&#x2B;&#x2B;edfldrX0NAQNlcsY/OILwwYMPDvOkR3DVGgEQCaaXaXm7feFSa3awoz9xyFy5lZVCOP4oC&#x2B;bq4EsBlOB3cG2m1ADENMJbJllzNyoMBoBAPbpugoFpeUkJ5AgMENsouNVI&#x2B;fZyym79HpKjdbYo1mNnPoUC/AxdmJIv7GklJoFhpI72&#x2B;NjQdf9p2D69eArMJiWHD0NHi4ukCLsCC2rCa837U1jF&#x2B;/C2qxG0O/2ndeX&#x2B;LAwEA3fDBnzD8jI6M4JiYm7ddff40LCgrSh4SGunfu3DnIYDC4UEsynS0QVQOq8vW42QIqrdJsItSCLWgWpIiF07POCojiViXihjopKJJGqaUCh5IWiPLdkGYSWJUdSMGlji9myCMQuLd/nTIBIwjlfRl5SvLyY6/WsUDpvCh1RbDaJ8EWZFo&#x2B;pygcaK0Or962sGKkgL0Md6U2k3LM7mhmgN0yA/YXW/fRZCiYjpCzU7mCv62gI797gi0TJRXhFLUd&#x2B;CSFEgHDI0fECBuuj7or5V9pS/BgFFt8jRF9J3OmFvZtr1mzJoHq3bv3MLDXCnbs2AZVqkRQGj06/lKQjVkBGF2raHTOkfGA5QSo8m0LQNvSPu7du4/S0BEs4G/AB0b8RFu1aiVz/AMI&#x2B;GPa/eLFi6Ffv36Vmm9R1A4JBkxl5hmmGmOE/plnRtL5RfIC2xF&#x2B;9tmnMHz4CFpn&#x2B;vRp9JsbNmwE33zzDbXxEwUR/yuGpA0eg0mTJlEJB4oeihkN0uwNzf6dlpqaCkOHDqOuH0qWn59Hf7G8QyQAUGAzMDCARGlr165lQwD89ttKygDB1piivfba65RVglk0mPlSGcOuGrt374THHqtUtwzBznJBZd27ggTQCADNNPsPWBVvT3i1QwtYdPQMHE1OZaBdAA8XTLE3OatFDMTbCgrqSGTP6gaRX8icZKfyaC7716pKCGUZYP1/MfOnE3Pz4FRqBqy/FAuFzGlzJHIpNfTH0wuLoEVoEHSrEQnuzk6w/XoCrD53BdpVMQkj3cjKhboBPmBw0bPfUkSlBTX9vGH3jSQ4lpwG07u2hXc6t4QPdh2CFuFBEOHleceeO39/f/2AAQPC&#x2B;/fvHxYXF1ewf//&#x2B;zG&#x2B;&#x2B;/vpK8xYt/KpWjTJERVU1YOuxMguQULqrCTYgUq6Ir/Y55T7pku3Ks9cVcsMFWZiXd6eVihXKBfEsegQWwG8NRq3FCm3JAp0CeLQiEHSyZSKJIH2t3pZd8VjyXvMyCXjnh5ddwCMGFIEZ6FRLCpREBZWiyGoZBbwyhIqQBErZADxdP6UGA/L1sS0nAn1jKbbxM/fu0yE8UU&#x2B;bV9QalOXj63jkjqKWoaAQ9Te9FoG8COq3bt1KYnLt2rWjqDOPQJASOFeuXCERthYtWtLrESOGU60t2pIlP0BOTjYcOXIUzpw5Cz//vBQ&#x2B;//wzq3OFqvsVjdwiOO7evQdlDKgZ1o/LxxE&#x2B;UCH/iSeehJUrf2PgoDHs3LkTmjZtSr9bJAwuX74Ezz47Cs6fv0QEAIJzVA1H8FIZw4yESZNeICJAbufOnaM0ZQSyHTt2gMzMLPjoo9kEbP78cy3MnTuXHdM9cN9991GrQiyZmD//S9IZ&#x2B;K/Znj27SOtg584d8OOPP7HzdIVaBqI5O2tw499uV69ehezsbEu5Bl6PmJETGhpqie5HRlaF3r17wvr1G9h4LyLSALU2sDwErw0k7eRzKOp9yK1Bgwb0qIwlJCRSCU7btu1IUBOJh5sE/0IlP6cRAJppptm/31BJf2LbJrDtWjz8dek6xOXmUqQdU7fCvFArIAqWHL9QHr0UUPDPKJvMrXEPOrh9o6tDNd9yIahADzdoGBwAV7NyYGdsPPi4OS5aiDeL4tJSaMdA&#x2B;3Otm4KvuynltHlYEDQODrJ0ADCynQtiDqHZfafyg6eb1IEStmPD126DxSfPw&#x2B;jmDaARcwqXnb4Ek&#x2B;6wUgAuMeLkpGNOpQEfSAQcPnw464fvv4s1MkAzfPjwKG9vH1fmBLuBBHQoRR7VxO/UItK8Ong5MaAUsbYX6ZajN0Gl2FyQPZeCFjloBVHEUAazyMqs2x9aaRIICrBM2qWAWxMuaYsoP/4C8Du6sddlOkGx5EBODvCyAJTAv11tCM75KBP1IhRKQOSv1YTm1LQGeCQDjzyw2jfxnKkAfnkWAH5GLE0pLSsVnNjEYRH0kx7LiqS2c1MBrIkb5S6GOuUxbh4cuE5hQQEUlxjBx9ubyqlQSR1b8EnHuZgVID2W16/HMgAaRRHqrl3vJQIAHXVsv4V1/Zs2bYLNmzdT&#x2B;v&#x2B;yZcvJQceWWhhtl&#x2B;6fF7svVKQ1Xnp6Brz11psOpeNihFj6&#x2B;3/55RcS5sP9wIwDbBOIPcWxLzh2GkDRPATh77zzDinmv/LKa&#x2B;Dn50efxWj8zRgek8ceGwJ6vQusXLnG6r0PP5wFCxcuoiglahacOnWa7pnY8hDJAcxUePnlV2DChIn/eR9j5sxZVAaAbSP79OlF5ys4OESVmNbs9htmz2DXjjZt2qqWcmD2j1QCY&#x2B;3aNTB58gswb94X1BUC9ULCw8NJ1wG7g4wcOYKuAbwOMbUfS1tGjhx1y/cf1f737dsLDz44iF5//vkcOHz4CPz113rSGLgNuFy4RetoBIBmmmn27zCsz7&#x2B;vVhS0qhIKB&#x2B;OToMBoUuVvHBIIET4GWHTsHJSUlpnq&#x2B;JlzlltoTQAEe3pYqlIpZRZLCdxdFZxgduOpYPQf2wBmFhbBY03qWsA/GgoC9q4VaXGgUcugkDlhUly4Ny4F2kaEUsnDhbQsIhIea1wHXt2yF8a1bGTpeHA3GHYQwEevXr1CLl&#x2B;&#x2B;nLdnz560U6dO5bu5ueseHPRglZo1a3qxm7GTGk5RVGjnRJt5pIH8r3KGADhMAthtwScvKZDdiQVOaFiaBaDUXR1AOZBvhdntxQ10HCJAAv4FXmmBWHKg6mk41rde6XiqCUcqnUN7n3WEGJA&#x2B;52UAyIE&#x2B;T7fAEY0CJR6Jov3OzjrstMGcWxIWcTVfFzzArrZdm6i/QucLedq/fBuOpv2jTZ8xHUaMGAF&#x2B;vr6oTwDTp8&#x2B;wpOjjNtCZR/CK0XZxuwj0sd99x44dYcOG9XD//f0olR/V/THCfe//uoKLswsJz6FIXrNmzdTmmQr11s7NzaEouI4j&#x2B;iknfbB9lzRyh&#x2B;37DhzYR4rgYWGh1NYPI5KPPjqEiAoEGFgvXKVKOAPcL8Po0c/esvkUe5hjpHrduj8hISGegRxTxBIJE/z9mIGwY8cOBjoOUh/zIUMehl697mP7EsmO8WY6Tv8Fw6wTpa4N27dvh969e9PrxYt/hKFDn6IMk9jYaxAVVc1uxwDNbp/h9fPss6MZWD9v1X1CblinL5YLYWYNkmJI1K1cuZJ9zouN9b8gOrouifoFBgbCjz8uIfD/&#x2B;edzaV5CcgAft5a8KIO3336LyAeRAMByH7G0BDOUblKT5D8Z/dcIAM00&#x2B;49asIcbEQFyuz86CjZevgHZxcXkxGYbrdVVI729TA6u2dlEBw7b8&#x2B;FyJRKgMubtqld1wmsG&#x2B;MCxpHQoMSs3G1xd4KdT52H1xWtQyBzlIIM77X&#x2B;ktyd96EBiMnSIuPt6xKJoYL169bzxwZzj0oMHD6bv27s37eeff4677777Qpo0aerv7u7upNRmTK1FOg9Qqd1n7aWvKwkSqhEFNusLCiBUJVdcUACptEzeqUAC6qxArOTHW2UL2KgRWgsV6mS7IwX/lvclLQ919hgJTsmBIBNCEHR8ssARfQilzA57IoQVFSlUK0GQkwDy9dWyDaRp8WWlpUKpOXVebwb/9iYl68wFTs2/Su893nFSJt&#x2B;UqKjy5RhJ3bRpI4waPZq2gY7u&#x2B;vXrKPL2&#x2B;htvgoE55mJdOtbATpgwwZRBVVxEtf7Xr1&#x2B;HJ598ChYu/AbefPNVqvNfs2YtqdNjSy7MELBn0ppdRwyzBaQlAwUF&#x2B;TB&#x2B;/DiK6Hfu3JnU81FE7PnnJ5gzAMpLzBA8snkLBg0aBE899RTV9yOwnDDhOdi/fz/7jY9RKvKoUaNV9wHrgpX60ivZ3r17GchZRUTKlStXLQQA7sORI4ehQ4f29NvefXcqpf5v376LShTwN9xN4B/JJPyd8qwPFDLcs2c31fHz2id&#x2B;&#x2B;&#x2B;1C6nYgEgCYXfLcc89R5gZGapEAqFGjhuZ4/UOGZTVvvPEGjVceqfPnn39QO01X6trkRB0/Pv74Q8rkQE2OadM&#x2B;gJSUFJg1axbNRRMmPE8dQfDa6NLlXppPbt&#x2B;YzCDiDb83LS2NiIdu3bpRppBp/wWrbhwVAPNy6WAlkC84sK07kiDQVDk000wziz3VqA6836U1jGrWAMK9DBCbnUvp9aJV8/FiDx8wlpqi72XMX/393GVIzM232RaB80pOifbaBXavHgHXs3Ig32i&#x2B;CTBH8qH60WxZLvSpFQXDm9anFoCeLi4Qxfb5VFLGXX/u2M3duVOnTsFjxoypPmnixGox27al/vD991fnfPLJhb1796TxQJeOE1wX8Y1y3bJ9QTcewJcCTB5RwCMO5Cr68u0qlTI47gYItvLz4g&#x2B;UFnyLIoTyyLYUMIJyUwHpe1YdC0CWVSBtZyhIjrWMFJCfH0GQeSKVdEmUsgPky6X/7J13e&#x2B;SDEhHAey59yNcpLaNZQygpNc9YDA27urjQrluNc0ltvr2hIeeT7DFh0tR/3jXGIztM9ba2zA5&#x2B;TnTY8Xl8fDw53QsWfAOrVq6k5WPGPEvO96wPZ0JOTg4tCwsLh4EDB1DE/6mnhjIwp6doNbbeCgoKprpZBP&#x2B;8Y1upuZrN8xgtLCdvyt/7/fffwWDwZEDhCNuXJ2DGjOkkQIiGEWHsPiAaiult2rSZUukReKNhPTIq869cudqhfcHsB6zJr4ghIYL79MEH71PLQTHCjWnTs2bNgBs3rkPTps1g6dIVlFVx4sQJArefffYZTJ36/l1z/8Dz&#x2B;O67b8OpU6ds3nv44UGwZctmblvFn376iY5VXp5JHA41G5Ys&#x2B;ZF0AA4c2M/GXk9a3qJFc83B&#x2B;ocMa&#x2B;0xgh4Xd8PmPWz9OWjQg1RehNeBs7MTEXMXLlxgwLopLF&#x2B;&#x2B;jIRAIyMjSCQTx/4LL7zIzmtvKsPhgX8E59j6EkkhqeE4eeON11TH4I8/LmbX2lLLMgT8HTt2Ij2Ts2fPUpaRj48f6YygIWnRqVOX23HYhAqQAHekaRkAmmmmmcTp1EF1Px96tAoPhgMJyVBQXAJebq4WR3Rok7rwwuZdEGwwlQNczcyFWbuPwoB6NSDcyx2KSwHOpmfAieR08NTfnimmtr8vhHi6w4H4VGgZHgi5bB9bs/1FAcAb2fn0HhpqBPjoXSElv&#x2B;C/dA51ERERhvfee69ucnJyEXNYs9avX58UExOTWq9ePa/o6GjPevXq&#x2B;8lTOXmAx7ZNnzJQUurpbiO0pxOst61QciBdphSFVotS21PKt/kB9hAgp0OBNG5rVWYg6Wogdi8Qt6WTaRJYRbrN/&#x2B;PKBMgECXUyrQEQZJ0NQFK2YEeDQE0ToiIEi9J6jpQUKAkZqgFTFO/H8V5sNJZhmguakyiGh&#x2B;NbOVNfAtb52TGOZMbwiBOV6gCreVZ0lLGWfPjw4TYtBrHmXxpNHzt2DJw8eYqidb/88jMJASJYxjZ6Bw7up9ZznTp1JEIBa3GxhR6myc6f/zWlsU&#x2B;cOIEB5BR45pnRUK1aNe7&#x2B;VMYQWKDwH7a5Q2fc9Nt1Fucc04MRZL/zztsEmLE1Hlp0dG1o0qRpuTPK6ROP&#x2B;9&#x2B;3b19Foig2Ntbqtyxa9C3Urh1dof2vVasWRfGRYOnZsye1QhQNW6F1794TWrZsaSmFMBgMVC6AbQBNEdO7wxCcLViwgB2DXjbvTZs2w6qjAR57BIWY9o1aDZ9&#x2B;&#x2B;hnVgqO9&#x2B;OILkJ2dQ6TQ1KlTaRyagFwQaPbPWPfu3Rh4Pk8lNVhaI7XXXnuNavrxusSMHZzN8JpC7Yb&#x2B;/ftS1s0DDwxg10ArWLduvUNZQVivj2UC&#x2B;Dn8PI4FzBb48891VJb0/vvTuJ9bv/4vylqqVasGDB48mI2ps1C/fgOYPHkKm0fmkaYJEgD4O3C/kTAYOnQotQOsJMAXZM/tUeeOrndHmJYBoJlmmnEtzMsA/WpXB4MMxDcK8Ye&#x2B;0dWgwJyC5enqArE5ufDZwePw4Z7jMG33IVhy8gJNzm7SunsdVDrKxHOgH29UBxYcPUUp/1gCkGc0Usu/LdduwPHkdJNTUyZAEXNsyv6j55DdrN26desWMnPmzAbjx42rxsCR8MW8edfmfDL7/I7t21MEqageVAwfq4F/eRBdTc3dEUAp/cv7ZwUYFYQNhZu9V3OipFYp7TK9AbnmgE7uMUhIAqmooQ5sQw8C5z35cRTkborsiwVJZwOB59ZwnqueH0Ed9MvPmRJolhNA8gg977NGBvjxmLC/AtUlE&#x2B;4n4wLxcvJExwWScvFI6TZ0Ot4LPvi3B/ilfxHwvvPeO3Dk6BHLmUVSTqxpxXRrsV98cnIStcbLzc2GY8eOsr&#x2B;5BFixx/rq1ashLDSM0rfRUJH74MED5KhjK7rLly9T7X&#x2B;7tu1g9uxPoGvXrqrzMApuVcTw&#x2B;H/11Zdm9XBnSjcWbfDgh9m&#x2B;JxP4//DDjyzgH61Pnz7Y4aTSl&#x2B;OaNWuoZ7lo&#x2B;DtPnz4FDz9snaKOZMnhw4dtPo96AqJh6joeExQXRMBB5DED/F27/o&#x2B;OsVQHAQmD119/nfqg36mGKd28MYplGpjtgMQUAnoswUDDdm/YGk7M9Jg1ayaNXwRseBy//vorS332lCkvUakJPlq1aq05Uv&#x2B;wzZ8/DyIiImH8&#x2B;LFEHso7XSAwRz2QOXM&#x2B;oQyaatWqEvE2ZMhjJOiHxJ44bzlaErR48Q&#x2B;g17sTgEd75ZWXqYMJzl0BAcpEEAp8vv/&#x2B;&#x2B;9SVw0QgvUcdP7DbRs2aNWDFiuVw4MAByjzAfcT58tlnx1QW/IMCiBdUSIKKbFcjADTTTLM725w4Tu/IZvWhXqA/Ce3hjIctBfVOzpBVZCTRFhTpQwe2TDaVlgm3bn7EMoBwL0/4&#x2B;shpeKl9M/B1d4PmoUHUDnDp6YtgZI5pnrEEYjPzLBkB/1XDG3hoaKj7kCFDIr/77rumDz74YCi7seaMHfPs0a1btyRdj72Wh4JpFSFopAJegmD90CmkqsuBmRrQ5LWEUyo/kJMBPFJAWucuX5f3WUcIAUWCwLyj0tc2rQ/NB0LMGJBqD&#x2B;hkBINOzCQA4DZhRMFOneR9AcA2tqFA2MjPj5w7EEsQ5KULiloEgmMZBUqaA2rHv5gB/lJK8Rd0eGwsSv5mcG4B82D9O5UC3LZ6AkqdHayL&#x2B;XWSf3KygNt1Q9YiEfujIyg&#x2B;efwETH1vqvl9J4r6o5K&#x2B;YGZrMMKMn8N0&#x2B;aKiQhLCc3VxhaioqiSU98AD/eGzzz&#x2B;F0LBwqMUcZPzcSy&#x2B;9BO3a3UN13NiSDtt2YdT6yaeeIiCAwE1OeIjkAab7YoROzdavX88AX3kUEdPCsaQA03ZRKAz7gWPN&#x2B;B9/rKX6/3vv7UL7LYp2icaL&#x2B;FfEpk591yIsh8DFVGIwy2odTE&#x2B;fMuVFGDz4QavlCCKQQBHtzTffgJiYrZa04rvZMC0byx14Q9zb24dE4jB9u3v37jBq1DMExDDaP3/&#x2B;FzRm8FijYCPqNSARgJFa/EynTp1oO4MGPUQkiWb/DkMdhoULv6WyGiTjpMSXSIR1734vXLx4kTJyBgwYYJmzMJvmiy/mQYcOHRz&#x2B;PhwvmPGDYwC1SRDAL1&#x2B;&#x2B;lIhF1NiQ6n5IDdfr0qULkWtz5syhbezZswe6dfsfTJw4kYH/32D06NHs7&#x2B;/QunUreO21V6kbx02aEsB3pE3gHV8WoBEAmmmmWYUNI&#x2B;7PtqgP/m5uDPQXUxQeATc670Y2LRpLy8DHTW/jCBeV3ro5E52Rtzq1guvZuZBeUAQhBlO97NQubaCqjydF/2Ni4yG9sAAaBgVqJ01y3Bo3buw7fvz4mm&#x2B;99VatpMTEwp&#x2B;W/HR93Lixx7Zs3pKUm5dXglE9eW9dOTkg75EuXc&#x2B;Rvrw8jQF7&#x2B;gKKAA2UiQErkkBh22r6AkpAVqkWvkIEgjT9XMKeCLIDJO1uIPB&#x2B;LH4GQZ3kfatWiZIDqwMJoBexLVgLFiqSASDTF&#x2B;C4TIIj7pUCKcA7hkhMlTJHz1hqFJyxpof9c3F20VkdZwnSFzjkhL3rQU4y2YwxB4gxef27dNvSvxhNXr58BZw6dZKipGK9O9bezpw1A3r07Ea1rkgG4LrOTk4E5p97bgID/A/AmbOn4eGHhzAHOxo&#x2B;&#x2B;ugjeO/d9&#x2B;DM6dOQl58H99/fB06fPgmTJ0&#x2B;mc96//wPM6fbmaidgJBBfo2Dg66&#x2B;b6nI3btzIjrdyvtTChQsoxRsVxdFQd0AsL/jppx/p95lARH8YPvxpAouYPo4pxrfa/Pz8Lb8Ho/y9evWidGOpffbZHDhx4hTpImBUUrwWzpw5bdEiQMPU5oceGgw1a95dwBXr8lFMUmqYIcIvXdBBELtPTp8&#x2B;jVKsUQAOAVhMzDYCb6joj1kXSKj4&#x2B;vqRnsPYsePYelNh/vwvLd0pNPt3mb&#x2B;/H9xzTztq6YckXKlZvwnFMkeOHE4lPNjicsuWrRRRx&#x2B;sVhTqfeOJxePnllyjqX5HrF8fBrFkfEljHeQsJwvDwCOZzNCLik2coMLhv3z7S4Ljnnvbwxx9/EkGI5SP4/d9//wN1K5k3bz58/vmnpENw9uxpEiu8BcBf&#x2B;lqtLMDRbd0xpmkAaKaZZpWyKOZYvtKhBWyPTYDTqRmQU1QEBezmEuFlgBZhIaTEP/fgSSoDwNkRMWFOYTED6rcuGh/o4QZT2jeDD3YegrNpmdAyPBhCDR4kBLj6wlUqRcDWgC1DNQKAZ3Xq1PHGR25ubgkDHdk7d&#x2B;7M2Lp1c5oLcxB79uwZ3K5d&#x2B;2Clll7WKuyCpfZXqd&#x2B;7uK7Yx10NX/E0B1Tarlu9z&#x2B;u9rhQJLqN9dKxsQJpVYK89Hq/loeXzHFE5q204qklgfq6TRL5tDpJ4niTZBlZRcoGPz&#x2B;XdC2waE0i7FogrSI&#x2B;x&#x2B;JrzPjeNQba8jA0SzOcvKCgsc3PTO&#x2B;E&#x2B;O&#x2B;mcdFKyRl7DbxlTMsE/Jf0H6edMD86AkpE10u&#x2B;Vr4rOc2mp0apNmlLrw&#x2B;07tsO3C7&#x2B;jzZaZO5mgaNrBAwehYYNGsHXrFmjYsCH4&#x2B;PpQtBYd9/Ub1kMRA3N9&#x2B;/Zj12YPctzRiZ8yZQoJ0oWGhlG6LtatmyJtgmr3hCVLlpB&#x2B;wK5dOyn1HXt9YwRfp&#x2B;OPvzNnzrL1fmD7FmOJICMgxIjh1q3bqN4X7Y033qK0eUwlx99w25xXi3iiSSxwxYoVDLC8SunDaBihxtp0bFPWo0dPyM3Ns/x&#x2B;7Cpw773/o9aK586dITCLCuNvvvn2XTW/Hzp0kOq5q1WrbgXQpCUNJrLX1D0jMTGJgfsC&#x2B;O23380kUTEkJSWzsTGX2jti1HXw4Idg5sxZtA0UaJOTaJrdPsOxi6UZ2GrP0U4XTzzxFDvn7mxe6ABffDHXUnaD58zPL4DAPep04HUiGmpiYKYPdsdo3/4eyiBSsj///BOuXr1CZJCUKMTlAwcOhFGjxtB3NWrUGGJidth8fteuXURU1a1bD7Zvj6FSp59//olKSX777TfSIhDHGRqW6KBOALYDvZlDqQLwhQpu5441jQDQTDPNKm01/LzpkVNcBKl5RVDK/IBgd3fwdddDfE4&#x2B;ZDOnwVfvQs4C&#x2B;giZ5hrCW2l1A/yoA8CKM5dgzcWr4MUcQyO7UablF0L9ID8Y17IReOi1qU7NvLy8XFq1ahWAD&#x2B;yZvm3btpSNGzakxMTEpLMbt3fnzp2DGahwVax55wExGejhkQflnzPdS3nkAY8kUCMD7AmwyQkBHmkgBfy2d3y&#x2B;uKB8Oa8tIk9Z35ZIsEXIXBAra6lne0xtay6kmg&#x2B;Wb5KIFIoZBKI2gU4mYGiVnWBOHRBkxIDlj0Sg0Ab/81od6kzRficnZx3W9ru4uOoYWKEKJOmxEniAQxRWVGuRyBmPDnrdNhu2apNo/pGbN2&#x2B;CFi1bga&#x2B;PD5cwM63rZAanP7H1vOG55yaSujYC0d27d5FSf1FxISz58UeYPftj5uRWgd27dsPhI4fhkYcfgd69&#x2B;zBHuQ5tA6Pry5Yto0gbqmQj8RAVFWVDuEnHh0h2YOT&#x2B;hx&#x2B;&#x2B;o5Z7GKHDFH0TqFYWtcNa4rVr/wBvb2/45JM59P1IHKDwHgLFTZu20HoYRcbU39sBfqTnzmDwsGQajRkzBlat&#x2B;p0BnC8oXRjX3blzO/z11zqKZKMafXJyqmVbqIY&#x2B;fPgwCAkJhVOnTkCbNu3g228/vumyhH&#x2B;bYSkGloBIzdTnvfw16iMg4MNIK5aVTJ8&#x2B;k7IGMOo6bdr74Oqqh6efHg7PPPMMATWtnd/fA/TFcY7RceyWwe7JRNZhBPzPP9dDixYtIDExAS5cuGgpv&#x2B;BZ1apVKdsH6/BfeeVVy3IkCTGDSGl&#x2B;xLIeXqtQVOPHeQmJJCTNJk2aAG3btrciAP744w/qLjB79hwqQcCMG2wziGUkYvs&#x2B;0V5&#x2B;eQq7VnfT8/XrN8KhQ4fY5z5i4zaSu2/vvvveLTnEoN4GkEcOOJoRcMcQA5pXrJlmmt20eevd6CG1QIMbDGkQDRuv3oC84mL2MEJ8XgG0vMXfjQhhQJ3q0K5KCIn/nU1NB72LM1T19oL2kaEQ4OGunaAKmLu7u3Pv3r3DevXqFXpg/4GMn3/5JWHrls2pderW9WrapKlvk6ZNfQ0Gg4slzVzmoCu1cZM7N9aAtRwNygELzymypxlg078d&#x2B;FkGOp1j73E7HNipc7cL4BUBKj9zoDJgyerHKTAmUoAvWJ&#x2B;Q8vcA&#x2B;EqPUhJIUADWgnVGgZUYolnhsKi4WHB1dXUSaQkGRJ3kZIy05l4n88gsRIOU3OGUdfDIJ95Ps2KEdDobAkduqEyNauhLlvxiznIps2xf/A4El4WFReDs7MbA/MOwafNm2LZ1G3y/eDHUrFELMjOzSOwvJiYGfvxxCfj6esPixUtg8gsvUgRObAkoRmujo6Mpyu3s7KLYxk9cV07QISAQwS5uW4ywiSr&#x2B;UktISCBwmJKSzJz95xkAuEqtBKdNm07ieZhSjtG62w2esbUcth5DwgIJZQQg4m/GMoqff17GgHwryMhIh5MnTxLwqVcvkv3WWhSxlp7z4cNHwtdff0lRz1mzPuIq398NhtkQ4tjeuXMXO8/&#x2B;dKxEIgoN2/s999zzROLgOEAdCAT/WCIxZ86nJAT4&#x2B;ONPaDfGv8k2s3kB6&#x2B;hRJBPFPMeNG0sZNp98MpudE0/2&#x2B;jlqxyeC4d9//42dwy3QoEF5tg0SXlFR1agk5o03XqcuHc2bNyfF/JsxFB9t27YNCUK2adOWMmlQPwTHDhIUFy6chyeeeIJU/rHWH&#x2B;e7KVMmQ0FBEREHOL9gRF801B9ITEykeQ&#x2B;zj/C6ffPN19lnXr7tHAsH1PPS/5UAveDgtjUCQDPNNPvvmRtz0oY2qQPtIkLhSFIK7I1LhrjsnNv2fdi1AB89a0ZqB/8WGKZgt2nbJgAf2E7wwIED6czZiP/00zlXHnlkSFjdenW9GQjxoV7rdkCiGkBV0haQghoRSPHLD2zLDeT12I6UGCiRCHIiQE3MUI084HU0sAa4yqUIckKAl31Qkedy8kaVTVHyejjt82zLCMpJArHkQMwIKCstpfoLBKmimJ8TtqngHFPbEguz8KE58i&#x2B;vOFAiXZQyVLi/Xy3qL9suOuwFBYU2Y1gE/mhnz52Ds2fOQL9&#x2B;/Rn4XADZzJl&#x2B;YeIE&#x2B;GvdOnLqMZo2&#x2B;OFB4OPlA127dqE6WhRXk4J5KZDHSC6CfzXDFF4sCZDvFwJo3C&#x2B;TkKKrpS7Y1dXF6izi8g0bNhBwePzxJ2HFimWkjP/BB1OJAJg4cVKF5xWMAIpaCBUiep2cKRKKJQ/4CAgItOwrpqkvX/4rERGrVq0igISK4qgTwJnX2DnoRwDr&#x2B;PHjpDCOpMLdqFhvOsY6OuazZk2nKOy4ceOtjj3qTaC6Ogr7IaDDyOvTT4&#x2B;gNGtvby/tRvg3GootPvTQIFi4cCG9RtCMuhQGgyeJ4yHoxrkGyS/UaYiNvUbnCFPlpQQAEoNvv/0OPX/ggYFQr15dAu9Yk19RInnNmtVEkOFnz549Az16dIfGjZvQ&#x2B;3Xq1GZjywg1atSE558fD9euXYVLly7DjBkz6H3MLnn44cFUaoBaEkgWjB//vGX7KEiJv6V///70XRj9nzBhAgmZ/g0EQJkCYFcC/0rR/zu2LaAmAqiZZprdVqsb6AuPNoiGqZ1bw301bVPKSqXiZJr9Kw3bCd5///3h8&#x2B;bNa/Tll182KCkpLv3s00&#x2B;vvPvO26cvXrqUw5ySMkcApKNOB6/dnlKGAS&#x2B;jQIlsUFumhAPlwnDyUnulbAS1DAMu&#x2B;QB80KvWoUCqpC/9nFIXBOnneNtTYYOUSCITwJceFEkHBPmnikuKBWNJicAcXTo8DNTqnJycdEqgXLHFnrk0waZYQsffhuL2dY4PV/m&#x2B;WCdH6MDF1cUGaCPIPnL0KD3HlH50eFHsD1PwDzNnF0F8w4aNSPDvrbfegmVLV8DwESOpzh/BPwJwaY22NcElKEb&#x2B;8X1MHc7MTFcA06aOA&#x2B;WgX3yutxANaKiUj7XDaH379oVFi36Abt26WZEKFbUvv5xvo0TuiD322GP0F9OWMcqP&#x2B;4CdBoYOfQq6dOlIJRgvv/wK&#x2B;7uFVM954F8OjocNewrOnz9Pgop3suXl5VI7Nyx5QENiA8GkSBDheHB396A2jBjZxzGDYxDbwiEBgGr&#x2B;mO69bNmvsH37Thg7dqwG/m&#x2B;zydvxoWGqPGYC6c3ZlKirgdlAeE0i&#x2B;MfsICy5QcPx/tprr8EjjwwhPRDRsHzj0KEDlDGEYyA7OxO&#x2B;&#x2B;GI&#x2B;dOrU2eF9w0g&#x2B;EpJY2//cc&#x2B;Mt&#x2B;4ok2WuvvUGlJWgo0pednUtzCZYGIQmBpThoOB4nTZoIHTt2gdWrV7FrtCuVHeD8IRpm4KBAJ&#x2B;4v/vaZM2fCxx/P/jtKceRR/zJwPO3/rikF0AgAzTTT7G8xbzdXqObnzZ0hc4uxk0CJBTQI2uH6d94w2J2&#x2B;atWqhuHDh1dbvPiHpn369Alc8M3X10aNeubod999d/XixYs5gpLqnk3jeoHfJ9BOyroc6PA1BQQbckCeUaBGBPDIBqw3lu&#x2B;yvHsBT6dAqcuB3TaIKleBva4EPL0Bq1R4jjieKhmgwGAI0naHgq0qv9jqsLCoqMwEZgUBqQIGvnQiEJUfR17qPwdxmyL&#x2B;vLc4UXpp/bscwFt1lhBfyAT/uOUbgqmmX4ymO6MitQ4k0W0dc&#x2B;Yz4NVXXqH1I6pEQGJSIkXrHnxwIIwePRKq16gJPXr0oP3DaB8Csvnz55J4Hh4veQmMdOzas1GjRjJnu4flc5jKjaru5QSAMx1h3Fe9pXxLoNT5cmCZRym6uA0sAUDAgcrhqMbtqCEIwegy2o0b14HNExVWjJcCnE6dOkBs7HUYMGAgtZxFLYIZ/2fvKsCj1propF4oLdIWK&#x2B;4Oxd3dHi4/FHce/nDXhz3ci7u7u7s7pVihUKDQFuqy/53ZZjebTbLboi05fKErSTa5SXZzzsyc&#x2B;XcqtQfTkhJ7s9aJpGrVqjWwevVanTFaQkWvXr0oXf/Fi5d03uCxR/KGY8Gfj1i7z2d6oCkiOsN36NCeOlIcPXoc5s9fQCTR3PFTEX9gaj8aaoqBhFr7lai9ZrGEY&#x2B;nSJbrvySZNGtG1g&#x2B;afW7ZsZufvSuq&#x2B;UaFCJd06vL2fwo0bN2HIkCHQt&#x2B;/f0KfP39Qhw1wnfzxH/vqrIbUFRCM/f/9Puu&#x2B;cS5cuQpUqlag9JGY8YUo/lo08ferF5j0EkydPpi4giEWLlsC9e/fZOdaOhEU8/2bM&#x2B;M/gs1AAmDFjJsybt4Cdg8egVavWVHL0EyBH/OW6AGjMIP4J7rZVFQBUqFDxS9GzaF6omtkNHGxtqItAQFjEL92e4MBguHHgInzxD1QPjgkxAL0C5s6dm2/SpEnZAwICIlAMGDig/90N69e9fOvrG2oUQpdoX2dSLFAgouIIqFz2gFgcMLUOKUNDjuPM4sXi98RCgDh7IC5tEM3VRuTIvzCbQJxhINX1QOm5WDQweI9tYGRkZIyGkSyM&#x2B;DMCYqFNN7eyAI6TNHjkZKL3YOpuKx6pQ&#x2B;Z6AEqZPArXERMTRQQUo/p8ZwW8WccbcysrS7hw4QK9h6mtly5fgi2bN0O/fn2gXLlycOzYcRg&#x2B;bJgu4o5mWZfZPAsXLtGZ&#x2B;UmJXeaIYthDG8UJJAv4HG&#x2B;qq1evCj16dGOP39G2aUm/1uzrxo3rFDVOntyJ3Lp54HzDhg2Gpk0bQ5EihYlUHjlyTFeDbA6QkPAEPjAwiG2TjcH1hpFGH59XuueYJmy4vDeNH4&#x2B;6deuR7wB6F&#x2B;zevYdahqEYIGzrZ&#x2B;b3F9VF/67AOm5TwEwKbK1Wu3ZtRqLmMWLWlcYW072xRAKFKYzOYir2kyePdSRw6dJlMG7cBHj27AUjo9cMHOBV/FhgCn&#x2B;jRn/BxYsXDLJtEFpfC/1zdOLHVpYIPOf9/T/T8UIh4MOHjxRZR5PHWrVqGpzXKPjMnz8Xli9fSeUyK1asNHv7Bg8eRKUFZ86comsKr1dEWFgotf/EMhw0I/z48QNdg5hBNGzYcPIu6N&#x2B;/P5XWYMlJQIA/&#x2B;54rS&#x2B;T&#x2B;/HmtyR8uKwZeg926dac2gD16dKfMgZ8oAABIp/ibQ/YTbPs/3fe7ejmqUKHiV6JoGhdwT&#x2B;0Cr4K&#x2B;whP/ADj24vU3pZB/K6IjImFu&#x2B;4mQu0wByFO&#x2B;IOQtXxiyFM4JVmonAekfESsrLm/evI6jR&#x2B;d1ZDeekexmPeDIkSP&#x2B;/fv3u1&#x2B;6dBmnqtWquubLm8&#x2B;Jk2LNUoKA8K9UHr2UmMBx8uxbQgxQKgEQO6fLvSf3mtijQG53pfwGxM/FIoJwd2V2UVYMMPc1JR8CqedCso77HcP&#x2B;i9GmrmOKP5p0cqDQGUJ82E2Z92nLDUyQYOAUu1KYowoYpfwLXP/xBhvXfeToUfDzewfNmzXXZQIgKdu8eSPVyi9cuICRWx9o1rwpjBgxEvLmyUvtu9j1QusS1vWPHDmSnuMNvNi8z7zN148RGrkJHb9nzpzBbq57UUs4jSaaIotY03uUbf/u3TuIbLZr15Zt91Zy&#x2B;OaRLl16iughKcdIOW43GovFBblz56HWXQgsaxBeK0gq0EgQWw9iqQESBzQUW7JkmW4eNDjDdmI8kES4urroyE5iw7p1a6FNm7bU0WDlyhKK865du4aR/m7QokVLg/NAK2xoKC0bo7UPHjyE3r176Yg&#x2B;ErfGjRvT48ePH1ENtoqfgz179pIgFhWb8YhlNjdvXodq1WpQZwu8PPjzGkWbFClSUWbQ/PnzIX/&#x2B;vNR5A1PysVQDr5/8&#x2B;fMbZNTkyJELBg4cRO0CMdMD23TGBZiFgOtDo08U3/gvWxQsq1WrTt4CuB24rVg&#x2B;U7JkSXYerqVMhRo1alDZAm7/2LHjIVeuXGZ5feAYzJkzhzw80OjzJwoAMaK/EPs4BuLfDjDBlAaod7QqVKj45cB73ExODjSVy5QWrH5hX&#x2B;HQLxhV0cDzm0/h4bk7cGLVQchSMAeUaloRSv5VQe15rAAHBwfrihUruuAUHBwctXPnTt//Zs70TpEihXW9evVdc&#x2B;XK6ejqmtrOSmAcaNhGTsG9Xi5DQIoNx&#x2B;MYGRF7iV9pqRICsQGheH4p00Lpz5e&#x2B;LuSMCsWZBVLmhOYYF5pqmygk/WKRgCf9UdFRGizkj4mOwWg/1fTr6jjFxFpAzI2EDUFpglQKv&#x2B;7AyJB&#x2B;4yi9VCaHxABznOw&#x2B;G4sWGnj95g2kdnWFmzdu0KJ4w5uEkVsk/ydPngD/T5&#x2B;garXK4NG2LQwbNoLdVNuBu7u&#x2B;/wkSfPG5Iib/UsaW5ogAuLyv71tdKj8uiy7b6M796dNndiN/BJo3bwFly5Ylh3CsyZ0wYSIRkpw5cxqsD4ki1g&#x2B;jd8HJkycZEW8Iu3btgTRp0ph9XaFAgsZ8GOWzs9M79&#x2B;N2YtR6yJDBlAUwZsxoqFChAgwYMMjguD948IDKJFC0wPmvXLnE1rc3UX5/LlgwFzZt2kwCgLDsQQro8SDVCx5Tt/E8wLRr7BSBpA3FIHE7QB5IulT8PNSsWQOCg0OhRIkSdL3Xr18XvLy8YNasOdCpU0ctMWPfnViHf&#x2B;rUSRJoWrRoTsIclmucPXuWMnBweUlSZ2UJo0aNptIdFIgmTZpIhqLmomhRd/pKxJT9169f634FY2KiSXzD7SpQID9Mnz4dDh06xL5rXsO&#x2B;fQdg4MAB1JWA/97nRU5z4OzsTK0DUSz8SZBL/Y8B&#x2B;Xp/U14ApjoD/HbZAqoAoEKFit8K9nF0h/7eCPDzBxtbG7BNagvpcrmBz6NXcOPwZQgM&#x2B;AwlGpQHzlIVAMxB0qRJrRjpyIjtBG/duhW4a/fu9wsXLnjFbl6S1q5d27VQ4cIp7O3sLaVbx2mMDd7MLAuQFAfEWQRSr0v1uzdTLJAqIRC/LkVGld5HzwFx20OpVohy7Q6lEiaUMg1MiQJGmQEakj&#x2B;4qEhG/mMN5SwstQ84g8J6w/1TIuRypFsjKRZpn0iZHhqKDPrXtAQ7WnqwdO/H6NaJ/2ysrSEyUtu7GtNdMfo2b&#x2B;4cMpzLlTsX3Lt7l6Lp&#x2B;fPmB492bSE8LAwGDRxMJLl06dJUJ4vg66/liDtlT8RmBMiVoSgtyy&#x2B;HRD6a7SNv8od18piGP2zYUEofbt26Fb3erl17irZlzZrV5LWMKfh449&#x2B;7999xIv&#x2B;Y7ozmhhcunCfnfVtbOzqv8UjhvmLkGssdsP0XCiXoAC4Gpri3atWCyC6KAJiJkFiBkXq&#x2B;lIE/bxC3bt2k8pBu3XoIhJX3usdo6IcGcdgJAVOo27fvoBMHBg36B96/f8/GsCUZJKr4tUAjPAS2w5swYTx956DT/&#x2B;rVK6FTp04kui1ZspiEHDRtRLEOxSAUcdB9n3fgNwUsNUJfEWzJFxdgaRB&#x2B;V0VFRVNrPvx&#x2B;QR8PPMemTJkMc&#x2B;bMJqETU/5TpXJm3yG1wcPDAypXrkriQ3yAGQc/kfwDSEf/xWReTiTQxOEzfmuoAoAKFSpUCBDo9wmJDIR&#x2B;DYXeK4fDyzvP4M6xa9rWW5b6lNMYdmP9/LYXcDEcOGdODY7OTurgScDFxcW2evXqrji9efMm9PDhw&#x2B;&#x2B;3bt3qO3369Gd58uZ1YETELUf27I56ZscZ9ooHw77vxnTPDDFAThTQ8CySMx0KlxMMFAQCqR7sUq0NpUifcSmBRkZEMBYHTA2L1G7J2TSId5URYA1mcCC5Q5KiI/1gXoRav08CXwSZOnsj0m&#x2B;wMtOfJSajoaEhlMKOJJ3ctkQCDBrl2dvZgyW7kUXibMMI/&#x2B;7du6BevYZU74/p6JUrV4ZDhw9Rb/QP7z9QZA5v4nv07A5p06eFAvnzUzq7NhqvoRtpodCh94KQJ/hSZSUm7zZj14XbEs0&#x2B;E/cXX8M2d1jfj/uDZKBatWo0PxINc8g/AlN7cTkk4HEBpggXLVqUIviHDh2mLARtCYW2Tjlt2rSwZ88e2LlzO0yfPlOXBSHcb1wGo92FCxeidolxrfVPSEiVykWXzs0LOAgPjzbw7NkzOtfq129Ir9nb25K4smvXLkoVR3&#x2B;FcuXKUwu26tVrisVYSiFX8fsASTYa&#x2B;d279wAWLJgHY8aMp&#x2B;sVjRkxnR7NGJcsWUru//EpdUGxCM8XTMOPKxnH6w6FxEyZMtJjFA8PHjxAJSUdO3aCoKBAyJEjJ3UGyZgxU0Ic/hgzSL4pc0AwUxD4bYUAVQBQoUKFCgE&#x2B;v/9M9qjo6p0qvStNhWuWgK&#x2B;fgvTf6OxGde&#x2B;sTXBsxX5KtUyfJwNU79IQClYtqg6gAtKnT2&#x2B;PHQQ8PDxivLy8vh4&#x2B;fPjjhAnjvTK4udnVqFnLpVzZsi6MfHEa4CO7YPA/HyMGQfd32V73SoxX&#x2B;JczIRjw7E3kQi&#x2B;ZXy8jBEg9V/ISUOpOIJdJoPTclBggzhYwultiTBZb97Fz3SL2OZJ/zoj2S/TViw&#x2B;Z5UQZGBr&#x2B;EEiUCxi1QZQk1OhoH0IGV&#x2B;PHj4eMmTJBFLa2EsyLkf7h7EYXXanv3rvLiHwBWLFyBZw6dYrqWgMDv1D9LdZRYxu6zp070XJbt26jm2VX19TQvVt32lck21JDYnwayW&#x2B;3UmtLJcEDW79hdPHMmdPQtm07quNFwzeMCmO/&#x2B;3jdKMahLdfdu3d0UUqM/Lu7u5PXgINDMhIQMMKIbuKrV69i896jjAp0D69Xr67OLEwIJEArV66Kcw/zhAg0XAsMjI4dc20GABo3ojiCZRjz5s3XCQBo3oj13f7&#x2B;H6FLl27kk&#x2B;Dq6ip5/qMAwPswqPj1sLGxJKNG7D6Bbv2HDh1g10w&#x2B;ivRjGj269mfLlo3a6sUXKFTG7xy0o&#x2B;sdv9NQPEiWzJFKCdBXYtq0aVC2bPnEcAiUMgCU6v&#x2B;VMgESnDGgKgCoUKFChQABvh&#x2B;17b1srODOseuQrWhOSJoiGTg6652Sbx&#x2B;9BnvnbgdNVDTYOkTDg9O34OG5uzD3wTpI4phUHUTThMIiT548jjh17do1at26dT7Lli7xWe65zKdc&#x2B;fIpChUq5MSIQ0p2ExzL7XhJgNP90vKE35D463vDS4kB/NycYI0aTYyCaBA7p7nlBwbCAifdL1AmB9/ckgMlkUDKo8AcAi5VJcETfzTzYzeDjPxbW2jXZ8GRURUncacjoyCIU/7lNBPd8eW3W3zwYg&#x2B;HwfoEy2D0iu9ZLe624OrqDJUqV4K///4bNm3aBNYS0ezyFSrCho0b4cSJ45Tqfub0aShYqBBF63bu3AlHjhyG27dvwfFjJ&#x2B;DJEy&#x2B;KkGGtLN4sa9tERseONSfZ/UFM7qVKFcwVS8QZIijK/PvvFKhbty60bNkSWrduSQJA//4Dftp1jaUC6DfACwCOjsmoxj8LtTusQa9hbTCmo2N0snXr/0GDBg3Bzc2NLfdB1jDsTyD/WvKl90jQtmnUZq5gqQYaNaI7u55E2sDUqdPUH5MEAL6lJx/Jd3BwJF&#x2B;QT58CYNasmWTU&#x2B;PixF0XYMauqfv2fa8r47t1bEjBx&#x2B;/Ac5Eul7OzsYdmyZfDo0WPKTEiSJNHc28RIiAAxYLoFoJIoYHyr8ZtDbQOoQoUKFQJ89PkAEaHhEBEWAfM7T4ZF3afDy7vPdO9HRUTBlb1nAasBnFyTQ/dF/0Cnuf3pBvzM&#x2B;iPqAMYRSZIkseratWuWzZs3FxozZkzWT/7&#x2B;YZMmTnzavVv3mwf273/z6OGjIB3pNWpFxwEYiAIaI2FA/LvMCwWKPd7N8vVRIP6GTM20SGBOC0T&#x2B;PYXsACExVMoiMM4&#x2B;0D9Gss9uWDWMeKChP6c1FLO24OfTm/pL2CTG0YTRaOyFJROgT87gOMO2f1JFIEiIzpw5Q&#x2B;mpUpuDN&#x2B;GdOnai1NprsW3ldMuzP&#x2B;EREdCwQQOKTmO665s3b2DUqFGwixH/MmVKw85dO8mpf9as2ZArV26qaS9QoBCRf8NDxxloIcanAyf5VxOPzidCEQDbEW7evAmcnJITycbtw/T6n4mLFy9C0aLFdM//&#x2B;qsxeHi0h6RJk0CFCtrIIdYRHzt2DE6cOAV9&#x2B;vSlOmeMOGKq/58ONEnkS0bQbyIkJJgyzNC3YcWKFdRzXUXCAxpoCttboj8DCpVr1qyFVatWs2vXnzKLhL4PPwu4HXfu3NV9b2HEH89DFOjw&#x2B;6Vq1WrQq1evxET&#x2B;QUT45YwA5eYBUNsAqlChQkXiQ7mWVSFHidzw&#x2B;d1nuHXkCtw5fg1eP3wBQ3ZMhrTZ3SA8NIyeW9vaQvo8mSB/pSJUEnBq7SE273Wo1b2RQdH67RPX4OUdb0iTJT0UqOIO9o5J1EGWEQLc3d1T4IQdBM6dO/dx7969H4YPH/a0U&#x2B;cu6RihSevmlj4JT0a1BEvq91e&#x2B;V73SazwdNKT&#x2B;GqN59LkDwowCnsQJsgnkygnkRAC5eaQMDBXmUyo7kNcVNHgjGGNpaWmBAgBmaPCdGowzAzSG4onC9pvKNjASAQQGjPqRhtiov35&#x2B;ocBjwVnQ5yDBHziwPxw9ely3T3zkmIzxYk34atWuBY8ePiSDPn59KN7FMOIVbWkFefPkgQe5csHK2N7ZGKXGG/YOHTtCurRpdeszPi8MdQwp00UpsUZOGDDnmAnnxXTiAwcOYZkNPce0/1Onfp7pm9ax/z4cPnyIRAAsBUD3/0ePHrExbE0tBbXbmYqmxAQ8tyzjYF6LzuwVK1Zkx4r9noSHwZs3vtSNIWnSZLraf/RnQNKFHgpo5oYp4VKu/yp&#x2B;f2zatMEgJd/Gxpqu1/3798CRI0cou&#x2B;PJE&#x2B;9fw4TZd19gYIDuvMMsExQ4U6RImZgPiZDgx4B0OQBIkH0513&#x2B;l11QBQIUKFSoSAgpVL87&#x2B;L0537xX&#x2B;Vx2WdJ8Bfi/fwq5pG6DH0sHUJjAiOBxiNNHgkiGNNrXP2gpylykAJ1YdgPc&#x2B;78A1o9Yp&#x2B;8zGo7B53AoICfwKllZWkLVoLhiwfgzYOdirA60A7CBQs2bNNDVq1Eg9efLkqFmzZnkPGjjgQWBgYFS/fv0zlSxV0jl58uTWVlb6yLTc761RgF3mdUN/AdBRXHELPBCVIRiSPzPIm1LXAqkNl7Tkl2l7KCcSSKyDb0WH0X4uFvgcyb&#x2B;pTZbdTjA2tzPHX5GfyagOPvY/KjkQ1fzr/mrLEiA8LBT8P/nr0myR/N&#x2B;6dQuOHD0C7TzaQYqUKdk1q4HUrmng&#x2B;Qtv3RG3jW0v15ERfFxXEXd32Lx5s24b0Jkeb4ax7zVGy4wJOqe4W&#x2B;YKI3LEXml5YRkBRg958o/AcahSpdp3uR4xDX3jxg3kI6AErEHv168vmfvh6NaqVQd69OgJ5cuXT7TfVVOnToXevXtTnb058PRcyojfPsrWCA0No1TrNWvWaH8vzpzWteUrXrw4/e3QoSNcvnwRPNg5jN0SVCQsIKG&#x2B;f/8&#x2B;CUR4HfFmemgUit872K5vyZJlkCnTrzHTQ/EK2/mh4ISZOZihc/r02UR5LAICAp5fvXr1MO42KEf5v0frv98eqgCgQoUKFTJ37xjxr9KxLmwZvxI&#x2B;vvaDsK8hEBUeQWUAoOHALqmt7v4/ZTpn&#x2B;PopEN4&#x2B;fkUCwNeAL7B35iYI&#x2B;hAArlnSgkvG1PDg1E04sfoA1OnVRB1fsw4Bxzk6OlqPGTMm99u3b0MvXbr0aePGjX6enstep0mTxqZa9RrOjf76y83C0pITkk0xgRRRLAVypl84hsiVXhowWNbIoFBjRAgNBQND0qqoD&#x2B;A8GhHzlurzJ8fMxUX2Yv&#x2B;AWL&#x2B;BqMhIDY6bhWFOv45gGo0lp98PSZYrarknFgGMNlPYz0EjcTclMP2Tyhgw3A4N2Njaas3q2EJIfi9dvgzt23lAnrx5wNbOFvr&#x2B;3Vd7x6eJAUsLbaotZg8gqb93/66OwNlg//QcOdiN&#x2B;yvwXLEcHjDSNXPmf0SuDYk5p6RlGBH27&#x2B;X4L9fiMD7Ytm0bNG3a1OR8L1&#x2B;&#x2B;JGIvJQBgNgS2LWvb1gP69u0H&#x2B;fPnI6O/YsWKUxpxYga2R0ODNPSVEI&#x2B;J0DgRDd&#x2B;w6wKaRyIJvHDhEqxatZKMEFE0QfNDFBGwtzvfP71ixUrw6ZM/&#x2B;TocOHAQJkyYkKDTsMVj8qfgxYsXcOnSFejTpzd5ZOCxR/d/FxcX2LlzF5UGoAfGrwS2j9y1ayd5EqA/R6FChRLN&#x2B;LPv99BHjx6dPX/&#x2B;/NUZM2Zc9/b2Do4l/dFgmPYvN4mNAZXM/xKUMKB6AKhQoUKFArIUzoG2/xAeEgGRjPhjtJEnJ1a2&#x2B;pq9pMkdSBh4/fAVPfe6/BA&#x2B;vvnA5rGCal3qw9Adk6Fsy2pwavUhdVDjgbRp09o3atQo/ebNm4usXr06fxF3d4cd27e9&#x2B;&#x2B;uvhlemTv330YcPH8I0Mhn7CqXzspxasSOgqAuB&#x2B;D2NiK7K&#x2B;QwYexoYzquRKURQVhCkzQEjIyI0WNSPKf4abbs1qu8HURq6Pros5vgK4oXImFCuVaGUCMCXEejIrPC2Kg68lsgFihvsVi00JBimTJ4MS5cug21bt0OnDp2oCwCu7q2vL6RO40rLYJ019rPmPwhd69Hdf&#x2B;LEieD1xAuyZMoEI0eNgjRp05hVSiFMyDC0ddAouvrHhcDHxytACtjX&#x2B;8GDB2atH6OXciQlLCyMetSjBwOmNTdt2pyM/RI7&#x2B;SeRkF1H2NJQOGbYKrJ27Zo0Lvw8kyZNYudfMGWS9OjRCwIDA6k14&#x2B;7dexjhz0NlEy1atIBp02bo1oMZLNiH/Z9/hsD27dup7WRCBD8227dv&#x2B;yN/t&#x2B;ztk7DJBubPXwBPnz6FgQMHQrNmzek9zATIkCFDvAW87wG8ttHhHx3/Fy9eBCtiS58SMqKjo6NevHhxa9euXaty5MjRuWDBggt79OhxiZH/EBnib27U3xwPALULgAoVKlQkNIQGBTOiHwbJ0&#x2B;hrVP0ZicdocExkFGiwN7i9LSP1NqDhQgyIjSUjEzHsOd8u8O0TH&#x2B;AsOEiaPBnkLp2fGEGVDnXh8u6z5CtQsGoxdcDjAWStGTNmTDr4n39y9OvbN&#x2B;bWrVuf169f/7ZD&#x2B;3a3ypevkDxnzlwONWvVTGOfJIkVmJFtzwnek3LCF5M74bziKL9Go4&#x2B;UG0gFwnUbZBEYtzA0/ivqVCgi4uJ1GIgI7INDQ0OjbW1tLelGPCaG41PkOVG/dfG&#x2B;6kzshIYWSowX5CP/wvp9qQ/iRHxfrjuA7q9Mqz&#x2B;MPOPfT58/Q46cOaBChQr0nrf3U3j56hU0qN8Ajh0/Cv9OmapbLioqkkQCJGjPnz2DESNGgouzC5QpWwaq2FXR9cSWOGNEz6UFpG8x&#x2B;ZMTCcxd14sXz6n23tfXF548eQI1atTQvYfkY/DgwbrnGM0eP34cfPr0CcqUKQNp06ajscF6fmwf6OaWXvIzMLK9aNGSP8apX3xMhMZt79&#x2B;/p1aT2CsdxxPHBAWAzZs3QuPGjSFz5kyUbo0R1&#x2B;HDR4CjoxMjhIPZOTdaMjqOjuwYKcYpIWLatKnQunUb8PRcQgLRnwjMiJk5cw4EBPhTJwzMjPmdgMdl8&#x2B;YtdB6nTJmwvTkY8Y&#x2B;8du3aaXY/cHbevHlP8Os9doqOnXjCL3ysFPU31RkAQDnq/1ubBaoCgAoVKlTEwt4xKSzoNAXyVCgMOUvmhaCPQXB48U52i29Bfc8srCxJALBPZs/eC4CIsHDdsnijhzeEEaGh9Dzw/WewtrMBuyR2kMTRgV7LUSIPRIVFwqMLd6FglaJmu6WrkL15sShRokQqnG7fvv1527Zt79atW/Nm5MjhT4cMGZopd57cjnly53V0SOZgLSZQuoisiUi1uJ2clLO7sKxAIywdMKp9F1oHGt81aEB6XsOyAk7317gaXfsKGvphej&#x2B;ek1bW1pYoYPFlEnLQp5VLCB4ynyckQlLGdsb&#x2B;Cxpj0z8QOfxrxK4KnCwRNiJMjHBhRAvLAY4fPwbLli0FLy8v2L5jByNeh4ncfgn6QoZqERGRbJyioEKFitCsWRPw8fGBMWPGMJJck8oC8MaYJ/6Gn8lLFRxIlZOI2/2ZemwuhONrzvI4/&#x2B;zZc6Bfv35w&#x2B;vQp8Pf3NxAAEAMG9Ke0fkw9xw4Kz58/o24C58&#x2B;fhxcvnkHhwu6wYMECilYXL15S8nNQUDK3/j0xALtMIHHHVH48DpgBwGPcuDEwb94CMpjE93Es0bm/Xbt25KT&#x2B;8eN7ao2IWQBo/pYzZy7KmkiMOHXqJJkdopiE196f2uUBMwB69Oj&#x2B;W4tYqVOnSdBj/OHDh9cPHz68v2bNmgvLly/3FhB&#x2B;JdIfDaYd/&#x2B;Ui/yDzHBTEAFUAUKFChYrfGXaOScGzzyxI5ZaavsdjorVpnqkzpQF7B3uKnDq7ucKH5&#x2B;8g8EOgjg9EhobT/BzfvzksDCw5CxINrO30USIr9vjRxfvUN9zCUhUAvhcKFSqUAqegoKDIu3fvBm7cuPHtqlUr3zKiF9OjZ0&#x2B;3unXrpnNycrLhFGrVpQixuAxfNp2dk/btM3xN&#x2B;l5BP7&#x2B;4jSEvUkjLBMJsATafhhFaDab2x2D7PjZZSBbfc7LEXWwfYNjzAOIkWIld&#x2B;yXlA2GmQOytFN9qkD8G4qwGueOFxD&#x2B;aEfZPnz&#x2B;B/8dP1MZzxMgRUKN6Tap1z5E9O7Rp25YR2kWCY6mhNGtMz8WILUazkfzLf475BoDi80g85lycxjJ&#x2B;gsGTJ4/ZfoVD8&#x2B;YtjCLMWLuOhB/7kG/cuJmMytasWUeiB7uJBn//j3D58mVo27YNODg4wLJly//o7xcUjxYuXEDn2aBB/0D37t1g5cpV1KYv1kwTrl27DsOHjwQfn1fQt28fNsbr6NhZWVlDly6dwdnZhdzgcTynTv2XWr8ldOC&#x2B;o5FdmjRpdOcpjgWmk&#x2B;N&#x2B;YmcIV1cX9lqM&#x2B;iOl4rshLCws&#x2B;MmTJw937tx5gX2/e9&#x2B;7dy9QRPzlphgZIUAuE0AoEAAolwkkGPKvCgAqVKhQIYLH1B6QMV8WuHvyBgR//kKvpcudEer1aUZp/ogiNUvCtX3n4eOrd9qbefYvODCYqI6tg7bNH6WGInGzsABLK32LKFt7W3j/3Fc2jRcFBwtL1Z4lvkDTwLJlyzrjFBgYGHngwIF3hw8f9p87Z7ZPo0aNXdp6eGRkN&#x2B;J21tZWFlLp2VK12kLCJvVYOz&#x2B;nKBAI3&#x2B;MzBcTv6YUCniRqlL0IsLY/KlpjaclxERGRGt7B3zJWhJIsoxdshLxRHwf6uL/sRuq2Uy8iSMwqZ4DI3rRhpDQKW/BR9ozhLRS2ytJg&#x2B;n1EJBn3CY8LRp1xGf542draUIT7w4cP0KF9e2qbli9vfhgzbhzUrVOX&#x2B;tC/8/MD9yJFIFu2rBT956Ft4WYB9vb2OvIvLQAICxX0I2NUriDYzm8l/0rrMmdZbCGHqfw4VhjVL1SoINWho9hx8&#x2B;ZN2Lp1O9Wrh4aGUrcDLIOYP38ePH3qRc7ks2b9R8ehefNW1NYvd&#x2B;7cie77Ak3akNy7u7srznf79i14/Pgx9OnTh8SSTZs2kgCAwgoSXUTZsmWgRImijAynhX79BpC4hOcUjv22bdtJYOKBpSaJASgYYar/tGnTdeUQKJKgmeG5c&#x2B;eoE8WpU6fY&#x2B;Rut/jip&#x2B;GY8e/bs8ZUrV&#x2B;5Pnz798o0bNz4LiH2UGcRfSgTQgHldAJTS/hNkVwBVAFChQoUKIYF0Tg4NBrSEap3rQ4DfJ8Aoaio3V0rn51GyUQVYN3wpvLzzFD68fAups6aH1w9fgp1DUnDNnFq7HpfkROY5Rl40MTGCG3MLbc9xNgmFAURkeCTsmbkR8lUsArnLFoCoyCiwsla/puMLJycn61atWmXA6fTp0x/YTcOLnj2638F&#x2B;92XKlHXq2KlT5hQpUtgqkX/&#x2B;dSkSp&#x2B;TCLlwNZnsomeIZO8drJM389f3lYzSMxGm0bRA1gKcXkn&#x2B;toZ4hZZX8IJk0cnHKvpEHgag&#x2B;QCiA8NkSBkZ4YDhu1lbWEIlp9dp2g&#x2B;D9zBtSObuAQ9Kk2q4LsfPdunkDtm7bRq3PyBU92vA4IOmg9psW&#x2B;JkxsGHDRjatgy1bt5Gh2siRo8Cdkd8UyZPT54Uzwouf3blzFwPyzw9HjE6EUCLYxp0eJAUPM93&#x2B;zYGhQKMr7zCoO1cCihqBgUHQoYMHI/y3GBmrAuvWradyBze3DERIMf0fCf&#x2B;OHTvgyJHD1AN8/vz5JLIMHDiICHKvXj0hJCQYqlWrlui&#x2B;I4YNG0qt9oRAszZMzcf0fT8/PyK0JUuWgnLlytPYe3t7Q44cOWnezJkzw549e6hrxNmzZymdeuTI0dCoUSN4//4ddOnSlS1XzoD8JzZgq7udO3dQpgmP5MlT0DmLWQ4ohMTEqBkAKuIH9p0X8fHjxw87d&#x2B;48NWLEiCsBAQHhYF6031wRwNzovynDQLkfjN8SaphJhQoVKiSQxDEppMuRAdJkdzMg/wjMBPjf5C4Q/PkrLOw6HQ7M3w73Tt0AR2cnyFpIe2OY0s0VIsIiGYmPpr/6XwUN/TSEB4eBFD97cvUhrB&#x2B;xBDaPWwGefWbD1T3nKAqq4ttQsWJFl3379hVfvXp1gTZt2rhevXolsGrVKpcH9O93x3PZMu&#x2B;vX79GklAj6mcvNfHkTPxX7j0pYid8bFReoJHuTIBRfoxYh4dHaCwttdF&#x2B;TPmXEiHiQv7FZQtCx39OTtUQfKYwi8Bgu1GcYAQdSRO23MMIKm4/zogRe&#x2B;yh/ujhAxK5SDBAnw1GPLFd1sYNG6B&#x2B;vboUhRZmxCCR2L17FxmksTGAp95PoW/fvyGZoyNUKF8eJk2cBFWrVgVHJyci/poY7b4kc0zGSJi9EXEXZl3IHzPOaFT1YoxYGzEm&#x2B;nIeCaYgXhemWmOnAnNhZ2cPXbt2ZsS9OiP&#x2B;a&#x2B;Hhw4dsbK&#x2B;Bs7MzXLp0EerWrU0t6GrXrkU&#x2B;AegHsHz5CoN2c5hV0b69B1t&#x2B;XaL5LggKCoK9e/fSY2y1JzSoQ4GlVq1alPGAwFZ9eM4igeeFFxQHXFyc6XHHjp0pAr506RJo1ao1I8K7ifyfO3cWWrZsRcLJ0KHDEu336syZ0ymbBM81BF7XCBxTTPsPCwsnjwi67lWoiAMCAwM/s9/sI/3791&#x2B;cLl26f3v16nWekf8wM8l&#x2B;lALxVyoNUEr7B1C279GAkq3PbwY1tKRChQoV8UCpRhXB5&#x2B;ELOLJ4D3hff8i&#x2B;6jnKDEiXKwO9nyl/FiIFIUHBEBLwlb0Qe4MZHkGCgrWt8dcv&#x2B;gW4ZkoDN&#x2B;6/gH1zt0J0RBTcOXoV/H0/Qq3uf4Hfi7eQJFkSSJbKST0A8UTmzJmTduzYMamHh0fGZ8&#x2B;efd20adPb9evXvWNE02f48BFZSpYsmSJb9uyORqRXxidAiejz70mlfguzCMRlBcIIu7a2X5/er9FGzy2kShIUXPok90HOvE5xHSLyL/tRsWn/GHlH0rmWEdCbN27A2XMXIIqRrPv370H27NnhxMkTUJ4RdyT&#x2B;wV&#x2B;DySTt5YuXVJc&#x2B;eswomDb1X8idKzc0bNgQQkPDiAR/DvhM0X/UazDF/eSpU7Bn9276XCT9etqub9PIseszxqDUQywCaOJVa69E/OUIvdLniNcjnHfNmlVsfJJTj3hzgGnrTZs2JVd6xPHjJ8ip/vbt23Dv3l0oW7YclCpVGmrXrgOFCxeWdGovXrx4gr7eQ0JCiLxjJwS&#x2B;NeGlS5dg1aoVUL9&#x2B;fcqSEB427HzQu3cvqFSpMj1//PgRpE6dWvc&#x2B;ilgjR44kso/AThNr166lyL8wyu/uXhSWLfPE9qVgYZFwY22Y1YDXpxxw/LZs2UYlFHv27KbyiGHDhseOhQaSJ3ci4Q1LT1SoMON6/frq1avXq1atOrtr166X7HoLUiDvMRD/TAAp13&#x2B;NjBAAIB39lxMEQEEE&#x2B;G1EAVUAUKFChYp4ALMAmo/sABnzZoGbhy7Dl48B0KB/C51PgFuezOCSJS28uuMNH175QeZC2QH7BGI0P2mKZGBtZ2t88w/aCCgSgIYDW4K1jS3sm7MF9szaBGGBwXB2ywlImSYVtBjfEbIXza0ehG/58WMkOmfOnI6jR492HDJkSParV69&#x2B;mjBhwvNBgwZ6de/ePS0jAC7Zc&#x2B;RwSJc2bRJqmSfl7GfM9vV3A6Iov/ixmOiJX4&#x2B;IiIjB6D5GznBb8TU&#x2B;2i9HFiU1ABnTP6G2ISbuRssreCQYZw8Yns9IKq9dv0YEaf6ChdR/3sEhKTx69BAesglN0xBHDh&#x2B;BXLlzsfeDIHmKFIyAVYQa1atD37/7wIyZM0gAwGvj2TNv4M0NIxlZu3b1Kvw3ayYjbb0NCL54O0xtr3E5h3y7P86EJ6LYZFIqld&#x2B;UYCQFJO8pUzrrnq9cuQIePHhAJQ9OTsaiILr&#x2B;Y1o2pmj/999/sG7dGti7dzeZ0vXs2Ru6detmdjlBQsSyZcugRInicPfuXTh//hy1K0SgN8LmzVv57wGDe3J0be/Xrz89DgwMhJMnT8KBAwco8&#x2B;TAgf1w4sRxEgeaNGmqWyZLlqxGn40EGLtNJGRgG8l58&#x2B;YoCgB9&#x2B;vSDhw8f0LU5YsRwaN1aK4wEBX2BsmXLkj8CZupkzJhR/dFRoYi9e/cex9r&#x2B;s2fPfgBpB39Taf3RJsQCUy3/xMRfLAJIkX5NQh3vP1UASJCGDSpUqPi9gKnJZZpVgeL1ykIkI/ZJnBwM3m85sj1MbDAYDi/ZA8Xrl4WbRy5Tl4D0OTIqEoHoyGhoOrwdPX508Q54X38CBxbuJOaCxoObxiyHgZvGgb1DEvUgfAfY2tpalitXDksEUjFCFThv3rxX/0791/vK5ctfBw4c5NakaZP0jMDaJXdyslEMlcuxy9jX5EQBHhjp5w3uOO0Jwkn1B5daByf&#x2B;QZON0HMGLf&#x2B;E6e&#x2B;K&#x2B;wXx61qJBnPt23WAZMkcYMLEiVRHXqSIOzRq1JgIKkbwEZ06dQBf37eMdLyEM2dPw5uevuD9zAtsbGwhd&#x2B;5cuvV9Df4Kyzw9IejLFyJ2GM2uXasWVKlcVWfiZxD5jwNxN5ZQjG0UpQ6xqfGLj&#x2B;mfFLRmc9r3nzx5Qi36SpUqBVeuXKYe47rvj&#x2B;go8p1AsWXkyOHUcg7bsW3Zsp0EFiwJSOyt&#x2B;3A/Bw0aAIsXLyFTvi5duunew9r&#x2B;/fv3Q926dRX702OZSfr06cnxH8/f3LnzwJIlS83OwEgoQFNIbJeJfhv8uYpGmrVq1WBjVF9xWfTjQA&#x2B;EvHnzUZr/o0eP4N9/J4Mnu0avXr1O82CHgBw5cqg/NCoM73PYF5Uv&#x2B;9I/d&#x2B;7c3UWLFt2KJf5ypD8GzE/lNyUQyLUDNLfmX04ISFDCwJ8gAKgkX4UKFT8U1va2NIlRuHYpqPC/mnBpx2mY1mQEfP0UBNiOvXDN4spO/4K2b2lzZICH5&#x2B;5AxnxZwWNad3h0/h6sHb4UvK8&#x2B;hPyVi2p/SKOi4f3zt8CxdbpkTG1kLqjCzONobW2BrQTZzWuKgICAiCtXrnxavXr123YeHrfxvS5duqZr3rx5Rls7O0tOiqhJu8KBrKNfLIkPDw&#x2B;PwfWzGyINuwG3MK6tN44kSxFLzgT5F5sXGrYf5HTe/xzILa9v02fcMjB2nWDscIgk69HjxzBt2r/QsEF9MsV0dXGFmm3bwMkTJ8Hr6VMi769fv6Eo653bd8DWxo5ILNb7b9&#x2B;&#x2B;M9a8TwM5suekD96wYQMUKFCAkeCFUL5cOTL7443GxPtgbLKoRLqNnf6VDrOUKaR4veaWF5iaD6PT/KaeOHECjh07rmslh9FqPgsAyRx6Jxw8eBAKFSoMkyf/S8JLYo72i5EsmSPtL5JaHAMhLl68AG3atIbPnwMpA0Bcnz5kyBCoX78emf6tXbueIuHp07slShJ7&#x2B;vRp2LhxAxw/fgweP35K5zYaGuL&#x2B;Y1nI&#x2B;PETdPOieWSGDNoSt8uXL9E5h2KIl9cT2LJlMxvPz1QGgNfm8OEjyCsB0aZNG3ZuJld/YFQQvjJcuHDhxu7dux&#x2B;w39fnwcHBETKkXIr4R8vMY8rwT05EUDL/E4oAMTKkP8FCLQFQoUKFih8Ij6k9wcbOBi5tP01EPVOh7OQfYC6wkwAulzJdKsheLC&#x2B;45ckKa4cuhseX7usEgF1T18GNg5epi0DmIjmgeqe6kKNkPnXwvwGMWNnUqFEjDU4fP34M3759u&#x2B;/atWv91q9f5&#x2B;fu7p60RYsWboxYpODEpF/8V6LQPoYRfWR6UUj4Gcm0tEQ9QVvbL01KRUZyvNt/LEdVpqsgafonzBkwIMu0QnPIqui5gXGg4fKhYWEwccIESO2amkg9il/vP/jBi&#x2B;cv6P2NmzZCylQpoXqN6oC6GKa0Y401uq9jhBGJLf5FYBs/JLb&#x2B;/p8hS9YsYGdra1T3L9weJfIvNz4iOUWxzMGcmn5zYcojgK&#x2B;rRmAZBZJ/FE7Q4C9PnjxUz4/AiDemqPfs2cuI/CYWvH3rC7a2dpAypXxtOWY5pEmTDk6ePAEzZsxg51QrRkbbUrtDXjjBjBuhMIKZA9gNAdv9IdDlH6fEAoz249hlyqTdJ0zxxxT9Pn36smszio2HNRunFpT5wJdJ8IR/0aKFsGrVGno&#x2B;ePA/ULduPbh16xaw70ZYsWIVTJw4Aby9n0LGjJlg4MCBumVV8q&#x2B;CnXcRT58&#x2B;fbZ///6bM2fOvOfn5xcmQb6lovNKpQCmhACl9&#x2B;VKAEyl/stF&#x2B;5XMAVUB4AdAY8ZjFSpUqPh1RDJ1Cug0uy8UrFIMfJ/4QMHqxahFYJy/7GL0vdatbKwh7Gs4Pff18oF9c7dR9B8j/z4bXsDjC3eh3bRekDSFA4QEhUKRmsXVA/ENcHZ2tu3WrVuWNm3aZGA3MO8WL17s27p16zulSpVKli1bdvuWLVu4Zc6SNZmllNmXMO0/JgYiMM2fEVt0sLPgLOSC7UbRf06qdZ&#x2B;Y/EsY9RkLCTyZ1ZP/2Di1nvyL2K5hZNs4qUFIvMU7lDSJPfTuPQj69usHvkN8wYaRLSTzTx4/YX8jGFFtDEkdHGDnjl2UAZAnT26KMkZGRun2W9v2j/8gC0iZypkdExfQdkQINxBXpFL/hUOjTMiVMx&#x2B;UvAPEYy5n/mhKKFCaF53WURRBYKu6sWNHMwJ2k5HWr3D8&#x2B;EmheAU1atRMdNfh169fqCsB1ty3bt0Ktm3boTi/hYUlnD9/lvwP0qVLA&#x2B;vXrycBAMUSbTmFti0rtZrUiQYOcPLkKZ1AkBiA5yBmx&#x2B;C5s2TJYhIBsMUjYujQ4VCsWDHq9IAGfhkyZIQLFy5Bvnx5KEtizJix1PJw3759sGPHdujffyA8eHCfjBSxReTHjx&#x2B;hfv0GlOY/YsTIOLWpVJH4wc6HSHaevJw4ceKhNWvWvBAQ62jRYzkhQI7ImxvhNxX5jwZpI0Cl1H9TPDNBcNDEkgEQVxdGFSpUqPhpQNf/Ms0rf58vOxQCkCPE&#x2B;sH5&#x2B;7yHqOgosLK0hmbDPSBN9gywbuRiWDFwLn3zYdeBKeeXUAaBim9D0qRJrZo3b&#x2B;6GU2wHAd/jx48HzJw543L79u1dS5cum6JW7Vppkjk4WOt&#x2B;eNjNNyOwGs7CgouKjNJYWlkS4&#x2B;bMIuucPFEU3JFwUmwVjDsQcEISj4aTILS444wEC/ltMCTDkjX3HGU2wOXLVyBb9uxEqF77&#x2B;MDR48fhxvVr8PLlSxgwcCB77Q107twldhkNpVqHhYbLpzOwD0biH62vR5Ak/PIk3px2fLElEZy0UaLU8TK3TMPU2CoJBhj1R98DTLn29X1Drv5Yn963b78/4vrD1PwsWTLDoEH/UEtDdKBXgpOTI0WnV69eC1mzZoFly5aSYIQt&#x2B;qpWrUbzoKEftkXUiwYWiYr8IxYtWgRVqlQmcj9jxkzo2bOH7j0k/5hBgnX8mHlz9OhRRuZdITAwAHbu3AmpUjnDnDlzoU6durBw4QIS7LATR8eOHeHq1avQrVt3SvfX/dap5F8F&#x2B;xrzYbhx44bX9OnTr5w/f94f5E344pIBoCQEyL0m975QhNAoiADiVoBK0f8EhYQmAChlOZq7/G/bkkGFChV//O8mMJJoxpec/msrRTpniAyNAGsba6jcoS5Y21pDqWsVYP/crZCpUA749OY9&#x2B;Dx4rgoA3xlZs2Z1GD58eM7&#x2B;/ftHMzIStGXLlndT/p38YvXqVb4jR43KljtXLkdbO1sra2sbC3Snt2CTpZWVlttpjH/M5Mi/QfRfY0gQOTmWK0c0Ban/evIvqvkXLS9HSMVdA4TZAzwZ1rr2P4fNWzbDjh07oE3btrBy&#x2B;QpI5ZISBg8ZBnVq12KELAImTZpA9cPFihXXGvlx8pkGpq8Mjcnov7TRHmf0WMk3QEzghWKLOcB5MYp/4cIF8PDwkM/yiEVAQAB4e3tT//pt27aw8y8b7Nu3n6LZfwIwbf/q1SuxGRAc2NnZsTGLMZgnMjICQkJCdV4IGJ0ePHgwlY2gWSR2AmDXJ43l0aPHaZ6WLVvGq/1jQsGdO3eoreFydt2hAKDRRIOwmcinT58YsV8Ijo6OJI7Uq1ePvDXwSlqyZInOV6NAgYLUDhGX7dGjB0yfPgPevXtL5SYqVCACAwMD7t&#x2B;/77V8&#x2B;fKrBw8efPP27Vthmr8GDKPt0XEUApQIfnyfi9v&#x2B;ydX7x4B5tf8JKhM9MXoAaOLwWCX/KlSo&#x2B;H3AbkTtHe0h4EOAARXhLORvUN1yZ4KM&#x2B;bOC75PXcH7LcajUthakyeYGEWGRkLNEXqjdcwRlIKj4MbC3t7d0d3dPgdOYMWOiPT09XzFyYp3UwcGGjwjr2vdx&#x2B;qJ9To6kS5BvnvxDrNmesEEdp8CUOSMyr0/9l/wJlMhKEL6l0RhH/sUUms96wGUxUl&#x2B;mbCl4&#x2B;aoRVKlShdqvNWvaHLJlz0bma2Fh4TRPtWo1IFeuXOS0Lm4xaLBZUhsBEh4GIF&#x2B;vz&#x2B;&#x2B;XXtgwbvcn7vZomAXASYoj5qT7iwUCbC&#x2B;3YME8aNSoEdv3ZLrXsXMCH93G8Rk0aCCR13r16oOn53Lw8XlFEVlh3/nEDqznxzFq3Lix7DxPnnjBvn17YciQodQysV279uDmlhGmTJlM7Q&#x2B;RrNaqVZtIf7p02u4T6PSfmIHGm5g58urVCxLkxF0PsJWkk1My8PUF8gLAcwqvwwsXLlI9f4MGDWk&#x2B;FJ1KlCjJ1jcdnJ21YrJK/lXEEv/Abdu2nWS/f9ffvHkTCtI19eKUf7n0/&#x2B;9F6k2tV4r8S5F&#x2B;OXd/ueh/gikNSAwCQHyVGNUzQIUKFb8Z/&#x2B;egTq8mYGVpSan&#x2B;SPzDQ8MgNChEMQza03MozGkzHnZMWQshgSHw9NpjygR49fAFOKVOqQ7sTxQD2rfvkCUkNFRPFgVRcVPEkJMh4OL3&#x2B;OwBTshSBaxX2vQvdladSZ5hur7SNnHyCQLG5JbTr5&#x2B;dxJA6dRpK3ebr9bNnz041/WhsiUBSgv3C8f2YGP39lLDDgJRQJiVAmEO8DaP3nGhEQfKzjbs66tdlEev7YE6tvzhLoGnTJrBw4Xw4eHA/NG/eUjffzZs3qW0fAlP9sRPC&#x2B;/d&#x2B;cOXKNXqtZMmSf8w1denSRTY&#x2B;h2DcuHE0dnxbTKmxRld6HKsmTZqBp&#x2B;dSMqgrU6YkO&#x2B;eyweTJ06BSpYp/3HdSzZo12ZjsgUaNmtB5hyn6wp8SFEr&#x2B;9z8Pdo3&#x2B;w0j&#x2B;NvDxeQlnz56l7BTMLqlTpw49xpaKWD7g6upq9mfz7SjVsoDEh1AGRvbf7ty58/L69eu9bt&#x2B;&#x2B;HahA&#x2B;OOS/q8B5Tp9c0i/xsRjpci/xgzy/9uT&#x2B;z9FAIjrgZAk/pxhWESFChUqfglSpnOBluO76EhCjpJ54c6x6xAWHAZGDBDIUR7usveTpnIC/1dvYc2wRWCXxBYiQiMgfc5M6oD&#x2B;fBVHROh50ifIwJcg&#x2B;eK/BoSSU/48EAgBYjFBmCCgTSTQ6LMIxOFt0TrEdfBGRFiQbs9nI&#x2B;h8CWKXwxTisLAw3fkcGRUpiNJrPwcFAXHk30jvknDhE7YcNCUGyJNzjeRHSHd5NDxGSP6xZOHJkyeQL18&#x2B;k&#x2B;n/V69eAxcXZ8iSJQuNS7p06WHChEmwatUKAwHAz89P9xjnOXjwMLRr55GoLxtstYfGci1btjJ4HbMdChUqpBtvfoyFj3mgmR8ej0aNGlJ5ABohDhs2jMQUa&#x2B;s/MwsKTQ1jYqIpowTHzMrKWpfWf/jwITonnz9/TqUVWIqD44fj2KdPP&#x2B;jatSuJKN27d6Xxq1OnXpw&#x2B;GzMtunTpxo5DdfV3IZHAl&#x2B;Hy5cv3Gem/t3379jdgOsL/LZMpci83mRIgNGA&#x2B;&#x2B;Y9L7X&#x2B;Cyi5PqAKAOcYLSq0ZABJRL0cVKlQkRh6pJRkVW9eA3KULwofnb3QsJTgoGGIitW3RkOhvGrsCkjjaQ9KUDtB&#x2B;ak94/fglRV1qd2&#x2B;oDuQvPH46YzgO4uxeo&#x2B;QKzykJARIvyaXsK61DL0RION/LuuWLDPBEv7bi5XgCJ0WcDdL&#x2B;pbYv1njQnCwA6ei8sH&#x2B;CYdaBEvnngWRq9erVcPr0KXKUnzt3nuy8/P6tXrMKkjAihqZpSMJSpUpFbexcXAyjqk&#x2B;fPqG//v7&#x2B;sGnTRpg3b67B&#x2B;hMjTpw4QWUOSNqFrf2aNWuhawHJcZaK6wgJCYayZctDtWpVoXz5ClTXnljr&#x2B;/H8sZDoOoJeCZMmTSSn/xEjRjDin0Q3L1YiIdFH/wTE27dv4dSpk7Bz5y5o0KAB7N&#x2B;/D&#x2B;rXbwh169bVjZ2Xlxe1Qfz7737sPHUxe/vQW&#x2B;DpUy&#x2B;4d&#x2B;8OZV6ISw9UJByEM9y5c&#x2B;eBp6fnpYMHD/r6&#x2B;PiExJFsR4N5pQDxfSxH8KWei9&#x2B;D70D&#x2B;VRPAH0j2v7doEJe0DhUqVKj4ZcCWcWmzp6cJYZvEFqp1qAd2SbX1v3YO9lC8QVm4efgy2EVEUzvAxkPaQMp0zurg/UZCju7XhpOfR5daDoaRf05uURMu8obkXbIo3qx2f&#x2B;buoyY2A4ATkGgLkE/XVyxV4ADk0g/kWg4qtegzFAHEI8pJ7q8wXV9c749AF/Tq1WtCmTKlKcsB68mR&#x2B;GAUFY3oMOqKryMZw/r1CuXLM/I/FBo3bgIHDuyHV69eMtJ7Hvbs2Wuw3RgJ79SpI7n9I3n777/ZjNQm3igqEvxz587RuL1&#x2B;/dpAAMC2f&#x2B;hGj9FoNLATLuPgkMxgPefPX4BChQqSV0JiBopOx48fh7FjxxmJALVr14KLF8&#x2B;z8dFQPT&#x2B;m/kdGRkNAwGci8ggURxB169aDNWvWUJo/CsbYIlEMFAPKly8Hjo5OcdrGpUuXUPvAFStWsGPXjVo4pkypGtEmJGALP/ZddHP58uVXVq9e/QLint4fn1IAc9L240v2lSL9cSH/Uhw1wXWjs0hAJF8Tz/VqFA6QSv5VqFCR4Ahlt4UDoWrHOvT88zt/aDulO9Tu0QhskyWBNUMWwswWo&#x2B;HuievqYP1OEPBNPjtASPwNiHvsP/GiGgm2K1yP4WMxIZY3/JNynzeX/AOf5QCiinpByUGchkn4uaJWf/o9UcgYkBBE9KSdM/m5hhURGqNjJXxv&#x2B;vTp0KpVS5g8eRIEB3&#x2B;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&#x2B;v9dQIA6AUFzth8QLesce96aRFANt2e4wxj6iaWMW5xKPF5whfpqYViyr&#x2B;SOaGJkZRcVso4UDxeOGEEFZ3Wr169Tr3T586dA0WKFIW1a1fD/fsPYPDgIdCuXTtd2nW2bFkYuX1O5Anr&#x2B;&#x2B;UQFBREadgJHevXr4XTp0/DrFlzyMlfCYx4UDeIChXKweLFS8mEbsiQwURUX758QePF95zH9PW0abUu9Pge1vq7u7vDoEH/JNixQiNMbZtDZaDnBJaP4ITZJbgcZpM0b96MWkNiuz80Qxw&#x2B;fBikSZMG7t27B&#x2B;/ff2Rjuhhy5swB5cqV/yZjPhz7xo3/Yuf4ejL1lAKaC6JhILZlXLx4Afj4vGHnwCz1B&#x2B;L3hObz588BR48evcKmp56ens8hbun95qbly73/LdF9jcz6paL7MWB&#x2B;xF8ueKzUUS7OJoG/koP/7iUARq2STRwEkFFt5Go2zPESUKFChYrfFrZ29nDr8CWIjAiFcUfmQTb3XJCjWC6Y3mIMrB&#x2B;1DCaenK8O0s8EpyfEcqTSZF2yKPXfXLYrF7XnFCPfGvOItLDmXi41X4LI60wHJbIdePJvMttA5PqvX6d82r70GBveUlhaWjDyFCNrcijXmpF/79q1a3Do0AFKtcb6aoxQjx49Fvz83sHZs6dh/vyFumgrAqPZlStXocdK5B&#x2B;REMn/2bNnoEgRd/JEQGBk/sSJU9ClS2eT5B&#x2B;d5lFIWb58JdWLI4F89OgB3LhxHb58&#x2B;QKZMmWCceMm6ObnyT8CCe&#x2B;CBQshefLkCfIrIzIyCq5fvwpz586FTp06UTaEGFjygOIAnndIuu/fv0cCAHpEYIvNKVOmwPTpM&#x2B;DVKx8YM2Y0OfrjcUAfiaJFi8OnT/7QrVu3OG8bfi7feQGBkf&#x2B;6dWvTYznyj9cIkv&#x2B;aNWvA5MmTyeMCRQsVvx/evHnju2rVqpNz5sy5/&#x2B;HDh4hfSPg1Csua69qvRPTF9f6/nPz/aiSmNoCmDpzSQVMFABUqVCRIoEngrunrwO/pW7h56DK41y0NecoWhiTJ7OHZtUfw6u4zyFggqzpQP&#x2B;sHCcmnMdc0Sf7FPeINViHBdOXWJybEBlFzM7IPhOsQmwcakH&#x2B;hyMHJ6xM60i5RQy923ce2lxKM3qSgYSA4SEZUjF0UcH5MTcc6coyGcpzxcZBrzYgT1jTPmzcHNmzYBG5u6Sm1P3PmLNS2buDAAUT&#x2B;U6bUElKs49emZg&#x2B;A/fsPJKrzHVs7BgUFUn33yJEjyVCOB2Y9LFq0CHx8fAyWwRRx9Efgl79z5zbs2rWbjWMG9vguvH3rC7169aD3li3zpHFNly4deSxIAcsjUqRIkWDHsHv3LnDx4kUyMRw7dqzudYzsozfCgQP74MqVy7By5Rqq41&#x2B;7di1cuHABlixZAkOHDoE2bTzg&#x2B;vVrlIGC5RN4LmLrzVy5clPHCRRlAgIC4rRNaCZ49&#x2B;4dMmfksy7Q36JRo7/omtmyZavhd17sdXL//n16jD4OJ0&#x2B;eIPGgRIkScPPmLfXH4TdBBMPNmzfv7dmz587GjRu9nz9/HgLfpxb/W2r1fwbhjxH8tMo9/t7k/7dFQhQApLyQNGYoLkpmD2obQBUqVCRIpHRzhlbjOsOWCatgdrvxULJhBXDNlBosGKmJYjeQQR8C1EH6mTCndR8Yp5UbEEzxj5gEqTUg1GDYek9I/pU&#x2B;XxjNluLcfNTfQEQwYOwmWu&#x2B;BVJkCJ8nrOQ7iYDwgm4Qg4/ZvLALgvk&#x2B;aNAlGjRqlixzzY4KEUin6j&#x2B;jWrSsjqb3h6NEjjHwmJ6d&#x2B;fPzixUuK9D969Jhc1UeOHAXTpk2FzZs3QYsWLSBHjhyJ6nTHSD3uW//&#x2B;A&#x2B;Djxw9G4/bunR8bqy5w7NgJeo4mf0uXLoXx48fT8wUL5oGlpTV7/wiVz2Ct&#x2B;MqVq0icqVixIqROnTrRf2U4Ozuzc3EKZMjgBvv27YUBA3LBq1evoGfP7kT08bwLCAjSReIXL14IBQoUJKM9JPYoRGEWCpaVVKhQCf7&#x2B;&#x2B;2&#x2B;oVKmygW&#x2B;E0FjRHPTr15fq&#x2B;MuWLac79xs3bkQZLZ6ey8nUkhcp0MiyQoUKEBkZAf/7X0t2DNfCokULaZvat29H86GQo&#x2B;LXISYmJtrb2/vZpUuXHrNr7&#x2B;rTp0&#x2B;D4fsZ&#x2B;EnNK/daXFL640r8wYzXzHX3N5f8J1gk9AwApZR&#x2B;U2YO4pNDhQoVKhIkanRtCEmTJ4Njy/fCpZ2nISYqBuyS2oOTSwpIrnYD&#x2B;Ln8H8Ck2784ei9Va64U/TciugLLANmWf6L1iKPbhmn7Wvd&#x2B;5Zp7Tic6CAk/LzqIyb94H412SaxeSKzTkIyDpJBgvG8aRjCtiKgIDwouf&#x2B;jQQRgzZozBdiFpQjd6rOUvXLgIucpjBB/rnpGopU/vRus/deoMeD31Brf06RnpacNI2SJyVZ82bQZFXjFtHfupIxo2/IsRqbJQsmQps2q8ExJwXHmiiT3nxTh16gT4&#x2B;b1nxHYf1KtXj1z916xZBcOHDyeSjxkCOL5jx44HW1sbKFiwEOTOnfuP&#x2B;s6YOnU6GR22bt0KQkPDYMCAQWT0d/PmDRKZypcvD3PmzAE3Nze4ceMGpdPj&#x2B;YikesOG9Wy&#x2B;mySUYG1/oUKFdH4T8b6xZuc3ZmPMmDETbGxs6RijuHXlyhUSsbDUo3bt2uTLgdkfCxfOh&#x2B;LFi8Phw4fo&#x2B;I4ZMwouX75M18WJE8cpY6BYseLqj8Mv4Ejse&#x2B;jr6dOnr61fv/7utm3bfKKion4U4Tcnsm9u7b4pp35ziX9cIv1xMf&#x2B;LSwvA31Yo&#x2B;B1NAPnHvHRpAcZGgPjYEqTNAMWT0PiPf24t/vv&#x2B;/fvpLi4uap6sChUqEizev3gLt45cgYfn78CnNx&#x2B;hXItqULVzXbDgLNTB&#x2B;Un4GhxMN/GSRF2OwPM/dtJudHrGikTLIJVeShvQRrp16foSbFl&#x2B;m0CSgItnEmYcmJpfLHaYTB6Q2zbgZM0J5fYJCQrW&#x2B;aOhHpIQJJpCklOyZDE4fvykruc5P3Xs1BEuX7oEwcFfIHWatBATHUOkatOmLZAuXVpaFiO1GH2tX78BRTqx3h1b/yU24Nh5enoyUjpA8n1fX18ipUgIK1YsD3v37tel46OQMnjwP9C5cxcitFinj2SySZPGVJOOTv/z5y8gI7smTZr&#x2B;0b3iMdW/adPGUKNGDVizZh3kzJmdhCQk&#x2B;cuXexKxtrKyZOfgJihVqhQ8fPgI2rRpA8OGDY/X52FtP57rSoIUlmB06NAe1q/fAKNHj4JZs/6j5fB8nzhxEvTs2Ys8BkqXLgGFChUhs0F0/McygAEDBsK//06lrITUqdMkOuHrd8cnhrNnz94YNGjQuadPn36FH1fPbw7RN0XwzXXnj090Py5Rf7nX4kv&#x2B;Tc6jmgD&#x2B;YAUMlE0BVQ8AFSpUJAq4Zk4L1bs0gPKtqkPolxBIkTaVacM5FT8Vcp0BONML6jMCTPzkGaXrS9x0GNe2GxNuyXZ7BusxL2NfLtNAifRLdTCQu1fC9fNRaD3J54hsnjhxjNLKkYxg9B7f5z8Oa//5GzBcHoUbrHuuWqUKzJk9Gw2yoHv37uDuXhR69&#x2B;5NLdX4sWvQoKHBNiB5Fd7MJZbrDmvT7927q3hs&#x2B;X3VOsvrx&#x2B;Ddu7dQsmRJyJAhA5kk8uOMBnFI&#x2B;LNly0pR60R1wymRzWMKGM3v1KkDmfbxp9CwYSNg0KABULlyRRJZUIBCwal06TLkvo/EW2iEGNdtHDRoIEyaNFnRnBGJPEb7cV/q169PPgxfv36lzheYPYMCAIpeWbJko3KXli1bkycBlnlgxgvClNmliu&#x2B;H0NDQ4OfPn79ix&#x2B;fS/v37X927dy/oGwl/XNP7v0cdvymn/vgQfgDz2/z9NPL/q5EQBACpTgAcmOfsL6fyGJ1wqgeAChUqEgvBtE&#x2B;WhCYVvwfRF6f6G70vulvghKFuGZYtjqRzhtRfkqVLbYeYfxum7lsYGf5p9B9mstWguLWgoVlfrOmf1NgJtwHkMweE6w8PD4OIiMhYEqWhaOm&#x2B;fQeoXhkJKE4oCODrKALgPNaxEWeMTqKxWoUK5SF//gJkWoaO/lu2bGNEtQkj/39LmzQajaM&#x2B;28Gsbg&#x2B;/KdC0D7MikNyhw3zNmjUV5&#x2B;fJvbW1lYFI8/jxEzhz5gxs3rwZ&#x2B;vbtR&#x2B;T/9OlTYG&#x2B;fhFojJjbgvo8aNZKi43JAAo3RfhxXFI0w&#x2B;6Fly&#x2B;awbNlyRsgnwpcvQdT54OHDB5RVgpkr&#x2B;fPnJ7KPJSa1a9clA0UsB4gvOnXqSEaLeDzwmhg/fhx07doN0qfXk/Vnz55Bs2ZNqOwFUaJESUrjv337NiP7&#x2B;4ns89cAlrZ4eHhAgwYNIFkyR8iZM5f6A/DzBKeYly9fvjp79uy9xYsX37lw4cIn&#x2B;HHp/ebW8ceV&#x2B;AOYn97/rVF&#x2B;Je6oRPITFfn/3QUAmSpKk4OtdDLEgLwPgAoVKlSoUPGjbtRMiwbSSoLBOsSGfTxJ1hJwGVZvtDynGLlXrv0Hk6RdjhwZaRIyhoJyny/32WiOtn79OsiePQeUKVOWSE1MjAbcixaHqTlykvEekn50R8e0cyReSKis2XI8SV&#x2B;7TuuwbmdnzwjrRtiwYQPkyp2bUp&#x2B;ljp&#x2B;UmPOrSyq/FcHBX8kUESP3gwYNBnd3dwgNDYHBg8cSwStSpIhg3mCKHguzL6ysDHvLY6Tfy&#x2B;sJVKxYCSpVqkSt/vr37w8zZvyXqK5rnvT/889AuHTpkuy82O6vd&#x2B;9e5I6/ffsOItTLli2lGv/Hjx9Rmv&#x2B;HD37QtGkTcvTHjgCdOnUhccvZ2SU2w8J8oNjAHyMhUGDA8gIEHmtsP4hlHHv37qPX0L&#x2B;iV6&#x2B;elPqP712/fh3Onz9HYg5mBKAA0bq1VgDANphJkyahen8VPw/sOy76GQO7nvaw4/KBHbPIH0j4v7eZn7lp/hr4/nX95hB/gPhH/RME&#x2B;UckpMJQUwfOXDUoRnSCgSoCqFChQoWK7wFhz3shOeQfG0XJle4YBOnVwlRrsQGeEmE3TWCMSTxn2L8QZJ16BITdYB9jJ0OSLMhWkKgjEH42J2rXJ95OunlhpBMn/jMOHDgAT5481s2PhD9tmjSMaG2j&#x2B;nOtsz9QTfOt27dpHksrK93yY8eOI2f/ChXKwezZsxgJawqzZ802i9gbdlNQ9ln43YDp5ZjtgEBzOSR/Q4cOo6gzAvvSnzt3BkaO1Neao&#x2B;ncpk0bdPupLavgIGPGTAZ1/AUKFKC2gCNGjIR169aCh0dbKFeuLFSqVDFBX&#x2B;OfP3&#x2B;mcUP8999Mqo3HcUPjO6HbPnZIWLBgPrx48UJHlq9fv0pClZeXF503&#x2B;HfFihWUjj9s2FB2nlpBkiRJ2XKL4J9/htD60qZNF2fyj&#x2B;sdP36s5HmozZLRHrPo6BhK7cc2g6dOnaL3sfUfdiS4evUa1fU3bvwXeTkcOLCfRItt27ZTecCECeOha9cuJBSp&#x2B;Dlg1&#x2B;rXw4cPn2HE37NIkSKe&#x2B;/fvf8POvXDUl9gUFTtFCv6KpygT8yq9HyXxOFr0XG6KFkzi58IpRvQ3WsDbpB5rJHid0nMA5TJwc7IBEjz5RyQUDwCNwn2SkoIDIJ8SYqA&#x2B;qSUAKlSoUKHiu/94iVPBOUOCzf&#x2B;4ceYuD1LO&#x2B;yZECYUItbjln2H6fewynL7NgGHZgYRgAGbUQcv18JMRKLTigaGgoEvjjyVGSD5r1KhJkX/hdmB7uRs3bhIZrVy5CqRNlxYuXDgPdWrXhuROTrrotauzKxQsmB8aNPgL6tWrTynw/GckVixbtgyOHDlMRnxo7IakH03nkLBiWcSbN6&#x2B;hbdu2UKVKVShatKhuORRI0OwNo9MYtZ4&#x2B;fTq4uLhCnTp1KL1feN5hCjsC09exH32ePHkM2tMlRGBWCJo/4rm3atVKXc/7ZMkcdOcLpu/37NkDDh48QIQaI/579&#x2B;6B9es3wsuXL8Hb&#x2B;ymNT&#x2B;HCheHWrZvQvXsPaNasBTsGBSk7hW9NGRcEBgYxoj4QlixZxravHtSqVcvgfTTws4rNesHNxGsF2/qhOWPHju2p7R9mamDWBtb5J0vmBAMHDmDbvB4aN24Kf/31F5QpU4b2e&#x2B;zY0bBw4UI6vnyrQBU/BqGhoSHsnPHZuXPntXnz5j308/MLw7Z&#x2B;ELcIfnzS&#x2B;81J649rtB/g29P8AeIf8Qf4MVH/BEX&#x2B;E5IAoCQIgMwBkyP9OFnInJQqVKhQoULFt/04yRn9cdLRfzkirFRDz6/BgLSbXAen6NwvjvzTvmB9t8Y8vi5V&#x2B;y5r&#x2B;Kdg/CcGEkYkpFjjj4shAcFa8g0bNsKECRPB1dWF6s&#x2B;xhjkqKlq3DLaZy5evAPVGR6KGAsCQwUPZcutoGzGlHdOXEUOHDYZFi5eCi7Oz5NiZI7AkNLx&#x2B;7QMjR47SdS&#x2B;wtrahSK&#x2B;n5zKYMuVfEkLy5ctPBm9hYSFEatGMDssEypQpDe/evaNI84sXL2kcsT4duy5IATsD8N0BEhL4Nof8MUbxCAUTNIW0tbWFLFmywJ07d8gUcsmSJbrlnj71YmPzGFq2bAU7d&#x2B;6gkgk/v3ewb99&#x2B;2LNnF3h4aD0QWrVqDe3atdetHwWS&#x2B;G7n0KGDSWzA7UEvAUzVF6JHj&#x2B;4k8CB4gcfBISmRfhR4UMBAYBtGfA3r/Nu3bw9t23oY&#x2B;AMghgwZRmIZjgGKR1LADgDYghNbFKqIOz58&#x2B;PBx7969F3bv3u21Z8&#x2B;etz&#x2B;I8Jtr8Geus39cW/aZk&#x2B;b/rS7&#x2B;P5r4Jzjyn5AFAAB5F0e5k8pCdGIZpIaoGQAqVKhQoeK7/UCZYQInaXTDp8RznNHLhtKBRkfbjWYSpOArbQcf9dcI2gZywu3i9L&#x2B;uckaBSiIAJ5/WYFJN0AseHBHPZYyUNmz4F2TMkIHeP3bsOKxbvxauXbsK8&#x2B;YtAG1ATCgacDB16hQYNOgfyJQpEyNZHmS4huZpPOHFqCaS3o0bN4GPzysi//yYmUPspYwBExLGjBlLbu5Y51&#x2B;qVGk4fPgguctjCzf0VEBy2qVLZ4pwo1jC95fHFHbMkMicOQtFrvE5&#x2B;iwkJiCJRgFp2rSpsGXLFra/ThAZGUG18Rs2rKcaemyTh2PDt7jD6Dp/Hk6fPo3S&#x2B;AsVKkydKLAlIjaoGDFiBHutAJFsBBLo7wHc1uPHj1GnACxHwG0RAj0tUIgYMmQokXJ7ezvYtm0LO96f4Nkzb7h69SqsWLGS5kXhBzM2&#x2B;PNfTP4RKC6YSv3HUo///pvN1ldP/UGIw0&#x2B;HD8OtW7e8unTpcsLPzy8cfmw9v1wdv1LrvvjW9Jsb7RfOA2BetB9MEH&#x2B;NCR75xxD/hCQAiNP/OYm/AKZTRmJEQoD45FehQoUKFSq&#x2B;CZwE&#x2B;ZeK/BuQf2F4n&#x2B;MkI/96vizToE84o5kChBGZ1wjWG5smLG84qLB/Aq8Cg7ckUv/Fe8PPgqRKOxwWMGHieHjq5QWtWrbSzYfu/FWrVmPEZi1069EFqlWpZqAphISEwhtfXyJE2Ecda5qxPv3o0aPsr5bIohDw99&#x2B;96bUFCxbI7k9iJP9akcSC9h/bymF6&#x2B;IkTJ9lYrcAe4mT2hiS/b9&#x2B;&#x2B;cO7cWYN9HT16JAwcOAh69OiZKK9hTKWvVq0yOd&#x2B;jiV6yZMlo/ydMmEAdIlAY4c8BJNN860kk1WFh4fR8x44dtNygQYMgU6bMJJ5gK8rGjZuAj89LIunfE5hdkTt3Hnbs/HUt&#x2B;ITw9X1NAhi6&#x2B;2PEHo8tbsOcObMpe2PUqLHk4B&#x2B;Xa4AHCnQoZAiXwRaaKHJg2QN2PJDLElChBTsWX65fv35v27Ztd9j0Mpb4fyvh/9FmfnFN95eL9n9rmr8UiTcV7f9W4p&#x2B;gyX9CEQBMDb6pg2tWGQAXHq42y1ahQoUKFd&#x2B;uAEiSYT0hNyL/wr8ytxj6t3m/f40xsZYxoBNpA2aRW&#x2B;FHGLXfkxABpNcjVDuM91NqPfhZGL0PYiQsJDSEDMoqV6oMw4YOIwKP44hkFWunERhlHDdurM7AjF9zWHgYfPL/RLXQufPkhj2791Jt87BhQ&#x2B;D0aS2hRdKCNe7NmjWD8uUrmE3oE5rRnxwwkp0ihbbWHMcUiSu6wWM2BJK2uXNng6enJxHLqVOn0nxnz56GefPmwefPgYn2Ev78&#x2B;RM0b96SjPk2bdoI3t7P6DzE0ghs1yc8DzCDhD9vsG7/3LnzULVqFWjatBk5/KdK5UxdD0JCgql8AA0U9&#x2B;3bA0eOHDN9g2tCxNuyZTMJEpiJgRF/9GVInjyl7hoQns4DBgxi&#x2B;7KJ2v&#x2B;huJY5c1bK2ujQwR86duwEpUqVitdYYekBjhF2AeD9OPA1vM6whSBecyg0PX78GHLlUtsDisYu6v79&#x2B;4/Pnz//eNSoUdf8/f0jIG4R/O&#x2B;Z3v&#x2B;txF/OwV8YyY8B5RJtc0i/0mugEv/EJwBImQDKRf9BQW3iRMSfFwJi7kybdbVI2XLOSQrld7LMkI7jYlPdVKhQoUKFCrN/rDSGxFCcTi6X8i8mlyDBnfWkWSINX6ZdoEZUvy8k3cLUf35buNjaf9AoaxMWnIWhqCF4bCA4aIz31aj0QAJdunWGNm3aQsMGDaFy5cpw7do1MvLj0615Q7OgoCBwdEoORYtqW9Zpo/sacHJ0gqnTpkHwly9QrHhxci338GhDkWus20ayi&#x2B;nbqVKV1N6ZxjrZm3&#x2B;cNQlaAMD2bxgBbtHifySs4JQ&#x2B;fTqoXbsmpE7tSi0T0S1&#x2B;zpx5FFEOD4&#x2B;Avn37wN69u2Hx4qWJ&#x2B;hrGdpBY5//gwX3o06c33Lhxm0ojMI0fs0nq1q2ru1bfvfOFsWPH0/OaNWvB2rXrwNvbC06ePMXGtiVkz56dJixVwY4B2D2gdev/kaiiBEzpP3PmNGUMyKFLly7w779ToEePXpQpg9dGVFSk4BrUX3xIwv/5ZzD4&#x2B;b0nMQPLabJmzQI1atQw6NwQVwQFBcKxY0fpWuWB4&#x2B;Tqmhp69uzFrq9U8P69H6xcuZJt67/qDwRDeHh4mJeX17NJkyYd27Jli0&#x2B;MNoXkRxB&#x2B;c8z8vke031QLv&#x2B;9l6gcQ/zT/byX&#x2B;ia5M/HcWAOSM/jgTB15M&#x2B;OVKATjhxVBp9vSVGVd5bplYuUblwkUKF8tSskRR&#x2B;9w5bS0zuqnfVipUqFChwiwYkHUl0z&#x2B;j5TiBWBBL3MHYcV/7WPBTaCL6L94uI/IvNRNqAhpeBNCn6BtG6jWSBoO84KB7i&#x2B;MkhQ79j7h&#x2B;OzDyz9fgI/GpUb0GRRPx&#x2B;ZIlixkZnRsrAGh/2jH1eODA/oz8F2NE5As50KMJIP8xRWKzBBC4nkGMAHVo30G37fx4m10uIRI7EqoIgNu9fPkyRljrMFI4iI1NJCP1iyhCjentLVu2pJ71SPx5x36sd2/VqhWZ3VWsWDHRX8c4RmPGjIaUKVPRGLi4uEC7du1g1apV1D2hYMECVDKB5QJolIdo1KgxGQG6urrSc6ELv7t7Ubh48TLcv3/PLNd8PN/t7Oxl3/f3/0gCzcGDB2MFAK05Jm9qGR0dBalTuxgsM2vWbCrpmD17js4g8FvIPwLLRVCMEwLLHWbMmAnPnz8n80Mcr4iI8D/&#x2B;t&#x2B;HNmzevb9y48djT0/OWwNQvvgZ&#x2B;32rmFx0P4g8gH/2Xq/MXP1aj/aoAYBb5N6f&#x2B;31TKv5IpoMFF9Crgc6jHzs1HLHdvPVk3Z&#x2B;60rYuVKlmmWLGKziXc09nly2PDOTqqd7cqVKhQoSLuwoAptUBAPIhqS7b648myNHE35cLPE20j8i/MUuAEBoCx84rJv5wIILNLkuQfMwj4dWjT8W2ofpp3kcd6//fvPzACpnWO10al9V6&#x2B;KATMmTMH2I00XLl6Df7u3Vv0&#x2B;Roi/fx&#x2B;Yao0TkKTv/iQQiVvh4SEy5evwrp1G6BTp47kTI815NOmzaDottR&#x2B;YT07GgX&#x2B;KcCykvfv35MQgucdklp0vcdSk759/yZB4MOHj9QiTwhhJNzgfGfrwBIBc1vmXb9&#x2B;HWrVqm1AtPF8xs9FYGlBoUIFKbMFuzmkTp0W3r3zg&#x2B;HDR9D7ISEhULKkNq0fCfqUKZPg8eOHUKlSBaPuAN8CGxtrXVYOD8zEQTGuXLkyVOpQtWpVyoz4ExHI8OTJE&#x2B;/ly5dfOXLkyJvnz5&#x2B;HwI&#x2B;p54&#x2B;LmV9iiParxD&#x2B;RCgBygoApsUAp9V88ibMAomOfW0THxETtefTgLZv22m9ae7hr0RJ5GpYqVapkgwYV7YoUtLFIkRxUqFChQoUKObbPCTz6NWaQf6kUesNyANHPoALpN1yHzCZKLMdvJ6fR74NGJz1oRQM5kUGRU4vq/vn9xSglmqghibh9&#x2B;zZcv3Ed2jIChan92Ff97t270KdPX5o/TZp0BsQdH7umdqX6auxNni1bNoPov3g/eaM28XvmEnnDDI2ESfyRCN65c5ui0f369SdXe0xbb9&#x2B;&#x2B;I9VrJ1Zg3b2TkyOJRbjfpoDGdeiMP336DCLRPj4&#x2B;ZIS4desWRqSnUmYA1vR369adov7xAZYCYCq&#x2B;HJIksdedb/j5HTq0o6sHO1bguYyt9erUqce26xzMnDkD/Pz8yGgP2/chatasTWLDypUrYNu2rXDgwCF2Lf0NadOm/z435bHfAXj9Cq&#x2B;HjRs3QJ48eclwEEULRn7B0dGBXZ/Z/6ifgHv37j04ffr0w/nz59979OjRlx9I&#x2B;M1N748L8deYIQCYG&#x2B;2PTws/gG839YsPif&#x2B;jusElVBNApRNETPwBTGcBRAvEgGj9LRxwoVGRkXMun3&#x2B;w6NqlJ01OnjjVpVyFqrmLFcvnUqq4q2VGN45LmlS92VWhQoUKFXqCq4klzBxnrF7LpuhzCj91ElF/GXZvKvovfmzwKeKPMMPoj98UUwKHgds/e&#x2B;vEieMUpWxQvyFt88AB/aFosWKxpQQcI2F74e3bt9CpU2dGxp5DMsdkYGNtrTNAjInRwP9at6GyAQRGR6XKL&#x2B;TS9M0l8cL1JHSgyNK27f/gwYNHZPLHIzGTf/Q6aNeuLbXtS59eX9KJBnpYQlKwYCHaf4z2X7p0kerWR4wYBoMHD4X//vsP8ufPC7169YBXr16Bm1t6KF26FCPTB6kkIq797flz6OvXrzB27GhYutRTdl6toZ52/gHs2nj69Cn5XZw9exaOHz9KXTCuX79KmRmLFi0i8n/48BHd8nxLvxcvXtC&#x2B;1atXl&#x2B;3PLN37w4YNpQ4Q6dLpxyQ4&#x2B;CusXr2KjUFv3Wu4nyNGDIcGDepDhQqVdK/fuHEdHj58CPXrN9Bl5uDnjBkzCubMmQ&#x2B;bNm2gTgMoXOC1&#x2B;fixV6L/7o&#x2B;IiAj38fF5s2XLlktjx469zZ5H/UDCbyrl/1uj/QDxa&#x2B;GnRvtVAeCHkH6lsgC5EytGdAclnKLBMCPASADgH0ewL7CNd26&#x2B;ZNPqTClSJuta5P/sXQV4E1kXvZMa7u4t7u6LuxZ3Z5Fiu6zAsiy6u&#x2B;j&#x2B;wOLu7lIW10IF1wKF4l4cSiltk//dl0wyM5mZTNIU2vIO35BkLNNkMvPOufeeW654jXIVSpSoWqVsspJF3V1y5sAcLzb6ZWBgYPjWRQBOIfqvgYiaW/1xKjX6vJmeTBaAUts&#x2B;2f0IBQpRuz659nziCLiga6Fm8s8/uru6w&#x2B;lTpyAoKAhamSKoefPlo6nJmE6MEc5ffv0VihcrSl38MQK6fv0G4Mg91qC3DAGMWQR6Td&#x2B;F9G9QEweUiFtCd/1H00OsA0&#x2B;s2L59O7Ro0UI0D2v00dRv3rz5Zpf6I0eOQN&#x2B;&#x2B;feDTpwjInj0nIaop4c6du9S9v2fPXoTsP4JevXrSNocVK1akrfKQcP/008&#x2B;QIkVKh44tIuITTJo0AcaNG09T9glJhA4dOkLt2nXM62AU/8CBfdClSzd6rGjEiMcYEnIDAgNPQatWLQnJ3wNXrlyG1atXQ40aNWH27Lmwc&#x2B;cOuq/y5SuY95XEZGSN7zdo0CDa4o9P1Z8w4S&#x2B;4fv0GPH36nGYEHDy4H&#x2B;rVawBTp/4PDh8&#x2B;KBIAMINgwYJ5VHQ4etSPts5E&#x2B;Pj4kG2zUM8I/H3g34RdBtAsccCA/jQDAH0A9u7dSwUWtWyHhI5Xr169PHz48Nk9e/bcXLp06R1w3MDPnvR&#x2B;W2Z&#x2B;Wmv87Y32qz23JQIAxK6Fn1ZBgJF&#x2B;LeOUr61qC26o0jsrJyXhkkmn8iicXEyT9DU/uUoe5ea5ymzn4qZzcc2dNm2K4bXqVq5UvETx/C29C3gUKqADN1dgYGBgYPj2gP3nP0VGyt7U1AQAMbfn5LflWTcSVx1nVSag8BayQoKcoQ6obKtGfkWGf6ZjdHF1BVdC2KNM7eX4ffH7CQ4Ohvr16xLi8IiSnUOHDsLu3b7wv/9Np4Ti8&#x2B;coqFS5AjWdw2h1TUJ2MMVf&#x2B;lEI9BCb4oqt&#x2B;UrrJnTH/8QMdOpHr4gyZcpA27atCUE&#x2B;ILve3r3/QcaMmaB48RKEoPqQ59ii7hbcvn2bkOFrtG3fhAkTIG3a9NCvXx96TmK6P5YOvHr1gpagSGvd7QF6K7i5ucD27Tvh5MkT0LRpY7h8ORhy5MhhEireQKdOneiybdu2w5YtW2hpC5YahIaGQqlSpWHMmDFQunRpcHV1oV0xdu3aTTsM2IvSpUtCuXLlye&#x2B;vAZQoUQLq1q0F166FQPv27Wi0fu/efXQ97BKBx4mdMzCaX6hQIULmM5HfczQ9NhTmsKsAduBADw/M2Clfvjz5PK/D6NFjyWfahv72dYkwOPaOgJw795cvXx6wdevW&#x2B;&#x2B;Sz&#x2B;AhfNtqvltZvT03/l4z2q83TSu5jFe0n13JDfLqWf00OHt&#x2B;ZqjD/Ua0DAKiccHqJiCAtEeAfYyTig8JwyIIofQzcevnifZ/N6w/B5vVH/zhyuFSnBo1q5SpXOk&#x2B;S0iVdXdKnY3dnBgYGhm8QttL&#x2B;OSsPAEtEnVNj2ma2a&#x2B;0uoJX8WzII5G900m3UfAas/ggCD3d3ePb8OY3wYws/odO43tQmoFixYrRGecrUKZQoLF&#x2B;xHPr360/fBwnDqFEjYeCAAdCnTz&#x2B;6nTDSLxwzScm/8rHal8rPCH/8B0aZu3TpAtWrV6OlIMaMa2ts27aVdpXANPhdu3xhyJAhNPUfyfagQQMJWR0Dw4YNNxPVxYuXmCPoCMwScBSPHj0i22envwVv72Z0Xo4cOaFMmXJm8o9YvXoV7RCAvgIYZcdjwd8NpvZjJgKKX1gK4ObmSo55CG21h5kN9uLOnds0i0FPxq9Nmzal2Q0PHz6Bw4cP0/fFCL7l2B9TvwgU4TDC7&#x2B;PTn3yWOwBjYGPHjoXu3bvR9bJkyQyBgYEwZsxY6N&#x2B;/PxVk&#x2B;L8tsZF/JJDr1q3bO2vWrPPkb34FXye9X4n0O&#x2B;LgryYAaIn2C7eV42Jyz8HGfLBDEND0nbGrZfwWAOQIvlIbQDlhQM4MkK/zl57UwjFajMo8ufdXnP46evDchGOHLtXOWyDzgCrVKhctWyafZ7UquV0LFQQuaRJ2tjEwMDB8a&#x2B;RfhlgKxyPCKDbYuAFK2a4tkmrV7k/o1qcQPddS8y9s98e37hMeE0b3O3fuRE360hBSUblKFVPqPsApQoTKlStLCIgOihQpDHPnzIGVK1dAm9ZtqCCAtf179&#x2B;4hRGMbjdBiBNGYQaAh00HBGNER5/6E3uovMQPJL0bot2/fRonpyZMnaV97OV6AhBZr2IcN&#x2B;wUCAgJpnTpGtn/&#x2B;&#x2B;SfYunULTWH/7bcRom2E5N9RHDhwgLzXM/jzz7&#x2B;oCWGKFMksmTDkfEKjSyGQQC9ZspR6FSApR&#x2B;JcsGBBmrGAAhlG3zHiXr68WDiwFyg&#x2B;dO3alZD65rTkJmvWrODu7go1alSHNWtWidZFQeLRo4ewbNkymDDhT6hbt555WZUqVQnxz0Kfz5gxk/5NfDZCbI4vPiKa4M6dO/f8/f2D//nnn3NXrlx5HwvCb4&#x2B;Zn5a0fq1R/thG&#x2B;&#x2B;WIfryP9rOrZcIQABwRCrRkAUh9ANQ6A8gJAmontPQ9XPTkhDt468YTMu3Iui1V0naFiuRt7tO/aNVOHcp4eHgksTE2ZGBgYGBI0DAoslRbafRioz6ZfWhJw5eQeM6ULcCZSK1FcQBLyz8F4s8TYKm/gFlDIK8xLVrUB5zMRIOxP0aNgooVKoFHEg8z&#x2B;UcsWDgPjhwpAIcOHYIKFSvQOmFs8Zc6TRq4dSsUFi5cQF3Y//57In1PY&#x2B;SfU/wIOM6atCOQQDlS789If/wGtuE7dSqIRscxhR1JNT5ier8cRwgMDKJGkmjuh2Z&#x2B;bdq0hsuXL9KI&#x2B;s8//wojR4506vENHfoDfa82bVpRR/7y5ctSoo2TUACIjo4SbYcGfIsXL6JiQdmy5aBUqVKU/L99&#x2B;xZ69OhBSwK2bNlsbvPnKFA42bBhPTVBRNHEyysfJfapU6chv2U30bopUqSA48ePUzEuZcoU4OMz0LwMTQD5kpz8&#x2B;fMnvqs4Aab5Hzly5Mz27duvrV&#x2B;//n5kZGQ02B/Bj0szPz3YjvLbQ/a1RPulwVQt9f5q88EOQYCR/m9QAFAzAJRbLtcNQCoE6B0g47gPF4UfjovkJNc/ef8u5t/TgVfIdC3tz0N3/vPPP5VbtmxZLS0WmTEwMDAwJE4JQEogTcRbzqhPyslBGrFXIKj8Yn64I96PYB&#x2B;mu6IoSg/Wdf&#x2B;84Z&#x2B;SECB9D3z08PCAFStXQPdu3Y2t9sh07tw5QlyKU3M/3O7KlSuQPl16s0jg4qIDX99d0LZtO2q4hrXFGzdsgJ9&#x2B;/gmWLlkOXbt2gQYNGkCNGjXMBEMLpJkVcgKG1u9Oq2jD8GUxb95cmDx5EjXH&#x2B;&#x2B;uvvwnpzwgRERGUKGPUXi8Qms6fPwdFihSlXQDQQb9ZsyZw48YNGv2vVq06rbfH6L8zgbX6ixcvhl69esEff4yiqfvY4hKBAoDlt2qAChUqGpmYXk/&#x2B;lr/gwoWLtNNA&#x2B;/YdYMqUqeTv8YDPnyPp7wFbYn748JG6/Xt5ecXqGNHVH1sQ3rgRAocOHYE6dWpB585d6DHhZygU8&#x2B;rXr09/h3jcEydOoq02EVhG0KVLZ5run9hAvo8Ycs26Tkj/uWnTpgW/ffs2Cpxj4GePwZ89Jn72mvsJBQAlMUC6Dov2MwHgq5J/6YnBKZwwwrR/Yas/2TGD4JFTEQSUyD5IfljC93MRiAX6169fx/Tu3fvYwoULLzVp0iRP69atK5CLaR5TVgADAwMDQ2KBqZjfTDxtZgLwyfrqbfcs5NtCyBV0AvFGfM0/8GKA9TYuOuNtLUYfAzpOJ&#x2B;t8z8noEk&#x2B;fPIVPnyJh3bo1lNDfuXOHupSfPn0GAoMCIISQrtmz55i3m/a/GXSf6EiPhmPh4eGQNl16Mn86lClT2rxfjPwbDNbRfyXDPyURxlHDP5YFEP&#x2B;ANf9kHAXdu/eEXLly0fR//I6wnR&#x2B;a0FkyVAy0I0C&#x2B;fPkJYfakbf2QgGPK&#x2B;u7d/0GBAgUI2U3q9OPLlCkTJdXFipWA4sVLwubNm6kYhqn8yZMno&#x2B;Qaz3dszVe9enWzAPDq1Uu67R9/jKbp&#x2B;Xy3Avw75syZCwcO7KctB5s0aerwseFvzWhiyEHbtm1oVwDMLsBWh7Vq1aafIy7PmtXi1v/06VPavQA7cKAXAf62J02aCL6&#x2B;vvQYO3XqkmjOLXIOfQoNDb29ePFi/0WLFt0k31O0Ewi/PQ7&#x2B;sWndp9XcTynaH5sWfgYVAm&#x2B;AuHXyZ8Q/NsOUeNQFABQIuFo3AACL&#x2B;79ShwDhxIG4I4C0S4Ct59J5OoV1dArriObXrFkzY58&#x2B;fUpUqlSpsJeXVx5g5QEMDAwMCRq0CwAhJJwkBV1KRuXa9VkxXdNzW4SU42Tq/YVvYhYirMkukn09IdoYGcXoYMYMGa1a/kkaEJj0DWMLQTT8W7R4EWzbupX2R7969So0atSAigKYxjx69GioVKkKJfO4LdY&#x2B;4/ZIhvj3Mc7jBNFH60Q/Ncd/Nbd/e4g8I/zxH3iOnjt3HipXrkTb5nl6etLUeSTUAwcOgB07dtHfX/fuXWHVqjWUYJ84cRIuXbpAHf95MSqugF0tkiRxp10sSpQoDteuXaeZClWqVII3b95A/vwF4MGDe7B16w6RiR&#x2B;KG0KzTOdek8KpFwGm8Q8f/pu5m8F//&#x2B;2GPXv2gJ/fcbhw4RL5zLpDkyaNoV279nT5qlUraBYOCnsIbDfYuXNHKqyMHDmKehMkZJBrgx5r&#x2B;4OCgq5NnTr17Pnz59&#x2B;C4xH82Jr5OUr8AZSj/1oi/wC2U/4TVbSfdQEwIiF5AEgNAAHkbJDlSwH0ArFAzghQSYBQivbrJI8uYG086CJYRy8RAujro0ePPiPTofTp0/s1aNAga7du3UrXqlWrArkJeLDbPAMDA0OCHFaab&#x2B;ycKO1fwZ3eRNxlWT3Ip7ZLCbHxXQ1WIoD5ZsiTf0E&#x2B;HZ1nAEr&#x2B;3VzdaO/un4b&#x2B;TAUA6SBJSv75v8&#x2B;cjsfp4Mrly/Dj0B&#x2B;o0RpGWpFEdO/eg5IfNG3jjzkmJlrkyG&#x2B;s81dK9ecU/26lgZxw34z8Jx5cuHCBCkqbNm2C/fv3UwGAd5j39vaGsLAwKFCgIH19/XownD59mrr8Y5R7586dtMXkoEGDNb3Xs2dPaXs7rJNH4qx0bmDKPjrn48SjU6f2MGvWbCqAoeh17NhRGjHH3wSWzGA0v0OHDlYO/nFB/jHbIHny5LBw4UKYNGkSpEuXhmbZNGzYmAp1S5Yshtq160Bk5Ce6fq5cOWm7QR5&#x2B;fifIug1hx44dVCjYt28PjB07Dvr27UczCBIqXhJcunTpxqxZs4JwHP769esoiJt6fq3R/9hG&#x2B;w02BABntPBTiuprjfZ/deLPkDAFAFlDZMlJxIF1/YqQfEtb/4HkOWg4yV1UiL9s6r8c8Ze&#x2B;JteimLVr194l0/02bdqc6datW8mqVauWSoc5kgwMDAwMCQsSgss/tyaxnFkEEC1UzHO3vhXqOIuAYCb//HvKjbRMzv2ht0LBK68XHDtyDL777jv48D4coqKjrbIUhEMucxoeIV6HDx0iJKwyTQXOnz8fuCfxgAf3H0D3bj2gUaNGhODkputiJFSOtFsLG5zimFCJmysRfEfS96XZGgzxB2iAd/fuHSoATJkyCerUqUPI6F5qTvfLL0MJyU1BHfKxtR8C29ChA3&#x2B;nTh3h6dPntDxg8ODB8NNPP9l8L6yPb9CgHnWyx&#x2B;i30rmApBgN/9BH4O&#x2B;/J9B5Fy9epBNG&#x2B;idOnEiFr379&#x2B;tLXISE34ePHj9SHwNixIG7x&#x2B;PEjeozoQzB9&#x2B;jTYunUrOaa/4eDBg1QAmDDhLzh16hQcOXIEdu7cRbcZOHAQLUXgkSFDBujRoxu8f/&#x2B;RfIauMG7cn9Q4MaGCfP4fdu3a5Tdw4MATZNwdGYeEX0vrPkdq/MGGAMCi/QyJTgBQU5TkjADlTlKefMeYCLhew3vI/Qh4Ag8yxF9nD/E3veaEzzdv3nyfTA/z5ct3rHnz5rm6d&#x2B;9e0dPTM1dKAmAlAgwMDAzxnf2LCK5SOzphSJ6uI&#x2B;yXLYq&#x2B;C7eXaxcoNPcTp/yL1HGBpoDEZMWKZdRp3z/gJJ2fx9OTGvKJBgiubqa0fEvrQDzOj&#x2B;EfaZ1/9WrVwIW8TpY0KSH9jWHWzFnmY46KirZJ2i2fB2clbtiq91ciZo6Qf0b44x8wK2Tw4IEwd&#x2B;58GD16FCGeP1NyfvnyVfodYyYAik&#x2B;Yuo7IlCkztGvXjj7HKDaa7D158oRmB/Ts2ZO8rqTpe8a2d0h8p0//F86cOU3bBvKkGH0p0MQSa&#x2B;GHD/&#x2B;VPkdy3a9fP8iVKzfMnz&#x2B;PRvIHDRpE32vcuPHg7&#x2B;8PTZs2hTx5PGnqPRoWasXr16/INq5Wv0ul8x7d/Tt06Eh/Sx07doBu3brD6tWroHlzbxrJx8wJPnLv5&#x2B;dHMxfQ3O&#x2B;776rReXxbPx7oR4BdAFAMadWqdYJM&#x2B;SekP/zBgwePNmzYELR69eqboaGhH9HoD2Jfz681vd&#x2B;e1n32RPsdjfgDOCfaz4h/Qh&#x2B;pxDMPAABlHwD&#x2B;UckLQMkHwFFfAA6U6/dla/rtfC3dPyd5bl6/QoUKabt161awfv36pfLmzeul0wlHigwMDAwM8WfAGQGRnz&#x2B;r3uc4wXwRYbXRr16Ov8iaBpoM/wyc/A0VBYBff/0FqlSuDIsWLaItyZDArFmzTtSq7Nq1azRVOWlSi1etKyFd14KvwZq1q2HihIlw99496N6tCyxZsoz2Aecj/koGhZxMdgSAxvaGSmUUDhB4Zvj3ZWDrs0XvCXSf543vHjy4Dzlz5oIFC&#x2B;YTQj0Xzp&#x2B;/BLVr16Jp6ug&#x2B;X716LVpDj47/GHmvXbu27H6RuGPEHckrekxoBQpeSNTR0b9u3Tpw8qQ/ZM&#x2B;enf4usCSgTZu28O&#x2B;/M6iJJRLm1q1b0a4CWOoSEOAPefPmg4sXL5DtAujvwVHg&#x2B;3Xp0gl&#x2B;//0PKFasmM31b94MgVq1asLMmbNg7dq1cOjQQdopYdmyJZAiRSq4desmLYc4f/4iPa7169fR9H9hxF8OHz58oPwtRYqUCeq8e0hw/PjxS6tWrbq6d&#x2B;/eZ&#x2B;D8en57zfzsIf4GOwQAAPVovy0RACB2LfzUiH68bOHHPABM9/KEfF&#x2B;RjKekbQGly4UlAcLUfz4rQLpfnczJL/wBCMm8QULwbWUAxMgskz7nBQHu1KlTL8j0yt3d/XSlSpXSzZw5s0nRokULumJ4hoGBgYEh/kCGUEod9Q3AR7gF7QF5Xdf0XI44SSPiVuRfmiKA6&#x2B;usPQQ83D3Ay9MLZvw7HcaO&#x2B;ZOQmbRQsGBhizEgef/wj&#x2B;HQrVtn2LfvgEgAwGVhYc9p677s2bLDrl07ab9zOfKvRrrVBmFq0X&#x2B;llH9HBnbymRkMzgAa7iF5HD9&#x2B;HBWWMA0f8e7dO0r20ZX/8uVLNEW&#x2B;ffuOMGTIEBpZ/&#x2B;mnH2H79p1w4sQJSJYsOU2zx3T2V69egZdXXkJc11N3eqxtNyZGykOJ2B44sI/&#x2B;curVqy8/KDaJBXPnYh1/hNln4MyZM/D333/TCHtgYCD1E8AoetasWcmx&#x2B;sHHj5&#x2B;AkE2acfDixQtqTmgPUJRD0o8&#x2B;AQgk6&#x2B;vWbaCdAfjffvPmTakA0aKFN6ROnUa0PWYaoODRp8/3UK1aNfoZo1CBXQgw6v/hwzv48cehZlHCmClgGylSpEgw51xEREQ4&#x2B;Z6CFy9eHLRjx45H5DP8HIeEX6uZn7Mc/G25&#x2B;rNoP0OiFACk5N5WW0Ah4QcQ&#x2B;wAAWJcBcBJiDzZ&#x2B;VFLyr5RFoCQESJ8rTXqBGKD7/PlzzPHjx59VrFhxZatWrbKTG02B2rVrl8&#x2B;QIUN6jo1gGBgYGOLB3cpgVecumwFgEN&#x2B;4DMK0ffM2xtuL1qs7xwsQpi1dXVwoqcCIph7b6pk8AviWX6tWroGiRY3RRVwvWuABgMs7depsIQAmVo6p2blz54FUhHzNmj2TEiFMef78OVpepJB8BtZlEMrkX7gvtUi9fFaBpoEnEwDiAEj827dvS1PMMaWeJ/9G4tmekNpRtJ6/d&#x2B;9ehCy/hB07toGPjw/s3bsHbt0KhSlTJsOFC&#x2B;dpuzx//0BYvnwZjbaXKVOW7kOaqq4Fvr67oHDhwtSAb9my5arrYlcBbOGHJBpT8BFLly6B9OkzwNy5c2h0/fjxo/DpUxRdFyP&#x2B;FStWomUwKCCoCRNKwIh8UNApmD17tuy5uWPHVvI37IaAgADYtGkDLY3AVog8eBEON1u6dDn9DFeuXEEFhJw5c9I2fjglRiDxDwwMvDhr1qzAbdu2PXYC4XeGmZ&#x2B;WGn9QEQKUBAC153Ed7dcqCDDSzwSAOBUC1MQAqSAAEkGAFwH419LuALbSZ&#x2B;TEALUsAKWaf1GkX2Yd2XKFyMjImHXr1t0l031ysznSt2/fvF27di2XP3/&#x2B;POkJ2GnNwMDA8JXAWRNMUKW8IEtCxQaCFnJs3Id85wD&#x2B;hsiB5Umfvt/DjBkzqFEaZ7C8R5q0aQgxS0IJvdCFn89MSJokCW0ZhlF9umfTQeC62XNkp87mUTF6yJM7t6neX3k8p0zQrU0NxaTfzo&#x2B;e1f7HC2A0u1ix4uT8GQ45cuQ0z9&#x2B;&#x2B;fRvs2bMXunbtQqP7WBe/dOkyGDduHMybN5eepxipxvMOo&#x2B;3u7m6AQxoUovgSAUeAQkKvXj1pXb8wyo7AkgOMkKdJY4yoHz9&#x2B;jKbQT548BX744Qd49eolhIU9g23btoBO5wo//TSU1vxjiQCa&#x2B;bVt245OscWlSxfhxYswCAwMgEqV0FxTPDxHR/6qVSvTzgNo5IdmiDNnzjZnKKAoh7X8KI5gecKkSZNpF46CBQtCYqwa/UwQEhJy69ixY8EjR448a2e0357af0da98XXaL/aPK3knkX7mQDwVcm/9LkS6ZdCKgIIlTO5jACdwg9JL0PslSL6ejufx9gQAUTLo6OjY&#x2B;bOnXuDTDfLli2bpnXr1p5t27atnC9fPi92ejMwMDB8hTuVDMG0drux5MqLCLJoO4OJEGPU3pQNYCrsl&#x2B;scIGwugNsgWUCX74ULFsDQoT&#x2B;L3j5j&#x2B;ozwPOw55M2bVyQAWKLvBlP7PutcfHzvLNmy00ch&#x2B;bfFp9Wi/2rbymUPOEreldoqMjgPadOmpVF2TI3HNPk&#x2B;ffrS&#x2B;Vjbj0C3fjTxq1evHk2tf/ToEfz880/Qu3dvyJw5M80c6NfPx2np50jaEVgHj5kt/PePHhe9evUghDk9rF&#x2B;/gb7ff//9R1vdoWEenv9YgoAp/w0bNoIMGdJBdLQe/v13Fs2WscdbQA3YwcDP7zg8fvwE6tatS7Mj3r17b74GYGo/ZlWcOOEPnTt3op4EN25cRxJM/RMQuBw9CKZMmUrLJQgxhmfPntGsh8QCPcHLly9f7dmzJ3Dfvn23sXMWfLn0/hgbBF8P2mv67SH7tqL9wm0BlCP8LNrPEO8FALWWf8LlsRUBDBLyHSOZb5CMUoRtBpXmqQkBcsaDnAbRQG5d2eVnz559SabXv//&#x2B;&#x2B;/mZM2dWqlGjRiGC/O7u7h7sVGdgYGD4MhCZ4MncOERklF&#x2B;Hj44bLGMuY6q&#x2B;jpIWHOzTxZzBmvwLHl0IKYmK&#x2B;ky3yZ4jB/wxciRMmz6dEJ3vRf3K3T3caQ0/b/onR8INKsyclgtIXPs1fjoab/WiAaRihoQ9af&#x2B;M/DsfSJKDg4OhaNGiIkJ8&#x2B;vQZqFOnFjlvY6BmzVqQP39&#x2B;KFu2LOTMmZ0a5mFZABpRIrnNmDEDfP99X5per9O5xPqYIiIiqIN/lSpV6e&#x2B;gSJGiEBQUSOvhhd8/kmn0swgJCYEDB/bTiD4aDbZp0wrKl69AzQcJ2STPy8G6desJKX8LSZMa0&#x2B;idRf4RKJIUKVIMfv55GLRt2xa6desKQ4caRQvM0gkLC6OZCCtXLqceCoMHD4HFixeK9jFp0gT6PSDhr1evDs0g6Nq1R6I5z&#x2B;7du3d/4cKFhydNmhSsN160nEX47UnvV0vrtxXlVzP3UxMA1Ig&#x2B;i/YzJCoBQIs4oDRyMNgpAsg9cgrEXycZxwnnCUUFOSFAM4kHDVF/LcuHDBnir9Ppgho0aJC5devW&#x2B;Rs1alSe3HQzusUmj46BgYGBwSa/FQ579Ep169giUEjeRXn&#x2B;xsi/TmfM4w&#x2B;&#x2B;Ggz5C&#x2B;Q3BeM5kXggvFkh&#x2B;V&#x2B;9eiVt&#x2B;5U8WTJqJtinTz/w3f0fBF&#x2B;7Bt9VrUqj/TguQ5M0TBfmo/&#x2B;yHNogH/0XPgoPX8nx3/q2bHtcKHXpVyLxjnYAYHAO0JBvyJBBcPDgYdH8gQP7g4/PIPD3PwFHjhymRHvLls2ETJentfSdO2OLOT/6&#x2B;uXLFzBlyj9OIf&#x2B;IU6eCoEOHdtC4cROa&#x2B;YKGfFiXX6ZMGXru4DDo2rVgWl6wb99&#x2B;&#x2B;O67KnDx4iVo2bIVYLwka9YsMGPGv9T8sl&#x2B;/YCpezJw5A3bu3EVLFoS1985Ap06doFmzZvDp0yf6eaLYMHDgIEiePCnNDrhy5QoEBQXBtm3bIFWqlNQMEL0MMPo/c&#x2B;a/cPjwYVqS8&#x2B;eff1JhDlP/ybgPMmfOkqDPrQ8fPry/dOnSjS1btpzftGnTPfJZfAT7I/ixjfbbSuuPAfUov7Oj/VpfA7BoP0MiEgCUBAGl57ZEAE6G9AuFACXiz0l&#x2B;dJyCECAk6QZQbkPocNRfbTn2Ot2zZ88jMj0hr/3QK8Db27sIueEWzpgxYyZ2&#x2B;jMwMDDE5R3KwA&#x2B;KQCeJ1PPp/gYZUoqbubrqYO3adfD0yRO4evUKLFy0mJJuDH6hgzo&#x2B;xpii99Tkz6Cnrc9&#x2B;GDIYatWsDSE3Q6Bq5So0HTh/vnyEAKUQEWrsR258LcuQVcm/dFWpgCAfaZcmz1nvQzKQVCTs9kTyWbu/OB5EurpCly5dRDX658&#x2B;fh5IlS9Oa/okTJ8CcObPhCTmP37x5A/7&#x2B;AfR8TZMmNYwYMQI2btxIo9rCuvzYAuvonz4No7X8SI6zZMkKderUIcQ9j8kDIAlMnjyJkmjsYoGkmXBNem5Mmzad1tDjMSLQw2Ds2DGwe7cv2UddyJAhg5MvEcZzEo/j&#x2B;fMw6NOnD/1sPn4Mh3z58kP//n3h8ePHtOvB1Kn/QEjIDXqsvXr1ptufO3eOZjA0bdoU&#x2B;vXrT499yJAfEuz5hOPW4ODgGwEBATf&#x2B;/vvvc/fu3YuIY8LvrNZ9jkT7lcQAe0UAtXlayT2L9jMBIN4Re6VlaqUAnEYRQOj6Ly0F4EA&#x2B;GwDAut0gpyIE6CWkXS9D/uVe6xXWcTgrYOHChTfJFFq8ePFjY8aMqVS9evXSaBqoS4wOMQwMDAxfGZzgFmRFPgURfDkyHBn5GYICA6FN27ZArtU0Uu/q4kqJwKXLl2itNN&#x2B;b&#x2B;&#x2B;HDB5AtW3ZImsSDupFjC7ajxw7D3j174PChQ1CkaFEoVLAQPQYxGbY2GLQSMDjOJvmXI&#x2B;bWRNs6ec8Rkz8tbQTlCJb8MTHEFtgGD9P3EWiMh0T&#x2B;/fv3NGW9RYvmcPHiRZqSj&#x2B;cldotAJ38UpWrXrknN&#x2B;d6/D4ft27c6JaUev2uM7FetWo0aCyYhv4edO3fCmTOnqEP&#x2B;q1cv6HqYDeDl5QU//DAEwsMjqEhh9LsAWp4gBZYGDBgwULG1oFZgRwQ8/7GGH4HvefLkSergv3TpUmjQoAH97IzHl5d8rt/DihXLqS/A4ME/0PUQ2J4wSZKk9DlmJGCJQIoUyanRZ0IFOUcifH19/dasWXN19&#x2B;7dj6PRbCFuDPz04LzWfWpp/0qvv3QLP7VoPyP&#x2B;3/L45Gt/dyo3ZFt3aiVSDirkXTpfJ/NcSP6V5sX20Rb5l4vw2yoTsHt50qRJXUaNGlWyWrVq&#x2B;cuXL1/CA2VxBgYGBgaH8ZGQHSTvQoLLcTqsBTDdUQRUWoaBC9veoRFYFkL0x48fC4MGD4G0adJSs7A2bVpD6TJlIFfOXDR6mjNnDpg69X9UJNi4cQONAqJTOJqw9SYkonkzb2rMJitECMm4xsi/mnBgHWmX1&#x2B;tt7UPuWO1t9&#x2B;doe0AGxzBt2v&#x2B;oY394eDjUqlWD&#x2B;lZ4enrRvvT9&#x2B;/vA2bNnaER&#x2B;5sxZsH//PnJ&#x2B;noDKlSvTkhUl3Lt3D3LkyGGOyCNRbtOmDaRKlcpqXTTG8/HpT97jqHlex44doEmTxtTYb9WqVYTMNydEHLMRXhNS7wNly5ajUXRM/&#x2B;/YsWOcfTbYvg/fz9XVBQ4dOkyOPzX8&#x2B;&#x2B;90CA6&#x2B;BsOGDYfChQtApkzo4J&#x2B;WihCHDh0hv2c9PH36GLJnz5Foz5kwgpMnT16cO3fu2QMHDoSBc&#x2B;r5HTHzc5T4AyhH/7VE/gFYtD&#x2B;&#x2B;8M4vjq/5USYGAUBNBJATA5ReK006G/N0CmKB0qNLLIQBtXmxEgmqVKmSrl27dvlbtGhRIWvWrFmYcSADAwODAwLARxQAIimrNd9odDpyo9cba/gx4UpISDnliHiypMng0uWL0LxpM7h45TJERUbBmDGjoFu3HuC7excsWDAf2rZuCz8MHUojmnhp37p5M7h7eEC16tXAzdWNEP801Klf6PQPylxffDyCdoNKIoA09d/6Nm2wuj0rvrfK&#x2B;EA9u0B5e0b&#x2B;4xYYxb569SqUKFECWrVqSd3/UWzy9z9JTemWLFlMe9b36NEdChTITw0Bsb5dC7CkpUKF8rQ&#x2B;HwUtP79jtCzm1KlTtIUgDzy3sU4ea/8xmn/79l06f&#x2B;BAH8iaNRuNuM&#x2B;fPw/27NkH7du3gQMHDsP9&#x2B;/fg0qVLZH9rqChx/foNSJMmbaw/D/ztY1IlXxKB59/mzZugb9/vCbHPTL0QfvttBDX58/LKQ8sS0AMhV66ckDx5Spriv3DhItrSL5HC8J7g1q1bd5cuXRq4Z8&#x2B;eB6GhoR/jiPBrMfNLTNF&#x2B;RvyZAJAoBIC4FAGUyD&#x2B;AtswANSEgtpkCLirCgIsD8&#x2B;wSBBAtWrTIPmjQoAq1atWqwoY3DAwMDHYIABER8BkzAASFYkKyz0kYMN9yj5MQb0yJfvjwISExA&#x2B;DR40fgd/wEIQovIXWaNJA2TWoYM3YMlCldhpp9fSYkDPfh4e4O5LpNDcyKFClC5/Eu/9bRdMWbsuQmaxQBbAkA8pF/&#x2B;d0bDOLXauMAR6L&#x2B;9goFDI4DTerQcM/P7yRNQ1&#x2B;wYCHtNnHw4AHYunULTZv39w&#x2B;EXbt20FZ6KVOm0rxvJP5Dhw6GYsWKU1KdI0cu8h7JoH//AaJz4tChg9RgsH79&#x2B;rQO/tmz5/S9v/&#x2B;&#x2B;Nz2Wu3fvw6JFC8nrPrTloDv5nbRt25q2IETBbseOndSEzxmYN28ulCxZknYgQBw9eoS68mPN/u&#x2B;/j4QGDepTcQA9OTDD5&#x2B;3bd&#x2B;QzykDWO0F&#x2B;q9E06o8ZPImO9RsMekL07&#x2B;7evfvs2rVrQ06dOvU6Dgm/FqIfA7GL9isRfi3Rfq0iAIBjpn5qRP&#x2B;bN/VjAkDCEACcIQKADMkH0J4NICT/WoQAJQEgNmUCXzwrgAw&#x2B;XchAMuPAgQPLlC9fvkiWLFky65xl0cvAwMCQSBHxKQI&#x2B;ffpsIvoWAcBMoq3q0XkjPqE5IEcjicOG/QpDfvgRxo4dDWvXrKOu30i41qxZA&#x2B;nSpwNvb29IkTwF6Fw4iImOgZF/jITnz57BypWrzcRfMd0f1AUAIfHnH9W2ExN1uU662sQDubR/R1r9MfL/ZYDmfr6&#x2B;O6Fnz96U2GbIkI7WseP5hy3tpk&#x2B;fQQhuZtltkexim0slFC1amDr4YwbL1q3baN37p08faa07fsf79&#x2B;&#x2B;ndfMtWnhDzpw5oUmTpvDPP1Ph4MFDMGnSRFo/X6hQYWjfvj106GBJ78djQ78C3B5bA6LHhhJCQ2/Bo0ePrdZBx378PQrx9u1byJw5A/z77ywqRCDKli1DRZChQ38in9VjmD17Nty8eYOaCfr5&#x2B;cP169ehdOnSkCZNmkR5fkQRPCaYOnXq3gULFoRGR0fHQOwM/OxN77fH0d&#x2B;eaL89LfxYtJ8JAPFOAHBNBN&#x2B;lkvs/p3LyS/sRSbcXuvZzgh&#x2B;5TvKck7yfMGPAINhWJ1lPD/ZnBejB8awAW4aBVh0E8CJ94MCBJ2Takzp16oPdu3f3IoPNohUqVCiZgoANexgYGBjkbuj8DcBAr/g6/pYguSsptbbD55i6v2bNKqhdpw58joykUctNmzfRaOLZM2egQMGCMHbMOGjUqBGcPn0Kdu/&#x2B;j5YD3L93D06c8Dea/fHk3Wyah8RHLDaYGbhMMb4w6s&#x2B;ZxQl14z/L4MqgSPzlnquRf60DNn57g6DzQnwb7CVGoAkgtppEUu3t3Yw60qNpXbdu3cj52URxO/SuwCh9jx49FZdXqlQZfvzxR2rg5&#x2B;bmDn379oZffhlGe91jpB1b4xUvXgwOHdoP6dJlgOPHj8L06f/S7WvWrEF/H9jtQupzjK&#x2B;xtR9OckBy/99//0GrVq2oyPbjj0NFAgCa8PXs2QM6d&#x2B;4CTZs2o10EMGMHTf4MBo6Qe6ORIBoQurm5QOPGjaFr107w/PlLWL16Nbx&#x2B;/Yrsrwb97HBKjJfBt2/fvjt8&#x2B;PAp8jmGrFq16l5kZGQ0xG2035mO/gYHBQDpcy0iAEDsWvixaD&#x2B;DY0JIAsgAALCdBSBdj1PYVq4kQPia0/haB45lByj5BDg7K8DphoH8lD179qTkhlyU3FhLkZunJ/MKYGBgYLDAXALA3zmE6e7UC8BACAgnT6ZN0fbkyZLTqOazZ0/hc1QM1K9XD7bt2AoFCxSkhKRNm7Zk2TMqCPTr2x8uXb4MTx4/grx580HefHnhU8Qn&#x2B;t5mAm8uNbAoESLTPwkrl0v7t1W3b7yXy2vxSjqDlPQrCQBxMKZgiANgBPzjx4/Uxd5WnADr89&#x2B;//wArV65SXQ&#x2B;JOJoIYmeL0qVL0awBY4u8vJArVy7sFU/b/Hl4uNP2mFu2bIv134Gt927evAk7duyif8v69eugffsO5uXobVCzZjU4cuQ4/ZuPHTsMI0b8QZd5euahJL9q1e9g0KCBsGHDetr60MfHh8yrAkOH/pxoo/3kuw8PDQ29t2HDhlPz588PefnyZSR8&#x2B;fR&#x2B;Rx39taT7A7Bof8InviwDgCKhZAAYNIoA0tZ/Sm0ChetyIG7nx8ksl77WaxAadArvI5wnzQ4AcF5WgB6cnBWAj48ePYr59ddfT5PpTOfOnXOPHDmyft68efMwIYCBgYFBeFMXV83z5B8HH8ZIvHytvY7T0ah/l65dIeRmCDRr0hTy5PGivdbzF8hP044jIyLJvDyE/PejhKtQoYJQrGhRaoaG5F&#x2B;6b&#x2B;tsAyMbN/CDId6PgI/0C6P/NloFWg&#x2B;mlBLx5D8n4fY602ekto7SgI6l/X99YL09Tlq&#x2B;PzQGHDx4oGi9NWtW06g/RvwRr1&#x2B;/hl69usOVK9coIce2fn/&#x2B;OZ7W&#x2B;6Oh4NWrwVRo2LRpMy0/cMb3jx0BsJNG2rTp4fHjx0bGpxefk2TMAwcPHqaP331XGXLmzE2FADQhTJ8&#x2B;PXmdi66XPHkyCA//QE3&#x2B;fH13W5UMJBY8ffr0yZYtW/y3b99&#x2B;6/Dhwy/0en3MFyD8Woi&#x2B;LQEAVIQAJQFA7bmaCABgOwNAbT7YIQgw0s&#x2B;QaAQAR0QAJUFA6YfiiBAApouSXCmAQWGekiggVyag0/AoJxDICQNyhN&#x2B;WSKBT237NmjV3yLSobNmyaYYNG1aePOb38vLy5NgojIGB4Ztl/2CKvktmY00&#x2B;J07JFxJ/IWLIui1btKSEGNdFP4CihOBjW7WP4R&#x2B;NO4/B3tmf6NUY6/9jomMEh2Bt2ici8RyI1&#x2B;DExF/O8E&#x2B;JeNsagwozB5T2I0cS7Un/F5YQaN2GIe5x5sxp&#x2B;t2XL1/ealny5ElFYo&#x2B;PTz9YuXIlNQrEen/EpUsX4cWLV5SUL1gwj4oLKAAgyd67dz91/i9VqpRTTfOwXh89BkqWLAGZM2cCDw83K1HKw8MDSpQoSbNwsOVnUFAgNGnSCM6fPw9DhvxAMxMQ&#x2B;fMXAFdXN3L856FSpcTlqUxIvv4eQVBQ0PX&#x2B;/fsff/v2bRTYX8&#x2B;vdV2tKf9ao/7OivYL1wFgLfwYmAAQL0QAAPVsAJAQfq1CAIB81wDh&#x2B;krlAVpEgbjKClASDXSgPSuAXy7a/uzZsy/bt2&#x2B;/n9yUjzZs2DBb586dS1aoUKEouSmn5YxuUAwMDAzfDIykXnKz4jjBg8FEijnQG/TmR4z&#x2B;82QWyT5PZnFeREQEveIKyTkl7AaL2iBN3RfX2YO544B5v6YFwlIBe932rV3/lc3/lMQDe53&#x2B;pcegLEgwfGkgaUdyjKn5zZo1geXL5VP8MRrOf3cPHz6Ay5cvE9JdGg4fPkQ7CHh6esG//06nUf9OnTrSmv5169bT9dDtP67q5zNlykiPDaP4yZKloB0DhDwLRY1y5YyCBmYfZMuWnQp1d&#x2B;/ehW7dusOYMWPM62InDvQTyJUrd6L5fl&#x2B;/fv2KjPmCly1bdm7fvn1PTGn&#x2B;WiP4sUnv19K6Lwa0RfntIfu2ov3SZWpCAACL9jMwASDORQAlIQBkRif2CAEA6lkAQsKvlxEfpG0G4yIrgFMh&#x2B;ra8AvSOLic3ghhTVsA9ckP0nThxYumuXbvWzJpIXW4YGBgYlO48nE5ITjnZm5aZjBvkU/bNUXB&#x2B;X6arr4j4SqRtuci/pdWeQU6toNvoyT&#x2B;j07&#x2B;wOwGnSrq1O/PLE3ZLNgTncC2ko&#x2B;IBg/Ph7&#x2B;8Po0aNhEOHjtCo&#x2B;NOnYYREJxWts3nzZmjTpg0kTZrEnJVy9epV2LBhI217iUT/119/oSaAqVKlgp9&#x2B;&#x2B;pmm1v/22whKvGvWrBWnfwOm&#x2B;2M5QUxMNO1QYHxuya7x8/MzCwAoDhgMMbB69Vp6rFgGgK0H589fSMUBLNPBv7FJkyYJ&#x2B;nuNjo6OunDhwtXjx4/fGD9&#x2B;/AWZaL&#x2B;zCb9Ser9a6z5bUX41cz81AYBF&#x2B;xmYABDPRACIh0KAkk&#x2B;AdLK3VCAhZAWIluv1et3w4cPPLFy4MNjb2zt3ly5dKubNmzcXuUmmZj87BgaGRM7/yZXVIHuHkmt/Jy0BEBJZgyBCD5y1aRCN&#x2B;nMGqzuXMPXe&#x2B;Cg2&#x2B;7PU/5syCayIPadKupUJt3X2gaKwIdPuz6HPm5H/rw7sAvDHH79DYGAAnD171mwCKPxOly1bCnPmzKYCQLp06c0ZKa9fv6F194RgQo0aNai7f5o0qQmxXgdFixah2QTObj6E7xsVFWWK8BuBWTYYzccUfzyP8XnSpMkgWbJk5nWwLSCPc&#x2B;fOEtL/jrYSRPTp8z3tEMCvj20LFy9enGDPTfJ5hF&#x2B;5cuXGyJEjDx45ciQsOjraVi2/I2Z/jjj6O9rCz55of2xM/QwqBN4ALNrPEA&#x2B;QULoAqO4ilttwKvtS6xqgNF9r9wBpJoDcc2d2EIhNVoBTOgiULFky1cCBA0tUrly5YLFixQqznx8DA0Niw8ePERD5OUpExHnib&#x2B;xGJtahpen3fMsyK1LLCUgyZ2ovqBD1l7630gy51H&#x2B;xY7/BiqxbjktNIJCKD9b3fKW/Vavpn5ygwPD1gFHyYsWKwPPnz&#x2B;HOnTtkukfr848dO0pb3iHy589LhQKsie/duxe8efMWypYtC//95wvBwdchX778sHfvXrh69QqUKVMWsmXLFkfHqoehQ38g7/8aypevAFmyZIEnT57AjRs3YM6cuZArVw4a1cfWf/nyeYGv739QqFAhum3VqpVhwIBBcPToYWpGiC0QJ0&#x2B;eQpdhGUDKlCkgffoMCfq7vHfv3v2goKBrixcvvnDgwIEwcG49vz3p/bEl/mrt&#x2B;&#x2B;Si&#x2B;tIIv14j6Vebp5Xcs2h/wuGdThUimQDghF19ISEAFEg/gPY2gpwDk5IooCYOqGUFaBEG1OY5LBIkT57ctWbNmpl69OhRvF69ehVTS22DGRgYGBK6ACBMyxfzeHP0nVO4F4oyADhjnT&#x2B;WAQgHDfw6vG8An8rPtxlUZecyIoBlEWflFSAVCSR/iSbyr3avd3QcwIh//AESe2/vZuDm5k5N/K5fvw6FCxcWCQDr16&#x2B;Hnj27g79/INy6dRPatWsP7u4u0KJFK9rir0GDRuSxdJyKFC4uLrBixXJaZvDmzRvq1I/H/OLFSxg&#x2B;fDjkyZObHv&#x2B;&#x2B;ffvhM/kdN2vWmAoAWAqAf2PhwoUgNPQmPfe8vVvCokWLIG3adAn&#x2B;&#x2B;3tBEBIScmfOnDkBhPQ/CQsL&#x2B;xxHhP9LRfvVBIAv2cJPLdrPiD8TAL7ae7smou/U3rIA6TYGFYFAmpKv1EJQrgMBgHOyAhKNV0B4eHjM7t27H5HpSaVKlU4PHTq0XLVq1UowrwAGBoaEP7rgHxUi2RyneJMyu9lLMwQ4I8HSCVoJWjn1Kxn5ydXxS8wCpcdgzFawrtdXHsNaCL895N/eqD&#x2B;L&#x2B;H9ZIGFetGgh9O/vY3MQi98JkmseSZMmNQsDPDp06ADbtm1GsglNmzaDiRMn0Jp7zAbInDlLnP89u3f7EkLfnHoOrF&#x2B;/EUJCbsCOHdupsR8aCx45cphmAZw44W8&#x2B;xzEjAMk/HWiR31/Lli1phgM&#x2B;dujQMcF/x&#x2B;jkv2nTpoAFCxZcv3Xr1gdwTj2/o2Z&#x2B;MQ4QfwDl6L9Snb/0OYv2M3xzcE2Ef5NBZihm7zZaxAApyQcFgi4VDKTrSL0CDPB1vALUyH&#x2B;ceQUEBga&#x2B;wA4CGTNmPNq8efOcvXr1Kl&#x2B;oUCGvdFggyMDAwJBgb0Oc8mvTS/NF2kbLOyFBlhJ82kXAdMm3EHfBdioigJTACx&#x2B;tvAZslAAIib807d&#x2B;mZqKx1R/Dl8Xt26GUNKsJAOhy7&#x2B;d3HOrVqw&#x2B;urq7m7xLd&#x2B;xFS259Hjx5D&#x2B;vTpqECAxn5xDTy&#x2B;R48eQpYsWWHhwoXQvLk3/P77SErqHzy4D/fv34O1a9fDx48foWfPHjBq1Gjq3o9AfwAsSxDir7/&#x2B;Ng6eXRPu8Jl8JhG3b9&#x2B;&#x2B;e&#x2B;DAgSsjR448Ex4eHg3OqeePjZmfM6L9jkb8AZwT7WfEn4EJAPFMDGBZAfE8KyAsLCxmyZIlt8h0u1ixYinbtm3r5e3tXZo8L&#x2B;Ti4uLKfqoMDAwJB5yEAHOqzv16TNvnCTY/W9JJwMpB33Spt3b9F2QPYMaAXi&#x2B;u8VeJ/iuRc2NWgPA4LC0Fed8AJeIvJffS&#x2B;n2t769VKGBwHp4/D6OmdnJAl/zXr1&#x2B;T5ZGwf/8&#x2B;KgCULl0Gtm7dTCPsuXLlomZ6&#x2B;fLlM2&#x2B;DEf/79&#x2B;9D7tx5vtjfsHr1aggPfw&#x2B;9en0PHz6E0yh/QIA/7Ny5E0JDQ2HhwsX02NHBH1P9K1SooHqeJWDib3hOsG/fvtN79uwJXbdu3YM4JPxa0/vtIf4GOwQAAPVov1YRAMCxFn5qRJ&#x2B;Z&#x2B;jEwAeArCAH2iAHxOSuAJ/iJMivgypUrb8h0YcyYMRebN2&#x2B;ebfz48fUKFCiQLymfU8jAwMAQX6k/B/K3A0qWwULaObAQcROBlrrLSNPxrczvwEK&#x2B;MdNapxMLAeabgnBbjeRfnagbrO6IWri5I07/0vIA5vj/BQeIri6itH4hli5dCqlSpYTKlavCq1dvaKu&#x2B;NGnSwL1796FFC2/YsGEDlCtXlrbHu3XrFqxduwamT58GP/44FNKnj12CX3R0NI3sJ0&#x2B;eXHQu3L59G7y8vCAyMpIeT7Vq1WHFimXQt29/2pbw&#x2B;fOn0KVLZ3j8&#x2B;Ck1JFyzZg3Ur9&#x2B;QbotWRFWqVEl03&#x2B;EbgmvXroWuXr36DPl77759&#x2B;/ZzHBJ&#x2B;Wyn/9kb7bTn4a23hx6L9DAzS&#x2B;3EiMgG0&#x2B;62dsA2nsi97Ogg4MysgvnYQ4Oc5ZB7YrFmzLI0aNfJs3rx5paxZs2bR6XQu7OfLwMAQ3/AxIoIQkM9mUsyTbYPkfmdFwiUt/OQi7byOy5n&#x2B;8SKB2fRPZDzIWV7yGQCmbUBQKqB0C&#x2B;aUF5jfh5OUOci19VPKAEgg44RvGqdOnYLRo/&#x2B;AvXv309foCRASEkLN/XLkyAbz5s2n6fzdu3cn5/wnePnyFSRNmgQyZcoM&#x2B;/cfhM&#x2B;fP1NCjsZ/y5evhCJFCsOVK1fI96mzQVpfU0KutB6a&#x2B;C1evAj8/E7SyD2ui&#x2B;fyqFEjaYr&#x2B;hAl/Q1jYc&#x2B;jXbwCUL1&#x2B;GtulDh/4SJUrQrIWOHTtCkyZNIH/&#x2B;gon2u4skX4i/v//ZMWPGHPfz83sJjhv42ZPeb8vMT0uNP4B96f5g47ktEQBAWws/gwqZZy38EhLxZSaAFN9yajXLCrA8d0QIsJUVYFfU39byXbt2PSLTk0GDBgW2a9cuZ58&#x2B;fcoWK1YsXyYCB8UcBgYGhrgYXkgc8IxXXl4GMKbgqw1OjBuZDQGFJFoUyQdR2oB5IGGwkH/heubUfwMn2sYS6VcSAwS3EI6zupsIOwbIZSlIxQB7Ivis3d&#x2B;Xw6tXr&#x2B;CPP0aCt3cLqF27Nq2RR5FIJ0gr6dy5I7Rs2Yq2unv06AnMnz&#x2B;f1tEjsNa/RYuWkDNnLhr1z5Ejh3m70aPHQo0aNelyOVKP3y868qdNmxbOnz8PPj79YcuWLZA9ew6rdTH6f&#x2B;bMGUrqw8LCCOH/E/788y/o0&#x2B;d7yJs3H20tOHPmTOrmT8YMdL2HDx9C1arfwaxZsyFjxoyKWQ0JHeSzib5&#x2B;/XpIQEDADUL8zz558iQCvmy0Xy2tP75G&#x2B;9XmaSX3LNrPkPBGKt9wBoAIb0f&#x2B;Can/HpXQswLk2gZ&#x2B;yawAuQi&#x2B;1nlKk&#x2B;L2efPmTdakSZMcvXr1qkJu8kV0wpEKAwMDw1cAnwEgSvc3XYlF2QBmZcD6VsFH50WO/5zBTO7FYoH1vdQgc2&#x2B;VdgmQlhVICbd4e85KB1Ai6kZPAGWib&#x2B;89n5F&#x2B;x8G3vcP0&#x2B;2bNmhHinkpxXSTcbdq0gUyZMhCi3xlGjBhJifOYMaNg505f6tyP5BmN8oKCAsDNzQPu3LkN332HxHoOFQxy5szp0HEioX/79g3UqVOXkPd/Yc&#x2B;ePeDru1uRqD99&#x2B;hQyZ85MSH8fOHLkEH2OJ2d0tJ6ed1FRURAW9owcb2Y4cOAQPHv2hPoOpEyZMtF9x3oCTPPfv3//KfIdXtu8efMj&#x2B;Drp/UqkX2tNvz1k31a0X7gtgHKEn0X7v0XiyzIAmAAgFQC4lCnA8DECOA93SDXyl9iKAZwdIoF0XSURQMtrJZFASSCQI/6OCgH2lAtoSv3Xshzx22&#x2B;/FW3atGmxUqVKFUmaNGkydoljYGD4Goj49Ikao/FypMFgSts3Rc9F9zyRGSCnQKb5kQJnEgeUo/WcaaFBQPQ5kwGhZd8Wn1tpmz6rSDtneV&#x2B;zWGEQzFYx/ZPW7TuqzzIBwHEsWbIErl&#x2B;/BnPmzKGp915eeRXX7dGjO3Xzx/r5J0&#x2B;e0Fp9H58BMHjwQKhfvwFNu8eWfpcvX4VixQoTgr4Hzp49A3Xr1qMR/9gAvQHy5s1LHfrfv38HeAu3ZbaH4kbZsqUJuX9KMwWWLl0GpUuXgkKFClEzv&#x2B;vXr0PFihUhXbp0ifK7Jd9FTEBAwPldu3Zdnj179g2Tk7&#x2B;zCL9aer&#x2B;WtH6tUX41cz81AUCN6LNoPwMTAJgA4LgAYIjRU1el1GN/S0xZAVoEAIAEmhVABgyupUuXTt2pU6cC3t7e5bMQMONABgaGLwlxBoCFcAuJOJ2lk79lcAot&#x2B;ziTaSAyb44TtusTVBuYXP9N5gM03V/pHisl/1bvzVk7Ewp0CvH7cvLZBMK0fxQAHDXwYyKANiApPnHiBNSoUYN&#x2B;1p06dYDKlatQ4t62bTtClLOb192xYztN0y9bthx93aBBfdiwYSM0btyQpvEHBvrDwYNHwNu7OYSG3oSiRYvDqlWr4NChQ9C6dWvZ9HxHMWnSROoP0Lx5C/q6ffv2MGPGDMiaNatoPcxCwJp/FAvw7xs/fiyMHTsebt68SbsNbNq0CcgYQNR5IJHB8PHjx/Dr16&#x2B;HLlq0yH/x4sW3o6OjY8D&#x2B;CH5cmvlJ54MGQUCN7GuJ9mt9DcCi/UwAYAKAmegxqAkD46cY3o762/Bu0nR7viW1i5GaGqlkcqJWTyW3TgwoK7oxMo9KU7TkudYpSvA8RvI6SuYxSmY76fIoybqfpdsTfD59&#x2B;vTLoUOHBnl5ec3p3LnzvK1btx54iHmMDAwMDF/kjm7izaYXvGEfkndzrTwYTOsIjP046YCAd&#x2B;sX1OgLovaicYNJETCYWDn9Z&#x2B;CshqsGQScC4QBEGq0XHYdATjYILACE&#x2B;1Gr/Zc&#x2B;ClsK2hqk8RODMtBoj/88MV1/9eqV5s9v6tT/wZAhP8CdO3fg1KlA8zZHjx6h9fjDhg2jry9fvkR73mPUHE3yfvnlVyoaYGr9wIEDyT5&#x2B;JOR6MxQtWozuz5nkH2FM9Td&#x2B;z2jut3HjRjh9&#x2B;pTVesOH/2pK9zf&#x2B;fQ0bNqbPecKPj4mR/GOa/82bN28R0r&#x2B;9UqVK08qWLbtq/vz5IWTMY2s8pThe0jj2Es6LURjjSSe5caTSMrlJr/BarzC&#x2B;VXptUBgvK423wcZ4XW5dm8SfkX&#x2B;G&#x2B;ArWX90OvPtzqsEQGQmp//rDnhGJJd9Sm2mgkomfdL503/ZkBRhAPitAegxyrQOlRoK2HmOTFaDVMFB2&#x2B;23btj0g0&#x2B;OMGTMeGTduXDlBBwEmfDEwMMQNOGGavpH4G2dzohZ8lui58DbAv7Zc7jnBZdtgEK9nMIjb/Jm7BgjfU9Ay0ELQLc/5yLyUvJv6D4puVHJutkou/2oeAFrGxMz4TxPBgBEjhsOoUWNodHz58uXQpUtX83KM8J886Qdz586BevXqmee3adMaWrduRVvl3bhxHS5cuACHDh2Ew4cPQZIkHtCqVQuoVasOTe0fOHCQ048bjfwCAgJoN4EMGTLQc5D/miMiPkLy5MkgXTpLq0CM&#x2B;t&#x2B;8GUKzG1KkSGH&#x2B;20&#x2B;fPg29evWkngEbNqynNf5o9JdYvt6wsLAX58&#x2B;fvz5jxoygo0ePPo&#x2B;IiFAK7mh17Lcnvd&#x2B;Wo78jrfzUgl32uvfHpoVfnEX7eeLPrk4MTABIjELA3/8zGD5HAufiCqlGD/vaHQSU5ql1EFDyCviSHQT0oK2DgN6GSKC3IRjoyU00ZsCAASd//vnnwCFDhhSqVatW/qpVq5ZOwY8kGBgYGJzF/zlLdJ4SbBMx500ADRaWDiKqzhlk2gRKUvA5yW1EknrPmbsH8M9FHF5g/Me/lk/LF3kImHwDqHShYD6gNbVfidRLSwgY&#x2B;dcGTMlHx/uqVatBmTKlwc3NFfR6yzmCtfwjRoyA9OnTg4uL8USYNWsm/PzzL2T&#x2B;71C0aGEqBjx&#x2B;/JQa&#x2B;KFTPxrshYeHw7hx4&#x2B;PkmAmJhUGDBsLGjRugffsOsHDhInoeurgYh6PNmnnDr78Oo2n&#x2B;PLD7AB4fZjvs2fMf7SSwdu1q2Lp1K9y4cRPGjBkDhQoVhnbt2iWOMSbBunXrDpHv7tTr16&#x2B;jwDn1/I6Y&#x2B;TlK/AGUa/2VUv&#x2B;lz&#x2B;1J&#x2B;Vebp5Xcs9p&#x2B;BiYAMNhxoZ44zWD49AlSj/v9W84K0JoN8CWzAqyWo3o&#x2B;efLky2QKJoOLAz179izYvHnz0uR5rmTJkjExgIGBIdYQDgN1nDjaL7y8Cy/aVlkANFtAT/436rKW7SU1&#x2B;qZHackBv3OxYaABxAF&#x2B;gyjFXkziTSYFps4DcjcatUg&#x2B;pyISCEsAhPsQCRmM&#x2B;GvCmjWr6XeLpNrNzZ1Ows8bHfUbN25CU/uRZKPB34ED&#x2B;6Fhw0bQvXtXyJgxA1y5gqZ&#x2B;RWHUqNHU0A9JNk5xpY8vWLAAVq1aCd26dQMPDw/qW4CP&#x2B;HdcvnwZdu/2herVq5nr//HvQO8C7BBw4MAB6NWrF7x69ZKeI6NHj4EsWbLArFmzaAlDQm7v9&#x2B;HDh/f37t17sGLFisDly5ffDAsL&#x2B;xxHhF8tA&#x2B;BLRvud0cIvttF&#x2B;RvwZvlkwE0ATlEwA6QgqKgq45MnIYzRgCQCXNCnwGQDg5gooAHBubkb35ehoe8UAmZEd6yAAX6iDAM5v0qRJlh49epRs1apVHVYewMDAEBuYTQAFqf78bZYScmEJAJJzYTs&#x2B;gynWzrf&#x2B;k5Bts1AgIyhwIN8e0FovsJBu2QwAq6wCwR/BcbICgLZWgiDz93CaWgcyyANr4jHt//r1EJomjwZ&#x2B;TZs2gylTptIafoz2t2nTFvLl84SuXbsRkvmRtvB79OghOUej4dSpU&#x2B;TxE5QrVx6SJEkSJ8eIKf2YVeDp6UVf58vnRdP0GzUy1u9jzT9mKODj1atXgXBg6klQrFhx0X7evXsHP/zwA237V6pUaepNgIJFQj5f0Mn/0aNHj319fU9v3rz55uHDh8PA&#x2B;QZ&#x2B;WjIA1Iz&#x2B;7In2q3lZCdeTPrdHBFCbJ/fISD9DvOSd/H3ya4FlAMQB3k3AEoHPkHrsCJYVEM&#x2B;zAnDavXv3IzI9LVmyZMDw4cPLlS9fvqCnp2duFz4nkYGBgUHr4EJg&#x2B;sen4Vva71mi88L6fTNhlpB5aY2&#x2B;vO5roJkC5vczdQrgebu4JEHe/d9MvIURePPKlh1wMsReKWqvNsiSi/orPWdQRpIkSWnk25hC70InJP4INIdftmwpbbHXpUs3WLp0KVnuBnPnzoa7d&#x2B;9B5cqVqWO&#x2B;rXZ7sUFUVBQtQbhy5TIcPHiYHtu7d&#x2B;jinw/Onz8HCxcuAPTonTNnLiH3gyFlylTk&#x2B;Wwr8o9AP4KpU6fSfaZJkwYScoMfdCwOCgo6P2PGjJNbt259jEIAxK6e3970fnta99kT7Xc04g/gnGg/I/4MDEwA&#x2B;Pp4&#x2B;9c/BkP4B0jWpiW4ly35rXkFSA0D7c0K4Il&#x2B;XHgFyC6/ePHi606dOh0ig6kjPXr0yNOkSZOCderUKU8GHik5LDpkYGBgsHkBN5gr&#x2B;6WXbXP5P438W0QAEWk2yJNh49jTYEkdkAgBgkp9M/nnSb9w/xZBQuj0L&#x2B;giAJaoPye5zdhy&#x2B;xfO10rgpZkA4r8X7NrXNzeAI&#x2B;Sd/5iwxh8FAHd3N/r6w4d3cPHiZZgw4W/o1as3JE&#x2B;eAr777jto2bJlnKbKP3z4AI4dOw6dO3cGPz8/8PXdRUn71atXIFOmTLTLQJMmjagR4N279&#x2B;HatWDIlSs3bNiwCbJlywa5c&#x2B;dR3DcaBiboMeHbt28CAgIurl&#x2B;//vKaNWvumVr4xUV6v1YzP3uIv8EOAQAgdtF&#x2B;gNi18FMj&#x2B;qyFHwMDEwC&#x2B;4KDQdBHh7BvJfOtZAXLkP86zAvR6vW7p0qW3yHQnderUhwYOHFiwRYsWpcqUKVPcJSEXGTIwMMQ5OFA3yeO7/0n99ISO/cJtjIKBuE2g9W3EIKsAWwi0xdTfYLAdYaf7wpI2jgMtNyyM7Nrbsk9rxgAj/wBHjhwFDw83KFiwEK2Xf/ToESH/LpAuXTryXerh5cuXkCpVSvj48SN4e7eg22DEfPv27dC4cWNwc3ODGTNmfJFjHTp0KD0eFAAWLZoP69atpyLAqFF/0Hr/NGnSwrNnz6BGjRqwdu06at6HqFy5SqL87iIjIz8FBweHHD58OHjMmDEXwsPDo&#x2B;KQ8Gs183Mkyq&#x2B;U7g9gX9QfgEX7GRiYAPCtCgF2igEsK0A&#x2B;K8AW4Y91VsDbt29jJkyYcHnKlClXv//&#x2B;e68ePXpUKFGiRJEkBBwbmTIwMMhScctV0xJHt9T5gyQ6rxMZ&#x2B;YmFAXP6vuk/6hmgN5YGGGdxohuAMOWffzM&#x2B;6o8O8cZgvyBib3L3NwgIt0GS8i8uQ5An51pr&#x2B;OWMAIWih/BRyWcgsQNN8rBmH3Ho0CGoW7cuZMqUgbbNc3f3gLCw5&#x2B;DjM4BG9LEEwMenPwwYMICaAVasWMk4uHN1A29v7y963G/evIHg4Ks04o&#x2B;eBA8ePIQLFy7C8ePHacs&#x2B;PNbSpctChw7toFOnLpA8efJEO8579uzZ0127dgVt27bt1p49e546gfBrSe&#x2B;3RfS11PiDihCgJACoPY/raL9WQYCRfgYG4b2YmQAa4UwTQM7DA9ADAMgNmC8BcCtTQu0ziK1poGj8p7KulPirzbcnK0BpUjILlJvniHGgrawApxsG4nJPT89kw4cPL12tWrXCBQoUyOcal0WUDAwMCQq8CaCR2Btr84UtAEUt&#x2B;/iUfYFcKuwIIKzhN9boW4gyLyZYR9KFl3FrDdiSVSBYn&#x2B;OsbgoG/mItNQWUec0/SjMB5LYTbqPFKDC&#x2B;jRXiGmfPnoWePbvBpUtX6XlUqFA&#x2B;QvSrU2L97t17uH//HmTLlhVq1apNCPYDQrAvEOL9GpYsWU7LADp37vJVj3/Bgvnw119/wqlTZwjRb0/Ivx/kzJkdKlSoAH369KXHjUJAYsW9e/fu792790z//v0DwLEIviPp/VrS&#x2B;r9UtF&#x2B;4DgAz9WOIb8SXmQAyASC&#x2B;CABOFgO&#x2B;VgcBqTDwpToISEm7rdIALZ0FtGxPToOkrt99912GPn36lKpWrVrxjBkzZmIlAgwMTADgBQAp2eevmrxRoHG0ahQBxI74/ODAtIlOlsubBQZpxwGx0Z&#x2B;8EGCs8eePyvKeojQuCWkXOvZLhQD1toLWxN7eW923Igj4&#x2B;vpCjx7dCdG/D&#x2B;fPn4dMmTJD/vz54cQJP/j&#x2B;&#x2B;&#x2B;9p&#x2B;zxs67d580ZIly4DFC1aBJ4/f07Wvej0Y0Hn/cDAAKhfv4FoflTUZ7h06Qrs378XQkNDYfHiJaLllSpVgA0bNkJwcDB19r948SL8&#x2B;uuvUKJEyUT5nb1&#x2B;/frVlStXbi1ZsuTU/v37nxBExAHh12rwpzXqb7AhBKiRfVvRfjkRAMB2BoDafLBDEGCkn4EJADbAIpfxDAnYK0AqJsQXrwA9xC4rQNErICIiQn/gwIEnZHru7u5&#x2B;aNCgQfl9fHxq58OeSwCsPICB4RsdXFjXXelB2L5PahIoNr8D6wi9hL/zWQNibwGj&#x2B;z/HyV36BT4CnOWyLSof4EsNcNcG/qU8&#x2B;Zf3KrAd1XdWOr&#x2B;cWWB8GtSh0R2SdIzOk3uC4nrYHu/9&#x2B;w&#x2B;E4Oczz6tSpQrkzp0L9u7dC82be0NISAhMnToFVqxYDt7ezeH330fCrl27qBP&#x2B;4MFD6LqYGWDvoPPMmTNQtmxZUOt8&#x2B;7///QN///0XrF&#x2B;/gbYTRGBq/4gRv8Hz58&#x2B;gXLkK8Msvv0r&#x2B;9lf070d/O3yfyMhIuHnzZqIj/&#x2B;Rv058/f/6yn59fyOTJky8S0v8J4raeXym9Xy2t31aUX83cT00AYNF&#x2B;BoYEDiYAxHMhwE4x4Gt6BYDpRmQrK0BOANArCBJx4RWg5gWgJALY9Ar4/PlzzLRp04JXrFgR2rhx42z9&#x2B;/evXKhQIc906dKlZ2czA8M3dfEWMHewfg7yRoHCVYVd/wwSEUCUVcBZdFsOpOQfRJc2C/k3WF3yRcqvwfruodyVAMz&#x2B;AHLdAaQRe3uNAuXEAzkxID4hLCwMOnfuCJ8&#x2B;fRKRXjz&#x2B;iRMnQJ8&#x2B;fSBjxkyUQDdoUJ&#x2B;a&#x2B;KEDPtbDo0s&#x2B;GvsVL14C5s2bBxs3boDAwEAqFPTp8z1MnjyV7qtp06bU3I9POMuQwcOuYxw7diztEoACgBICAgJg2rT/wU8//UL/Jh5Y39&#x2B;6dWvaRjBZMnENP5oQdurUEfLmzQsXL16AgQMHkGN/Tv6WuYnm5/2G4L///gsg9/orBw8efK439l2MLeG3N9rvaOu&#x2B;2Eb7Y2PqZ1Ah8AZg0X4GBiYAMMhfvBJZVoDwuU5GFHBWVoAc&#x2B;Y&#x2B;zrICXL1/qV61adZtM98ggKJmPj0&#x2B;RGjVqFCpTpkwJnVqohYGBIVHxf0suvumyZo5Ui9P2hT4BekIGdXgp0UkUWYPgImowGfuRfzqzp6BB5pLLH4IBrJi&#x2B;6QVn2pIziwjiQxcb9IGoE4HwciY1A5Qj6dL5sYncqwkSjpYYOAvo0F&#x2B;gQAHo18&#x2B;H1urzuHXrFowc&#x2B;Qe8ePGCEOvp0KtXL/odYIr8unVrIXNmI/nH7&#x2B;HFizA4cuQwuLm5QsmSpWH8&#x2B;PHUNE/4ecam2gz39&#x2B;eff4rmXb58GfLlywdJkyalr8eNGwcTJ06EQYOGwMuXL8jxHIFatWrRVnx16tQVbfvq1SvYsWM7bN68Cfbu3U/WPQTVq9ekLf1u3gyB9u3bJ/jf9WOC48ePX5wxY8bZoKCgN2BfBN&#x2B;Z6f2xIf5aov1KYgCAeso/i/YzMDABgCEuhQA7xYDElhUA4JhpoL1ZAVrbCCpmBYSGhr7/5ZdfTnl4eJwjA8Kdw4YNK1u3bt0yWbJkycrOZgaGRAzz1cogZcJm4m25gJqr8EXk3CBI5zdnAQgugxaV1ULieXGAX5fjpCn5cpdrsXBgcekXHDJYBAEp4VYj/sL5ctkAsRmfK2UafO0xf8mSJQn57w/37t2F4sWLm&#x2B;djTX/atKlh&#x2B;vQZ0LdvP0iWLCmcPBlA6/39/f1p1HzPnt3w4MFjmnpfpEhR6uhfv359SJkypVOPEbUb4fc1c&#x2B;ZMGqXv168f/PjjUDrvypWLtLPAli2bYPToMeSYpinuLygoEGbNmknLHvr37ws1a9am8zHDQC3LIL7jzZs3r2/cuHF78eLFp3bt2vXg2bNnkXFE&#x2B;LWY&#x2B;cU2ym9Qef2lW/gZbIxVGfFnYGACAEMciAEJNStAKgrEdVaAPW0EFQWDyMhI/eXLl1937dr1iKenZ9DIkSPL1qlTp1SuXLlysqwABoZExv15Iz7RFZQvsLcU&#x2B;Fu1vzNfIQ3mQnyDyRyQMwjj/MLtOLOEYHHbF0oLAvItisILRQhOdEnnOw7wrfo4QYtCMYmXJ&#x2B;RSkcC6S0Hc1&#x2B;0rGRR&#x2B;me&#x2B;foz3vz549Q4i2C03VR2D0/O&#x2B;/JxAyPRoOHtwPFSpUhEWLFsLdu3cgSZIkkCNHTvKYlBDoftC5c2fInDlLHI4fLMcaFBQEM2dOJ2T3LcyZMxu6d&#x2B;8OLi6ukC1bdujduxd8&#x2B;PCeChENGzZU3F/t2nVg&#x2B;/adVOSoWLFiQh9b6UNCQm5t3779zIYNG26fP3/&#x2B;DcTOwC&#x2B;2Zn5aWvdpbeUnl9ovF/kHYNF&#x2B;BgYmADAkDDHgG8gK4CBhZAXwy622v3PnTsz3339/zNXV9UTr1q1zkOdlixQp4pWNgJ3JDAyJ5aIMZglT7Mqvk/UIsE61F1J9g/qF1yrbwGIkyJneR35sLGdECAIRwHgsBpkkBrU7jVyrP6XXBhkhxBlEnX&#x2B;Pr1EKgCXh165dg1evXsOECX/Bd999B0&#x2B;ePIGCBQtCz569YMGCBZAxY2b45ZefqHs/psdjjf&#x2B;IESMI4e4Nzr4VoBcBmvJlzZpVVgBYunQxIf7zgNybwMdnAAwfPgwePnxEjw0/uhEjfoc//hit&#x2B;h4eHh6QK1cuOiVUfCa4detW6IQJEw6uWbPmHjgewXemmV9iiPYz4s/AwAQAhi8hBDgoBrCsANsZAM7ICqDLo6Oj9Rs2bLhLpgeenp7JOnTo4NmoUaNiFStWLOmemJskMzB8A9xfSLKMFzXOeiYfYdeJlQIk/5zpUmfg0wgETv/oESCI7ZtLBaTdA0QEWOLSb9w3Z7qIWS7txu0tpQe8wZ&#x2B;QwEtbDWoRAuTG6EKSzq/nzMi9lu3iQiB49uwpVK1aFYoWLQ6TJ0&#x2B;C9evXw7lzZ2jE/8CBA/DgwX1K&#x2B;s&#x2B;dOwsZM2aEgwcPQOXKVcHV1RXiQgceNuxXKkBs2rQZtm3bCi1btiLvpSOT0UMAHfpTpkxFSP8DyJ49G6xevYpmAJQqVRp69OgB3bp1J&#x2B;dB4mxqg2Om1wR79&#x2B;4N9PX1vblu3boHcUj49TaEAEei/QYNAoDWaL9WEQDAsRZ&#x2B;akSfmfoxMHxhcF/7dxRfHHzfjvwTuJQpwPAxAjgPdzDE6FHKNxbLRUUBlzwZeYwGQ2QkNoAHw2fySG6S4OYKhk&#x2B;fgHNzMw7ooqPJ9h5k&#x2B;WcAVzcwhH&#x2B;AZG1agluZEl/r83XkA&#x2B;Y0PAcZAi9dV245Z8drnY3nnEQckAoFsckK4EBbVoAtw0C7lhcpUiTl7Nmz65UrV65YShyVMTAwJCh8jIiAyMjPYvLPWSoBjERXfA80uu8bwOjqZxCH2SVsW9pBAF/rdBZzQCORN20vkzrAmcg/B3K9SoVlBJzNdH1OomtID1muQ4CaV4CSaOCMcYIzTQjVcOzYUUL&#x2B;i9HvoVWrllCuXHnawi88PBxiYqJh6VJs59eCuuyvX78WtmzZAteuXSfkO4doP4sWLYDSpcvQ7aWYPv0fGDhwCNjSirEFX8eO7WkZQvbsOQmZ7wxhYa/A0zM3ObbWlPDzZoCuru6wZMkSCAwMgCpVKkODBo3ADcc1iRAfCK5duxaycePG8/PmzbtJvpsocE49v9b0/riK9tvTwo9F&#x2B;xm&#x2B;TeIbjzrHfM1TmmUAJHLEg6wAqRjwrWcFqC4PDg5&#x2B;U7t27a01a9Y83qhRo9ytWrWqkDt37pxkIMayAhgYEvK1mCfInMwSQaMASwm/QTXfXigE6PUyNfcGbTVbvKO/8VZhEJkNiowIDXpjCYNgr9aZAAIBgjxiOjztemA6LjViL/QNkBoNOjtSH5f&#x2B;ACj&#x2B;/PPPP3DixHFIliwZIfve4O9/kpL5du3aUy&#x2B;AqVOnEuI9DtPOYfLkKVbkPyIiAkaPHgWzZs02CwArVqyg9flbtmwm206AH3/8xeaxYGr&#x2B;kiVLIW3adNCoUUNC8t3oe9atW4&#x2B;2GXR3d4MePXpBcPBV6NSpEzRv3pxOifUn&#x2B;JZg0aJFe7dv334nICDgFTk/Y8D&#x2B;CH4MOM/Mzx7ib2&#x2B;0Xynyr0UEANDWws&#x2B;gQuZZCz8GhngMJgB8g2LAF/YKkJYIJFSvAB3Itw50hleA1fKjR48&#x2B;I9Pz4cOHn23UqFGWXr16lahUqVKRHDlyZJejEAwMDPHymmtJnQdL4z2jeZ/YYd/MqHXSmXJRf8sllNoNcJw5u0CW7pseLHYBYuNAOUIuPATxvq1bDQrfT0zyLZde0WdhoyxAup4zfQFsfU&#x2B;OAkn7yZMn4N27tzBt2j&#x2B;QOXNmWLlyNVSvXgN2794D6dOnN6/bpUsXavqXNKk7tGjRympfWB7QuHFTuHDhIrRp046&#x2B;xnT8rl270FZ72KpPy&#x2B;Fi1gGSf0T16tXAz&#x2B;84trODQYMGw9WrV2ipwtSp/4OYmJhYtRWMzyB/W8ytW7du&#x2B;/v7X5swYcJZ8vwDxF16v72t&#x2B;&#x2B;yJ8stF9lm0n4GBgQkADPZfWFlWgFOzAhyK&#x2B;ttavmfPnkdkepo1a9bjtWrVyjR27NhGefPm9dKhxTQDA0M8u8BKCDUnvcgZU/51OrHJnlWwX5QOrzcvNLf9MxkF6gyc0RPAvANTCz/OYuwnd5EXkmxQWG6M&#x2B;nMyl3hBO0JBlwCcj9kIWDMuN3yX1v0rEW81cUBNsNAKafTfGVxj7ty5MHbsKNiyZQdMnDgZmjZtAgUKFKT7F5J/BBrydezYQXFfN25ch9OnT8Hs2XMpOZ84cQKkSpWCputnyZLFeD5I8OrVKzh48CC0a9fO/LddvHgRqlSpQl9jSv/48eOoKSC2Kvzvv72QIkUKuiwxkv8XBKdPn746b968M4cPH35uSvP/EoQ/xgbBt0X8QUUIUBIA1J6riQAAtjMA1OaDHYIAI/0MDEwAYIhvYgDLCoj/WQFPnjyJWbt27d0tW7Ys8vHxydewYcNCZHBXinkFMDDEPwhT8eUuoLzFDP/cEu2WJO4bBBdNg&#x2B;CFwL7PuJox5593/uc1BGPNv7G7IH/VszQjMFgRYbVaf7nLvbT&#x2B;3yw6cPLrWCobxOn&#x2B;tgQBtawBR4QAW/uyZ79RUVHw&#x2B;vUr6NChA9SvX49OsUGNGrXA09MLqlevTo8jQ4YMlLijeeD8&#x2B;fOpyMLj8uWL4Ou7G86ePQsfP4aLBABsy8cLAKlSpaLCg5eXF32dJk2aRPebi46OjgoKCrp45MiR69OmTbv6&#x2B;vXrqFgQfmeb&#x2B;X2paL9wHQDWwo&#x2B;BgYEJAAxaLsAsKyB&#x2B;ZwVERkbqZ8yYcY1MIQUKFDjUtm1bz06dOlXKlStXjhR8SIeBgeErMX9rgsmJDPUsdfL8Knw2AEjIM5/6Tx8NHM/7xRc/ziAw/DPwrQNEF2lTsoD5/axb&#x2B;6mXAsiP8ZU8Ya1Jv7Q7gRIBV2sJqOQd4EiZgHBf0qwER4Bmeb//PpLW/DsDWKf/448/0LT/du06QP78BSh5L1SoMPVrEB47egNkyZIVRo0aDcWKFTMvCw0NhVevXsDbt28hKCgAhg8fDgMGDITE2GTmPcGDBw8ejhgx4r&#x2B;dO3c&#x2B;gbip53ck2q8kBoAGIUCN7NuK9kuXqQkBACzaz8Dw7Q1VWBcAIxJrF4BYfjesg0DcZgU4tYNA9erVM5ABY9GaNWsW8/T0zAPMK4CB4YtD2gVASOT5e56REBssHQBMrvzm9n48oZe7Twoi7UbPAJ35XiXk/zqj2wAI3QeEIgTHWcbsYkItvhzLEWyhqZ/loAyyz6WZANKWhdK7jPD91DsQWBsKOqNtoPQ949IwUAlbt26B1q3b0OdVq1ahn1GXLl2hX7/&#x2B;QEguLF26FJ49e0aXf/jwAeR031WrVsGECX9B6tSpISjoNBQuXBCCg68npp&#x2B;a4c6dO3ePHDlymXweV06ePPkqjgm/kpmfWus&#x2B;pei&#x2B;FnM/NQGARfsZGBI47xTeb74GWAYAg6YLtROzAqTLpFkBcvthWQEalh8/fvwZmcJcXV39hg0bVsTHx6dOVgIXbOrMwMDwdQYbYN1&#x2B;TkieORMzNphIP23RZ&#x2B;DD/CbbQFFWgIRNC2oJxBdfyyWVAwm5lagJQpM/4/FZD1CEpByj0OjwLxQNLORY7BGghfTLDYiURAfpekq3pthkBch5BIgFj7gDfq5Y54&#x2B;GfylTpoSdO3fAw4ePoW1bY2p/0qQe1L2fh1LSV8GCBeH69RBInz4N9O7dC0aPHp0ofk/Pnj17ev369bv//vtvwMGDB5&#x2B;&#x2B;f/8&#x2B;GmJfz681vV/N0d/RFn72RPtjY&#x2B;pnUCHwBmDRfgaGb2tswjIAjGAZAJq/L5YVkECyApInT&#x2B;7Wvn37XE2bNi1Qs2bNcmnTpk0DLCuAgSFOgRkAn/A&#x2B;YeXczykTYAm5NPUKUNzGEni37higfHE17lOHbflM&#x2B;6YXNR1nbiMoJvTiun45EUCeZMtZuoDVvuXeJzYZAXE9rpAehzPew9fXl5D9zOZWf4g&#x2B;fXrDP/9Mo5F7fJ&#x2B;yZctAw4YNYcqUyRAdrSdE/g&#x2B;4desOrF27xqagsXz5csiXLy9Uq1Y9wf&#x2B;ubty4cXPjxo1By5YtC7lz585HcDyCH9v0/tgSf4MGsi&#x2B;M6ksj/HqNpF9tnlZyz6L9DImP&#x2B;LIMAAoWGWRw&#x2B;ILOsgKsHmMkZNxZWQFKhoGqWQHh4eH6pUuX3iLTbXd394NDhw4t1LJly5KFChXyIoPLNOxsZmD4wtdPvvZfQMB58i9HKuUi51adAoTsWUYM4MylANZp8vjIk3/p&#x2B;4vfW5srvxauINxM6Elg9bcJ3kcL&#x2B;ZczCXR2yr6tzgn2olu3LuDt7Q2LFy&#x2B;lTvyzZ88ipH0lDBv2G2319/vvv8PgwYPpsiJFitJtXr9&#x2B;A127dtZ0rD179kzQv5cIgps3b4bu3bv3MrbEtYPwx0YciMtovy0B4Eu18DPY&#x2B;NEy4s/AkMjBBACGWIsBTuggIH0OGoSC&#x2B;NpBwCAQDHQQd1kBetDeQYD7/PmzfvLkyZfJdLVatWrpu3btWqh9&#x2B;/a1U6VKlZqdyQwMTmX54gi&#x2B;6apFySgI6vzB5M4vIbkYoTcTd4NYAzVHzzmx2z/w&#x2B;zZ5CQiFAdrKjy8RMFgyAPj3sCa3YlIu1RUMBoMV4RZHxpUu&#x2B;9puE3JZAML9ywkBcsTf2SKANPof2/1euxZMnf13794Nly5dgtKlS8P79&#x2B;/QyR6ePn1KXf3XrVtDywHOnbtA10P06tUbihcvlmh/Pnq9Pob8/c/I33vK19c3VGDqF5eEX83ML8YB4g&#x2B;gHP1n0X4GBgYmADAkHiHAQTEgsWYFcILBg5DExzYrQGsbQUXBwM/P7zmZXowbN&#x2B;7smDFjylaqVKlg4cKFC7gSsLOZgSGW4FvtcfKUl&#x2B;Pb91mUAZHpn54Qdl4EkJJiESmXEnXhysJHCVk1CPsKyvByuXIDuaG9sIWfMDKuXBagdAm3zxtA&#x2B;j5fyphPznRQq8jg7&#x2B;8PKVOmIMS9BERGfgIPjyRQ&#x2B;P/s3QmcVOWZ7/HnFN0iAjKKio4LKi4IARUBQaOTkGhQEcXBiZHkSjIZr1HHJXuuE51Mxsz1fu7HGRLjEjdi7rhEAkRFBRdEZBVFdhAUBVH2feul6txT3bWc89b7vuecWnr9ff3Up5fqqmraqtP9/N/nPO9ZfeThhx/xCvrvyl//OqkhALjjjh/KhAkTpK6uVl5//TXZvHmz9OzZU/7wh0fkkksatxZMf11btM2zcOHClc8///ziP/zhDx&#x2B;JviW/HO39cYb5lWO1v9gVf5HyrPZT&#x2B;AMgAEDThAF0BRR0BTghRX&#x2B;TdwVs2LAhdeONN85MJBKzr7322hOuuOKKXsOHDx98xBFHHEkYABR7EMy&#x2B;4B1fUe5bQc8Vk6nGolEpzPMr/9lC01WKTydQ/Cd8xb/TUJRn2&#x2B;mdwNA/tfW/ceCgW/jYEtxKMF&#x2B;YqzsFiLE1v7A4Nxf/DY/uOtrwwRQKxGn1150aUMxUf93WgbYdErL27Nkj3//&#x2B;9&#x2B;Qb3/iG/OIXd8n48U/KbbfdLulD7Le&#x2B;db28/PKUXMCSbvu/8sqrGj5On/t/3XXfkgEDBsiRRx7ZZl8tuz2zZs1aePfdd89asGDBDin/&#x2B;fxx2/vjFP5ujABAxL7aHxYCiJS2hZ&#x2B;t0GeoH0AAAJQvCCgyDGgNXQG6z0XpCkgpRX&#x2B;zdwWkWy6fe&#x2B;65T7zLOu/jGbfffvsZw4cP7/21r33t/Orq6kN4NgPxOOJr1fev1jdM&#x2B;M&#x2B;U28osAP&#x2B;5&#x2B;sFjqe/wlT2UpryvVCb/a2vrXEqQKDzA5XYVcPyluOaxRQrzU3uBrB7yC08NsN2PFAQNtuGAusezhQXl7hawhQnZYYlXXz1K7rjjTrn77l/KO&#x2B;&#x2B;8I716ndYw4X/evDkyf/58uffe3&#x2B;RuM3HiBBk2bJj84Ae3tNnXRzKZrF&#x2B;0aNFyr/D/8Fe/&#x2B;tX727Ztq6lgwR91mF&#x2B;5JvhH3cKP1X4ABABo&#x2B;2FAC&#x2B;8KEMm3&#x2B;kfpCtB1FDhSuNLfqroC0tePGzduhXdZNXr06AW33HLLkHPOOad3N4/3vy/BsxkIL/8bisGE75x6J1/i5/r1neCsgOBgwMZVeHUKv&#x2B;SCA/92gI13l7AdBv2r15kQItt37/rvWjTdCJkHcDL/kKhb&#x2B;plX6V1NCKAPBNThgMGZh26k8EH3femG&#x2B;RVzKoFt9kD2/jt37iy/&#x2B;c1/NFy3du3Hsn79Onn11Vcb2v7T5/xff/2YhkAgff2tt94iW7dul969z2xzr4p6z44dO7Z7//b5zz///KoXX3zxCyn&#x2B;fP447f1hhX6Uc/zFEgSYAgDb&#x2B;5Ve7Y8aCFD0AwQAQNMEAUWGAU3RFZBSPnaU&#x2B;3ckWldAQinw43YF6HYSqFRXgPH6CRMmrPMun3Xv3r3jz372s34XX3zxmQMGDPgSXQFAhENWwzBA/wn6&#x2B;RLfzdX4mkOar/jPDgxs7CZwCgYG5g4omVBA3MJz9hu/VinU/dsH&#x2B;gcG&#x2B;g6xuVCiYNieY5kLkN81IM62fYWH4&#x2B;B9&#x2B;r9lXYeArTDXPXYlaxr/423ZskVqa2vl&#x2B;OOPb/h4yJChMnPmTDn00I5y8sk9ZcyY78h1110n9933v2XatKkyY8YM&#x2B;cUv/pccc0yPNvWK&#x2B;OCDD5Y&#x2B;/vjjs9Pn9ns/j3qJv4Jf7tX&#x2B;qKv&#x2B;zbXab/tc1OKe1X4ABABomWFAK&#x2B;gKUAt6U1eAaVhgnK6AKKcChHUFaFf1xb7NoPX6bdu2pX7605&#x2B;&#x2B;673/XnoHgTFjxvS&#x2B;4oorBh177LE9qqqqqnk2A2oRmCmnlaXrXPHvaI5uvoI/e95AQxHecBpBvs1ct81fsPh2GuYGqEW5oVI3VtHa0xM0RXjYefr2YjysxsjnuFEKf11xH2Vl37/DQPzgQoyP93/&#x2B;z31y99335O5ryJAhcvBgjfzudw/Ijh075IgjjkgPv5PVqz&#x2B;UzZs3yejR18o99/xrm/gVv3Pnzl0rVqxIb0M7L3162Z49e&#x2B;qkadr7kyEFfkqin9Mfp9gPW&#x2B;3331bEvMLPaj8AAgC0jyCgyDCgKboCRPSnBOhW/10xdwWoXQCm0wDUr4nbFaD7OPKqf9j12R0EvMJ/zi233HL67bff/vVTPDyTgcIjUK6Y9PWxO5Kf2pfbCMB/AMo1DaQLyUSmXV8pZHNbCqZX//Or8vniuHAVPZHIdAL4P5k95LnB9CJ38HQM57b7T1cQfTdAWJEcLRTQHZb1GUbw9IDCQYWmToByzwRIb&#x2B;M3f/48OfPMs2TVqlUN5/pnrVy5Um64YWzD&#x2B;&#x2B;niP6179&#x2B;7y2GNPyIYNGxq2/OvQoUOrfcqnPF7R/&#x2B;HUqVMXPf744yuWL1&#x2B;&#x2B;t4wFf5z2fltbf9gqv224ny0AsBX6rPYDIAAAbL&#x2B;EKtwVoIYAaleAeptydQXovj7sNIBydgXEWvUPu977IzeVnhXw2GOPrbnkkkt63HTTTQPPOeecM47xMCsA7f5Yli6QXd9QP39RnR4M5&#x2B;R3CPDnA65SiLu&#x2B;miAwHT93EMkf6rJFvr&#x2B;wDW6XF&#x2B;Uo6uSGBop/Rdw3p0At/guP40oO4hQW3P7BeeYi3DEclg15i6Ghwd&#x2B;JYDrnX50noNs5IGpXwNKlS&#x2B;Xyyy&#x2B;TV1&#x2B;dJuvWfSozZrwt1dUdZPz48fLnPz8n8&#x2B;e/p71d9jSB1vh03&#x2B;KZPXv2kt///vfvTZ8&#x2B;fYv3&#x2B;yEp8VfwS13tj7rq70q0tn9bsR9ltT/qxyKs9gMgAABBQEW7AkQp&#x2B;PX7UjV9V4CuSyDslIFm7wrYt29fcvLkyeu9y4YePXocOnbs2F5XXnllv/SsgE7pPa2Adlj&#x2B;5yb/&#x2B;Zens6v0jmEMXso3LiBdbKcygwRz5&#x2B;cXVOuNJbnr5B4zlXK10/ID0YTraIvzQPVuWPUPBBy&#x2B;gYGORF9FV1f/3UjJRPBzmai44FQENQzQBRBxv8c4xX/a/v375aabbpJu3Q6XNWtWy7e//S3ZunVbQ&#x2B;v/vff&#x2B;Wk477dSCbRIr0YnQFLZ6pk6dOu&#x2B;ee&#x2B;6Z99FHH&#x2B;2vcMFfrq37ilntN4UB6tew2g&#x2B;gVXCa&#x2B;1jQUn7p7brr1&#x2B;J07SLu/gPidDxE3GQq3c/WuBJSVydO58O8t/Xi1tSI49U1bq33tkOVSHWVuAcPilNd3bhiUl/v3b6jd32tSFW1uPv2ymGjR0n1gP4820p7nhTzRHEivC&#x2B;a4l73tbatA0WCq/1xugJ0oUDC8HHC8jlTV4Bpt4AoswKKuj6RSHQ4/vjjO/3iF78457LLLhtwcnralYjDsxjtwX7vd0iN9/uhsahLKAeZ4DT/QGroFG7R598xQHIHDSfwV38id5pB/v79RaV6TnuUKf6ObvS&#x2B;ZV6ALQwwHbnV7ytaMeyI/hQB/bdo&#x2B;/eFFfXq96R&#x2B;ren7TJ8CUFVVJRs3bpRrrrlaPvtsg/Tv319uvPFGueqqq7X/Zl0w0lLt9qxZs&#x2B;aTp556ap53&#x2B;WjHjh11UpkBfikp39Z9trZ/08dNvYWfG5KCUfgDbajuVI/7TY0OALQKdAXE6grIFuPq6QNhwUBZugJSqVRy/fr19TfffPOso48&#x2B;esGdd97Z95prrhl8yimnnHTIIYd05NmMNn608v1V7xYW/rkDg9tQoLqZwr9x&#x2B;H9&#x2B;7F5jcZg/kuRb8IMf54vJ4FFLLSzzg&#x2B;6k4JSA/GkISvWsVtamE&#x2B;0tQYDulICGf7fratv17Yd3V/SzXvOdDaZOgODH&#x2B;pZ/3akJ6s8vH6Tov8908Z&#x2B;&#x2B;Ln0&#x2B;/7PPPif79u2Tk07qKV26dNH&#x2B;W3XbEra0joA6z2effbZhwoQJcyZPnvzx3Llzd6aP81L6&#x2B;fzFDPMrtvAXMa/&#x2B;R1n5F4nX8m/7nO4tRT&#x2B;ApgtC6ABoRAdAq0zxWnNXgHpdm&#x2B;4KSH/8la985agf/vCHg/r163dapisAaHPSLeAH08f/TAeAv3U&#x2B;IYmCYjS7yJ&#x2B;dC&#x2B;BkrwyUvI6mtd9XuOe6AtzM1zqZ2X6Nn014v8eChWywdvcPzItw4DUurasBgJv7fvQt&#x2B;aX9TWAa9eIU860bOxJs32fYqn3hForx/yZqzjCgtra25p133llw//33z50yZcoXUvwKfrHt/WET/Vntp/AHWmXdGef3QiXQAYBWq5V3Bagr/W26KyB9/VtvvbXJu7ycnhVwzTXXnOhd&#x2B;g0aNKhvt27d/oZnM9rQXxe5Ujy7yp1b1c91BGTb/huvSfiKSdd3akC&#x2B;qG5sFcgdBBLKVnyinFcvmfZ/cbR/ZBSuvAe7AuIU7MEDYr7jwd8FkHLNHQHqY5hW3PWHct3OroWH6oIBi6I7XcDVFva2PyDDfu3E&#x2B;eNOfVx1YGJT/mrd7pk1a9aiRx555P2pU6duygz1q8T5/FEK/aSUttpvKvijrPZHDQFMnxOxD/Wj6AdAAACUGga00B0EXNF3CsTpCoizg4AaDoQV/bqAIM4OAtkiP9IOAps2bUo99NBDH3qXNZ07d37pmWee&#x2B;fqFF154zpFHHtmdZzJa/bFIgsVzsJwXbeGYKz7TK/WpVEEXQEF1oPlTP&#x2B;EkvEI71XiagG&#x2B;/P/vEfrehO0AtgEMOtvoKWhME5DoAdKdAKEV5WEGuX5VXD9uOhHUD6MIA/&#x2B;NE6QKIHlLE&#x2B;h1mLPxtswjK5aBn0aJFy6dNm7b8vvvuW7pv3766Egv&#x2B;uO39USf6x13tL3bFX6Q8q/0U/gAIAICmCAKKDAOaqivAlbbXFZCSIroC0rsIjBw58uU&#x2B;ffrMHDVq1Mnf/OY3B51yyik9u6gnzAKtKAEIrrw7DSf45wf0KbMBsi38jSfGB8&#x2B;xT79cfK9sx3eUcpQjSspJNZbarhMYCGj6HnNFunbAXbBY1p72rzvB3vhwbkFXgK34NxXG5qDCNRwys7dpfD87JyA/h8D/b3ONoYApDNDtFhDl1ICoYYB6&#x2B;yjdCXGkz&#x2B;Nft27d&#x2B;ilTprz39NNPr5o7d&#x2B;4Ozbn95WrvjzrML07h78YIAERKW&#x2B;0XKW0LP1uhzxZ&#x2B;AAgAgHKGAXQFROoKcCzFf5SugLBTA6xdAcuXL9/pXRbfe&#x2B;&#x2B;9Sy&#x2B;66KLuY8eO7fvlL3&#x2B;5zxlnnHEaz2S0VrmiN9u&#x2B;7yukE4lMUekb7pd/4Te&#x2B;ZNPXpNvnE9lZAk5jMRsscTP3kH3F&#x2B;1bf/d9D9v10l4D/9ABfMZibFZAfRqcWxCLalMBfxSvVfPZfFnW7QP32fcE5Bf4hfYWHb/VtYVbr/1ZN/0bbartpVwBdeFDKVn/&#x2B;gr/cswA&#x2B;&#x2B;uijjydOnDjvpz/96fsVLvijDvMrZpXf1O4vEm/VX4TVfgAEAEDbCwKKDAPaYleAGg5E6QpQA4IOET4Xpysgd/uZM2du9i5bu3XrNmfYsGHH/PjHP75o0KBBZ1dXpydtAq3gmNO4xJ4rtHUrzv7CMbs9n3p4cSU/4M9xsyW8eiTxF4b6MrtgOJ9m&#x2B;znbodFUdjTcJFJNoukAUL5T2xZ&#x2B;8U8NEM3hO7iDQEOQYhkKmA8JXONjh/zeKXnF3tRhoHuMKL/aNnuWL1/&#x2B;0W9/&#x2B;9s5b7/99pZt27bVNEHBH1boRznHXyxBgCkAsL1f6dX&#x2B;qIEART8AAgCgqcIAugJaRFeAegncfteuXclJkyat9y7Pfv/73583fPjw0y&#x2B;&#x2B;&#x2B;OIBRx999FE8k9HCEwClQFM6&#x2B;w0FojokMFe8u9nV//xQQbehzz/d8u82Vja&#x2B;ICG3ip7&#x2B;tOMWBAH&#x2B;Itx/uoC62mwqMHWnBDR&#x2B;i&#x2B;b5AK7SmRD899q38NMX6K725xj8fm2H7&#x2B;A4A93jqmGH7f&#x2B;dGqioBXu5Vu91WxHa7jvd0j9//vxFM2bMWPm73/1u&#x2B;YYNGw4oxXQp5/Pb2vujtPU31Wq//2tE2MIPAAEA0H6DgBLCAJO22hWgK9RL7QqIvI3gY489tsa7fHz88ce/PWrUqJNuuOGGwaeffvrJ3Twi4vCMRkuUL0Ylt&#x2B;KcL9hcpdB0zAeagqI0uMrvZAtSUYpmdfJ9dtXd0RTf4p9ToH8bPIaGFOkxthGwzQjQzh/QFMXhq&#x2B;1uwc&#x2B;58HBcWPCbAgE1bLANDPSHA8WeDqA&#x2B;rum&#x2B;s/bs2bP3tddem3PffffNX7Bgwc7Muf1RV/BLae&#x2B;PsnVfUqKd0x&#x2B;n2A9b7VdDAFsQIMJqPwACAKDthwFOvL/ITJ0AdAVUpiug4foNGzYkH3jggZXe5cOBAwceMXr06FNGjRo1mFkBaKFHl0ChmN1uL1jQ&#x2B;j/2rfsrK84J3&#x2B;EpfR5/IrMXYK7wV8tbNx8cOL4dAbKnJ2TnCqiT&#x2B;rPX24pc3cq5YQSAPi3wV9khYYD6GKZMQdcurxbMUWqyqCVYnFMRdPMBdEV7jN9Zpvt2P/vssw3Tpk17f/LkyR&#x2B;&#x2B;&#x2B;OKLGytc8Jva&#x2B;21t/WGr/LbhfrYAgNV&#x2B;ACAAAIr/JdwOuwJ0hX6L7gpYsGDBVu&#x2B;y/Ve/&#x2B;tWif/3Xfz1n5MiRA9I7CHTs2PFQns1oGceUwvPIdUWp/3z0guJf3PwquLiZwl85AJmm8ftKl0ALv28woFp864rNOG3sBSGArug3LOfnByK6IdsXmu/GfkqA7dAcLbMIhjeFQYMuDMhut2gaClhKR0D6dps3b966fPnyNePHj18wYcKE9fv27auX0s/nr/Qwv7jt/qbV/lKG&#x2B;rmWAt4VVvsBtFFOcx&#x2B;DKrGfbTF23fVrcbp2EXf/AXE6HiJuMpU&#x2B;eS49qlmkrk6czod5b&#x2B;vFrakRp1MncWu9tx2qRKqrxD14UJz0fLL0L/f6eu/2Hb3ra0WqqsXdt1cOGz1Kqgf059nWGl8gxT1BnQjvi6a4132tY3lfpPiuAN1tEpaPExHDANP2gY6hmLcW&#x2B;XGur6qq6jBixIjjrrrqqtOHDx8&#x2B;6Jhjjjna&#x2B;6O7A89iNKV9&#x2B;/bLwYM1jefWK1Wqv5AuLPr0Q&#x2B;nUI1DjUEH9ID210HZ8RxN/x4HpqBboAlA&#x2B;pzvn3VS42obrFXyhIQRQQwpbIBD1KB19YKApow0/JUENAcL&#x2B;zinllIDFixcvmzRp0nt/&#x2B;ctf1i5dunSPxFvBL2d7f6mFv237PtcSBojYW/5Z7QfQIuvOzPGg2R6bDgAg4i/rdtIV4A8I/Kv6/lMDWkJXQMH19fX1ycmTJ6/3Lhu8j2f84z/&#x2B;46k33HDDeWeddVavozw8m9Gkf2TkXpyZ0tVtLGfzW&#x2B;3pprqHF7YF0/NDQgD/LbM7Chhq20Dxrz6G7rQAU&#x2B;FvPCo64V8YdbtA/91ECRvCC23dWVqm3wvmIMDU7m/7AzDajgaN6urqar1if9XEiRPfS2&#x2B;bWsGCP8owv3Ks9tsCgKbcws8N&#x2B;V1O4Q&#x2B;gzSAAAGL&#x2B;Am8HswJ096sW/qYZAXFmBTghYUGcWQEF1z/&#x2B;&#x2B;ONrvMvHffv2PXz06NEn/&#x2B;AHP/hGjx49jhGGBqKShX8gmstM5s&#x2B;&#x2B;kDIt4CKO723hirltwF7jOf9ulANWww0bCkrlgBE4yGRqe8fRT&#x2B;hXwwC1aA1&#x2B;HAwyAt&#x2B;/o3xv6hf4fgDqv88UCKgllW1woG1yv/lw7Rgf0/T/y3HspwLYZgSYtv1LerZv375typQp81544YXVkydP/lxKO5&#x2B;/1GF&#x2B;Ubbui7qVn661X7fyL8JqPwAQAADNGQTEDAPoCmiGroD022XLlu3wLrseeOCBFT/5yU/6fe1rX&#x2B;vTr1&#x2B;/szp6eDaj7McHUYr1TFWYHdbnFLzcs0VlPhgo3HLPiV1/OP7l8URmYKD/gOIq369mSL6/DV/tDEgPInTECZ1yr07Ttx4xDV&#x2B;onhKg7hgQ/FlZj92GoYauZVCguV3CVN6lUm5g9oOb26JRf1qA/3q/vXv37n733XeXegX/0kcffXRNTU1NUipzPn&#x2B;cYX5tYbWfwh8AAQCA0sIAugJaflfAtm3bkj//&#x2B;c8XVFVVLRw6dOiRY8aM6T18&#x2B;PABx3oIA1D2GMA7JGSn9bu&#x2B;ToD8q9yU7eWLwsZjS0JzTrl6K2W1Xl31TqWCK/a&#x2B;rgRtDZ5933EL7j/wOAXfa2EgIMq2fmqtX3ClYey/6dSE/M4G9vP182GEfrXd//OKW/sFd2zQhx3qMEVTh0D6zdatW7c98MADU1544YV1ixYt2lXBgj9qe3&#x2B;cwt&#x2B;NEABEXe2PGgKIFLeFn63QZ6gfAAIAANF&#x2B;&#x2B;dMV0PJnBcycOXOzd9nqfTxr7Nixp1x55ZVnXnrpped36dKlK89mlCq37Z6TyBV82le/k68Y87fJF5DZeQFqAWka&#x2B;p8r1t3gsEDjIcl/n5r7KxhIGGMwn7ndPf9v1D6Ov3PBcGP/6r9bwrZ&#x2B;4acEiHKodUXNas2nahQGAtnb6U5HSB&#x2B;XVq5c&#x2B;eFbb7217P7771/06aef7q9gwR/W8h93tT9sgn/ULfxY7QcAAgCg9YYBLbArQAzFf0vsCjB9TdlnBYwfP/4j77J24MCB8/793//9ov79&#x2B;59&#x2B;7LHH9nCy1RsQ6/XfuK1f7qXqBIvJXLndeNK9r0rNFLbKufXZwjSVWcU3FdTq&#x2B;efiWAbq&#x2B;apw9WBjnUlgqY/UQYFhIYAuvIhQsWtPSfB/zhH9UMXC7QLt9V7&#x2B;e3cNyU3mEd3g&#x2B;2og4A921Pv3LqktW7ZsnTNnzqKHH3544fTp07ekgwApboBfnPb&#x2B;sGF&#x2B;Uc/xj7vab3s/LAQQibaFn2sp5tnCDwAIAIDKBwExw4BKdgXoPtdUXQEi0bYStJ0SELUrQC3yI3UNLFiwYOvw4cP/2rlz56o777yzz7Bhw04fOnTouYceemgnns2Iyr&#x2B;Cb5ri31C2ZnYC8BejlvV03&#x2B;4Bpi0ElR0FfO3xhefMu8E62z&#x2B;rIJtPZN66ptpXRLtdnz&#x2B;4UEOMOLW&#x2B;MTFQ0gM1ELDdhWm13h8G6M7NN4cZTkH96bpO6LddW1tbM3v27IXTpk1b/uijj67esWNHrTTtar&#x2B;trZ/Vfgp/AG39b5XmPp61lP0Yd931a3G6dhF3/wFxOh4ibjKVnuTTODyprk6czod5b&#x2B;vFrakRp1MncWu9tx2qRKqrxD14UJzq6sZtnurrvdt39K73fp9XVYu7b68cNnqUVA/oz7MNcbsC1ILf9r76OcfwtWqhL1KergBHed9R3ncM14WdImA6bSAsBEiU4/r0DgLf&#x2B;973zrziiivO7dmz54mEAQizb/9&#x2B;OXiwJjd7r1AisBuevzgNvJB9BX/2d6VpRT1/XfC&#x2B;crc1BgHB22e/KcdfvOfuQyn&#x2B;dd&#x2B;z4f5137/u36LuDmg8Whp&#x2B;cOqgQDWo0D1OlOGE0Q7b5p0Dsnbv3rXrk08&#x2B;XX/HHbe/lDkFqTna&#x2B;01Ff9RV/rBiP85qv/&#x2B;2piKf1X4Aba7uzP2OJQAgAABhQBnDAMfwVjSFvYi5CyAsGLBdEpZQQL0uSleAI8V3BYSFAGGBgDNmzJieP/nJT77Sv3//Lzkt6TcIWlwAcODAwcxUd7WV3vEVmo4kHDe37p8tHxPqbgEhY/QTCcd3v/lbmgpbW5FuLbZ9RwrHt3WgKQxQi3BT4BD1pWT9MiUE8Bf&#x2B;Yd9PpN0JIv&#x2B;9Unh9Mpms/&#x2B;STteteeumld59//vk18&#x2B;bN21FCwR9nmF&#x2B;Utv6oq/ylrvbrCn228ANAANBMOAUAaL4XflPOClDb&#x2B;Ss9K8DRfA&#x2B;6WQH&#x2B;jxMR3kadFaCbBRA2MNA6K&#x2B;C///u/1z7zzDPrhgwZcsQdd9xx3uDBg3uf4Ong4dkM/ys036rf&#x2B;FLITsN3spP/M8/8wMZ8vpPwncL&#x2B;9MJCN1NEp7ecawwBgjsEmFreda3yBYFAdpeAzDA&#x2B;xz8rIOLfK&#x2B;qQPmvXgaYg1x8zQ&#x2B;YGOIVDCk2nKeh&#x2B;vLbHidLB4D/cbtjw&#x2B;efLly9bM27cuHmvvfba5lQqpTu3v9SCv5RhfilLcR91tT/Kef5qoZ&#x2B;yFPms9gMAAQDQfoKAmGFA3FkBoinyRVOgmz4Xd1aAYwkfRJpmVkBYwR82MLDg9uk/4mfPnr3Fu0zr1KnTG2PGjDnlmmuu6XvhhReec/jhh3cVEToDqP995&#x2B;snAi/F3Ep9Q4Hpnz7vZopOp3BtXt3LLlvoKgMCE5nzDUy7BegK24Jz97PFspsKPJVd3525/lMClDmHgW4Hy24B6e0R1W0ETd&#x2B;z6bz9KAmBaT6AKZRQH183wd8fCGiCAHfjxi82PvLII9P&#x2B;9Kc/rfn0008PSHkG&#x2B;MUZ8BdniF/c4X7&#x2B;AMAUBqhfw2o/ABAAAAj7Q6QddgWI6LcSjNIVoJsZUPGugAMHDiQfe&#x2B;yx1d7lo&#x2B;7du0&#x2B;94447zvrud7/71eM9PJPbL0f8e8LnJ8mni//sTICCVXnXyYQAbuYUAF8MEOGkeNN8AN0k/9xdOuqWdiGFteHAY5xAmt1oQDkvv3BSf3CwobrKnt1qTxdgiC4osXyh/7HV4r8gHDENcVS&#x2B;z/Rl//79&#x2B;1asWLH65ZdfXnLfffctqampSZah4I8zwb&#x2B;YrfviDvczrfaXMtTPtRTwrlRwtZ/CHwABAIAWGQTEDANae1eAWviXuyvAdCpBMdsIBm6/bdu25C9/&#x2B;cuFTzzxxKp/&#x2B;Id/OOX6668ffMYZZ/RiaGC7fQUHXjq6U/iDr&#x2B;r8y0Ld494R8&#x2B;kA6iq0f/vA7AwCWy3v&#x2B;nciULbS066S&#x2B;5bj3YJ97STX3ZCbD5B&#x2B;39fpoGvHd6Rw20N/cV34PYefBmD82HGs/071tAnToMD091fr2bx586YXX3xx3sSJE9fMmDFjq5Q2wK&#x2B;UYX7FFv4i5tX/KCv/IuEt/6z2A0ALwxDADIYAosW/WEsfGiiiHwqou66pdhCwDQvUFf5RdxBwLIV&#x2B;k&#x2B;wg0K9fv8N/9KMfnXvBBRf07tWr16mJRIJZAe3Avn375cDBGs3rN/g7L19UNlbKhav4mc8HzmNXXpjp30&#x2B;Gijhs0F6U1nrtJH3lhrmUzjfKoOAIo4kYdSGDuRPAMGQw0nB&#x2B;c/tA2EBE3a4E6dX&#x2B;6dOnz580adLyp556aq0U17JfbHt/JVb73ZAAoKm28LOt9lP4A2hTdWfmuNRsj00HANBKlKErwNTvS1dAeboCAtcvWbJkx9ixY9/q1q3brKFDhx516623njdw4MA&#x2B;PXr0OEaYFdCWX6mZYtP3THUcX7HvKz8d3cBA8U30z67MO7m32WdOQ9FqmWAXHDyY/2NDXVUP2WSgsBNAWY53s3fiKAcR/305&#x2B;vkDajeAqRPAtr1epAn&#x2B;/iV9y4wANRDw/VPdrVu3bFuydOmq//jNb2YaVvtLHeAXpQOglHP8JSQAiLraHzUEsH1O95aiHwAIAACE/WFThlkBtiCgPcwKiNoVkCr2&#x2B;l27diVfffXVz73LRu/jl5944omLRowYMeToo48&#x2B;hmdyW&#x2B;Qor4hMoS/Bc9r9q/MN5/4nHOPQvmyrfsJx9IP7AjFfMJ/LDrDzt9TrAgFdvRxt5H9hguCkg4HsP9r3ylWDhkDxbzj1oHAmgPh&#x2B;boWZREGQoWtzMA1HUL6Xuvq6&#x2B;oXvL1w8e/bsD3/zm3sXea/lWinP&#x2B;fxR2/vjbN0XZ7W/2BV/kfKs9lP4AwABAIBSgoCYYUClugJ0gYH6Ne26KyB9&#x2B;d73vjfjuOOOmzdq1KiTvvvd7w7u1atXzyOOOOJIns1tNQpwM6vhjavkuuJfLWJ1H6elfOfs&#x2B;wtVbWpQeKwIfm9KJ4Bu1qA61V/fKp&#x2B;/A/92gf6rA8mjpctAFwjYggr/dZG7AApCkuD3UefZsnnzxtdff33h008/s&#x2B;Ltt2dszWzhV4n2/qjD/OIU/m6MAECktNV&#x2B;kdK28LMV&#x2B;mzhBwAEAACi/AHUzF0BrsTrCvAX7SLtpCvgiy&#x2B;&#x2B;SD744IOrvMvq9KyAf/qnf&#x2B;pz8cUX9z777LO/xDO5DbwW/cWuUvk2vEzTK/4dOmjP/8t2CWTr1PSH6e6AXACgDAjUDg209fSL&#x2B;Vz7sCCgYHifZqJ/w1vHCVZwmsewHaV0QxDVn1VhiOJo633jwEDNuQ/vzn/3/fHjn5z3&#x2B;OOPf1zhgj/qML9yTfAPm&#x2B;rPaj8AEAAAaO1BQMwwoDm7AlJKMNBcXQG24r&#x2B;iswJuu&#x2B;22OR07dpw/YMCAI&#x2B;66664hw4YNG9ypU6fOPJtbb/GfK&#x2B;CzH/sLTl8QIEp7u64Yz&#x2B;1DH3i1Ob4nf2OhrF2hV0fba4p/07BAW2nl2mo19TGzL0Zfl4B/TIIlqzCHBCFDDkNq/dw727Zu3bpq1aqPHn300fkTJ05cX1NTU19iwR&#x2B;lvT&#x2B;s0I9yjr9YggBTAGB7v9Kr/VEDAYp&#x2B;ACAAAFBqGEBXQMvvCkjvHT5nzpwtI0aMmDJq1KiFI0eOPP3rX//6uSeccMLxwtDAVsM/Bd8NvDqC56&#x2B;bqmv1nPdEIqGsdgeHBPq3D/TvHFCwd142hMh87Poez19Qq1sLWnKEgiAg0BVgODHfNSzNO4ZwQTegz/WfV2AIT2zSLf1LlixZMWXKlA&#x2B;ee&#x2B;65NatWrdoj8Vfwi2nvj9LW31JX&#x2B;22fi1rcs9oPAAQAAJoyCIgZBrTkroBsgR&#x2B;3KyAlxW0lGNYVEHsWgO36SZMmrfcuGzp16jTzm9/8Zs&#x2B;xY8cO6NOnTy8GB7aiFMD3jEy/5NLt&#x2B;4lsAZzpAtAW5/670axyh03tVwvlQFeApX4qnLwf95/sBN4qdx5ID3JdAL6jQ8OPy9UcVRz7v81fE9qGGqYfcsOGzz&#x2B;fM2f20gd&#x2B;/8B7c&#x2B;fM3V6hgj/qgL&#x2B;oq/5uSBBgK/bDVvv9txUxr/Cz2g8ABAAAWnsY0Aa6AvyP3Rq6AkwhgLEr4MCBA8nx48d/5F3W9unTp8uoUaNO9i7nDhgwoL/TkjazRU4qV9AHP5fwr7CrNY2mRd8fAGS7APyT79WXZu40gcAmBI7vBefmy3NLihAcTGjuAlC3EfTvGBA5fPDdiXo6gP/V3PBG2ZFAt2OAGmZk3k9t375960svvTT7nnvueXfz5k01Utnz&#x2B;U3t/ba2/rBVfttwP1sAYCv0We0HAAIAAO0xCIgZBtAVUHpXgC4kCO0KWL58&#x2B;S7vsuTee&#x2B;9devvtt585ZsyY8/r27XvGYYcd1oVnc0tinlbv&#x2B;gttXSHsr7KzxXgqlXvfX5TrtrZX6/ls0a8urBeM/tfMItAV1GoA4X/c4AvbtGOA5v7Ug4jre/Fb5gLYdgxI2717166lS5etev755xc&#x2B;9dQfP0qHaWUo&#x2B;OOu9kdZ9ReJ3vZvK/ajrPZH/VgshT&#x2B;r/QBAAACgrYQBbaArwH/fzdEVoCvudZ8LOzXAOktg3Lhxy73LqmHDhh01cuTIXldfffX5xx9//HFVVVXVPJubufx3XM1&#x2B;9W5ulVv34vFX746T2yuwsdhPr/6nQ4CGre50AwPTX&#x2B;cECubGt8GaTLsqX3ggKKjubefXa2b9FcwGsD1uwc9J9yL176SgKf6zj5FW41m/fv1nEyY8P&#x2B;fFF19cu3Dhwl0SbwW/nO39cab4F7PabwoD4oYAts9FLe5Z7QcAAgAArTkIiBkGtKSuAEeavytAt1uALjQIGxgY1hWQevPNNzd5ly0//OEP51999dXHjx07tv&#x2B;gQYPO6tGjx7GcItCSQgFH&#x2B;yy3dgH4K&#x2B;xsIKB9zTrajn519dzVvNwCnwnZOlB3fr26/Z66baC/WDfOJdCdEpE9aV/9PnVHDE99sj7pFfsf/Mtdd70&#x2B;c&#x2B;bMLRUs&#x2B;KMM8yul6LcFAHEuIuXZws8NOd5T&#x2B;AMAAQCAthYGtLGuAMcSALTaroBUKpWYOHHip97ls&#x2B;OOO&#x2B;7Nf/7nf&#x2B;7zgx/84LLDPYlEogPP5qZ83eSn9&#x2B;uK6PwLIdNO70j&#x2B;HPh0kW26U011nz9X3/9ljnFiv39dXnIFuSEECN4wEALYBgXGadvP3sA/zC&#x2B;wO0H2VAj1SCENcxVS27dt2zrznZkf/PGPf1z89owZmzNb&#x2B;BU7wK/UYX5Rtu6LupWfrrVft/Ivwmo/ACAmp7mPxS1lkWrXXb8Wp2sXcfcfEKfjIeImU&#x2B;m9grw/rb0/4urqxOl8mPe2XtyaGnE6dRK31nvboUqkukrcgwfFqa5uXKGpr/du39G7vlakqlrcfXvlsNGjpHpAf55taP0HjOJesE6E90UKB/ypX6u73on4sSkkUC8JzfUJzdeUY1aA6eOoXQHW67t27Vp10003nTlixIi&#x2B;gwYN&#x2B;lKnTp068wyuvD1798rBgzW5328p7/eILgzw/w50lAGBBSvtomwdaNgxwF&#x2B;k23/nukoIEHJqQMhjmsIBXUdANvxQAwHT4&#x2B;f&#x2B;XZmPa2oOHnjvvfcWT5s6bfnDDz&#x2B;8cu/ePfVSmfP54wzzawur/RT&#x2B;ANrD37Et5ntpzsMiAQABANAcQYCp0BdDkR/l83G6ApyYAYBoCvxiwoC4XQFRQwDj7b3is6p3796db7jhhjOvuuqqgSeddNLfEgZUzt59&#x2B;&#x2B;TAgYOBoti2au4oE/htLxhtMa5Zco8SAORv5uR2CSjoCDA9tmbngLDwwbRdoS0AyM0F8O53/YbP1r/41xfmPvnkEytWr169p76&#x2B;Plmhgj8VEgQUs9rvRggAoq72Rw0BRIrbws9W6DPUDwABAAEAAQABADiY0hUgraQrIP35K6644tjrrruuz6WXXjrwGA/P4PLydwCEFfv&#x2B;AXumkEA9DyasGI8eBPjzg&#x2B;AZO/kV&#x2B;uIe1/bYppsahgSmPv74o4&#x2B;mT5&#x2B;&#x2B;&#x2B;O67716we/fuWinP&#x2B;fxR2/srtdofZws/VvsBgACgrJgBAKDUA1hLnBUQJQwo56yAqDMCmmJWgPX6KVOmbPAuG3v06DHrgQce&#x2B;LtBgwb1PvHEE09I2PrUUdQvdsdwDr3t/ZgPYp/8F3Lf&#x2B;S93NS9OSy9AyMBAf7jh/4NL3a4wEET4TkfYtHHTF8uWLVs9bty4uXPmzN564MCBeol3Pn/Ur43S8h931T/uar9p5T9KCCASbQs/11LMs4UfALQzBAAAyhoExAwDKrWDgOlzUXcQ8IcEUXYQUAcGNvcOAqHXb9q0KXnttddO7dq16xvf&#x2B;c53Trn88st7X3TRRQPSgwN5NpciWPyqBbh/1V8NAXTPZtfwQgkU4/63SvGvvW/fvRQU4r6a3n9CQMGcAPVxNfMAdLmB8qW5x6vzvPfeex&#x2B;88cYby8c/&#x2B;eTqjRs3HpDKtffH3bovziq/bmWf1X4AAAEAgLYfBtAV0PK7Avbs2ZN88MEHV3mXNd26dZv64x//uO9ll13W78wzzzy1S5cuXXk2l/Q6CBT61oJfKdobn4BOpNSsoMouojU/&#x2B;O24mR0KHOXJrhkWWLDFYXCHAt3j5oMAR/bu3bPnlZdfeeff/u1Xcz/55JN9TVjwJ0MK/LDCXyxBgCkAsL1vCwFEwjsAbJ&#x2B;XGIEART8AtHHMAMhgBgBQ8dc6swLidQWYiv8mmxXws5/97OJBgwb1O/TQQzvxDI5mz970EMAD2uvSZ1n4w4Ds70A1FAjMCvBP6Xf0LxBts75pBH/E38NO7j6CuVx&#x2B;eJ9jng&#x2B;guX//3xrJZLL&#x2B;iy&#x2B;&#x2B;&#x2B;PyVV15&#x2B;9&#x2B;UpL6958803tpRQ8Jd7mF9Trfb7v0aELfwAoN3Unf7f&#x2B;c2BDgAATXWgoysgfleA7pSAppwV8OfevXu//POf//y8wYMHn&#x2B;E5rYOHZ3Npv&#x2B;yzIUB6i0BHs1ru/xo3d0Z&#x2B;hK36/E/wbOFv2DHA/7jmjEB31o2rTeB0j6H&#x2B;u7ds2bJp8eJFHz737LMLn3vuuXVS3Ap&#x2B;JVb7TWGARAgCbMV&#x2B;2Gq/ep0tCBBhtR8AQAAAoLUGATHDAGYFBAt921yAss4KWLly5a6xY8e&#x2B;1bFjx5l///d/f8LIkSPPvOSSSwZ18xAG6J&#x2B;EDf&#x2B;DXeVZqSmIsx0B2YLcFBqYThvIbZNnerKrtZthFoH2sfz3lZ1H0FDc&#x2B;x/PEEoEZyAklyxZsmzS5EnvvTxlyqfe82mvlGeAX5wBf2FD/Eyr&#x2B;1GG&#x2B;9kCAFb7AQAEAACg/pFJV0DFugJirfrbrq&#x2B;pqUk&#x2B;/fTTa73LukMOOeTNW2&#x2B;99YyxY8cO7devXx&#x2B;eycHa19HETv4ZALqCXh0OGBo0qDMFDC8Ox1ScKzsQ6LsQMl/mm9rval54uiCgrq6udunSpcuee&#x2B;7Zdx966KEPy1Twx5ngX8rWfVHb/U2r/aUM9XMtBbwrrPYDAAgAALSVICBmGNDSugLUYKAldAVEWfVXQ4DQroDa2trk/fffv&#x2B;zJJ59cff3115/iXQb069fvzPTQQKclnWDXPM/m/Gq5&#x2B;FbpQ7b6yxbhuu0B1dV62wBBx3G0gzB0xb9uYF/hrgX&#x2B;7zHzsW/rQP&#x2B;AwGR9sm6r57XXXpv3wgsvrJ42beomKX4Fv9T2/lILfzdCse9f1VdX&#x2B;FMRi37b56IW96z2AwAIAAC07jCgFXYFOJpAoiV0BYQV/GEDAY1dATt27Ej9/ve/X&#x2B;ldVvfs2bPTHXfc0e&#x2B;rX/1qX88ZVVVV1e34OZx/GmS65p1EcMVejaF0hb8aAqgdBKYwwLZLQOPpCW4wFMhW9pm3riaYaHzrCwFyOYIre/bs2TVn9uyF06ZNW/XYY4&#x2B;tlsqdz99Uq/1hAUBTbeHnhgSfFP4AAAIAAG0rCIgZBjRnV4BkCpYoXQHqbVOGQKKpuwJMIUBoV8Cnn36avPPOO&#x2B;d6hf&#x2B;7Q4cOPfKmm246&#x2B;&#x2B;tf//p5Rx999DHtuSvA9f7lCV2LvaMPAdT3o54S4H&#x2B;GNrTkK&#x2B;fy655YxhBAxBgw5E4F8OzevXvnpIkTp//2t79d/PHHH&#x2B;9tgoLfNswvWUThLyEBAKv9AAACAABoZWFAS&#x2B;0K8L&#x2B;f0IQC5eoK0BX/FesKqK&#x2B;vT82cOXOzd3nzxBNPnPPLX/5ywGWXXTbwBI&#x2B;ItPkgIFt8N66aNxbQrihT/V0nd2699llr6AzQFeTZkMD/&#x2B;OrtUrnHtr7ICt/XvNSSnmXLli1/a/qbS8aPH79y7dq1&#x2B;6Q85/NHbe8vZuu&#x2B;KKv9xa74i5RntZ/CHwBAAAAApj9k23FXgEj8boBiugKiDgw0dgWsX78&#x2B;eeONN87s2rXr3Msuu&#x2B;y4m2&#x2B;&#x2B;&#x2B;fw&#x2B;ffr0SncFtNXnZ/oMfP92f2qR7riZ/43pt7rleMf4vC&#x2B;YIeA/NUANAtTAwA2ZQWAr/tNF/6ZNmzbOmzdv8eOPPbpo7ty521KpVFLKez5/3Pb&#x2B;OIW/GyMAELGv9oeFACKlbeFnK/QZ6gcAIAAA0L6DgCLDgNbaFaCGApXuCoizjaAxMNizZ0/qz3/&#x2B;86fe5bNevXod9u1vf/u0yy&#x2B;/vN/ZZ5/dp6OnjT0vjQV5cBs9t3E&#x2B;gLrtniZ2MhXxasAQZ1ig&#x2B;IYFmnYLSG/hN2vWrPkvvvTikueefXbt7t27aytY8Ecd5leuCf5Rt/BjtR8A0KY4zf17oqWcGrrrrl&#x2B;L07WLuPsPiNPxEHGT3t8EqVR6o&#x2B;b0fkbidD7Me1svbk2NOJ06iVvrve1QJVJdJe7Bg&#x2B;JUVzf&#x2B;wVRf792&#x2B;o3e993dSVbW4&#x2B;/bKYaNHSfWA/jzbgMofT4o5oDgR3hdNAa9&#x2B;re56J8bHiZD3HSUcUIOCUroCHInWFRB2aoB6vfH2iUSiw2mnndb5nnvuGTxixIgLDz/88G5t4Tm4e89e2b9/f&#x2B;D3W9j0/4IYyYn9vNfOCjB1DJi&#x2B;p&#x2B;xndu7atfOjNavXjP/jH&#x2B;c98/TTn2RW&#x2B;0sp&#x2B;E23C/tc3HP8xRIEmAIA2/uVXu2PGgiE8v4fue1&#x2B;Aw4AaCV1Z8NBvhlrcDoAALQZdAWUtSvAtLtAqV0BDdd7BUvqww8/3DVmzJg3L7roog&#x2B;uvfba00eMGNEwK6C6urqV7yCgH6RnXaV3lT9OXEMMpfljJt8hkO/cj9IR4O8oqKurq12/bt36SZMmzXnllVc&#x2B;Wbjw/R0SfwW/3Kv9UVf9m2u13/a5qMV9WVb7WfQHABAAACAMkHYxK8CR1jErwHj9zJkzt3iXrbfddtu8kSNHHnfjjTcO6N&#x2B;//2knelptBBDYWc81TvPXtfU3fBwYBKidxxfYoi/7mLr71Z3/3/A5778NGzZ8tmzp0tUPP/zw/Bkz3trShAV/MqTAT0n0c/rjFPthq/3&#x2B;24qYV/ibbbWfoh8AQAAAACF/LBcZBpSjK0A0hb9I&#x2B;&#x2B;0KsF7/wgsvfOZdvvBq/07XXHPNSaNGjeo3dOjQAYd4WtFzLve/rfF9x1jo6wf3Nf7vDE7316RMmmGD2WBA/bwSCKTShf9//uf9L7/&#x2B;2mveuxsOSGXP5ze199va&#x2B;sNW&#x2B;W3D/WwBgK3Qb9Gr/ek2f47oAAACAACIGQY0cVeAeopAa&#x2B;0KSIh&#x2B;68CKdAWkdxAYN27cCu&#x2B;yavTo0XNuu&#x2B;22C/v3739mN08Lf5YFB/0phb26Sq8W7f7bub6J/I7kV&#x2B;2L3Uxx//79&#x2B;5YuXbpi2rSpSx5&#x2B;6KEVBw8eTEr5zucv19Z9SbGv8pd7tT/qxyLNtNrPSj8AgAAAAMoQBBQZBtAVYO4AKGrVP&#x2B;z6CRMmrPMuG84///y/ueKKK06&#x2B;9tprB/fs2fPETp6WWv/rZ/mZJ/yFDefLFv&#x2B;u03gfjv35nbuf2tqagxu/2PjFK6&#x2B;&#x2B;8u5fJkz4cNGiRbtSqVR9jCK&#x2B;XKv9cbfuK2a13xQGqF/T4lf76&#x2B;vr3UQiwcEaAEAAAACVCAPoCmj5XQHz5s3b5l2233333R9ceumlPcaMGXPWxRdf3O/kk0/u2WKeUE62hd97m1usd33zAPL/Wxwn/Xkn9Nz9XKt/ZuvAxvv2rnMd32MEY6Tdu3fvmvXOO&#x2B;&#x2B;&#x2B;9NKLK9JbMDZBwV&#x2B;Orftsbf&#x2B;mj5t6Cz835JhQUuGfTCYbCn/vLQdnAAABAABUOggoMgxwLH/sO0JXQNm7AqZNm/a5d9nUvXv32d/5zndO/dGPfjS8h6dhBwHT1LwmeSL5fpyu73&#x2B;iY9ssIvsczA8NzN5GN8Avd8eO8qH38ZYtWzauWLFi9d2//Jfpy5cv3y2lDfArdZhflK37om7lp2vt1638i8Rr&#x2B;bd9Tve2IkW/aUgkAAAEAADQRGFAGboC1Pd1xQJdASV0BWzbti35X//1X8u9y8qbb775tEsvvfT0Czp1Oe9vjjrqb6q&#x2B;dJY4TT47MPOjdIJVvesr2h3JDwZs/JLGLgD12RZWEGbDgdq62toPFi78YOY7Mz989A9/WLZ9&#x2B;/ZaKW4FvxzD/Fjtjyjd5s/RFgBAAAAALSwIKDIMKLYrQHc/dAVEuP7BBx9c5V1Wn3TU0W&#x2B;NOqP3KdcNvWhIr6GDTzzivHO7Vp10ovcVTdUV4Fv69/&#x2B;vcPz/E93g/2zfzgH&#x2B;LQRNRX&#x2B;dZ8OGDevmzp2z7OGHHvpg1apVe1KpVLJCBX8qJAgox2q/qeCPstofNQQQKW6oX9mK/rq6etff5QEAAAEAALTgMKAJugJ0QQFdAdGvd9Zt3bJ33NYtS8fNnrl8yAkndb&#x2B;q3zm9vnv9t77R/YIh3apO7SlFj9GP/lzxte27mdMCCiOhwIwA//9IzZaB/rtfu3btx48/9tgbjz76hw/Fvhof53z&#x2B;qO39cSb6x1ntj7OFXyVW&#x2B;yta&#x2B;KePH/X1nNcPACAAAIBWGQQUGQa09a6ApFKMl6srwBQChHUFOHM/W7fZu2x9Yv7spbcMufDcYUMu6H/qhUNPOvSsM6o79Dim7LMCXN8WfgVb&#x2B;/mDgOyncs&#x2B;l4P&#x2B;WxqeZk7nOla1bt29atXLFmj/9vz&#x2B;9&#x2B;/KUKZ/X1tbWS/wV/KSUb5hfnMLfjRkAmFb&#x2B;o4QAIqVt4Wcr9GMV/ulz&#x2B;9P/H1MpjpsAAAIAAGgzYQBdAYHVftcXGCSkPF0BYacGhHYFrN62dfcdU/46s9O0l&#x2B;dc1uuMvx153sDewy648Lxjzju3&#x2B;yF9z0o4XTpX6jniyxhc3xvfjzO7O4CTnRPQuOWfV0DWLV&#x2B;2dNnUaVMXvfDXv368evXqvVK59v5kzEI/ziq/qd1fpA2u9tfV1bGFHwCAAAAA2noQUGQY0Fa7AhxfYekv4kvtCij61ID02wN1dcmJK5d96l3WyX//8fVbz7/wzKsGnHd23yFDTjvm8kuO7HDUUWUt/vMhgGOpN4P/J3bu3LnttWlTZz/80MPvrVixfI9EG7xXjoI/bJhfWOEvliDAFADY3reFACLhHQC2z0uMQCBC0V&#x2B;bntogiUQHaRzFAAAAAQAAtJswgK6Agq4AJ6ToL3dXgOk2gcd4YN6s5d5lRb&#x2B;//Lnbv0y/8sK/G/aVQd3PP79bh5NPLG4Hgewiv2&#x2B;IX/apYA4CHKmvq6vfsWPH5jfeeGPuk088sWTJksU7xbzqHla8l3uYX1Ot9vu/RqQVbOF3sKbW7ZBI&#x2B;P6JAAAQAABAuw0CigwDWkNXgO5zUboCUkrR39RdAdqgYcnmjdu/Of7RKSdMev7NO4d8&#x2B;Zyh5w04s/9FF/c9tG/vqg7H/22sHQTUCf7Zp0IwCGj88e7evXtnegu/qVOnLnvyySfWWAptW/FeidV&#x2B;UxggEYIAW7EfttqvXmcLAkSaYbW/xiv6Ewmn4f9zimn&#x2B;AAACAACALgxo4V0BIvlW/yhdAbqOAkcKV/qbuyvAFgKoX&#x2B;98tmtn/Y&#x2B;mvvROxzdenXvxs08fde15g/t89fzzBx43ZPAxh/Xve4jTtWvkEKDx/3lhEFBTU7P/888/Xzd58qRZr7766qdLlyzZZSikbW34xQQCUSb6q19TzHA/WwDQilf7a9yE4wg1PwCAAAAAEDkIKDIMaIqugJTysaPcvyPRugISSoEftytAt5NA1K6AZMwQIKkLHWrq65Ovfbzmc&#x2B;/yhTz/9Jv/87zzT7v2ggsHXvTt6y&#x2B;oOu1USRx5hPV/VrYLwF8sum4qOW/uvHfuv///vjV79uxtEm1VPWwqf9T2fttE/2K38Iuz2l/KUD/XUsC7UsHV/traWjf7Uk0yzh8AQAAAACglDGgFXQFqQW/qCjANC4zTFRDlVICwrgDTNoJR7tP/1v/vcR55b96qJxYu&#x2B;PDv337r7f8xaOj5/QYP7H3MBUOOrT7peEftCsgP//MeNJVK7ty5c&#x2B;P8&#x2B;XMXPP300wtnvPXWVu9zthX0qK34xbT3l1r4uxGKff&#x2B;qvrrCn4pY9Ns&#x2B;F7W4L221/2CN65R5i0gAAAgAAIAgoKV3BYjoTwnQrf67Yu4KULsATKcBqF8TtysgEeO6sAAgEATUpZLOs4veX&#x2B;tdPjnqmc7V/zz4gn4Xnzugz3kXXTSwU9&#x2B;zDq06/VTvm2/88dXW1uxdvHjxu6&#x2B;//vrip/44fvWePXvqxd4SH6cgj1vol2O1PywAaKot/NyQcKykwv/AwYPuoR07ps/z5&#x2B;AEACAAAABUPgyocFeAGgKoXQHqbcrVFaD7&#x2B;rDTAOJ2Bdgm/8cJAQqKf/XftXXfvrp7pr82X6a/9u6QPz/z17EDz&#x2B;837MIvX5i8YFD1C7NnvT7uP//z/U2bNtUkk0lb0VtMCBCn0E8WUfhLSADQBlf7D7r19Umprq6WlEubPwCgbXPcZp5mQ4sdANgPkyV&#x2B;vRPhOtMOAE7I52wfR70kLB8nDEV4nILeOvTP8hjG4l/zc9H9bG0r2GEBQJTiP6ytvxyr/cWu&#x2B;IuUZ7W/ooV/kbcBAKBkzVmDEwAAQNsMAmzFv2P4WsfytU5IERw4Z16idwXECQUSls9Fbe9PiHnFP27x71h&#x2B;nrZt6tRV81JDgGLO8XdjBAD&#x2B;71V9P04IIFLcFn62Qj/uHzEU/QCAdh0AcAoAALSS3xVFhAFRZwX4CzDdrAAR&#x2B;&#x2B;kAlZoVoJsdEDZI0DYzIFVk8W8r/J0IP39bUVxMCFCOVX5Tu7/pe2K1HwCANoAOAABoxcfwEm/TnF0B6nWV6goIeytinwHgRPh3qj8f06A6tShOKe8XEwLEOac/rNhPWb43iRgCiETbws8N&#x2B;VmFBQIU/QCAVosOAABAUb8/iggDWkpXgLrS31RdAbqwICmG7f8sAYaI/RQAkfDTAMLa7aMU8y1ttd/2uajFPav9AABUCB0AANDGjusl3qYSXQG6602r65XsChDL19gep5j2f7EUxLZuAFuRHtYVYPtaW7Efttrvv62I/dQGU&#x2B;BhKsxZ7QcAtDsMAQQAtIQwoK3tIBCn4NcN/Qub/m/7&#x2B;UQZAhhl1T1uIBDldrYV/pSw2g8AAAEAAQAAtJsgQKTtdQWEFf5xJv87MX&#x2B;utvPjowQAUsZiP8pqf9SPTQGHqTBntR8AAGEGAACgwr9niggDmnpWgCvlmxXgL&#x2B;JTmsI&#x2B;JfYV/6REX/2PuguARCiuiwkCwj5nCgPUr2G1HwCAdoAOAABop8f/Em/T2roCbNdHeRxTEGD6GbiWMCDKLIA4q/lxBvlVYgs/N6RYp/AHAMD/i40OAABAU//uKSIMaO1dAWEr/7rgIaUJJkSinwbgWt4W0wlgCwBs78dp&#x2B;bd9TveWoh8AgFaCAAAA4BYZBKhhgKO5L1cp5tXbuZpiWlfcixTXFWD6/vxhQCrkfsM6GeIEAFEKcLcCl6iPK8JqPwAABAAAgHYTBBQbBpg0V1eAZIp83fuO5v7jDv5zivj5hA0EzH6cihEGZEOMsABB91im78n2eYp&#x2B;AAAIAAAAbTAMcIq8TUvpCjDdLhEzAFCDAIkQBESZAxAnACil0C9mtZ/CHwAAAgAAQDsMAuKEAS2pK8B0nr8r4Sv&#x2B;ajgRd/s/3c8lbCZAnKI/agggUtoWfm6EUIOiHwAAAgAAQBsMA1pTV4Ba8Mcp9ssZANhW1otZvWe1HwAAEAAAAJosCIhTDDdnV4Du4zjn&#x2B;8ed/G/7GUQJAEop&#x2B;kVKW&#x2B;2PGghQ9AMAQAAAAGinYUBL6woQib/SbzrXvxzt/yLxugCiFP1xPxe1uGe1HwAAAgAAACIVfS2hK0D9nCkYcEOK/CjFvxPj3xYlBBCJtrJf6iT/qIEART8AAAQAAABYi8GW1BUgljBARL/qLyHFfylBR5Tz8qOEA2H3EVbcs9oPAAABAAAAZQsCSi2WTYV31K4AUxighgJRCn8n5r/Jjfixa7guzqq&#x2B;7b6iBgIU/QAAtGGO6zbv73HHcfi/AADt6PdOibcJK8BNK/pRrotb9BcTaoS147sRbsNqPwAArVhz1uB0AAAAmvR3XokFdFhIoBa56laAus/bvjfTKQnl&#x2B;hmEFe7FFP0U/gAAgAAAANAiw4CmmBVgCwNEzKv/riFokAjfu1vE56IGAravoegHAAAEAACAFh0ExAkDiukKcMV8vr8pEFDfd8XcNRD3e3ZD7iNK0U/hDwAACAAAAK06DCi1KyAsDLAFAmFFsVPivy3suihFfNROAIp&#x2B;AABAAAAAaBVBQJyCW71NWBhgCgTEEgqUOgfAjflxpYp&#x2B;Cn8AAAgAAABosWFAMV0BUYp2J0Jh7YQUzWGzA4opvksJCyj6AQAAAQAAoNUHAZUMAypZ0Me9vVvGx6HwBwAABAAAgFYdBjhF3i5uIBAlJCi2&#x2B;HZLuC1FPwAAIAAAALSrIKCYMMBUJEcNBWwhRHMO4qPwBwAABAAAAMKAMhfQYWGB2wz/dgAAAAIAAABhQBsqvCn6AQAAAQAAACGFstMG/g0AAAAEAAAAlFhQOy3s&#x2B;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" />
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>